_unit_id,_created_at,_id,_started_at,_tainted,_channel,_trust,_worker_id,_country,_region,_city,_ip,relations,step_1_select_the_valid_relations,step_2a_copy__paste_only_the_words_from_the_sentence_that_express_the_relation_you_selected_in_step1,step_2b_if_you_selected_none_in_step_1_explain_why,b1,b2,baselinedec,e1,e2,rel-type,sent_id,sentence,term1,term2
724352386,5/21/2015 08:54:21,1640184245,5/21/2015 08:53:38,false,prodege,1,16101132,GBR,G1,Hounslow,90.207.88.197,[OTHER],[OTHER],failure,Failure,124,214,1,135,225,TWrex-cause,812625-FS1,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, HEPATOMEGALY in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD TYPE II",HEPATOMEGALY,GSD TYPE II
724352386,5/21/2015 08:56:42,1640185337,5/21/2015 08:55:59,false,prodege,1,22031444,GBR,B7,Bristol,92.236.71.128,[SYMPTOM],[SYMPTOM],"substrate accumulation within the organ cells (eg, HEPATOMEGALY in hepatic forms of GSD TYPE II",N/A,124,214,1,135,225,TWrex-cause,812625-FS1,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, HEPATOMEGALY in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD TYPE II",HEPATOMEGALY,GSD TYPE II
724352386,5/21/2015 08:58:41,1640186265,5/21/2015 08:57:34,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, HEPATOMEGALY in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD TYPE II",n/a,124,214,1,135,225,TWrex-cause,812625-FS1,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, HEPATOMEGALY in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD TYPE II",HEPATOMEGALY,GSD TYPE II
724352386,5/21/2015 09:01:31,1640187813,5/21/2015 09:00:13,false,clixsense,1,22947672,GBR,"","",88.144.127.68,[CAUSES] [ASSOCIATED_WITH] [SIDE_EFFECT],"[CAUSES]
[ASSOCIATED_WITH]
[SIDE_EFFECT]","Organomegaly may resulting in substrate accumulation within the organ cells (e<span id=""transmark""></span>g, HEPATOMEGALY in hepatic forms of GSD and GSD TYPE II",n/a,124,214,1,135,225,TWrex-cause,812625-FS1,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, HEPATOMEGALY in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD TYPE II",HEPATOMEGALY,GSD TYPE II
724352386,5/21/2015 09:02:44,1640188427,5/21/2015 09:02:17,false,neodev,1,28630436,USA,DE,Wilmington,162.223.93.178,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",a of,N/A,124,214,1,135,225,TWrex-cause,812625-FS1,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, HEPATOMEGALY in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD TYPE II",HEPATOMEGALY,GSD TYPE II
724352386,5/21/2015 09:11:37,1640193063,5/21/2015 09:11:15,false,elite,1,32732290,GBR,A7,Birmingham,86.147.79.250,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",in hepatic forms of,N/A,124,214,1,135,225,TWrex-cause,812625-FS1,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, HEPATOMEGALY in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD TYPE II",HEPATOMEGALY,GSD TYPE II
724352386,5/21/2015 09:13:06,1640193841,5/21/2015 09:12:26,false,neodev,1,15848372,AUS,02,Jannali,14.200.59.55,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",in hepatic forms of in,N/A,124,214,1,135,225,TWrex-cause,812625-FS1,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, HEPATOMEGALY in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD TYPE II",HEPATOMEGALY,GSD TYPE II
724352386,5/21/2015 09:35:37,1640205098,5/21/2015 09:35:22,false,elite,1,30654968,USA,OR,Portland,67.213.218.73,[SYMPTOM],[SYMPTOM],storage,N/A,124,214,1,135,225,TWrex-cause,812625-FS1,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, HEPATOMEGALY in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD TYPE II",HEPATOMEGALY,GSD TYPE II
724352386,5/21/2015 09:46:34,1640210323,5/21/2015 09:46:23,false,elite,1,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],cardiomegaly,N/A,124,214,1,135,225,TWrex-cause,812625-FS1,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, HEPATOMEGALY in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD TYPE II",HEPATOMEGALY,GSD TYPE II
724352386,5/21/2015 10:14:33,1640224257,5/21/2015 10:14:19,false,elite,1,31685662,USA,VA,Manassas,207.244.89.77,[ASSOCIATED_WITH],[ASSOCIATED_WITH],forms,N/A,124,214,1,135,225,TWrex-cause,812625-FS1,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, HEPATOMEGALY in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD TYPE II",HEPATOMEGALY,GSD TYPE II
724352386,5/21/2015 10:15:00,1640224448,5/21/2015 10:13:46,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],HEPATOMEGALY GSD TYPE II,N/A,124,214,1,135,225,TWrex-cause,812625-FS1,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, HEPATOMEGALY in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD TYPE II",HEPATOMEGALY,GSD TYPE II
724352386,5/21/2015 10:27:26,1640230211,5/21/2015 10:27:14,false,zoombucks,1,4711962,CAN,ON,Markham,174.88.29.12,[CAUSES],[CAUSES],GSD,none,124,214,1,135,225,TWrex-cause,812625-FS1,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, HEPATOMEGALY in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD TYPE II",HEPATOMEGALY,GSD TYPE II
724352386,5/21/2015 10:31:44,1640232214,5/21/2015 10:31:33,false,elite,1,30655282,USA,AZ,Tempe,23.235.227.109,[SIDE_EFFECT],[SIDE_EFFECT],forms,N/A,124,214,1,135,225,TWrex-cause,812625-FS1,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, HEPATOMEGALY in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD TYPE II",HEPATOMEGALY,GSD TYPE II
724352386,5/21/2015 10:39:50,1640236239,5/21/2015 10:39:04,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,[PART_OF],[PART_OF],in hepatic forms of,n/a,124,214,1,135,225,TWrex-cause,812625-FS1,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, HEPATOMEGALY in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD TYPE II",HEPATOMEGALY,GSD TYPE II
724352386,5/21/2015 10:45:42,1640239466,5/21/2015 10:43:53,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],"(eg,",N/A,124,214,1,135,225,TWrex-cause,812625-FS1,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, HEPATOMEGALY in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD TYPE II",HEPATOMEGALY,GSD TYPE II
724352387,5/21/2015 07:02:46,1640124595,5/21/2015 07:02:31,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,[CAUSES],[CAUSES],DEFICIENCY causes syndrome of HEREDITARY FRUCTOSE INTOLERANCE,n/a,61,104,1,70,135,TWrex-cause,814093-FS1,Fructose 1 phosphate aldolase (aldolase B) deficiency:  This DEFICIENCY causes the clinical syndrome of HEREDITARY FRUCTOSE INTOLERANCE,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE
724352387,5/21/2015 07:10:19,1640128696,5/21/2015 07:10:07,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],causes,N/A,61,104,1,70,135,TWrex-cause,814093-FS1,Fructose 1 phosphate aldolase (aldolase B) deficiency:  This DEFICIENCY causes the clinical syndrome of HEREDITARY FRUCTOSE INTOLERANCE,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE
724352387,5/21/2015 07:10:50,1640128989,5/21/2015 07:10:38,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],causes,N/A,61,104,1,70,135,TWrex-cause,814093-FS1,Fructose 1 phosphate aldolase (aldolase B) deficiency:  This DEFICIENCY causes the clinical syndrome of HEREDITARY FRUCTOSE INTOLERANCE,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE
724352387,5/21/2015 07:15:12,1640131350,5/21/2015 07:14:50,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[CAUSES] [PART_OF],"[CAUSES]
[PART_OF]",causes of,N/A,61,104,1,70,135,TWrex-cause,814093-FS1,Fructose 1 phosphate aldolase (aldolase B) deficiency:  This DEFICIENCY causes the clinical syndrome of HEREDITARY FRUCTOSE INTOLERANCE,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE
724352387,5/21/2015 07:24:35,1640136555,5/21/2015 07:24:14,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CAUSES],[CAUSES],causes,N/A,61,104,1,70,135,TWrex-cause,814093-FS1,Fructose 1 phosphate aldolase (aldolase B) deficiency:  This DEFICIENCY causes the clinical syndrome of HEREDITARY FRUCTOSE INTOLERANCE,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE
724352387,5/21/2015 07:27:03,1640137846,5/21/2015 07:26:33,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],causes the clinical syndrome of,N/A,61,104,1,70,135,TWrex-cause,814093-FS1,Fructose 1 phosphate aldolase (aldolase B) deficiency:  This DEFICIENCY causes the clinical syndrome of HEREDITARY FRUCTOSE INTOLERANCE,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE
724352387,5/21/2015 07:38:12,1640143739,5/21/2015 07:37:47,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[CAUSES] [PART_OF],"[CAUSES]
[PART_OF]",causes of,N/A,61,104,1,70,135,TWrex-cause,814093-FS1,Fructose 1 phosphate aldolase (aldolase B) deficiency:  This DEFICIENCY causes the clinical syndrome of HEREDITARY FRUCTOSE INTOLERANCE,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE
724352387,5/21/2015 07:39:37,1640144457,5/21/2015 07:39:24,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],causes,N/A,61,104,1,70,135,TWrex-cause,814093-FS1,Fructose 1 phosphate aldolase (aldolase B) deficiency:  This DEFICIENCY causes the clinical syndrome of HEREDITARY FRUCTOSE INTOLERANCE,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE
724352387,5/21/2015 07:42:28,1640145982,5/21/2015 07:42:13,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],causes,n/a,61,104,1,70,135,TWrex-cause,814093-FS1,Fructose 1 phosphate aldolase (aldolase B) deficiency:  This DEFICIENCY causes the clinical syndrome of HEREDITARY FRUCTOSE INTOLERANCE,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE
724352387,5/21/2015 07:57:27,1640153960,5/21/2015 07:56:51,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[CAUSES] [PART_OF],"[CAUSES]
[PART_OF]",causes of,N/A,61,104,1,70,135,TWrex-cause,814093-FS1,Fructose 1 phosphate aldolase (aldolase B) deficiency:  This DEFICIENCY causes the clinical syndrome of HEREDITARY FRUCTOSE INTOLERANCE,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE
724352387,5/21/2015 07:59:50,1640155299,5/21/2015 07:59:29,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CAUSES],[CAUSES],causes,N/A,61,104,1,70,135,TWrex-cause,814093-FS1,Fructose 1 phosphate aldolase (aldolase B) deficiency:  This DEFICIENCY causes the clinical syndrome of HEREDITARY FRUCTOSE INTOLERANCE,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE
724352387,5/21/2015 08:03:43,1640157278,5/21/2015 08:03:30,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,[CAUSES],[CAUSES],causes,-,61,104,1,70,135,TWrex-cause,814093-FS1,Fructose 1 phosphate aldolase (aldolase B) deficiency:  This DEFICIENCY causes the clinical syndrome of HEREDITARY FRUCTOSE INTOLERANCE,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE
724352387,5/21/2015 08:28:33,1640170744,5/21/2015 08:28:14,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[CAUSES],[CAUSES],DEFICIENCY causes HEREDITARY FRUCTOSE INTOLERANCE,n/a,61,104,1,70,135,TWrex-cause,814093-FS1,Fructose 1 phosphate aldolase (aldolase B) deficiency:  This DEFICIENCY causes the clinical syndrome of HEREDITARY FRUCTOSE INTOLERANCE,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE
724352387,5/21/2015 08:32:43,1640173166,5/21/2015 08:32:22,false,bitcoinget,1,30546513,GBR,G6,Hull,194.42.67.50,[CAUSES],[CAUSES],causes,N/A,61,104,1,70,135,TWrex-cause,814093-FS1,Fructose 1 phosphate aldolase (aldolase B) deficiency:  This DEFICIENCY causes the clinical syndrome of HEREDITARY FRUCTOSE INTOLERANCE,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE
724352387,5/21/2015 08:33:55,1640173802,5/21/2015 08:33:06,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[CAUSES] [ASSOCIATED_WITH],"[CAUSES]
[ASSOCIATED_WITH]","(aldolase B) DEFICIENCY causes HEREDITARY FRUCTOSE INTOLE<span id=""transmark""></span>RANCE",n/a,61,104,1,70,135,TWrex-cause,814093-FS1,Fructose 1 phosphate aldolase (aldolase B) deficiency:  This DEFICIENCY causes the clinical syndrome of HEREDITARY FRUCTOSE INTOLERANCE,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE
724352388,5/21/2015 11:14:42,1640253129,5/21/2015 11:13:57,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],caused by,N/A,30,59,1,39,74,TWrex-cause,812472-FS1,164  Babesiosis  Treatment of BABESIOSIS   +    caused by  BABESIA MICROTI.,BABESIOSIS,BABESIA MICROTI
724352388,5/21/2015 11:17:31,1640254235,5/21/2015 11:17:13,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[CAUSES] [TREATS],"[TREATS]
[CAUSES]",Treatment caused,n/a,30,59,1,39,74,TWrex-cause,812472-FS1,164  Babesiosis  Treatment of BABESIOSIS   +    caused by  BABESIA MICROTI.,BABESIOSIS,BABESIA MICROTI
724352388,5/21/2015 11:28:10,1640258694,5/21/2015 11:27:58,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[CAUSES],[CAUSES],caused,N/A,30,59,1,39,74,TWrex-cause,812472-FS1,164  Babesiosis  Treatment of BABESIOSIS   +    caused by  BABESIA MICROTI.,BABESIOSIS,BABESIA MICROTI
724352388,5/21/2015 11:37:33,1640262978,5/21/2015 11:37:23,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],caused,n/a,30,59,1,39,74,TWrex-cause,812472-FS1,164  Babesiosis  Treatment of BABESIOSIS   +    caused by  BABESIA MICROTI.,BABESIOSIS,BABESIA MICROTI
724352388,5/21/2015 11:50:30,1640268977,5/21/2015 11:49:20,false,prodege,1.0,12656479,CAN,NB,Fredericton,198.164.157.90,[CAUSES],[CAUSES],caused,N/A,30,59,1,39,74,TWrex-cause,812472-FS1,164  Babesiosis  Treatment of BABESIOSIS   +    caused by  BABESIA MICROTI.,BABESIOSIS,BABESIA MICROTI
724352388,5/21/2015 12:17:21,1640280881,5/21/2015 12:17:11,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],Treatment,N/A,30,59,1,39,74,TWrex-cause,812472-FS1,164  Babesiosis  Treatment of BABESIOSIS   +    caused by  BABESIA MICROTI.,BABESIOSIS,BABESIA MICROTI
724352388,5/21/2015 13:15:10,1640306078,5/21/2015 13:14:34,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],BABESIA MICROTI.,N/A,30,59,1,39,74,TWrex-cause,812472-FS1,164  Babesiosis  Treatment of BABESIOSIS   +    caused by  BABESIA MICROTI.,BABESIOSIS,BABESIA MICROTI
724352388,5/21/2015 13:28:52,1640313047,5/21/2015 13:27:27,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused,N/A,30,59,1,39,74,TWrex-cause,812472-FS1,164  Babesiosis  Treatment of BABESIOSIS   +    caused by  BABESIA MICROTI.,BABESIOSIS,BABESIA MICROTI
724352388,5/21/2015 13:32:21,1640314799,5/21/2015 13:31:38,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],BABESIOSIS caused by BABESIA MICROTI.,N/A,30,59,1,39,74,TWrex-cause,812472-FS1,164  Babesiosis  Treatment of BABESIOSIS   +    caused by  BABESIA MICROTI.,BABESIOSIS,BABESIA MICROTI
724352388,5/21/2015 14:20:27,1640342365,5/21/2015 14:19:53,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],caused by,N/A,30,59,1,39,74,TWrex-cause,812472-FS1,164  Babesiosis  Treatment of BABESIOSIS   +    caused by  BABESIA MICROTI.,BABESIOSIS,BABESIA MICROTI
724352388,5/21/2015 14:22:49,1640343634,5/21/2015 14:22:38,false,neodev,1.0,32103286,GBR,H9,London,193.109.196.83,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",NO,NO,30,59,1,39,74,TWrex-cause,812472-FS1,164  Babesiosis  Treatment of BABESIOSIS   +    caused by  BABESIA MICROTI.,BABESIOSIS,BABESIA MICROTI
724352388,5/21/2015 14:22:48,1640343637,5/21/2015 14:22:39,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[CAUSES],[CAUSES],caused,N/A,30,59,1,39,74,TWrex-cause,812472-FS1,164  Babesiosis  Treatment of BABESIOSIS   +    caused by  BABESIA MICROTI.,BABESIOSIS,BABESIA MICROTI
724352388,5/21/2015 14:24:33,1640344936,5/21/2015 14:24:19,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[CAUSES],[CAUSES],caused by,N/A,30,59,1,39,74,TWrex-cause,812472-FS1,164  Babesiosis  Treatment of BABESIOSIS   +    caused by  BABESIA MICROTI.,BABESIOSIS,BABESIA MICROTI
724352388,5/21/2015 14:25:00,1640345168,5/21/2015 14:24:32,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[CAUSES],[CAUSES],caused by,n/a,30,59,1,39,74,TWrex-cause,812472-FS1,164  Babesiosis  Treatment of BABESIOSIS   +    caused by  BABESIA MICROTI.,BABESIOSIS,BABESIA MICROTI
724352388,5/21/2015 14:26:19,1640346010,5/21/2015 14:26:04,false,neodev,1,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],Treatment,N/A,30,59,1,39,74,TWrex-cause,812472-FS1,164  Babesiosis  Treatment of BABESIOSIS   +    caused by  BABESIA MICROTI.,BABESIOSIS,BABESIA MICROTI
724352389,5/21/2015 06:58:14,1640122203,5/21/2015 06:57:10,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,[NONE],[NONE],n/a,states that dexamethasone is a test done to screen for cushing's syndrome,77,14,-1,94,27,TWrex-cause,803004-FS1,The overnight DEXAMETHASONE test is the procedure of choice in screening for CUSHING'S SYNDROME,CUSHING'S SYNDROME,DEXAMETHASONE
724352389,5/21/2015 07:01:05,1640123793,5/21/2015 06:59:28,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],procedure in screening,N/A,77,14,-1,94,27,TWrex-cause,803004-FS1,The overnight DEXAMETHASONE test is the procedure of choice in screening for CUSHING'S SYNDROME,CUSHING'S SYNDROME,DEXAMETHASONE
724352389,5/21/2015 07:07:44,1640127246,5/21/2015 07:07:32,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],screening,N/A,77,14,-1,94,27,TWrex-cause,803004-FS1,The overnight DEXAMETHASONE test is the procedure of choice in screening for CUSHING'S SYNDROME,CUSHING'S SYNDROME,DEXAMETHASONE
724352389,5/21/2015 07:08:41,1640127780,5/21/2015 07:08:12,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]
[PART_OF]",is of for,N/A,77,14,-1,94,27,TWrex-cause,803004-FS1,The overnight DEXAMETHASONE test is the procedure of choice in screening for CUSHING'S SYNDROME,CUSHING'S SYNDROME,DEXAMETHASONE
724352389,5/21/2015 07:16:43,1640132247,5/21/2015 07:15:34,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],test of choice in screening for,N/A,77,14,-1,94,27,TWrex-cause,803004-FS1,The overnight DEXAMETHASONE test is the procedure of choice in screening for CUSHING'S SYNDROME,CUSHING'S SYNDROME,DEXAMETHASONE
724352389,5/21/2015 07:16:55,1640132328,5/21/2015 07:16:17,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],screening for,N/A,77,14,-1,94,27,TWrex-cause,803004-FS1,The overnight DEXAMETHASONE test is the procedure of choice in screening for CUSHING'S SYNDROME,CUSHING'S SYNDROME,DEXAMETHASONE
724352389,5/21/2015 07:30:53,1640139926,5/21/2015 07:30:29,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",is of,N/A,77,14,-1,94,27,TWrex-cause,803004-FS1,The overnight DEXAMETHASONE test is the procedure of choice in screening for CUSHING'S SYNDROME,CUSHING'S SYNDROME,DEXAMETHASONE
724352389,5/21/2015 07:34:31,1640141703,5/21/2015 07:34:12,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],screening for,N/A,77,14,-1,94,27,TWrex-cause,803004-FS1,The overnight DEXAMETHASONE test is the procedure of choice in screening for CUSHING'S SYNDROME,CUSHING'S SYNDROME,DEXAMETHASONE
724352389,5/21/2015 07:37:09,1640143091,5/21/2015 07:36:53,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],screening,www.toptal.com › Blog,77,14,-1,94,27,TWrex-cause,803004-FS1,The overnight DEXAMETHASONE test is the procedure of choice in screening for CUSHING'S SYNDROME,CUSHING'S SYNDROME,DEXAMETHASONE
724352389,5/21/2015 07:49:56,1640149803,5/21/2015 07:49:43,false,elite,1,31913360,GBR,"","",88.150.133.60,[CAUSES],[CAUSES],screening,fgdgg,77,14,-1,94,27,TWrex-cause,803004-FS1,The overnight DEXAMETHASONE test is the procedure of choice in screening for CUSHING'S SYNDROME,CUSHING'S SYNDROME,DEXAMETHASONE
724352389,5/21/2015 07:51:22,1640150617,5/21/2015 07:51:00,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",is of,N/A,77,14,-1,94,27,TWrex-cause,803004-FS1,The overnight DEXAMETHASONE test is the procedure of choice in screening for CUSHING'S SYNDROME,CUSHING'S SYNDROME,DEXAMETHASONE
724352389,5/21/2015 07:52:01,1640151067,5/21/2015 07:51:38,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],test,N/A,77,14,-1,94,27,TWrex-cause,803004-FS1,The overnight DEXAMETHASONE test is the procedure of choice in screening for CUSHING'S SYNDROME,CUSHING'S SYNDROME,DEXAMETHASONE
724352389,5/21/2015 07:56:01,1640153316,5/21/2015 07:55:03,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,[OTHER],[OTHER],test,-,77,14,-1,94,27,TWrex-cause,803004-FS1,The overnight DEXAMETHASONE test is the procedure of choice in screening for CUSHING'S SYNDROME,CUSHING'S SYNDROME,DEXAMETHASONE
724352389,5/21/2015 08:10:06,1640160639,5/21/2015 08:09:42,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[IS_A] [PART_OF] [SYMPTOM],"[SYMPTOM]
[IS_A]
[PART_OF]",is of SYNDROME,N/A,77,14,-1,94,27,TWrex-cause,803004-FS1,The overnight DEXAMETHASONE test is the procedure of choice in screening for CUSHING'S SYNDROME,CUSHING'S SYNDROME,DEXAMETHASONE
724352389,5/21/2015 08:17:11,1640164533,5/21/2015 08:16:33,false,clixsense,1.0,12843982,AUS,08,Perth,180.216.79.226,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],DEXAMETHASONE test screening for CUSHING'S SYNDROME,N/A,77,14,-1,94,27,TWrex-cause,803004-FS1,The overnight DEXAMETHASONE test is the procedure of choice in screening for CUSHING'S SYNDROME,CUSHING'S SYNDROME,DEXAMETHASONE
724352390,5/21/2015 09:00:52,1640187504,5/21/2015 09:00:09,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[OTHER],[OTHER],and then separate from,N/A,133,105,-1,159,127,TWrex-cause,804612-FS1,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate IRON DEFICIENCY ANEMIA from NON IRON DEFICIENCY ANEMIAS",NON IRON DEFICIENCY ANEMIAS,IRON DEFICIENCY ANEMIA
724352390,5/21/2015 09:05:25,1640189764,5/21/2015 09:04:48,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate IRON DEFICIENCY ANEMIA from NON IRON DEFICIENCY ANEMIAS",n/a,133,105,-1,159,127,TWrex-cause,804612-FS1,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate IRON DEFICIENCY ANEMIA from NON IRON DEFICIENCY ANEMIAS",NON IRON DEFICIENCY ANEMIAS,IRON DEFICIENCY ANEMIA
724352390,5/21/2015 09:18:25,1640196449,5/21/2015 09:18:03,false,neodev,1.0,15848372,AUS,02,Jannali,14.200.59.55,[OTHER],[OTHER],then separate from,N/A,133,105,-1,159,127,TWrex-cause,804612-FS1,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate IRON DEFICIENCY ANEMIA from NON IRON DEFICIENCY ANEMIAS",NON IRON DEFICIENCY ANEMIAS,IRON DEFICIENCY ANEMIA
724352390,5/21/2015 09:37:28,1640205978,5/21/2015 09:37:15,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],from,N/A,133,105,-1,159,127,TWrex-cause,804612-FS1,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate IRON DEFICIENCY ANEMIA from NON IRON DEFICIENCY ANEMIAS",NON IRON DEFICIENCY ANEMIAS,IRON DEFICIENCY ANEMIA
724352390,5/21/2015 09:48:29,1640211156,5/21/2015 09:48:18,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[LOCATION],[LOCATION],from,N/A,133,105,-1,159,127,TWrex-cause,804612-FS1,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate IRON DEFICIENCY ANEMIA from NON IRON DEFICIENCY ANEMIAS",NON IRON DEFICIENCY ANEMIAS,IRON DEFICIENCY ANEMIA
724352390,5/21/2015 10:16:55,1640225276,5/21/2015 10:16:44,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[PART_OF],[PART_OF],from,N/A,133,105,-1,159,127,TWrex-cause,804612-FS1,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate IRON DEFICIENCY ANEMIA from NON IRON DEFICIENCY ANEMIAS",NON IRON DEFICIENCY ANEMIAS,IRON DEFICIENCY ANEMIA
724352390,5/21/2015 10:23:49,1640228743,5/21/2015 10:23:06,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],IRON DEFICIENCY ANEMIA from NON IRON DEFICIENCY ANEMIAS,N/A,133,105,-1,159,127,TWrex-cause,804612-FS1,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate IRON DEFICIENCY ANEMIA from NON IRON DEFICIENCY ANEMIAS",NON IRON DEFICIENCY ANEMIAS,IRON DEFICIENCY ANEMIA
724352390,5/21/2015 10:29:55,1640231383,5/21/2015 10:29:37,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[CAUSES],[CAUSES],IRON DEFICIENCY ANEMIA,none,133,105,-1,159,127,TWrex-cause,804612-FS1,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate IRON DEFICIENCY ANEMIA from NON IRON DEFICIENCY ANEMIAS",NON IRON DEFICIENCY ANEMIAS,IRON DEFICIENCY ANEMIA
724352390,5/21/2015 10:33:43,1640233195,5/21/2015 10:33:28,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[SIDE_EFFECT],[SIDE_EFFECT],from,N/A,133,105,-1,159,127,TWrex-cause,804612-FS1,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate IRON DEFICIENCY ANEMIA from NON IRON DEFICIENCY ANEMIAS",NON IRON DEFICIENCY ANEMIAS,IRON DEFICIENCY ANEMIA
724352390,5/21/2015 10:44:11,1640238674,5/21/2015 10:43:33,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[NONE],[NONE],n/a,two types,133,105,-1,159,127,TWrex-cause,804612-FS1,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate IRON DEFICIENCY ANEMIA from NON IRON DEFICIENCY ANEMIAS",NON IRON DEFICIENCY ANEMIAS,IRON DEFICIENCY ANEMIA
724352390,5/21/2015 10:53:35,1640243633,5/21/2015 10:52:38,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and then separate,N/A,133,105,-1,159,127,TWrex-cause,804612-FS1,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate IRON DEFICIENCY ANEMIA from NON IRON DEFICIENCY ANEMIAS",NON IRON DEFICIENCY ANEMIAS,IRON DEFICIENCY ANEMIA
724352390,5/21/2015 10:54:13,1640243960,5/21/2015 10:53:25,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],separate from,N/A,133,105,-1,159,127,TWrex-cause,804612-FS1,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate IRON DEFICIENCY ANEMIA from NON IRON DEFICIENCY ANEMIAS",NON IRON DEFICIENCY ANEMIAS,IRON DEFICIENCY ANEMIA
724352390,5/21/2015 10:55:32,1640244588,5/21/2015 10:54:30,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],determining,n/a,133,105,-1,159,127,TWrex-cause,804612-FS1,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate IRON DEFICIENCY ANEMIA from NON IRON DEFICIENCY ANEMIAS",NON IRON DEFICIENCY ANEMIAS,IRON DEFICIENCY ANEMIA
724352390,5/21/2015 11:13:54,1640252723,5/21/2015 11:13:31,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[CAUSES],[CAUSES],from,N/A,133,105,-1,159,127,TWrex-cause,804612-FS1,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate IRON DEFICIENCY ANEMIA from NON IRON DEFICIENCY ANEMIAS",NON IRON DEFICIENCY ANEMIAS,IRON DEFICIENCY ANEMIA
724352390,5/21/2015 11:30:02,1640259596,5/21/2015 11:29:40,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],from,n/a,133,105,-1,159,127,TWrex-cause,804612-FS1,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate IRON DEFICIENCY ANEMIA from NON IRON DEFICIENCY ANEMIAS",NON IRON DEFICIENCY ANEMIAS,IRON DEFICIENCY ANEMIA
724352391,5/21/2015 07:05:49,1640126125,5/21/2015 07:05:31,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,[NONE],[NONE],n/a,does not show any relation in the sentence,36,0,-1,44,28,TWrex-cause,803249-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
724352391,5/21/2015 07:12:52,1640130085,5/21/2015 07:12:42,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],THERAPY,N/A,36,0,-1,44,28,TWrex-cause,803249-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
724352391,5/21/2015 07:17:44,1640132759,5/21/2015 07:16:49,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[OTHER],[OTHER],during,N/A,36,0,-1,44,28,TWrex-cause,803249-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
724352391,5/21/2015 07:20:06,1640134221,5/21/2015 07:19:15,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PREVENTS],[PREVENTS],PREGNANCY,N/A,36,0,-1,44,28,TWrex-cause,803249-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
724352391,5/21/2015 07:31:07,1640140080,5/21/2015 07:30:15,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[ASSOCIATED_WITH],[ASSOCIATED_WITH],during,N/A,36,0,-1,44,28,TWrex-cause,803249-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
724352391,5/21/2015 07:33:27,1640141230,5/21/2015 07:31:54,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[NONE],[NONE],N/A,It's not in any context.,36,0,-1,44,28,TWrex-cause,803249-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
724352391,5/21/2015 07:43:09,1640146219,5/21/2015 07:42:04,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PREVENTS],[PREVENTS],REPLACEMENT,N/A,36,0,-1,44,28,TWrex-cause,803249-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
724352391,5/21/2015 07:44:39,1640147079,5/21/2015 07:44:22,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],THERAPY during,N/A,36,0,-1,44,28,TWrex-cause,803249-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
724352391,5/21/2015 07:45:12,1640147378,5/21/2015 07:44:51,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],during,n/a,36,0,-1,44,28,TWrex-cause,803249-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
724352391,5/21/2015 08:01:48,1640156212,5/21/2015 08:00:51,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[TREATS],[TREATS],THERAPY,N/A,36,0,-1,44,28,TWrex-cause,803249-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
724352391,5/21/2015 08:04:07,1640157434,5/21/2015 08:03:39,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[OTHER],[OTHER],during,N/A,36,0,-1,44,28,TWrex-cause,803249-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
724352391,5/21/2015 08:18:53,1640165454,5/21/2015 08:18:33,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,[TREATS],[TREATS],THERAPY,-,36,0,-1,44,28,TWrex-cause,803249-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
724352391,5/21/2015 08:33:19,1640173470,5/21/2015 08:32:54,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[ASSOCIATED_WITH],[ASSOCIATED_WITH],NICOTINE REPLACEMENT THERAPY PREGNANCY,n/a,36,0,-1,44,28,TWrex-cause,803249-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
724352391,5/21/2015 08:40:11,1640177031,5/21/2015 08:39:43,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[ASSOCIATED_WITH] [OTHER] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]
[OTHER]","NICOTINE REPLACEMENT THERAPY during PREGN<span id=""transmark""></span>ANCY",n/a,36,0,-1,44,28,TWrex-cause,803249-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
724352391,5/21/2015 08:45:35,1640179681,5/21/2015 08:42:40,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[LOCATION],[LOCATION],PREGNANCY,N/A,36,0,-1,44,28,TWrex-cause,803249-FS1,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY
724352392,5/21/2015 08:55:09,1640184630,5/21/2015 08:54:47,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,[TREATS],[TREATS],Treatment,Treatment,49,116,-1,67,148,TWrex-cause,803921-FS1,"Glaspy JA, Souza L, Scates S et al. Treatment of HAIRY CELL LEUKEMIA with granulocyte colony stimulating factor and RECOMBINANT CONSENSUS INTERFERON or recombinant interferon alpha 2b.",HAIRY CELL LEUKEMIA,RECOMBINANT CONSENSUS INTERFERON
724352392,5/21/2015 08:57:31,1640185678,5/21/2015 08:57:16,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[TREATS],[TREATS],Treatment of with,N/A,49,116,-1,67,148,TWrex-cause,803921-FS1,"Glaspy JA, Souza L, Scates S et al. Treatment of HAIRY CELL LEUKEMIA with granulocyte colony stimulating factor and RECOMBINANT CONSENSUS INTERFERON or recombinant interferon alpha 2b.",HAIRY CELL LEUKEMIA,RECOMBINANT CONSENSUS INTERFERON
724352392,5/21/2015 09:00:08,1640187104,5/21/2015 08:59:25,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Treatment of HAIRY CELL LEUKEMIA with granulocyte colony stimulating factor and RECOMBINANT CONSENSUS INTERFERON or recombinant interferon alpha 2b.,n/a,49,116,-1,67,148,TWrex-cause,803921-FS1,"Glaspy JA, Souza L, Scates S et al. Treatment of HAIRY CELL LEUKEMIA with granulocyte colony stimulating factor and RECOMBINANT CONSENSUS INTERFERON or recombinant interferon alpha 2b.",HAIRY CELL LEUKEMIA,RECOMBINANT CONSENSUS INTERFERON
724352392,5/21/2015 09:02:57,1640188546,5/21/2015 09:02:01,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],"Treatment of HAIRY CELL LEUKEMIA with RECOMBINANT INTER<span id=""transmark""></span>FERON",n/a,49,116,-1,67,148,TWrex-cause,803921-FS1,"Glaspy JA, Souza L, Scates S et al. Treatment of HAIRY CELL LEUKEMIA with granulocyte colony stimulating factor and RECOMBINANT CONSENSUS INTERFERON or recombinant interferon alpha 2b.",HAIRY CELL LEUKEMIA,RECOMBINANT CONSENSUS INTERFERON
724352392,5/21/2015 09:03:49,1640188979,5/21/2015 09:03:19,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[PART_OF] [ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[PART_OF]",of with or,N/A,49,116,-1,67,148,TWrex-cause,803921-FS1,"Glaspy JA, Souza L, Scates S et al. Treatment of HAIRY CELL LEUKEMIA with granulocyte colony stimulating factor and RECOMBINANT CONSENSUS INTERFERON or recombinant interferon alpha 2b.",HAIRY CELL LEUKEMIA,RECOMBINANT CONSENSUS INTERFERON
724352392,5/21/2015 09:12:22,1640193415,5/21/2015 09:12:06,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],Treatment of,N/A,49,116,-1,67,148,TWrex-cause,803921-FS1,"Glaspy JA, Souza L, Scates S et al. Treatment of HAIRY CELL LEUKEMIA with granulocyte colony stimulating factor and RECOMBINANT CONSENSUS INTERFERON or recombinant interferon alpha 2b.",HAIRY CELL LEUKEMIA,RECOMBINANT CONSENSUS INTERFERON
724352392,5/21/2015 09:14:46,1640194735,5/21/2015 09:13:35,false,neodev,1.0,15848372,AUS,02,Jannali,14.200.59.55,[OTHER],[OTHER],Treatment with,N/A,49,116,-1,67,148,TWrex-cause,803921-FS1,"Glaspy JA, Souza L, Scates S et al. Treatment of HAIRY CELL LEUKEMIA with granulocyte colony stimulating factor and RECOMBINANT CONSENSUS INTERFERON or recombinant interferon alpha 2b.",HAIRY CELL LEUKEMIA,RECOMBINANT CONSENSUS INTERFERON
724352392,5/21/2015 09:36:04,1640205305,5/21/2015 09:35:52,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],Treatment,N/A,49,116,-1,67,148,TWrex-cause,803921-FS1,"Glaspy JA, Souza L, Scates S et al. Treatment of HAIRY CELL LEUKEMIA with granulocyte colony stimulating factor and RECOMBINANT CONSENSUS INTERFERON or recombinant interferon alpha 2b.",HAIRY CELL LEUKEMIA,RECOMBINANT CONSENSUS INTERFERON
724352392,5/21/2015 09:47:07,1640210538,5/21/2015 09:46:52,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],Treatment,N/A,49,116,-1,67,148,TWrex-cause,803921-FS1,"Glaspy JA, Souza L, Scates S et al. Treatment of HAIRY CELL LEUKEMIA with granulocyte colony stimulating factor and RECOMBINANT CONSENSUS INTERFERON or recombinant interferon alpha 2b.",HAIRY CELL LEUKEMIA,RECOMBINANT CONSENSUS INTERFERON
724352392,5/21/2015 10:15:09,1640224503,5/21/2015 10:14:56,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],Treatment,N/A,49,116,-1,67,148,TWrex-cause,803921-FS1,"Glaspy JA, Souza L, Scates S et al. Treatment of HAIRY CELL LEUKEMIA with granulocyte colony stimulating factor and RECOMBINANT CONSENSUS INTERFERON or recombinant interferon alpha 2b.",HAIRY CELL LEUKEMIA,RECOMBINANT CONSENSUS INTERFERON
724352392,5/21/2015 10:16:55,1640225275,5/21/2015 10:16:02,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],Treatment of HAIRY CELL LEUKEMIA with RECOMBINANT CONSENSUS INTERFERON,N/A,49,116,-1,67,148,TWrex-cause,803921-FS1,"Glaspy JA, Souza L, Scates S et al. Treatment of HAIRY CELL LEUKEMIA with granulocyte colony stimulating factor and RECOMBINANT CONSENSUS INTERFERON or recombinant interferon alpha 2b.",HAIRY CELL LEUKEMIA,RECOMBINANT CONSENSUS INTERFERON
724352392,5/21/2015 10:28:03,1640230542,5/21/2015 10:27:45,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[CAUSES],[CAUSES],HAIRY CELL LEUKEMIA,none,49,116,-1,67,148,TWrex-cause,803921-FS1,"Glaspy JA, Souza L, Scates S et al. Treatment of HAIRY CELL LEUKEMIA with granulocyte colony stimulating factor and RECOMBINANT CONSENSUS INTERFERON or recombinant interferon alpha 2b.",HAIRY CELL LEUKEMIA,RECOMBINANT CONSENSUS INTERFERON
724352392,5/21/2015 10:32:13,1640232507,5/21/2015 10:32:00,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],Treatment,N/A,49,116,-1,67,148,TWrex-cause,803921-FS1,"Glaspy JA, Souza L, Scates S et al. Treatment of HAIRY CELL LEUKEMIA with granulocyte colony stimulating factor and RECOMBINANT CONSENSUS INTERFERON or recombinant interferon alpha 2b.",HAIRY CELL LEUKEMIA,RECOMBINANT CONSENSUS INTERFERON
724352392,5/21/2015 10:40:42,1640236761,5/21/2015 10:40:24,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],Treatment of with,n/a,49,116,-1,67,148,TWrex-cause,803921-FS1,"Glaspy JA, Souza L, Scates S et al. Treatment of HAIRY CELL LEUKEMIA with granulocyte colony stimulating factor and RECOMBINANT CONSENSUS INTERFERON or recombinant interferon alpha 2b.",HAIRY CELL LEUKEMIA,RECOMBINANT CONSENSUS INTERFERON
724352392,5/21/2015 10:46:08,1640239690,5/21/2015 10:45:45,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],Treatment of,N/A,49,116,-1,67,148,TWrex-cause,803921-FS1,"Glaspy JA, Souza L, Scates S et al. Treatment of HAIRY CELL LEUKEMIA with granulocyte colony stimulating factor and RECOMBINANT CONSENSUS INTERFERON or recombinant interferon alpha 2b.",HAIRY CELL LEUKEMIA,RECOMBINANT CONSENSUS INTERFERON
724352393,5/21/2015 08:56:32,1640185241,5/21/2015 08:55:51,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,[CONTRAINDICATES],[CONTRAINDICATES],not,Contraindicates,253,336,-1,259,349,TWrex-cause,800137-FS1,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for GIARDIA because there are underlying risks in current therapies.[28] For instance, METRONIDAZOLE is rapidly absorbed and easily enters fetal circulation.",GIARDIA,METRONIDAZOLE
724352393,5/21/2015 08:58:38,1640186226,5/21/2015 08:58:00,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[CONTRAINDICATES],[CONTRAINDICATES],"advised not to receive treatment for GIARDIA For instance, METRONIDAZOLE is rapidly absorbed and easily enters fetal circulation.",N/A,253,336,-1,259,349,TWrex-cause,800137-FS1,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for GIARDIA because there are underlying risks in current therapies.[28] For instance, METRONIDAZOLE is rapidly absorbed and easily enters fetal circulation.",GIARDIA,METRONIDAZOLE
724352393,5/21/2015 09:02:25,1640188264,5/21/2015 09:01:06,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG] [SYMPTOM] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[SYMPTOM]","It also interferes with glucose uptake of the organism.[28] [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation Pregnant patients who are infected but asymptomatic are advised not to receive treatment for GIARDIA because there are underlying risks in current therapies.[28] For instance, METRONIDAZOLE is rapidly absorbed and easily enters fetal circulation.",n/a,253,336,-1,259,349,TWrex-cause,800137-FS1,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for GIARDIA because there are underlying risks in current therapies.[28] For instance, METRONIDAZOLE is rapidly absorbed and easily enters fetal circulation.",GIARDIA,METRONIDAZOLE
724352393,5/21/2015 09:14:46,1640194739,5/21/2015 09:14:05,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[CONTRAINDICATES],[CONTRAINDICATES],"underlying risks in current therapies.[28] For instance,",N/A,253,336,-1,259,349,TWrex-cause,800137-FS1,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for GIARDIA because there are underlying risks in current therapies.[28] For instance, METRONIDAZOLE is rapidly absorbed and easily enters fetal circulation.",GIARDIA,METRONIDAZOLE
724352393,5/21/2015 09:16:25,1640195522,5/21/2015 09:15:54,false,neodev,1.0,15848372,AUS,02,Jannali,14.200.59.55,[CONTRAINDICATES],[CONTRAINDICATES],not receive,N/A,253,336,-1,259,349,TWrex-cause,800137-FS1,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for GIARDIA because there are underlying risks in current therapies.[28] For instance, METRONIDAZOLE is rapidly absorbed and easily enters fetal circulation.",GIARDIA,METRONIDAZOLE
724352393,5/21/2015 09:36:30,1640205483,5/21/2015 09:36:20,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[CAUSES],[CAUSES],because,N/A,253,336,-1,259,349,TWrex-cause,800137-FS1,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for GIARDIA because there are underlying risks in current therapies.[28] For instance, METRONIDAZOLE is rapidly absorbed and easily enters fetal circulation.",GIARDIA,METRONIDAZOLE
724352393,5/21/2015 09:47:35,1640210757,5/21/2015 09:47:21,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],because,N/A,253,336,-1,259,349,TWrex-cause,800137-FS1,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for GIARDIA because there are underlying risks in current therapies.[28] For instance, METRONIDAZOLE is rapidly absorbed and easily enters fetal circulation.",GIARDIA,METRONIDAZOLE
724352393,5/21/2015 10:15:41,1640224756,5/21/2015 10:15:25,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[CAUSES],[CAUSES],because,N/A,253,336,-1,259,349,TWrex-cause,800137-FS1,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for GIARDIA because there are underlying risks in current therapies.[28] For instance, METRONIDAZOLE is rapidly absorbed and easily enters fetal circulation.",GIARDIA,METRONIDAZOLE
724352393,5/21/2015 10:19:38,1640226814,5/21/2015 10:18:27,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],GIARDIA METRONIDAZOLE rapidly absorbed,N/A,253,336,-1,259,349,TWrex-cause,800137-FS1,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for GIARDIA because there are underlying risks in current therapies.[28] For instance, METRONIDAZOLE is rapidly absorbed and easily enters fetal circulation.",GIARDIA,METRONIDAZOLE
724352393,5/21/2015 10:28:40,1640230809,5/21/2015 10:28:25,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[TREATS],[TREATS],METRONIDAZOLE,none,253,336,-1,259,349,TWrex-cause,800137-FS1,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for GIARDIA because there are underlying risks in current therapies.[28] For instance, METRONIDAZOLE is rapidly absorbed and easily enters fetal circulation.",GIARDIA,METRONIDAZOLE
724352393,5/21/2015 10:32:42,1640232721,5/21/2015 10:32:29,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[CAUSES],[CAUSES],because,N/A,253,336,-1,259,349,TWrex-cause,800137-FS1,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for GIARDIA because there are underlying risks in current therapies.[28] For instance, METRONIDAZOLE is rapidly absorbed and easily enters fetal circulation.",GIARDIA,METRONIDAZOLE
724352393,5/21/2015 10:41:48,1640237326,5/21/2015 10:41:26,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],current therapies.[28],n/a,253,336,-1,259,349,TWrex-cause,800137-FS1,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for GIARDIA because there are underlying risks in current therapies.[28] For instance, METRONIDAZOLE is rapidly absorbed and easily enters fetal circulation.",GIARDIA,METRONIDAZOLE
724352393,5/21/2015 10:49:28,1640241485,5/21/2015 10:48:00,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],"because there are underlying risks in current therapies.[28] For instance, METRONIDAZOLE",N/A,253,336,-1,259,349,TWrex-cause,800137-FS1,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for GIARDIA because there are underlying risks in current therapies.[28] For instance, METRONIDAZOLE is rapidly absorbed and easily enters fetal circulation.",GIARDIA,METRONIDAZOLE
724352393,5/21/2015 10:50:02,1640241827,5/21/2015 10:49:07,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CONTRAINDICATES],[CONTRAINDICATES],not to receive treatment for,N/A,253,336,-1,259,349,TWrex-cause,800137-FS1,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for GIARDIA because there are underlying risks in current therapies.[28] For instance, METRONIDAZOLE is rapidly absorbed and easily enters fetal circulation.",GIARDIA,METRONIDAZOLE
724352393,5/21/2015 10:50:42,1640242146,5/21/2015 10:48:40,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[ASSOCIATED_WITH] [TREATS] [SYMPTOM],"[TREATS]
[SYMPTOM]
[ASSOCIATED_WITH]",with therapy asymptomatic,n/a,253,336,-1,259,349,TWrex-cause,800137-FS1,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for GIARDIA because there are underlying risks in current therapies.[28] For instance, METRONIDAZOLE is rapidly absorbed and easily enters fetal circulation.",GIARDIA,METRONIDAZOLE
724352394,5/21/2015 07:02:59,1640124723,5/21/2015 07:02:48,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,[TREATS],[TREATS],MALATHION treatment HEAD LICE,n/a,27,0,-1,35,9,TWrex-cause,804184-FS1,MALATHION for treatment of HEAD LICE,HEAD LICE,MALATHION
724352394,5/21/2015 07:10:36,1640128841,5/21/2015 07:10:21,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment,N/A,27,0,-1,35,9,TWrex-cause,804184-FS1,MALATHION for treatment of HEAD LICE,HEAD LICE,MALATHION
724352394,5/21/2015 07:11:02,1640129096,5/21/2015 07:10:52,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,27,0,-1,35,9,TWrex-cause,804184-FS1,MALATHION for treatment of HEAD LICE,HEAD LICE,MALATHION
724352394,5/21/2015 07:15:38,1640131592,5/21/2015 07:15:15,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF],[PART_OF],of,N/A,27,0,-1,35,9,TWrex-cause,804184-FS1,MALATHION for treatment of HEAD LICE,HEAD LICE,MALATHION
724352394,5/21/2015 07:24:55,1640136775,5/21/2015 07:24:36,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],for treatment of,N/A,27,0,-1,35,9,TWrex-cause,804184-FS1,MALATHION for treatment of HEAD LICE,HEAD LICE,MALATHION
724352394,5/21/2015 07:27:35,1640138027,5/21/2015 07:27:05,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],treatment of,N/A,27,0,-1,35,9,TWrex-cause,804184-FS1,MALATHION for treatment of HEAD LICE,HEAD LICE,MALATHION
724352394,5/21/2015 07:38:36,1640143883,5/21/2015 07:38:15,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF],[PART_OF],of,N/A,27,0,-1,35,9,TWrex-cause,804184-FS1,MALATHION for treatment of HEAD LICE,HEAD LICE,MALATHION
724352394,5/21/2015 07:40:04,1640144700,5/21/2015 07:39:38,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],treatment,N/A,27,0,-1,35,9,TWrex-cause,804184-FS1,MALATHION for treatment of HEAD LICE,HEAD LICE,MALATHION
724352394,5/21/2015 07:42:45,1640146053,5/21/2015 07:42:29,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment,n/a,27,0,-1,35,9,TWrex-cause,804184-FS1,MALATHION for treatment of HEAD LICE,HEAD LICE,MALATHION
724352394,5/21/2015 07:57:48,1640154156,5/21/2015 07:57:30,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF],[PART_OF],of,N/A,27,0,-1,35,9,TWrex-cause,804184-FS1,MALATHION for treatment of HEAD LICE,HEAD LICE,MALATHION
724352394,5/21/2015 08:00:09,1640155409,5/21/2015 07:59:51,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],treatment of,N/A,27,0,-1,35,9,TWrex-cause,804184-FS1,MALATHION for treatment of HEAD LICE,HEAD LICE,MALATHION
724352394,5/21/2015 08:04:09,1640157439,5/21/2015 08:03:44,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,[TREATS],[TREATS],treatment,-,27,0,-1,35,9,TWrex-cause,804184-FS1,MALATHION for treatment of HEAD LICE,HEAD LICE,MALATHION
724352394,5/21/2015 08:28:49,1640170878,5/21/2015 08:28:36,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[TREATS],[TREATS],MALATHION treatment HEAD LICE,n/a,27,0,-1,35,9,TWrex-cause,804184-FS1,MALATHION for treatment of HEAD LICE,HEAD LICE,MALATHION
724352394,5/21/2015 08:32:54,1640173245,5/21/2015 08:32:45,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[TREATS],[TREATS],treatment,N/A,27,0,-1,35,9,TWrex-cause,804184-FS1,MALATHION for treatment of HEAD LICE,HEAD LICE,MALATHION
724352394,5/21/2015 08:34:21,1640173984,5/21/2015 08:33:57,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],"MALATHION treatment of HEAD LIC<span id=""transmark""></span>E",n/a,27,0,-1,35,9,TWrex-cause,804184-FS1,MALATHION for treatment of HEAD LICE,HEAD LICE,MALATHION
724352395,5/21/2015 09:01:44,1640187901,5/21/2015 09:01:26,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[CAUSES],[CAUSES],conditions that cause include,N/A,28,103,1,39,118,TWrex-cause,814020-FS1,"Other conditions that cause PANCYTOPENIA include hypoplastic myelodysplastic syndrome, acute leukemia, MEGALOBLASTOSIS and large granular lymphocytic leukemia.",PANCYTOPENIA,MEGALOBLASTOSIS
724352395,5/21/2015 09:19:15,1640196842,5/21/2015 09:19:02,false,neodev,1.0,15848372,AUS,02,Jannali,14.200.59.55,[PART_OF],[PART_OF],include,N/A,28,103,1,39,118,TWrex-cause,814020-FS1,"Other conditions that cause PANCYTOPENIA include hypoplastic myelodysplastic syndrome, acute leukemia, MEGALOBLASTOSIS and large granular lymphocytic leukemia.",PANCYTOPENIA,MEGALOBLASTOSIS
724352395,5/21/2015 09:38:20,1640206258,5/21/2015 09:37:55,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],include,N/A,28,103,1,39,118,TWrex-cause,814020-FS1,"Other conditions that cause PANCYTOPENIA include hypoplastic myelodysplastic syndrome, acute leukemia, MEGALOBLASTOSIS and large granular lymphocytic leukemia.",PANCYTOPENIA,MEGALOBLASTOSIS
724352395,5/21/2015 09:49:11,1640211480,5/21/2015 09:48:58,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],"syndrome,",N/A,28,103,1,39,118,TWrex-cause,814020-FS1,"Other conditions that cause PANCYTOPENIA include hypoplastic myelodysplastic syndrome, acute leukemia, MEGALOBLASTOSIS and large granular lymphocytic leukemia.",PANCYTOPENIA,MEGALOBLASTOSIS
724352395,5/21/2015 10:17:39,1640225712,5/21/2015 10:17:27,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[ASSOCIATED_WITH],[ASSOCIATED_WITH],include,N/A,28,103,1,39,118,TWrex-cause,814020-FS1,"Other conditions that cause PANCYTOPENIA include hypoplastic myelodysplastic syndrome, acute leukemia, MEGALOBLASTOSIS and large granular lymphocytic leukemia.",PANCYTOPENIA,MEGALOBLASTOSIS
724352395,5/21/2015 10:25:31,1640229412,5/21/2015 10:24:57,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],cause PANCYTOPENIA include MEGALOBLASTOSIS,N/A,28,103,1,39,118,TWrex-cause,814020-FS1,"Other conditions that cause PANCYTOPENIA include hypoplastic myelodysplastic syndrome, acute leukemia, MEGALOBLASTOSIS and large granular lymphocytic leukemia.",PANCYTOPENIA,MEGALOBLASTOSIS
724352395,5/21/2015 10:30:41,1640231680,5/21/2015 10:30:26,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],MEGALOBLASTOSIS,none,28,103,1,39,118,TWrex-cause,814020-FS1,"Other conditions that cause PANCYTOPENIA include hypoplastic myelodysplastic syndrome, acute leukemia, MEGALOBLASTOSIS and large granular lymphocytic leukemia.",PANCYTOPENIA,MEGALOBLASTOSIS
724352395,5/21/2015 10:36:35,1640234632,5/21/2015 10:36:24,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[ASSOCIATED_WITH],[ASSOCIATED_WITH],include,N/A,28,103,1,39,118,TWrex-cause,814020-FS1,"Other conditions that cause PANCYTOPENIA include hypoplastic myelodysplastic syndrome, acute leukemia, MEGALOBLASTOSIS and large granular lymphocytic leukemia.",PANCYTOPENIA,MEGALOBLASTOSIS
724352395,5/21/2015 10:45:23,1640239360,5/21/2015 10:44:55,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],conditions that cause,n/a,28,103,1,39,118,TWrex-cause,814020-FS1,"Other conditions that cause PANCYTOPENIA include hypoplastic myelodysplastic syndrome, acute leukemia, MEGALOBLASTOSIS and large granular lymphocytic leukemia.",PANCYTOPENIA,MEGALOBLASTOSIS
724352395,5/21/2015 10:55:10,1640244417,5/21/2015 10:54:43,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],that cause,N/A,28,103,1,39,118,TWrex-cause,814020-FS1,"Other conditions that cause PANCYTOPENIA include hypoplastic myelodysplastic syndrome, acute leukemia, MEGALOBLASTOSIS and large granular lymphocytic leukemia.",PANCYTOPENIA,MEGALOBLASTOSIS
724352395,5/21/2015 10:55:38,1640244636,5/21/2015 10:55:17,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],conditions that cause,N/A,28,103,1,39,118,TWrex-cause,814020-FS1,"Other conditions that cause PANCYTOPENIA include hypoplastic myelodysplastic syndrome, acute leukemia, MEGALOBLASTOSIS and large granular lymphocytic leukemia.",PANCYTOPENIA,MEGALOBLASTOSIS
724352395,5/21/2015 10:58:02,1640245745,5/21/2015 10:57:05,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[CAUSES] [ASSOCIATED_WITH],"[CAUSES]
[ASSOCIATED_WITH]",cause include,n/a,28,103,1,39,118,TWrex-cause,814020-FS1,"Other conditions that cause PANCYTOPENIA include hypoplastic myelodysplastic syndrome, acute leukemia, MEGALOBLASTOSIS and large granular lymphocytic leukemia.",PANCYTOPENIA,MEGALOBLASTOSIS
724352395,5/21/2015 11:16:28,1640253703,5/21/2015 11:16:15,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[PART_OF],[PART_OF],include,N/A,28,103,1,39,118,TWrex-cause,814020-FS1,"Other conditions that cause PANCYTOPENIA include hypoplastic myelodysplastic syndrome, acute leukemia, MEGALOBLASTOSIS and large granular lymphocytic leukemia.",PANCYTOPENIA,MEGALOBLASTOSIS
724352395,5/21/2015 11:30:53,1640259980,5/21/2015 11:30:37,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],cause,n/a,28,103,1,39,118,TWrex-cause,814020-FS1,"Other conditions that cause PANCYTOPENIA include hypoplastic myelodysplastic syndrome, acute leukemia, MEGALOBLASTOSIS and large granular lymphocytic leukemia.",PANCYTOPENIA,MEGALOBLASTOSIS
724352395,5/21/2015 11:33:39,1640261181,5/21/2015 11:32:42,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,[OTHER],[OTHER],cause,caused by,28,103,1,39,118,TWrex-cause,814020-FS1,"Other conditions that cause PANCYTOPENIA include hypoplastic myelodysplastic syndrome, acute leukemia, MEGALOBLASTOSIS and large granular lymphocytic leukemia.",PANCYTOPENIA,MEGALOBLASTOSIS
724352396,5/21/2015 07:02:09,1640124324,5/21/2015 07:01:36,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,[ASSOCIATED_WITH],[ASSOCIATED_WITH],HAPTEN MEDIATED AIHA HEMOLYSIS,n/a,150,129,1,158,149,TWrex-cause,814147-FS1,"With α methyldopa type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With HAPTEN MEDIATED AIHA HEMOLYSIS ceases when the drug is cleared from the plasma.",HEMOLYSIS,HAPTEN MEDIATED AIHA
724352396,5/21/2015 07:09:50,1640128352,5/21/2015 07:08:59,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],drug,N/A,150,129,1,158,149,TWrex-cause,814147-FS1,"With α methyldopa type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With HAPTEN MEDIATED AIHA HEMOLYSIS ceases when the drug is cleared from the plasma.",HEMOLYSIS,HAPTEN MEDIATED AIHA
724352396,5/21/2015 07:10:22,1640128754,5/21/2015 07:10:05,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],drug,N/A,150,129,1,158,149,TWrex-cause,814147-FS1,"With α methyldopa type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With HAPTEN MEDIATED AIHA HEMOLYSIS ceases when the drug is cleared from the plasma.",HEMOLYSIS,HAPTEN MEDIATED AIHA
724352396,5/21/2015 07:14:15,1640130846,5/21/2015 07:13:44,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[ASSOCIATED_WITH] [CAUSES] [IS_A],"[CAUSES]
[ASSOCIATED_WITH]
[IS_A]",With ceases is,N/A,150,129,1,158,149,TWrex-cause,814147-FS1,"With α methyldopa type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With HAPTEN MEDIATED AIHA HEMOLYSIS ceases when the drug is cleared from the plasma.",HEMOLYSIS,HAPTEN MEDIATED AIHA
724352396,5/21/2015 07:23:46,1640136106,5/21/2015 07:22:34,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],ceases,N/A,150,129,1,158,149,TWrex-cause,814147-FS1,"With α methyldopa type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With HAPTEN MEDIATED AIHA HEMOLYSIS ceases when the drug is cleared from the plasma.",HEMOLYSIS,HAPTEN MEDIATED AIHA
724352396,5/21/2015 07:26:01,1640137295,5/21/2015 07:25:20,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[PART_OF],[PART_OF],HAPTEN MEDIATED AIHA HEMOLYSIS,N/A,150,129,1,158,149,TWrex-cause,814147-FS1,"With α methyldopa type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With HAPTEN MEDIATED AIHA HEMOLYSIS ceases when the drug is cleared from the plasma.",HEMOLYSIS,HAPTEN MEDIATED AIHA
724352396,5/21/2015 07:37:07,1640143084,5/21/2015 07:36:32,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[CAUSES] [ASSOCIATED_WITH] [IS_A],"[CAUSES]
[ASSOCIATED_WITH]
[IS_A]",ceases within a With ceases is,N/A,150,129,1,158,149,TWrex-cause,814147-FS1,"With α methyldopa type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With HAPTEN MEDIATED AIHA HEMOLYSIS ceases when the drug is cleared from the plasma.",HEMOLYSIS,HAPTEN MEDIATED AIHA
724352396,5/21/2015 07:39:03,1640144146,5/21/2015 07:38:12,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[SIDE_EFFECT],[SIDE_EFFECT],ceases when the drug is cleared,N/A,150,129,1,158,149,TWrex-cause,814147-FS1,"With α methyldopa type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With HAPTEN MEDIATED AIHA HEMOLYSIS ceases when the drug is cleared from the plasma.",HEMOLYSIS,HAPTEN MEDIATED AIHA
724352396,5/21/2015 07:41:56,1640145691,5/21/2015 07:41:17,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],ceases,n/a,150,129,1,158,149,TWrex-cause,814147-FS1,"With α methyldopa type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With HAPTEN MEDIATED AIHA HEMOLYSIS ceases when the drug is cleared from the plasma.",HEMOLYSIS,HAPTEN MEDIATED AIHA
724352396,5/21/2015 07:56:23,1640153505,5/21/2015 07:55:50,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[ASSOCIATED_WITH] [CAUSES] [IS_A],"[CAUSES]
[ASSOCIATED_WITH]
[IS_A]",With ceases within ceases is,N/A,150,129,1,158,149,TWrex-cause,814147-FS1,"With α methyldopa type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With HAPTEN MEDIATED AIHA HEMOLYSIS ceases when the drug is cleared from the plasma.",HEMOLYSIS,HAPTEN MEDIATED AIHA
724352396,5/21/2015 07:59:06,1640154841,5/21/2015 07:56:59,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CAUSES],[CAUSES],ceases when drug cleared,N/A,150,129,1,158,149,TWrex-cause,814147-FS1,"With α methyldopa type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With HAPTEN MEDIATED AIHA HEMOLYSIS ceases when the drug is cleared from the plasma.",HEMOLYSIS,HAPTEN MEDIATED AIHA
724352396,5/21/2015 08:03:12,1640156980,5/21/2015 08:02:51,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,[PART_OF],[PART_OF],HAPTEN MEDIATED AIHA HEMOLYSIS,-,150,129,1,158,149,TWrex-cause,814147-FS1,"With α methyldopa type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With HAPTEN MEDIATED AIHA HEMOLYSIS ceases when the drug is cleared from the plasma.",HEMOLYSIS,HAPTEN MEDIATED AIHA
724352396,5/21/2015 08:15:34,1640163587,5/21/2015 08:14:59,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[ASSOCIATED_WITH] [IS_A] [CAUSES],"[CAUSES]
[ASSOCIATED_WITH]
[IS_A]",within a With ceases is,N/A,150,129,1,158,149,TWrex-cause,814147-FS1,"With α methyldopa type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With HAPTEN MEDIATED AIHA HEMOLYSIS ceases when the drug is cleared from the plasma.",HEMOLYSIS,HAPTEN MEDIATED AIHA
724352396,5/21/2015 08:27:24,1640170186,5/21/2015 08:26:42,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[TREATS],[TREATS],"AIHA, hemolysis HAPTEN MEDIATED AIHA HEMOLYSIS",n/a,150,129,1,158,149,TWrex-cause,814147-FS1,"With α methyldopa type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With HAPTEN MEDIATED AIHA HEMOLYSIS ceases when the drug is cleared from the plasma.",HEMOLYSIS,HAPTEN MEDIATED AIHA
724352396,5/21/2015 08:32:04,1640172743,5/21/2015 08:30:59,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[NONE],[NONE],N/A,Not related,150,129,1,158,149,TWrex-cause,814147-FS1,"With α methyldopa type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With HAPTEN MEDIATED AIHA HEMOLYSIS ceases when the drug is cleared from the plasma.",HEMOLYSIS,HAPTEN MEDIATED AIHA
724352397,5/21/2015 08:55:50,1640184935,5/21/2015 08:55:10,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,[ASSOCIATED_WITH],[ASSOCIATED_WITH],develop,Associated,98,141,1,103,144,TWrex-cause,812762-FS1,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ATAXIA followed by dementia; patients with FFI are unable to sleep.",ATAXIA,FFI
724352397,5/21/2015 08:57:59,1640185920,5/21/2015 08:57:32,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[NONE],[NONE],N/A,TWO UNRELATED TERMS,98,141,1,103,144,TWrex-cause,812762-FS1,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ATAXIA followed by dementia; patients with FFI are unable to sleep.",ATAXIA,FFI
724352397,5/21/2015 09:01:05,1640187601,5/21/2015 09:00:09,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ATAXIA followed by dementia; patients with FFI are unable to sleep.",n/a,98,141,1,103,144,TWrex-cause,812762-FS1,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ATAXIA followed by dementia; patients with FFI are unable to sleep.",ATAXIA,FFI
724352397,5/21/2015 09:14:04,1640194395,5/21/2015 09:12:24,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[OTHER] [NONE],"[OTHER]
[NONE]",N/A,No apparent relation.,98,141,1,103,144,TWrex-cause,812762-FS1,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ATAXIA followed by dementia; patients with FFI are unable to sleep.",ATAXIA,FFI
724352397,5/21/2015 09:15:53,1640195219,5/21/2015 09:14:47,false,neodev,1.0,15848372,AUS,02,Jannali,14.200.59.55,[OTHER],[OTHER],patients with,N/A,98,141,1,103,144,TWrex-cause,812762-FS1,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ATAXIA followed by dementia; patients with FFI are unable to sleep.",ATAXIA,FFI
724352397,5/21/2015 09:36:18,1640205385,5/21/2015 09:36:06,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[MANIFESTATION],[MANIFESTATION],followed,N/A,98,141,1,103,144,TWrex-cause,812762-FS1,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ATAXIA followed by dementia; patients with FFI are unable to sleep.",ATAXIA,FFI
724352397,5/21/2015 09:47:20,1640210636,5/21/2015 09:47:08,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[SIDE_EFFECT],[SIDE_EFFECT],followed,N/A,98,141,1,103,144,TWrex-cause,812762-FS1,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ATAXIA followed by dementia; patients with FFI are unable to sleep.",ATAXIA,FFI
724352397,5/21/2015 10:15:22,1640224636,5/21/2015 10:15:11,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[SIDE_EFFECT],[SIDE_EFFECT],followed,N/A,98,141,1,103,144,TWrex-cause,812762-FS1,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ATAXIA followed by dementia; patients with FFI are unable to sleep.",ATAXIA,FFI
724352397,5/21/2015 10:18:26,1640226134,5/21/2015 10:16:57,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION],[MANIFESTATION],ATAXIA followed by dementia; patients with FFI,N/A,98,141,1,103,144,TWrex-cause,812762-FS1,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ATAXIA followed by dementia; patients with FFI are unable to sleep.",ATAXIA,FFI
724352397,5/21/2015 10:28:24,1640230697,5/21/2015 10:28:03,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[CAUSES],[CAUSES],ATAXIA,none,98,141,1,103,144,TWrex-cause,812762-FS1,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ATAXIA followed by dementia; patients with FFI are unable to sleep.",ATAXIA,FFI
724352397,5/21/2015 10:32:27,1640232618,5/21/2015 10:32:15,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[SYMPTOM],[SYMPTOM],followed,N/A,98,141,1,103,144,TWrex-cause,812762-FS1,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ATAXIA followed by dementia; patients with FFI are unable to sleep.",ATAXIA,FFI
724352397,5/21/2015 10:41:24,1640237106,5/21/2015 10:40:43,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[OTHER],[OTHER],patients with FFI,related condition,98,141,1,103,144,TWrex-cause,812762-FS1,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ATAXIA followed by dementia; patients with FFI are unable to sleep.",ATAXIA,FFI
724352397,5/21/2015 10:47:57,1640240663,5/21/2015 10:46:18,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],followed by dementia; patients with FFI,N/A,98,141,1,103,144,TWrex-cause,812762-FS1,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ATAXIA followed by dementia; patients with FFI are unable to sleep.",ATAXIA,FFI
724352397,5/21/2015 10:48:39,1640241001,5/21/2015 10:46:58,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[MANIFESTATION] [ASSOCIATED_WITH],"[MANIFESTATION]
[ASSOCIATED_WITH]",develop with,n/a,98,141,1,103,144,TWrex-cause,812762-FS1,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ATAXIA followed by dementia; patients with FFI are unable to sleep.",ATAXIA,FFI
724352397,5/21/2015 10:49:03,1640241222,5/21/2015 10:46:12,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[NONE],[NONE],N/A,There's no relation between the terms in the sentence.,98,141,1,103,144,TWrex-cause,812762-FS1,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ATAXIA followed by dementia; patients with FFI are unable to sleep.",ATAXIA,FFI
724352398,5/21/2015 08:50:22,1640182069,5/21/2015 08:49:56,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,[TREATS],[TREATS],substituted,Treats,138,89,-1,149,117,TWrex-cause,800267-FS1,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for ORAL CLONIDINE HYDROCHLORIDE in mild to moderate HYPERTENSION",HYPERTENSION,ORAL CLONIDINE HYDROCHLORIDE
724352398,5/21/2015 08:53:07,1640183523,5/21/2015 08:52:26,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS],[PREVENTS],Transdermal clonidine has been successfully substituted for ORAL CLONIDINE HYDROCHLORIDE in mild to moderate HYPERTENSION,n/a,138,89,-1,149,117,TWrex-cause,800267-FS1,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for ORAL CLONIDINE HYDROCHLORIDE in mild to moderate HYPERTENSION",HYPERTENSION,ORAL CLONIDINE HYDROCHLORIDE
724352398,5/21/2015 08:54:01,1640184015,5/21/2015 08:53:39,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[TREATS],[TREATS],substituted for in mild to moderate,N/A,138,89,-1,149,117,TWrex-cause,800267-FS1,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for ORAL CLONIDINE HYDROCHLORIDE in mild to moderate HYPERTENSION",HYPERTENSION,ORAL CLONIDINE HYDROCHLORIDE
724352398,5/21/2015 08:55:03,1640184576,5/21/2015 08:53:44,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],"ORAL CLONIDINE HYDROCHLORIDE in mild to moderate HY<span id=""transmark""></span>PERTENSION",n/a,138,89,-1,149,117,TWrex-cause,800267-FS1,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for ORAL CLONIDINE HYDROCHLORIDE in mild to moderate HYPERTENSION",HYPERTENSION,ORAL CLONIDINE HYDROCHLORIDE
724352398,5/21/2015 08:57:02,1640185437,5/21/2015 08:56:34,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[LOCATION],[LOCATION],mild,N/A,138,89,-1,149,117,TWrex-cause,800267-FS1,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for ORAL CLONIDINE HYDROCHLORIDE in mild to moderate HYPERTENSION",HYPERTENSION,ORAL CLONIDINE HYDROCHLORIDE
724352398,5/21/2015 09:08:54,1640191592,5/21/2015 09:08:13,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],in,N/A,138,89,-1,149,117,TWrex-cause,800267-FS1,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for ORAL CLONIDINE HYDROCHLORIDE in mild to moderate HYPERTENSION",HYPERTENSION,ORAL CLONIDINE HYDROCHLORIDE
724352398,5/21/2015 09:09:09,1640191750,5/21/2015 09:08:50,false,neodev,1.0,15848372,AUS,02,Jannali,14.200.59.55,[OTHER],[OTHER],substituted,N/A,138,89,-1,149,117,TWrex-cause,800267-FS1,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for ORAL CLONIDINE HYDROCHLORIDE in mild to moderate HYPERTENSION",HYPERTENSION,ORAL CLONIDINE HYDROCHLORIDE
724352398,5/21/2015 09:23:38,1640198869,5/21/2015 09:23:05,false,clixsense,1.0,28570371,NLD,"","",91.213.37.165,[PREVENTS],[PREVENTS],successfully substituted,N/A,138,89,-1,149,117,TWrex-cause,800267-FS1,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for ORAL CLONIDINE HYDROCHLORIDE in mild to moderate HYPERTENSION",HYPERTENSION,ORAL CLONIDINE HYDROCHLORIDE
724352398,5/21/2015 09:27:42,1640200977,5/21/2015 09:27:02,false,neodev,1.0,31195295,GBR,"","",46.208.164.162,[TREATS],[TREATS],in,N/A,138,89,-1,149,117,TWrex-cause,800267-FS1,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for ORAL CLONIDINE HYDROCHLORIDE in mild to moderate HYPERTENSION",HYPERTENSION,ORAL CLONIDINE HYDROCHLORIDE
724352398,5/21/2015 09:34:14,1640204420,5/21/2015 09:34:01,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],moderate,N/A,138,89,-1,149,117,TWrex-cause,800267-FS1,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for ORAL CLONIDINE HYDROCHLORIDE in mild to moderate HYPERTENSION",HYPERTENSION,ORAL CLONIDINE HYDROCHLORIDE
724352398,5/21/2015 09:45:05,1640209525,5/21/2015 09:44:54,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],moderate,N/A,138,89,-1,149,117,TWrex-cause,800267-FS1,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for ORAL CLONIDINE HYDROCHLORIDE in mild to moderate HYPERTENSION",HYPERTENSION,ORAL CLONIDINE HYDROCHLORIDE
724352398,5/21/2015 10:07:51,1640220913,5/21/2015 10:07:01,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],ORAL CLONIDINE HYDROCHLORIDE in HYPERTENSION,N/A,138,89,-1,149,117,TWrex-cause,800267-FS1,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for ORAL CLONIDINE HYDROCHLORIDE in mild to moderate HYPERTENSION",HYPERTENSION,ORAL CLONIDINE HYDROCHLORIDE
724352398,5/21/2015 10:12:40,1640223197,5/21/2015 10:12:26,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],moderate,N/A,138,89,-1,149,117,TWrex-cause,800267-FS1,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for ORAL CLONIDINE HYDROCHLORIDE in mild to moderate HYPERTENSION",HYPERTENSION,ORAL CLONIDINE HYDROCHLORIDE
724352398,5/21/2015 10:25:34,1640229428,5/21/2015 10:25:18,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[TREATS],[TREATS],HYPERTENSION,none,138,89,-1,149,117,TWrex-cause,800267-FS1,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for ORAL CLONIDINE HYDROCHLORIDE in mild to moderate HYPERTENSION",HYPERTENSION,ORAL CLONIDINE HYDROCHLORIDE
724352398,5/21/2015 10:29:38,1640231285,5/21/2015 10:28:33,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],substituted for in,N/A,138,89,-1,149,117,TWrex-cause,800267-FS1,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for ORAL CLONIDINE HYDROCHLORIDE in mild to moderate HYPERTENSION",HYPERTENSION,ORAL CLONIDINE HYDROCHLORIDE
724352399,5/21/2015 08:51:44,1640182823,5/21/2015 08:51:08,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],screened,Diagnosed,32,57,-1,33,60,TWrex-cause,803017-FS1,Patients should be screened for TB with a chest x ray or PPD,TB,PPD
724352399,5/21/2015 08:54:44,1640184385,5/21/2015 08:53:59,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[OTHER],[OTHER],Patients should be screened for TB with a chest x ray or PPD,n/a,32,57,-1,33,60,TWrex-cause,803017-FS1,Patients should be screened for TB with a chest x ray or PPD,TB,PPD
724352399,5/21/2015 08:54:56,1640184542,5/21/2015 08:54:26,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Patients should be screened for with,N/A,32,57,-1,33,60,TWrex-cause,803017-FS1,Patients should be screened for TB with a chest x ray or PPD,TB,PPD
724352399,5/21/2015 08:57:18,1640185591,5/21/2015 08:56:17,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"screened for TB with PP<span id=""transmark""></span>D",n/a,32,57,-1,33,60,TWrex-cause,803017-FS1,Patients should be screened for TB with a chest x ray or PPD,TB,PPD
724352399,5/21/2015 08:59:45,1640186812,5/21/2015 08:58:40,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[IS_A] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]",a or,"129 , 131 Discontinue ETANERCEPT if serious infection or SEPSIS develops.
Which of the following statements is EXPRESSED in the SENTENCE above?
SEPSIS causes ETANERCEPT
ETANERCEPT causes SEPSIS
-causes- is NOT EXPRESSED between the two PHRASES",32,57,-1,33,60,TWrex-cause,803017-FS1,Patients should be screened for TB with a chest x ray or PPD,TB,PPD
724352399,5/21/2015 09:09:44,1640192054,5/21/2015 09:09:15,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],screened with,N/A,32,57,-1,33,60,TWrex-cause,803017-FS1,Patients should be screened for TB with a chest x ray or PPD,TB,PPD
724352399,5/21/2015 09:10:09,1640192262,5/21/2015 09:09:51,false,neodev,1.0,15848372,AUS,02,Jannali,14.200.59.55,[PART_OF],[PART_OF],with,N/A,32,57,-1,33,60,TWrex-cause,803017-FS1,Patients should be screened for TB with a chest x ray or PPD,TB,PPD
724352399,5/21/2015 09:24:48,1640199433,5/21/2015 09:24:10,false,clixsense,1.0,28570371,NLD,"","",91.213.37.165,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],screened,N/A,32,57,-1,33,60,TWrex-cause,803017-FS1,Patients should be screened for TB with a chest x ray or PPD,TB,PPD
724352399,5/21/2015 09:28:29,1640201354,5/21/2015 09:28:12,false,neodev,1.0,31195295,GBR,"","",46.208.164.162,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],screened,N/A,32,57,-1,33,60,TWrex-cause,803017-FS1,Patients should be screened for TB with a chest x ray or PPD,TB,PPD
724352399,5/21/2015 09:34:41,1640204669,5/21/2015 09:34:28,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[SIDE_EFFECT],[SIDE_EFFECT],or,N/A,32,57,-1,33,60,TWrex-cause,803017-FS1,Patients should be screened for TB with a chest x ray or PPD,TB,PPD
724352399,5/21/2015 09:45:38,1640209810,5/21/2015 09:45:26,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[SIDE_EFFECT],[SIDE_EFFECT],or,N/A,32,57,-1,33,60,TWrex-cause,803017-FS1,Patients should be screened for TB with a chest x ray or PPD,TB,PPD
724352399,5/21/2015 10:09:53,1640221954,5/21/2015 10:09:08,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],screened for TB chest x ray or PPD,N/A,32,57,-1,33,60,TWrex-cause,803017-FS1,Patients should be screened for TB with a chest x ray or PPD,TB,PPD
724352399,5/21/2015 10:13:24,1640223586,5/21/2015 10:13:05,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],screened,N/A,32,57,-1,33,60,TWrex-cause,803017-FS1,Patients should be screened for TB with a chest x ray or PPD,TB,PPD
724352399,5/21/2015 10:26:12,1640229764,5/21/2015 10:25:50,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[CAUSES],[CAUSES],PPD,none,32,57,-1,33,60,TWrex-cause,803017-FS1,Patients should be screened for TB with a chest x ray or PPD,TB,PPD
724352399,5/21/2015 10:30:47,1640231730,5/21/2015 10:29:42,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],should be screened,N/A,32,57,-1,33,60,TWrex-cause,803017-FS1,Patients should be screened for TB with a chest x ray or PPD,TB,PPD
724352400,5/21/2015 10:39:49,1640236255,5/21/2015 10:39:32,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[ASSOCIATED_WITH],[ASSOCIATED_WITH],typically,N/A,66,8,1,80,11,TWrex-cause,813857-FS1,"Pain in RSD starts typically more distally in a limb Gout  Acute, SPONTANOUS PAIN most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",SPONTANOUS PAIN,RSD
724352400,5/21/2015 11:06:15,1640249433,5/21/2015 11:04:26,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],most commonly,n/a,66,8,1,80,11,TWrex-cause,813857-FS1,"Pain in RSD starts typically more distally in a limb Gout  Acute, SPONTANOUS PAIN most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",SPONTANOUS PAIN,RSD
724352400,5/21/2015 11:08:17,1640250360,5/21/2015 11:06:43,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",starts typically more distally,N/A,66,8,1,80,11,TWrex-cause,813857-FS1,"Pain in RSD starts typically more distally in a limb Gout  Acute, SPONTANOUS PAIN most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",SPONTANOUS PAIN,RSD
724352400,5/21/2015 11:13:19,1640252518,5/21/2015 11:12:10,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[PART_OF] [MANIFESTATION] [SYMPTOM] [IS_A],"[SYMPTOM]
[MANIFESTATION]
[IS_A]
[PART_OF]",starts in PAIN in affect,n/a,66,8,1,80,11,TWrex-cause,813857-FS1,"Pain in RSD starts typically more distally in a limb Gout  Acute, SPONTANOUS PAIN most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",SPONTANOUS PAIN,RSD
724352400,5/21/2015 11:26:32,1640257997,5/21/2015 11:26:18,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],distally,N/A,66,8,1,80,11,TWrex-cause,813857-FS1,"Pain in RSD starts typically more distally in a limb Gout  Acute, SPONTANOUS PAIN most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",SPONTANOUS PAIN,RSD
724352400,5/21/2015 11:35:30,1640261962,5/21/2015 11:35:10,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],can affect,n/a,66,8,1,80,11,TWrex-cause,813857-FS1,"Pain in RSD starts typically more distally in a limb Gout  Acute, SPONTANOUS PAIN most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",SPONTANOUS PAIN,RSD
724352400,5/21/2015 11:46:57,1640267504,5/21/2015 11:46:06,false,prodege,1.0,12656479,CAN,NB,Fredericton,198.164.157.90,[CAUSES],[CAUSES],distally,N/A,66,8,1,80,11,TWrex-cause,813857-FS1,"Pain in RSD starts typically more distally in a limb Gout  Acute, SPONTANOUS PAIN most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",SPONTANOUS PAIN,RSD
724352400,5/21/2015 11:49:07,1640268448,5/21/2015 11:47:24,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[ASSOCIATED_WITH] [SIDE_EFFECT],"[ASSOCIATED_WITH]
[SIDE_EFFECT]",most commonly,n/a,66,8,1,80,11,TWrex-cause,813857-FS1,"Pain in RSD starts typically more distally in a limb Gout  Acute, SPONTANOUS PAIN most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",SPONTANOUS PAIN,RSD
724352400,5/21/2015 12:15:01,1640279736,5/21/2015 12:14:26,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[CAUSES],[CAUSES],starts,N/A,66,8,1,80,11,TWrex-cause,813857-FS1,"Pain in RSD starts typically more distally in a limb Gout  Acute, SPONTANOUS PAIN most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",SPONTANOUS PAIN,RSD
724352400,5/21/2015 12:34:09,1640288390,5/21/2015 12:33:00,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Pain in RSD SPONTANOUS PAIN,N/A,66,8,1,80,11,TWrex-cause,813857-FS1,"Pain in RSD starts typically more distally in a limb Gout  Acute, SPONTANOUS PAIN most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",SPONTANOUS PAIN,RSD
724352400,5/21/2015 13:11:23,1640304162,5/21/2015 13:10:30,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[LOCATION],[LOCATION],limb Gout,N/A,66,8,1,80,11,TWrex-cause,813857-FS1,"Pain in RSD starts typically more distally in a limb Gout  Acute, SPONTANOUS PAIN most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",SPONTANOUS PAIN,RSD
724352400,5/21/2015 13:20:06,1640308669,5/21/2015 13:19:08,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SYMPTOM],[SYMPTOM],RSD SPONTANOUS PAIN commonly in,N/A,66,8,1,80,11,TWrex-cause,813857-FS1,"Pain in RSD starts typically more distally in a limb Gout  Acute, SPONTANOUS PAIN most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",SPONTANOUS PAIN,RSD
724352400,5/21/2015 13:20:06,1640308685,5/21/2015 13:18:42,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],affect,N/A,66,8,1,80,11,TWrex-cause,813857-FS1,"Pain in RSD starts typically more distally in a limb Gout  Acute, SPONTANOUS PAIN most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",SPONTANOUS PAIN,RSD
724352400,5/21/2015 14:00:51,1640329973,5/21/2015 13:59:20,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[ASSOCIATED_WITH] [SIDE_EFFECT],"[ASSOCIATED_WITH]
[SIDE_EFFECT]",starts most commonly,n/a,66,8,1,80,11,TWrex-cause,813857-FS1,"Pain in RSD starts typically more distally in a limb Gout  Acute, SPONTANOUS PAIN most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",SPONTANOUS PAIN,RSD
724352400,5/21/2015 14:06:43,1640333621,5/21/2015 14:05:54,false,clixsense,1.0,12843982,AUS,08,Perth,180.216.79.226,[SYMPTOM],[SYMPTOM],Pain in RSD SPONTANOUS PAIN,N/A,66,8,1,80,11,TWrex-cause,813857-FS1,"Pain in RSD starts typically more distally in a limb Gout  Acute, SPONTANOUS PAIN most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",SPONTANOUS PAIN,RSD
724352401,5/21/2015 07:01:12,1640123864,5/21/2015 07:01:01,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,[CAUSES],[CAUSES],(ORNITHOSIS caused by CHLAMYDIA PSITTACI,n/a,56,78,1,65,96,TWrex-cause,810745-FS1,Chlamydial Infections  Treatment of psittacosis   +    (ORNITHOSIS caused by  CHLAMYDIA PSITTACI,ORNITHOSIS,CHLAMYDIA PSITTACI
724352401,5/21/2015 07:08:16,1640127545,5/21/2015 07:07:58,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],caused,N/A,56,78,1,65,96,TWrex-cause,810745-FS1,Chlamydial Infections  Treatment of psittacosis   +    (ORNITHOSIS caused by  CHLAMYDIA PSITTACI,ORNITHOSIS,CHLAMYDIA PSITTACI
724352401,5/21/2015 07:09:50,1640128346,5/21/2015 07:09:38,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],Treatment,N/A,56,78,1,65,96,TWrex-cause,810745-FS1,Chlamydial Infections  Treatment of psittacosis   +    (ORNITHOSIS caused by  CHLAMYDIA PSITTACI,ORNITHOSIS,CHLAMYDIA PSITTACI
724352401,5/21/2015 07:13:09,1640130252,5/21/2015 07:12:45,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]",of caused by,N/A,56,78,1,65,96,TWrex-cause,810745-FS1,Chlamydial Infections  Treatment of psittacosis   +    (ORNITHOSIS caused by  CHLAMYDIA PSITTACI,ORNITHOSIS,CHLAMYDIA PSITTACI
724352401,5/21/2015 07:21:54,1640135116,5/21/2015 07:21:33,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CAUSES],[CAUSES],caused by,N/A,56,78,1,65,96,TWrex-cause,810745-FS1,Chlamydial Infections  Treatment of psittacosis   +    (ORNITHOSIS caused by  CHLAMYDIA PSITTACI,ORNITHOSIS,CHLAMYDIA PSITTACI
724352401,5/21/2015 07:24:36,1640136580,5/21/2015 07:24:10,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],caused by,N/A,56,78,1,65,96,TWrex-cause,810745-FS1,Chlamydial Infections  Treatment of psittacosis   +    (ORNITHOSIS caused by  CHLAMYDIA PSITTACI,ORNITHOSIS,CHLAMYDIA PSITTACI
724352401,5/21/2015 07:36:00,1640142546,5/21/2015 07:35:29,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]",of caused by,N/A,56,78,1,65,96,TWrex-cause,810745-FS1,Chlamydial Infections  Treatment of psittacosis   +    (ORNITHOSIS caused by  CHLAMYDIA PSITTACI,ORNITHOSIS,CHLAMYDIA PSITTACI
724352401,5/21/2015 07:37:45,1640143526,5/21/2015 07:37:34,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],caused by,N/A,56,78,1,65,96,TWrex-cause,810745-FS1,Chlamydial Infections  Treatment of psittacosis   +    (ORNITHOSIS caused by  CHLAMYDIA PSITTACI,ORNITHOSIS,CHLAMYDIA PSITTACI
724352401,5/21/2015 07:40:57,1640145189,5/21/2015 07:40:42,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],Treatment,n/a,56,78,1,65,96,TWrex-cause,810745-FS1,Chlamydial Infections  Treatment of psittacosis   +    (ORNITHOSIS caused by  CHLAMYDIA PSITTACI,ORNITHOSIS,CHLAMYDIA PSITTACI
724352401,5/21/2015 07:55:22,1640153005,5/21/2015 07:55:07,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]",of caused by,N/A,56,78,1,65,96,TWrex-cause,810745-FS1,Chlamydial Infections  Treatment of psittacosis   +    (ORNITHOSIS caused by  CHLAMYDIA PSITTACI,ORNITHOSIS,CHLAMYDIA PSITTACI
724352401,5/21/2015 07:56:36,1640153631,5/21/2015 07:56:18,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CAUSES],[CAUSES],caused by,N/A,56,78,1,65,96,TWrex-cause,810745-FS1,Chlamydial Infections  Treatment of psittacosis   +    (ORNITHOSIS caused by  CHLAMYDIA PSITTACI,ORNITHOSIS,CHLAMYDIA PSITTACI
724352401,5/21/2015 08:02:16,1640156399,5/21/2015 08:01:01,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,[CAUSES],[CAUSES],caused,-,56,78,1,65,96,TWrex-cause,810745-FS1,Chlamydial Infections  Treatment of psittacosis   +    (ORNITHOSIS caused by  CHLAMYDIA PSITTACI,ORNITHOSIS,CHLAMYDIA PSITTACI
724352401,5/21/2015 08:14:33,1640162960,5/21/2015 08:14:16,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[PART_OF] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]",of caused by,N/A,56,78,1,65,96,TWrex-cause,810745-FS1,Chlamydial Infections  Treatment of psittacosis   +    (ORNITHOSIS caused by  CHLAMYDIA PSITTACI,ORNITHOSIS,CHLAMYDIA PSITTACI
724352401,5/21/2015 08:26:16,1640169602,5/21/2015 08:26:00,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[CAUSES],[CAUSES],(ORNITHOSIS caused CHLAMYDIA PSITTACI,n/a,56,78,1,65,96,TWrex-cause,810745-FS1,Chlamydial Infections  Treatment of psittacosis   +    (ORNITHOSIS caused by  CHLAMYDIA PSITTACI,ORNITHOSIS,CHLAMYDIA PSITTACI
724352401,5/21/2015 08:32:21,1640172870,5/21/2015 08:30:38,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[CAUSES],[CAUSES],"(ORNITHOSIS caused by CHLAMYDIA PSIT<span id=""transmark""></span>TACI",n/a,56,78,1,65,96,TWrex-cause,810745-FS1,Chlamydial Infections  Treatment of psittacosis   +    (ORNITHOSIS caused by  CHLAMYDIA PSITTACI,ORNITHOSIS,CHLAMYDIA PSITTACI
724352402,5/21/2015 07:06:51,1640126787,5/21/2015 07:06:30,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,[PREVENTS],[PREVENTS],PULMONARY AND EXTRAPULMONARY TUBERCULOSIS ISONIAZID suppress,n/a,12,151,-1,52,160,TWrex-cause,804350-FS1,"b  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
724352402,5/21/2015 07:13:34,1640130418,5/21/2015 07:13:21,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],effective,N/A,12,151,-1,52,160,TWrex-cause,804350-FS1,"b  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
724352402,5/21/2015 07:20:31,1640134435,5/21/2015 07:20:03,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],therapy,N/A,12,151,-1,52,160,TWrex-cause,804350-FS1,"b  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
724352402,5/21/2015 07:21:42,1640134945,5/21/2015 07:21:11,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",with or,N/A,12,151,-1,52,160,TWrex-cause,804350-FS1,"b  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
724352402,5/21/2015 07:34:02,1640141530,5/21/2015 07:32:25,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],therapy,N/A,12,151,-1,52,160,TWrex-cause,804350-FS1,"b  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
724352402,5/21/2015 07:35:57,1640142529,5/21/2015 07:35:24,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],as adjunctive therapy,N/A,12,151,-1,52,160,TWrex-cause,804350-FS1,"b  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
724352402,5/21/2015 07:45:06,1640147318,5/21/2015 07:44:19,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",with or,N/A,12,151,-1,52,160,TWrex-cause,804350-FS1,"b  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
724352402,5/21/2015 07:46:11,1640147902,5/21/2015 07:45:54,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],therapy,N/A,12,151,-1,52,160,TWrex-cause,804350-FS1,"b  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
724352402,5/21/2015 07:46:17,1640147952,5/21/2015 07:45:56,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],adjunctive therapy,n/a,12,151,-1,52,160,TWrex-cause,804350-FS1,"b  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
724352402,5/21/2015 08:03:12,1640156977,5/21/2015 08:02:36,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",with or,N/A,12,151,-1,52,160,TWrex-cause,804350-FS1,"b  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
724352402,5/21/2015 08:06:11,1640158546,5/21/2015 08:05:43,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],therapy,N/A,12,151,-1,52,160,TWrex-cause,804350-FS1,"b  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
724352402,5/21/2015 08:20:25,1640166366,5/21/2015 08:19:58,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,[TREATS],[TREATS],therapy,-,12,151,-1,52,160,TWrex-cause,804350-FS1,"b  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
724352402,5/21/2015 08:34:58,1640174318,5/21/2015 08:34:14,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[TREATS],[TREATS],PULMONARY AND EXTRAPULMONARY TUBERCULOSIS ISONIAZID,n/a,12,151,-1,52,160,TWrex-cause,804350-FS1,"b  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
724352402,5/21/2015 08:43:45,1640178859,5/21/2015 08:43:14,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,[TREATS],[TREATS],therapy,Treated with,12,151,-1,52,160,TWrex-cause,804350-FS1,"b  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
724352402,5/21/2015 08:44:14,1640179073,5/21/2015 08:42:22,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],"PULMONARY AND EXTRAPULMONARY TUBERCULOSIS therapy with ISONIAZID to suppress manifesta<span id=""transmark""></span>tions",n/a,12,151,-1,52,160,TWrex-cause,804350-FS1,"b  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
724352403,5/21/2015 07:07:08,1640126913,5/21/2015 07:06:53,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,[ASSOCIATED_WITH],[ASSOCIATED_WITH],HYPERSENSITIVITY REACTIONS including STEVENS JOHNSON SYNDROME,n/a,90,23,1,113,49,TWrex-cause,815002-FS1,"Sensitivity Reactions  HYPERSENSITIVITY REACTIONS  Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME  1 ,   2 ,   93 ,   99   erythema multiforme.",STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTIONS
724352403,5/21/2015 07:13:50,1640130616,5/21/2015 07:13:34,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,90,23,1,113,49,TWrex-cause,815002-FS1,"Sensitivity Reactions  HYPERSENSITIVITY REACTIONS  Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME  1 ,   2 ,   93 ,   99   erythema multiforme.",STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTIONS
724352403,5/21/2015 07:21:14,1640134749,5/21/2015 07:20:32,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[SYMPTOM],[SYMPTOM],"reactions,",N/A,90,23,1,113,49,TWrex-cause,815002-FS1,"Sensitivity Reactions  HYPERSENSITIVITY REACTIONS  Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME  1 ,   2 ,   93 ,   99   erythema multiforme.",STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTIONS
724352403,5/21/2015 07:24:00,1640136237,5/21/2015 07:23:19,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[LOCATION] [SYMPTOM],"[LOCATION]
[SYMPTOM]",SYNDROME,N/A,90,23,1,113,49,TWrex-cause,815002-FS1,"Sensitivity Reactions  HYPERSENSITIVITY REACTIONS  Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME  1 ,   2 ,   93 ,   99   erythema multiforme.",STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTIONS
724352403,5/21/2015 07:34:45,1640141825,5/21/2015 07:34:04,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]",including,N/A,90,23,1,113,49,TWrex-cause,815002-FS1,"Sensitivity Reactions  HYPERSENSITIVITY REACTIONS  Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME  1 ,   2 ,   93 ,   99   erythema multiforme.",STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTIONS
724352403,5/21/2015 07:37:04,1640143046,5/21/2015 07:35:59,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES] [MANIFESTATION] [SYMPTOM],"[CAUSES]
[SYMPTOM]
[MANIFESTATION]",Sensitivity Reactions including,N/A,90,23,1,113,49,TWrex-cause,815002-FS1,"Sensitivity Reactions  HYPERSENSITIVITY REACTIONS  Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME  1 ,   2 ,   93 ,   99   erythema multiforme.",STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTIONS
724352403,5/21/2015 07:46:02,1640147796,5/21/2015 07:45:09,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[SYMPTOM],[SYMPTOM],SYNDROME,N/A,90,23,1,113,49,TWrex-cause,815002-FS1,"Sensitivity Reactions  HYPERSENSITIVITY REACTIONS  Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME  1 ,   2 ,   93 ,   99   erythema multiforme.",STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTIONS
724352403,5/21/2015 07:46:36,1640148145,5/21/2015 07:46:12,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[SIDE_EFFECT],[SIDE_EFFECT],"Serious cutaneous reactions,",N/A,90,23,1,113,49,TWrex-cause,815002-FS1,"Sensitivity Reactions  HYPERSENSITIVITY REACTIONS  Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME  1 ,   2 ,   93 ,   99   erythema multiforme.",STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTIONS
724352403,5/21/2015 07:46:36,1640148148,5/21/2015 07:46:17,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],including,n/a,90,23,1,113,49,TWrex-cause,815002-FS1,"Sensitivity Reactions  HYPERSENSITIVITY REACTIONS  Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME  1 ,   2 ,   93 ,   99   erythema multiforme.",STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTIONS
724352403,5/21/2015 08:04:33,1640157721,5/21/2015 08:03:14,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[SYMPTOM],[SYMPTOM],SYNDROME,N/A,90,23,1,113,49,TWrex-cause,815002-FS1,"Sensitivity Reactions  HYPERSENSITIVITY REACTIONS  Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME  1 ,   2 ,   93 ,   99   erythema multiforme.",STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTIONS
724352403,5/21/2015 08:06:36,1640158765,5/21/2015 08:06:12,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[IS_A],[IS_A],including,N/A,90,23,1,113,49,TWrex-cause,815002-FS1,"Sensitivity Reactions  HYPERSENSITIVITY REACTIONS  Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME  1 ,   2 ,   93 ,   99   erythema multiforme.",STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTIONS
724352403,5/21/2015 08:20:54,1640166636,5/21/2015 08:20:26,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,[PART_OF],[PART_OF],including,-,90,23,1,113,49,TWrex-cause,815002-FS1,"Sensitivity Reactions  HYPERSENSITIVITY REACTIONS  Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME  1 ,   2 ,   93 ,   99   erythema multiforme.",STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTIONS
724352403,5/21/2015 08:35:48,1640174714,5/21/2015 08:34:59,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",HYPERSENSITIVITY REACTIONS including STEVENS JOHNSON SYNDROME,n/a,90,23,1,113,49,TWrex-cause,815002-FS1,"Sensitivity Reactions  HYPERSENSITIVITY REACTIONS  Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME  1 ,   2 ,   93 ,   99   erythema multiforme.",STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTIONS
724352403,5/21/2015 08:44:12,1640179063,5/21/2015 08:43:33,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SIDE_EFFECT],[SIDE_EFFECT],"Sensitivity Reactions HYPERSENSITIVITY REACTIONS Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME erythema multiforme.",n/a,90,23,1,113,49,TWrex-cause,815002-FS1,"Sensitivity Reactions  HYPERSENSITIVITY REACTIONS  Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME  1 ,   2 ,   93 ,   99   erythema multiforme.",STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTIONS
724352403,5/21/2015 08:44:19,1640179096,5/21/2015 08:43:47,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,[ASSOCIATED_WITH],[ASSOCIATED_WITH],including,Associated with,90,23,1,113,49,TWrex-cause,815002-FS1,"Sensitivity Reactions  HYPERSENSITIVITY REACTIONS  Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME  1 ,   2 ,   93 ,   99   erythema multiforme.",STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTIONS
724352404,5/21/2015 07:07:50,1640127308,5/21/2015 07:07:28,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,[TREATS],[TREATS],Treatment OVERT STATUS EPILEPTICUS DIAZEPAM,n/a,116,352,-1,139,360,TWrex-cause,804239-FS1,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates OVERT STATUS EPILEPTICUS      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% DIAZEPAM and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,OVERT STATUS EPILEPTICUS,DIAZEPAM
724352404,5/21/2015 07:14:14,1640130844,5/21/2015 07:14:06,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],Treatment,N/A,116,352,-1,139,360,TWrex-cause,804239-FS1,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates OVERT STATUS EPILEPTICUS      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% DIAZEPAM and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,OVERT STATUS EPILEPTICUS,DIAZEPAM
724352404,5/21/2015 07:22:38,1640135532,5/21/2015 07:21:46,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],drug therapies,N/A,116,352,-1,139,360,TWrex-cause,804239-FS1,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates OVERT STATUS EPILEPTICUS      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% DIAZEPAM and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,OVERT STATUS EPILEPTICUS,DIAZEPAM
724352404,5/21/2015 07:25:22,1640136996,5/21/2015 07:24:44,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",of or,N/A,116,352,-1,139,360,TWrex-cause,804239-FS1,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates OVERT STATUS EPILEPTICUS      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% DIAZEPAM and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,OVERT STATUS EPILEPTICUS,DIAZEPAM
724352404,5/21/2015 07:35:56,1640142523,5/21/2015 07:35:12,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],Treatment success,N/A,116,352,-1,139,360,TWrex-cause,804239-FS1,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates OVERT STATUS EPILEPTICUS      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% DIAZEPAM and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,OVERT STATUS EPILEPTICUS,DIAZEPAM
724352404,5/21/2015 07:37:57,1640143635,5/21/2015 07:37:33,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],Treatment,N/A,116,352,-1,139,360,TWrex-cause,804239-FS1,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates OVERT STATUS EPILEPTICUS      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% DIAZEPAM and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,OVERT STATUS EPILEPTICUS,DIAZEPAM
724352404,5/21/2015 07:47:10,1640148427,5/21/2015 07:46:52,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],drug therapies,n/a,116,352,-1,139,360,TWrex-cause,804239-FS1,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates OVERT STATUS EPILEPTICUS      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% DIAZEPAM and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,OVERT STATUS EPILEPTICUS,DIAZEPAM
724352404,5/21/2015 07:47:26,1640148532,5/21/2015 07:46:47,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",of or,N/A,116,352,-1,139,360,TWrex-cause,804239-FS1,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates OVERT STATUS EPILEPTICUS      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% DIAZEPAM and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,OVERT STATUS EPILEPTICUS,DIAZEPAM
724352404,5/21/2015 07:47:26,1640148534,5/21/2015 07:46:58,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],Drug therapies,N/A,116,352,-1,139,360,TWrex-cause,804239-FS1,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates OVERT STATUS EPILEPTICUS      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% DIAZEPAM and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,OVERT STATUS EPILEPTICUS,DIAZEPAM
724352404,5/21/2015 08:06:15,1640158617,5/21/2015 08:05:40,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",of or,N/A,116,352,-1,139,360,TWrex-cause,804239-FS1,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates OVERT STATUS EPILEPTICUS      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% DIAZEPAM and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,OVERT STATUS EPILEPTICUS,DIAZEPAM
724352404,5/21/2015 08:07:22,1640159176,5/21/2015 08:06:55,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],Treatment,N/A,116,352,-1,139,360,TWrex-cause,804239-FS1,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates OVERT STATUS EPILEPTICUS      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% DIAZEPAM and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,OVERT STATUS EPILEPTICUS,DIAZEPAM
724352404,5/21/2015 08:23:29,1640168005,5/21/2015 08:21:15,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",Treatment,-,116,352,-1,139,360,TWrex-cause,804239-FS1,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates OVERT STATUS EPILEPTICUS      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% DIAZEPAM and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,OVERT STATUS EPILEPTICUS,DIAZEPAM
724352404,5/21/2015 08:37:18,1640175456,5/21/2015 08:36:30,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[TREATS],[TREATS],OVERT STATUS EPILEPTICUS DIAZEPAM,n/a,116,352,-1,139,360,TWrex-cause,804239-FS1,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates OVERT STATUS EPILEPTICUS      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% DIAZEPAM and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,OVERT STATUS EPILEPTICUS,DIAZEPAM
724352404,5/21/2015 08:44:40,1640179240,5/21/2015 08:44:21,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,[TREATS],[TREATS],Treatment,Treated with,116,352,-1,139,360,TWrex-cause,804239-FS1,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates OVERT STATUS EPILEPTICUS      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% DIAZEPAM and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,OVERT STATUS EPILEPTICUS,DIAZEPAM
724352404,5/21/2015 08:46:10,1640180001,5/21/2015 08:45:07,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Treatment success of 4 drug therapies for status epilepticus at 12 hours Drug therapies Success rates OVERT STATUS EPILEPTICUS Subtle status epilepticus Lorazepam 67.0% 26.1% Phenobarbital 63.0% 24.4% Phenytoin 51.0% 19.5% DIAZEPAM and phenytoin 59.6% 23.4% COMMENTARY Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,n/a,116,352,-1,139,360,TWrex-cause,804239-FS1,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates OVERT STATUS EPILEPTICUS      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% DIAZEPAM and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,OVERT STATUS EPILEPTICUS,DIAZEPAM
724352405,5/21/2015 11:29:13,1640259142,5/21/2015 11:29:04,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[CAUSES],[CAUSES],caused,N/A,33,96,1,61,103,TWrex-cause,810511-FS1,fever with renal syndrome     An ARTHROPOD BORNE VIRAL DISEASE caused by Hanta virus or related VIRUSES,ARTHROPOD BORNE VIRAL DISEASE,VIRUSES
724352405,5/21/2015 12:18:53,1640281502,5/21/2015 12:18:40,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[CAUSES],[CAUSES],caused,N/A,33,96,1,61,103,TWrex-cause,810511-FS1,fever with renal syndrome     An ARTHROPOD BORNE VIRAL DISEASE caused by Hanta virus or related VIRUSES,ARTHROPOD BORNE VIRAL DISEASE,VIRUSES
724352405,5/21/2015 13:17:29,1640307260,5/21/2015 13:16:26,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[PREVENTS],[PREVENTS],ARTHROPOD,N/A,33,96,1,61,103,TWrex-cause,810511-FS1,fever with renal syndrome     An ARTHROPOD BORNE VIRAL DISEASE caused by Hanta virus or related VIRUSES,ARTHROPOD BORNE VIRAL DISEASE,VIRUSES
724352405,5/21/2015 13:34:44,1640316110,5/21/2015 13:33:34,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused,N/A,33,96,1,61,103,TWrex-cause,810511-FS1,fever with renal syndrome     An ARTHROPOD BORNE VIRAL DISEASE caused by Hanta virus or related VIRUSES,ARTHROPOD BORNE VIRAL DISEASE,VIRUSES
724352405,5/21/2015 14:23:44,1640344188,5/21/2015 14:23:34,false,neodev,1.0,32103286,GBR,H9,London,193.109.196.83,[LOCATION] [SYMPTOM] [NONE],"[LOCATION]
[SYMPTOM]
[NONE]",NO,NO,33,96,1,61,103,TWrex-cause,810511-FS1,fever with renal syndrome     An ARTHROPOD BORNE VIRAL DISEASE caused by Hanta virus or related VIRUSES,ARTHROPOD BORNE VIRAL DISEASE,VIRUSES
724352405,5/21/2015 14:24:37,1640344996,5/21/2015 14:23:47,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],caused by,N/A,33,96,1,61,103,TWrex-cause,810511-FS1,fever with renal syndrome     An ARTHROPOD BORNE VIRAL DISEASE caused by Hanta virus or related VIRUSES,ARTHROPOD BORNE VIRAL DISEASE,VIRUSES
724352405,5/21/2015 14:26:20,1640346017,5/21/2015 14:26:09,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[CAUSES],[CAUSES],caused by,N/A,33,96,1,61,103,TWrex-cause,810511-FS1,fever with renal syndrome     An ARTHROPOD BORNE VIRAL DISEASE caused by Hanta virus or related VIRUSES,ARTHROPOD BORNE VIRAL DISEASE,VIRUSES
724352405,5/21/2015 14:28:16,1640347106,5/21/2015 14:27:51,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[CAUSES],[CAUSES],caused by,n/a,33,96,1,61,103,TWrex-cause,810511-FS1,fever with renal syndrome     An ARTHROPOD BORNE VIRAL DISEASE caused by Hanta virus or related VIRUSES,ARTHROPOD BORNE VIRAL DISEASE,VIRUSES
724352405,5/21/2015 14:37:35,1640353177,5/21/2015 14:36:55,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[SYMPTOM] [CAUSES],"[CAUSES]
[SYMPTOM]",fever with renal syndrome ARTHROPOD BORNE VIRAL DISEASE caused by Hanta virus,n/a,33,96,1,61,103,TWrex-cause,810511-FS1,fever with renal syndrome     An ARTHROPOD BORNE VIRAL DISEASE caused by Hanta virus or related VIRUSES,ARTHROPOD BORNE VIRAL DISEASE,VIRUSES
724352405,5/21/2015 14:51:10,1640360657,5/21/2015 14:50:14,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES],[CAUSES],ARTHROPOD BORNE VIRAL DISEASE caused by Hanta virus or related VIRUSES,N/A,33,96,1,61,103,TWrex-cause,810511-FS1,fever with renal syndrome     An ARTHROPOD BORNE VIRAL DISEASE caused by Hanta virus or related VIRUSES,ARTHROPOD BORNE VIRAL DISEASE,VIRUSES
724352405,5/21/2015 14:59:32,1640365118,5/21/2015 14:58:41,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],ARTHROPOD BORNE VIRAL DISEASE caused by VIRUSES,N/A,33,96,1,61,103,TWrex-cause,810511-FS1,fever with renal syndrome     An ARTHROPOD BORNE VIRAL DISEASE caused by Hanta virus or related VIRUSES,ARTHROPOD BORNE VIRAL DISEASE,VIRUSES
724352405,5/21/2015 15:03:40,1640367507,5/21/2015 15:03:27,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],ARTHROPOD BORNE VIRAL DISEASE caused Hanta virus related VIRUSES,na,33,96,1,61,103,TWrex-cause,810511-FS1,fever with renal syndrome     An ARTHROPOD BORNE VIRAL DISEASE caused by Hanta virus or related VIRUSES,ARTHROPOD BORNE VIRAL DISEASE,VIRUSES
724352405,5/21/2015 15:05:15,1640368427,5/21/2015 15:03:55,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],ARTHROPOD BORNE VIRAL DISEASE caused by VIRUSES,na,33,96,1,61,103,TWrex-cause,810511-FS1,fever with renal syndrome     An ARTHROPOD BORNE VIRAL DISEASE caused by Hanta virus or related VIRUSES,ARTHROPOD BORNE VIRAL DISEASE,VIRUSES
724352405,5/21/2015 15:25:30,1640379789,5/21/2015 15:23:14,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,[CAUSES],[CAUSES],caused,caused by hanta virus,33,96,1,61,103,TWrex-cause,810511-FS1,fever with renal syndrome     An ARTHROPOD BORNE VIRAL DISEASE caused by Hanta virus or related VIRUSES,ARTHROPOD BORNE VIRAL DISEASE,VIRUSES
724352405,5/21/2015 15:39:28,1640387454,5/21/2015 15:38:59,false,neodev,1,31861180,GBR,M9,Stafford,82.16.53.211,[IS_A],[IS_A],caused by VIRUSES,n/a,33,96,1,61,103,TWrex-cause,810511-FS1,fever with renal syndrome     An ARTHROPOD BORNE VIRAL DISEASE caused by Hanta virus or related VIRUSES,ARTHROPOD BORNE VIRAL DISEASE,VIRUSES
724352406,5/21/2015 09:02:10,1640188096,5/21/2015 09:01:46,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[CAUSES],[CAUSES],caused by inhalation of hay dust containing,N/A,77,135,1,89,161,TWrex-cause,810634-FS1,Antigens are commonly categorized by type and occupation (see  Table 55 4 ); FARMER'S LUNG caused by inhalation of hay dust containing THERMOPHILIC ACTINOMYCETES is the prototype.,FARMER'S LUNG,THERMOPHILIC ACTINOMYCETES
724352406,5/21/2015 09:19:37,1640197006,5/21/2015 09:19:17,false,neodev,1.0,15848372,AUS,02,Jannali,14.200.59.55,[SIDE_EFFECT] [CAUSES],"[CAUSES]
[SIDE_EFFECT]",caused by inhalation,N/A,77,135,1,89,161,TWrex-cause,810634-FS1,Antigens are commonly categorized by type and occupation (see  Table 55 4 ); FARMER'S LUNG caused by inhalation of hay dust containing THERMOPHILIC ACTINOMYCETES is the prototype.,FARMER'S LUNG,THERMOPHILIC ACTINOMYCETES
724352406,5/21/2015 09:39:49,1640207038,5/21/2015 09:38:21,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[CAUSES],[CAUSES],caused,N/A,77,135,1,89,161,TWrex-cause,810634-FS1,Antigens are commonly categorized by type and occupation (see  Table 55 4 ); FARMER'S LUNG caused by inhalation of hay dust containing THERMOPHILIC ACTINOMYCETES is the prototype.,FARMER'S LUNG,THERMOPHILIC ACTINOMYCETES
724352406,5/21/2015 09:49:24,1640211627,5/21/2015 09:49:12,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],caused,N/A,77,135,1,89,161,TWrex-cause,810634-FS1,Antigens are commonly categorized by type and occupation (see  Table 55 4 ); FARMER'S LUNG caused by inhalation of hay dust containing THERMOPHILIC ACTINOMYCETES is the prototype.,FARMER'S LUNG,THERMOPHILIC ACTINOMYCETES
724352406,5/21/2015 10:18:01,1640225939,5/21/2015 10:17:40,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[CAUSES],[CAUSES],caused,N/A,77,135,1,89,161,TWrex-cause,810634-FS1,Antigens are commonly categorized by type and occupation (see  Table 55 4 ); FARMER'S LUNG caused by inhalation of hay dust containing THERMOPHILIC ACTINOMYCETES is the prototype.,FARMER'S LUNG,THERMOPHILIC ACTINOMYCETES
724352406,5/21/2015 10:26:16,1640229771,5/21/2015 10:25:32,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],FARMER'S LUNG caused by THERMOPHILIC ACTINOMYCETES,N/A,77,135,1,89,161,TWrex-cause,810634-FS1,Antigens are commonly categorized by type and occupation (see  Table 55 4 ); FARMER'S LUNG caused by inhalation of hay dust containing THERMOPHILIC ACTINOMYCETES is the prototype.,FARMER'S LUNG,THERMOPHILIC ACTINOMYCETES
724352406,5/21/2015 10:30:56,1640231819,5/21/2015 10:30:42,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],THERMOPHILIC ACTINOMYCETES,none,77,135,1,89,161,TWrex-cause,810634-FS1,Antigens are commonly categorized by type and occupation (see  Table 55 4 ); FARMER'S LUNG caused by inhalation of hay dust containing THERMOPHILIC ACTINOMYCETES is the prototype.,FARMER'S LUNG,THERMOPHILIC ACTINOMYCETES
724352406,5/21/2015 10:36:49,1640234797,5/21/2015 10:36:38,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[CAUSES],[CAUSES],caused,N/A,77,135,1,89,161,TWrex-cause,810634-FS1,Antigens are commonly categorized by type and occupation (see  Table 55 4 ); FARMER'S LUNG caused by inhalation of hay dust containing THERMOPHILIC ACTINOMYCETES is the prototype.,FARMER'S LUNG,THERMOPHILIC ACTINOMYCETES
724352406,5/21/2015 10:45:52,1640239581,5/21/2015 10:45:24,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by inhalation of dust containing,n/a,77,135,1,89,161,TWrex-cause,810634-FS1,Antigens are commonly categorized by type and occupation (see  Table 55 4 ); FARMER'S LUNG caused by inhalation of hay dust containing THERMOPHILIC ACTINOMYCETES is the prototype.,FARMER'S LUNG,THERMOPHILIC ACTINOMYCETES
724352406,5/21/2015 10:55:51,1640244734,5/21/2015 10:55:13,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],caused by,N/A,77,135,1,89,161,TWrex-cause,810634-FS1,Antigens are commonly categorized by type and occupation (see  Table 55 4 ); FARMER'S LUNG caused by inhalation of hay dust containing THERMOPHILIC ACTINOMYCETES is the prototype.,FARMER'S LUNG,THERMOPHILIC ACTINOMYCETES
724352406,5/21/2015 10:56:47,1640245186,5/21/2015 10:55:42,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,77,135,1,89,161,TWrex-cause,810634-FS1,Antigens are commonly categorized by type and occupation (see  Table 55 4 ); FARMER'S LUNG caused by inhalation of hay dust containing THERMOPHILIC ACTINOMYCETES is the prototype.,FARMER'S LUNG,THERMOPHILIC ACTINOMYCETES
724352406,5/21/2015 10:59:28,1640246501,5/21/2015 10:58:04,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES] [PART_OF] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[ASSOCIATED_WITH]
[PART_OF]",categorized by occupation caused containing,n/a,77,135,1,89,161,TWrex-cause,810634-FS1,Antigens are commonly categorized by type and occupation (see  Table 55 4 ); FARMER'S LUNG caused by inhalation of hay dust containing THERMOPHILIC ACTINOMYCETES is the prototype.,FARMER'S LUNG,THERMOPHILIC ACTINOMYCETES
724352406,5/21/2015 11:17:02,1640254005,5/21/2015 11:16:31,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[ASSOCIATED_WITH],[ASSOCIATED_WITH],containing,N/A,77,135,1,89,161,TWrex-cause,810634-FS1,Antigens are commonly categorized by type and occupation (see  Table 55 4 ); FARMER'S LUNG caused by inhalation of hay dust containing THERMOPHILIC ACTINOMYCETES is the prototype.,FARMER'S LUNG,THERMOPHILIC ACTINOMYCETES
724352406,5/21/2015 11:31:06,1640260129,5/21/2015 11:30:55,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],caused,n/a,77,135,1,89,161,TWrex-cause,810634-FS1,Antigens are commonly categorized by type and occupation (see  Table 55 4 ); FARMER'S LUNG caused by inhalation of hay dust containing THERMOPHILIC ACTINOMYCETES is the prototype.,FARMER'S LUNG,THERMOPHILIC ACTINOMYCETES
724352406,5/21/2015 11:34:28,1640261540,5/21/2015 11:33:41,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,[OTHER],[OTHER],caused by,caused by,77,135,1,89,161,TWrex-cause,810634-FS1,Antigens are commonly categorized by type and occupation (see  Table 55 4 ); FARMER'S LUNG caused by inhalation of hay dust containing THERMOPHILIC ACTINOMYCETES is the prototype.,FARMER'S LUNG,THERMOPHILIC ACTINOMYCETES
724352407,5/21/2015 11:16:00,1640253566,5/21/2015 11:14:44,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],See table History and Physical Examination,N/A,53,221,1,61,224,TWrex-cause,812817-FS1,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of HEMATURIA ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",HEMATURIA,RCC
724352407,5/21/2015 11:18:27,1640254623,5/21/2015 11:17:32,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[PART_OF] [SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]
[PART_OF]",including: Cough Fever night sweats Weight loss Bone pain Fatigue family history suggest Examination,n/a,53,221,1,61,224,TWrex-cause,812817-FS1,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of HEMATURIA ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",HEMATURIA,RCC
724352407,5/21/2015 11:28:29,1640258824,5/21/2015 11:28:12,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[PREVENTS],[PREVENTS],metastatic,N/A,53,221,1,61,224,TWrex-cause,812817-FS1,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of HEMATURIA ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",HEMATURIA,RCC
724352407,5/21/2015 11:50:39,1640268996,5/21/2015 11:50:30,false,prodege,1.0,12656479,CAN,NB,Fredericton,198.164.157.90,[SYMPTOM],[SYMPTOM],Symptoms,N/A,53,221,1,61,224,TWrex-cause,812817-FS1,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of HEMATURIA ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",HEMATURIA,RCC
724352407,5/21/2015 12:17:50,1640281025,5/21/2015 12:17:23,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[SYMPTOM],[SYMPTOM],Symptoms,N/A,53,221,1,61,224,TWrex-cause,812817-FS1,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of HEMATURIA ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",HEMATURIA,RCC
724352407,5/21/2015 13:15:31,1640306269,5/21/2015 13:15:11,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[SYMPTOM],[SYMPTOM],Cough Fever night sweats Weight loss Bone pain Fatigue,N/A,53,221,1,61,224,TWrex-cause,812817-FS1,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of HEMATURIA ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",HEMATURIA,RCC
724352407,5/21/2015 13:30:59,1640314081,5/21/2015 13:28:55,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],Symptoms,N/A,53,221,1,61,224,TWrex-cause,812817-FS1,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of HEMATURIA ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",HEMATURIA,RCC
724352407,5/21/2015 13:34:33,1640315944,5/21/2015 13:32:22,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SYMPTOM],[SYMPTOM],HEMATURIA suggesting RCC,N/A,53,221,1,61,224,TWrex-cause,812817-FS1,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of HEMATURIA ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",HEMATURIA,RCC
724352407,5/21/2015 14:21:32,1640342909,5/21/2015 14:20:29,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM],[SYMPTOM],may suggest,N/A,53,221,1,61,224,TWrex-cause,812817-FS1,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of HEMATURIA ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",HEMATURIA,RCC
724352407,5/21/2015 14:23:03,1640343715,5/21/2015 14:22:50,false,neodev,1.0,32103286,GBR,H9,London,193.109.196.83,[CAUSES] [SYMPTOM] [NONE],"[CAUSES]
[SYMPTOM]
[NONE]",NO,NO,53,221,1,61,224,TWrex-cause,812817-FS1,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of HEMATURIA ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",HEMATURIA,RCC
724352407,5/21/2015 14:25:12,1640345274,5/21/2015 14:24:35,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[CAUSES],[CAUSES],may suggest a genetic predilection,N/A,53,221,1,61,224,TWrex-cause,812817-FS1,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of HEMATURIA ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",HEMATURIA,RCC
724352407,5/21/2015 14:26:22,1640346023,5/21/2015 14:25:03,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[MANIFESTATION],[MANIFESTATION],may suggest a genetic predilection,n/a,53,221,1,61,224,TWrex-cause,812817-FS1,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of HEMATURIA ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",HEMATURIA,RCC
724352407,5/21/2015 14:26:38,1640346198,5/21/2015 14:26:20,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],Symptoms,N/A,53,221,1,61,224,TWrex-cause,812817-FS1,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of HEMATURIA ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",HEMATURIA,RCC
724352407,5/21/2015 14:35:55,1640352007,5/21/2015 14:35:16,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[SYMPTOM],[SYMPTOM],"Abdominal flank pain Episodes HEMATURIA Symptoms suggesting possible metastatic disease, including: Cough Fever night sweats Weight loss Bone pain Fatigue",n/a,53,221,1,61,224,TWrex-cause,812817-FS1,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of HEMATURIA ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",HEMATURIA,RCC
724352407,5/21/2015 14:36:45,1640352596,5/21/2015 14:36:11,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],HEMATURIA Symptoms Cough Fever night sweats Weight pain Examination Elements RCC,na,53,221,1,61,224,TWrex-cause,812817-FS1,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of HEMATURIA ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",HEMATURIA,RCC
724352408,5/21/2015 07:03:54,1640125205,5/21/2015 07:03:25,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,[TREATS],[TREATS],BASAL INSULIN TYPE 1 DIABETES MELLITUS give rapid acting insulin,n/a,56,25,-1,79,38,TWrex-cause,803670-FS1,Intensive replacement of BASAL INSULIN in patients with TYPE 1 DIABETES MELLITUS give rapid acting insulin analog at mealtime: a 3 month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,TYPE 1 DIABETES MELLITUS,BASAL INSULIN
724352408,5/21/2015 07:11:31,1640129370,5/21/2015 07:11:15,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,56,25,-1,79,38,TWrex-cause,803670-FS1,Intensive replacement of BASAL INSULIN in patients with TYPE 1 DIABETES MELLITUS give rapid acting insulin analog at mealtime: a 3 month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,TYPE 1 DIABETES MELLITUS,BASAL INSULIN
724352408,5/21/2015 07:12:09,1640129644,5/21/2015 07:11:02,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],Intensive replacement,N/A,56,25,-1,79,38,TWrex-cause,803670-FS1,Intensive replacement of BASAL INSULIN in patients with TYPE 1 DIABETES MELLITUS give rapid acting insulin analog at mealtime: a 3 month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,TYPE 1 DIABETES MELLITUS,BASAL INSULIN
724352408,5/21/2015 07:16:53,1640132323,5/21/2015 07:16:11,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF] [ASSOCIATED_WITH] [IS_A] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",of with a of or,N/A,56,25,-1,79,38,TWrex-cause,803670-FS1,Intensive replacement of BASAL INSULIN in patients with TYPE 1 DIABETES MELLITUS give rapid acting insulin analog at mealtime: a 3 month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,TYPE 1 DIABETES MELLITUS,BASAL INSULIN
724352408,5/21/2015 07:27:22,1640137962,5/21/2015 07:26:33,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],give rapid acting insulin,N/A,56,25,-1,79,38,TWrex-cause,803670-FS1,Intensive replacement of BASAL INSULIN in patients with TYPE 1 DIABETES MELLITUS give rapid acting insulin analog at mealtime: a 3 month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,TYPE 1 DIABETES MELLITUS,BASAL INSULIN
724352408,5/21/2015 07:29:18,1640138958,5/21/2015 07:28:32,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],replacement of in patients with,N/A,56,25,-1,79,38,TWrex-cause,803670-FS1,Intensive replacement of BASAL INSULIN in patients with TYPE 1 DIABETES MELLITUS give rapid acting insulin analog at mealtime: a 3 month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,TYPE 1 DIABETES MELLITUS,BASAL INSULIN
724352408,5/21/2015 07:39:41,1640144478,5/21/2015 07:39:08,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH] [IS_A],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",of with a of or,N/A,56,25,-1,79,38,TWrex-cause,803670-FS1,Intensive replacement of BASAL INSULIN in patients with TYPE 1 DIABETES MELLITUS give rapid acting insulin analog at mealtime: a 3 month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,TYPE 1 DIABETES MELLITUS,BASAL INSULIN
724352408,5/21/2015 07:41:32,1640145515,5/21/2015 07:40:45,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],Intensive replacement,N/A,56,25,-1,79,38,TWrex-cause,803670-FS1,Intensive replacement of BASAL INSULIN in patients with TYPE 1 DIABETES MELLITUS give rapid acting insulin analog at mealtime: a 3 month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,TYPE 1 DIABETES MELLITUS,BASAL INSULIN
724352408,5/21/2015 07:43:33,1640146407,5/21/2015 07:43:13,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],Intensive replacement in patients,n/a,56,25,-1,79,38,TWrex-cause,803670-FS1,Intensive replacement of BASAL INSULIN in patients with TYPE 1 DIABETES MELLITUS give rapid acting insulin analog at mealtime: a 3 month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,TYPE 1 DIABETES MELLITUS,BASAL INSULIN
724352408,5/21/2015 07:58:50,1640154738,5/21/2015 07:58:24,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG] [IS_A] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",with a of or,N/A,56,25,-1,79,38,TWrex-cause,803670-FS1,Intensive replacement of BASAL INSULIN in patients with TYPE 1 DIABETES MELLITUS give rapid acting insulin analog at mealtime: a 3 month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,TYPE 1 DIABETES MELLITUS,BASAL INSULIN
724352408,5/21/2015 08:01:25,1640156019,5/21/2015 08:00:41,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],replacement,N/A,56,25,-1,79,38,TWrex-cause,803670-FS1,Intensive replacement of BASAL INSULIN in patients with TYPE 1 DIABETES MELLITUS give rapid acting insulin analog at mealtime: a 3 month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,TYPE 1 DIABETES MELLITUS,BASAL INSULIN
724352408,5/21/2015 08:08:07,1640159635,5/21/2015 08:06:30,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,[TREATS],[TREATS],rapid acting,-,56,25,-1,79,38,TWrex-cause,803670-FS1,Intensive replacement of BASAL INSULIN in patients with TYPE 1 DIABETES MELLITUS give rapid acting insulin analog at mealtime: a 3 month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,TYPE 1 DIABETES MELLITUS,BASAL INSULIN
724352408,5/21/2015 08:29:56,1640171545,5/21/2015 08:29:24,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[TREATS],[TREATS],Intensive BASAL INSULIN TYPE 1 DIABETES MELLITUS,n/a,56,25,-1,79,38,TWrex-cause,803670-FS1,Intensive replacement of BASAL INSULIN in patients with TYPE 1 DIABETES MELLITUS give rapid acting insulin analog at mealtime: a 3 month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,TYPE 1 DIABETES MELLITUS,BASAL INSULIN
724352408,5/21/2015 08:36:32,1640175140,5/21/2015 08:35:17,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[OTHER],[OTHER],"replacement of BASAL INSULIN in patients with TYPE 1 DIABETES MEL<span id=""transmark""></span>LITUS",na,56,25,-1,79,38,TWrex-cause,803670-FS1,Intensive replacement of BASAL INSULIN in patients with TYPE 1 DIABETES MELLITUS give rapid acting insulin analog at mealtime: a 3 month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,TYPE 1 DIABETES MELLITUS,BASAL INSULIN
724352408,5/21/2015 08:41:22,1640177518,5/21/2015 08:40:04,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,Associated with,56,25,-1,79,38,TWrex-cause,803670-FS1,Intensive replacement of BASAL INSULIN in patients with TYPE 1 DIABETES MELLITUS give rapid acting insulin analog at mealtime: a 3 month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,TYPE 1 DIABETES MELLITUS,BASAL INSULIN
724352409,5/21/2015 09:04:19,1640189253,5/21/2015 09:03:59,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[MANIFESTATION],[MANIFESTATION],exhibiting,N/A,174,124,1,189,136,TWrex-cause,815099-FS1,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La Ongpant M, et al. Sequence analysis of RABIES VIRUS in humans exhibiting encephalitic or PARALYTIC RABIES",PARALYTIC RABIES,RABIES VIRUS
724352409,5/21/2015 09:21:43,1640197904,5/21/2015 09:21:24,false,neodev,1.0,15848372,AUS,02,Jannali,14.200.59.55,[MANIFESTATION],[MANIFESTATION],exhibiting,N/A,174,124,1,189,136,TWrex-cause,815099-FS1,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La Ongpant M, et al. Sequence analysis of RABIES VIRUS in humans exhibiting encephalitic or PARALYTIC RABIES",PARALYTIC RABIES,RABIES VIRUS
724352409,5/21/2015 09:41:10,1640207636,5/21/2015 09:40:59,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[MANIFESTATION],[MANIFESTATION],encephalitic,N/A,174,124,1,189,136,TWrex-cause,815099-FS1,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La Ongpant M, et al. Sequence analysis of RABIES VIRUS in humans exhibiting encephalitic or PARALYTIC RABIES",PARALYTIC RABIES,RABIES VIRUS
724352409,5/21/2015 09:50:32,1640212240,5/21/2015 09:50:19,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CONTRAINDICATES],[CONTRAINDICATES],encephalitic,N/A,174,124,1,189,136,TWrex-cause,815099-FS1,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La Ongpant M, et al. Sequence analysis of RABIES VIRUS in humans exhibiting encephalitic or PARALYTIC RABIES",PARALYTIC RABIES,RABIES VIRUS
724352409,5/21/2015 10:19:31,1640226684,5/21/2015 10:19:15,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[SYMPTOM],[SYMPTOM],exhibiting,N/A,174,124,1,189,136,TWrex-cause,815099-FS1,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La Ongpant M, et al. Sequence analysis of RABIES VIRUS in humans exhibiting encephalitic or PARALYTIC RABIES",PARALYTIC RABIES,RABIES VIRUS
724352409,5/21/2015 10:30:05,1640231469,5/21/2015 10:29:07,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],analysis RABIES VIRUS in humans exhibiting PARALYTIC RABIES,N/A,174,124,1,189,136,TWrex-cause,815099-FS1,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La Ongpant M, et al. Sequence analysis of RABIES VIRUS in humans exhibiting encephalitic or PARALYTIC RABIES",PARALYTIC RABIES,RABIES VIRUS
724352409,5/21/2015 10:32:26,1640232616,5/21/2015 10:32:13,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[CAUSES],[CAUSES],PARALYTIC RABIES,none,174,124,1,189,136,TWrex-cause,815099-FS1,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La Ongpant M, et al. Sequence analysis of RABIES VIRUS in humans exhibiting encephalitic or PARALYTIC RABIES",PARALYTIC RABIES,RABIES VIRUS
724352409,5/21/2015 10:38:05,1640235443,5/21/2015 10:37:49,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[SYMPTOM],[SYMPTOM],exhibiting,N/A,174,124,1,189,136,TWrex-cause,815099-FS1,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La Ongpant M, et al. Sequence analysis of RABIES VIRUS in humans exhibiting encephalitic or PARALYTIC RABIES",PARALYTIC RABIES,RABIES VIRUS
724352409,5/21/2015 10:47:38,1640240495,5/21/2015 10:47:17,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[SYMPTOM],[SYMPTOM],humans exhibiting,n/a,174,124,1,189,136,TWrex-cause,815099-FS1,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La Ongpant M, et al. Sequence analysis of RABIES VIRUS in humans exhibiting encephalitic or PARALYTIC RABIES",PARALYTIC RABIES,RABIES VIRUS
724352409,5/21/2015 11:00:00,1640246776,5/21/2015 10:59:11,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[MANIFESTATION],[MANIFESTATION],exhibiting,N/A,174,124,1,189,136,TWrex-cause,815099-FS1,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La Ongpant M, et al. Sequence analysis of RABIES VIRUS in humans exhibiting encephalitic or PARALYTIC RABIES",PARALYTIC RABIES,RABIES VIRUS
724352409,5/21/2015 11:03:10,1640248155,5/21/2015 11:01:58,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[SYMPTOM],[SYMPTOM],exhibiting encephalitic,N/A,174,124,1,189,136,TWrex-cause,815099-FS1,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La Ongpant M, et al. Sequence analysis of RABIES VIRUS in humans exhibiting encephalitic or PARALYTIC RABIES",PARALYTIC RABIES,RABIES VIRUS
724352409,5/21/2015 11:05:47,1640249266,5/21/2015 11:04:44,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[DIAGNOSE_BY_TEST_OR_DRUG] [SYMPTOM] [LOCATION],"[DIAGNOSE_BY_TEST_OR_DRUG]
[LOCATION]
[SYMPTOM]",analysis in exhibiting,n/a,174,124,1,189,136,TWrex-cause,815099-FS1,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La Ongpant M, et al. Sequence analysis of RABIES VIRUS in humans exhibiting encephalitic or PARALYTIC RABIES",PARALYTIC RABIES,RABIES VIRUS
724352409,5/21/2015 11:18:18,1640254598,5/21/2015 11:18:03,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[MANIFESTATION],[MANIFESTATION],exhibiting,N/A,174,124,1,189,136,TWrex-cause,815099-FS1,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La Ongpant M, et al. Sequence analysis of RABIES VIRUS in humans exhibiting encephalitic or PARALYTIC RABIES",PARALYTIC RABIES,RABIES VIRUS
724352409,5/21/2015 11:33:18,1640261043,5/21/2015 11:32:54,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in,n/a,174,124,1,189,136,TWrex-cause,815099-FS1,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La Ongpant M, et al. Sequence analysis of RABIES VIRUS in humans exhibiting encephalitic or PARALYTIC RABIES",PARALYTIC RABIES,RABIES VIRUS
724352409,5/21/2015 11:38:46,1640263679,5/21/2015 11:37:02,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],analysis of in humans exhibiting encephalitic or,n/a,174,124,1,189,136,TWrex-cause,815099-FS1,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La Ongpant M, et al. Sequence analysis of RABIES VIRUS in humans exhibiting encephalitic or PARALYTIC RABIES",PARALYTIC RABIES,RABIES VIRUS
724352410,5/21/2015 08:49:25,1640181549,5/21/2015 08:48:53,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,Associated,43,23,-1,61,26,TWrex-cause,803037-FS1,"The specificity of the PPD (10 mm) and the QUANTIFERON TB GOLD was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture positive active TB.",QUANTIFERON TB GOLD,PPD
724352410,5/21/2015 08:50:50,1640182325,5/21/2015 08:50:23,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[PART_OF],[PART_OF],of,N/A,43,23,-1,61,26,TWrex-cause,803037-FS1,"The specificity of the PPD (10 mm) and the QUANTIFERON TB GOLD was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture positive active TB.",QUANTIFERON TB GOLD,PPD
724352410,5/21/2015 08:51:55,1640182915,5/21/2015 08:51:10,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"The specificity of the PPD (10 mm) and the QUANTIFERON TB GOLD was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture positive active TB.",n/a,43,23,-1,61,26,TWrex-cause,803037-FS1,"The specificity of the PPD (10 mm) and the QUANTIFERON TB GOLD was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture positive active TB.",QUANTIFERON TB GOLD,PPD
724352410,5/21/2015 08:52:50,1640183401,5/21/2015 08:51:50,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[ASSOCIATED_WITH] [OTHER],"[ASSOCIATED_WITH]
[OTHER]","specificity of t<span id=""transmark""></span>he PPD the QUANTIFERON TB GOLD",n/a,43,23,-1,61,26,TWrex-cause,803037-FS1,"The specificity of the PPD (10 mm) and the QUANTIFERON TB GOLD was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture positive active TB.",QUANTIFERON TB GOLD,PPD
724352410,5/21/2015 08:52:59,1640183462,5/21/2015 08:52:23,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[NONE],[NONE],N/A,TERMS NOT RELATED,43,23,-1,61,26,TWrex-cause,803037-FS1,"The specificity of the PPD (10 mm) and the QUANTIFERON TB GOLD was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture positive active TB.",QUANTIFERON TB GOLD,PPD
724352410,5/21/2015 09:07:40,1640190882,5/21/2015 09:06:29,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[OTHER] [NONE],"[OTHER]
[NONE]",N/A,"They are related by specificity, but no word expresses relation in the sentence.",43,23,-1,61,26,TWrex-cause,803037-FS1,"The specificity of the PPD (10 mm) and the QUANTIFERON TB GOLD was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture positive active TB.",QUANTIFERON TB GOLD,PPD
724352410,5/21/2015 09:08:15,1640191175,5/21/2015 09:07:58,false,neodev,1.0,15848372,AUS,02,Jannali,14.200.59.55,[OTHER],[OTHER],and,N/A,43,23,-1,61,26,TWrex-cause,803037-FS1,"The specificity of the PPD (10 mm) and the QUANTIFERON TB GOLD was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture positive active TB.",QUANTIFERON TB GOLD,PPD
724352410,5/21/2015 09:22:29,1640198283,5/21/2015 09:21:06,false,clixsense,1.0,28570371,NLD,"","",91.213.37.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],specificity,N/A,43,23,-1,61,26,TWrex-cause,803037-FS1,"The specificity of the PPD (10 mm) and the QUANTIFERON TB GOLD was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture positive active TB.",QUANTIFERON TB GOLD,PPD
724352410,5/21/2015 09:26:39,1640200443,5/21/2015 09:26:04,false,neodev,1.0,31195295,GBR,"","",46.208.164.162,[NONE],[NONE],N/A,seperate entities,43,23,-1,61,26,TWrex-cause,803037-FS1,"The specificity of the PPD (10 mm) and the QUANTIFERON TB GOLD was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture positive active TB.",QUANTIFERON TB GOLD,PPD
724352410,5/21/2015 09:33:46,1640204116,5/21/2015 09:33:35,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[LOCATION],[LOCATION],was,N/A,43,23,-1,61,26,TWrex-cause,803037-FS1,"The specificity of the PPD (10 mm) and the QUANTIFERON TB GOLD was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture positive active TB.",QUANTIFERON TB GOLD,PPD
724352410,5/21/2015 09:44:38,1640209338,5/21/2015 09:44:27,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[IS_A],[IS_A],was,N/A,43,23,-1,61,26,TWrex-cause,803037-FS1,"The specificity of the PPD (10 mm) and the QUANTIFERON TB GOLD was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture positive active TB.",QUANTIFERON TB GOLD,PPD
724352410,5/21/2015 10:06:04,1640219976,5/21/2015 10:05:03,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PPD and the QUANTIFERON TB GOLD,N/A,43,23,-1,61,26,TWrex-cause,803037-FS1,"The specificity of the PPD (10 mm) and the QUANTIFERON TB GOLD was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture positive active TB.",QUANTIFERON TB GOLD,PPD
724352410,5/21/2015 10:12:08,1640222931,5/21/2015 10:11:52,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[SIDE_EFFECT],[SIDE_EFFECT],and,N/A,43,23,-1,61,26,TWrex-cause,803037-FS1,"The specificity of the PPD (10 mm) and the QUANTIFERON TB GOLD was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture positive active TB.",QUANTIFERON TB GOLD,PPD
724352410,5/21/2015 10:24:58,1640229194,5/21/2015 10:24:40,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"QuantiFERON,",none,43,23,-1,61,26,TWrex-cause,803037-FS1,"The specificity of the PPD (10 mm) and the QUANTIFERON TB GOLD was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture positive active TB.",QUANTIFERON TB GOLD,PPD
724352410,5/21/2015 10:26:16,1640229769,5/21/2015 10:25:36,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],and,N/A,43,23,-1,61,26,TWrex-cause,803037-FS1,"The specificity of the PPD (10 mm) and the QUANTIFERON TB GOLD was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture positive active TB.",QUANTIFERON TB GOLD,PPD
724352411,5/21/2015 09:01:25,1640187751,5/21/2015 09:01:13,false,prodege,1,22031444,GBR,B7,Bristol,92.236.71.128,[CAUSES],[CAUSES],caused by,N/A,30,53,1,40,72,TWrex-cause,811056-FS1,26  Brucellosis  Treatment of BRUCELLOSIS caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
724352411,5/21/2015 09:19:00,1640196699,5/21/2015 09:18:48,false,neodev,1,15848372,AUS,02,Jannali,14.200.59.55,[CAUSES],[CAUSES],caused,N/A,30,53,1,40,72,TWrex-cause,811056-FS1,26  Brucellosis  Treatment of BRUCELLOSIS caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
724352411,5/21/2015 09:37:54,1640206127,5/21/2015 09:37:43,false,elite,1,30654968,USA,OR,Portland,67.213.218.73,[CAUSES],[CAUSES],caused,N/A,30,53,1,40,72,TWrex-cause,811056-FS1,26  Brucellosis  Treatment of BRUCELLOSIS caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
724352411,5/21/2015 09:48:57,1640211358,5/21/2015 09:48:46,false,elite,1,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],caused,N/A,30,53,1,40,72,TWrex-cause,811056-FS1,26  Brucellosis  Treatment of BRUCELLOSIS caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
724352411,5/21/2015 10:17:24,1640225597,5/21/2015 10:17:10,false,elite,1,31685662,USA,VA,Manassas,207.244.89.77,[CAUSES],[CAUSES],caused,N/A,30,53,1,40,72,TWrex-cause,811056-FS1,26  Brucellosis  Treatment of BRUCELLOSIS caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
724352411,5/21/2015 10:24:56,1640229170,5/21/2015 10:24:27,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],BRUCELLOSIS caused by BRUCELLA MELITENSIS.,N/A,30,53,1,40,72,TWrex-cause,811056-FS1,26  Brucellosis  Treatment of BRUCELLOSIS caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
724352411,5/21/2015 10:30:26,1640231622,5/21/2015 10:30:12,false,zoombucks,1,4711962,CAN,ON,Markham,174.88.29.12,[CAUSES],[CAUSES],BRUCELLOSIS,none,30,53,1,40,72,TWrex-cause,811056-FS1,26  Brucellosis  Treatment of BRUCELLOSIS caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
724352411,5/21/2015 10:36:22,1640234444,5/21/2015 10:36:09,false,elite,1,30655282,USA,AZ,Tempe,23.235.227.109,[CAUSES],[CAUSES],caused,N/A,30,53,1,40,72,TWrex-cause,811056-FS1,26  Brucellosis  Treatment of BRUCELLOSIS caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
724352411,5/21/2015 10:44:55,1640239012,5/21/2015 10:44:42,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by,n/a,30,53,1,40,72,TWrex-cause,811056-FS1,26  Brucellosis  Treatment of BRUCELLOSIS caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
724352411,5/21/2015 10:54:41,1640244187,5/21/2015 10:54:17,false,gifthunterclub,1,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],caused by,N/A,30,53,1,40,72,TWrex-cause,811056-FS1,26  Brucellosis  Treatment of BRUCELLOSIS caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
724352411,5/21/2015 10:55:13,1640244459,5/21/2015 10:54:52,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,30,53,1,40,72,TWrex-cause,811056-FS1,26  Brucellosis  Treatment of BRUCELLOSIS caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
724352411,5/21/2015 10:57:04,1640245290,5/21/2015 10:56:37,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,[TREATS] [CAUSES] [MANIFESTATION],"[TREATS]
[CAUSES]
[MANIFESTATION]",Treatment caused by,n/a,30,53,1,40,72,TWrex-cause,811056-FS1,26  Brucellosis  Treatment of BRUCELLOSIS caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
724352411,5/21/2015 11:16:13,1640253606,5/21/2015 11:16:00,false,elite,1,31227441,USA,IL,Chicago,173.193.202.116,[CAUSES],[CAUSES],caused,N/A,30,53,1,40,72,TWrex-cause,811056-FS1,26  Brucellosis  Treatment of BRUCELLOSIS caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
724352411,5/21/2015 11:30:35,1640259821,5/21/2015 11:30:21,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],Treatment,n/a,30,53,1,40,72,TWrex-cause,811056-FS1,26  Brucellosis  Treatment of BRUCELLOSIS caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
724352411,5/21/2015 11:32:41,1640260772,5/21/2015 11:31:38,false,gifthunterclub,1,31241093,GBR,G9,Prescot,2.124.219.3,[NONE],[NONE],n/a,n/a,30,53,1,40,72,TWrex-cause,811056-FS1,26  Brucellosis  Treatment of BRUCELLOSIS caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
724352412,5/21/2015 08:51:06,1640182437,5/21/2015 08:50:23,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,[TREATS],[TREATS],management,Treatment,120,91,-1,140,101,TWrex-cause,803951-FS1,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, DALTEPARIN reduced death and MYOCARDIAL INFARCTION at 1 month but not at 3 months.",MYOCARDIAL INFARCTION,DALTEPARIN
724352412,5/21/2015 08:53:58,1640183990,5/21/2015 08:53:08,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS],[PREVENTS],"CONCLUSION In patients who received noninvasive management for unstable coronary disease, DALTEPARIN reduced death and MYOCARDIAL INFARCTION at 1 month but not at 3 months.",n/a,120,91,-1,140,101,TWrex-cause,803951-FS1,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, DALTEPARIN reduced death and MYOCARDIAL INFARCTION at 1 month but not at 3 months.",MYOCARDIAL INFARCTION,DALTEPARIN
724352412,5/21/2015 08:54:25,1640184263,5/21/2015 08:54:02,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[TREATS],[TREATS],patients who received reduced death and,N/A,120,91,-1,140,101,TWrex-cause,803951-FS1,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, DALTEPARIN reduced death and MYOCARDIAL INFARCTION at 1 month but not at 3 months.",MYOCARDIAL INFARCTION,DALTEPARIN
724352412,5/21/2015 08:56:15,1640185119,5/21/2015 08:55:05,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS] [OTHER],"[TREATS]
[OTHER]","DALTEPARIN reduced MYOCARDIAL INFARCTION at 1 mon<span id=""transmark""></span>th",n/a,120,91,-1,140,101,TWrex-cause,803951-FS1,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, DALTEPARIN reduced death and MYOCARDIAL INFARCTION at 1 month but not at 3 months.",MYOCARDIAL INFARCTION,DALTEPARIN
724352412,5/21/2015 08:58:38,1640186230,5/21/2015 08:57:04,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[CONTRAINDICATES],[CONTRAINDICATES],CONCLUSION,N/A,120,91,-1,140,101,TWrex-cause,803951-FS1,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, DALTEPARIN reduced death and MYOCARDIAL INFARCTION at 1 month but not at 3 months.",MYOCARDIAL INFARCTION,DALTEPARIN
724352412,5/21/2015 09:09:14,1640191780,5/21/2015 09:08:55,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",reduced,N/A,120,91,-1,140,101,TWrex-cause,803951-FS1,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, DALTEPARIN reduced death and MYOCARDIAL INFARCTION at 1 month but not at 3 months.",MYOCARDIAL INFARCTION,DALTEPARIN
724352412,5/21/2015 09:09:49,1640192096,5/21/2015 09:09:11,false,neodev,1.0,15848372,AUS,02,Jannali,14.200.59.55,[OTHER],[OTHER],reduced,N/A,120,91,-1,140,101,TWrex-cause,803951-FS1,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, DALTEPARIN reduced death and MYOCARDIAL INFARCTION at 1 month but not at 3 months.",MYOCARDIAL INFARCTION,DALTEPARIN
724352412,5/21/2015 09:24:07,1640199067,5/21/2015 09:23:41,false,clixsense,1,28570371,NLD,"","",91.213.37.165,[TREATS],[TREATS],reduced death,N/A,120,91,-1,140,101,TWrex-cause,803951-FS1,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, DALTEPARIN reduced death and MYOCARDIAL INFARCTION at 1 month but not at 3 months.",MYOCARDIAL INFARCTION,DALTEPARIN
724352412,5/21/2015 09:28:11,1640201186,5/21/2015 09:27:43,false,neodev,1,31195295,GBR,"","",46.208.164.162,[PREVENTS],[PREVENTS],reduced,N/A,120,91,-1,140,101,TWrex-cause,803951-FS1,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, DALTEPARIN reduced death and MYOCARDIAL INFARCTION at 1 month but not at 3 months.",MYOCARDIAL INFARCTION,DALTEPARIN
724352412,5/21/2015 09:34:27,1640204507,5/21/2015 09:34:15,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],reduced,N/A,120,91,-1,140,101,TWrex-cause,803951-FS1,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, DALTEPARIN reduced death and MYOCARDIAL INFARCTION at 1 month but not at 3 months.",MYOCARDIAL INFARCTION,DALTEPARIN
724352412,5/21/2015 09:45:23,1640209705,5/21/2015 09:45:06,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[SYMPTOM],[SYMPTOM],"disease,",N/A,120,91,-1,140,101,TWrex-cause,803951-FS1,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, DALTEPARIN reduced death and MYOCARDIAL INFARCTION at 1 month but not at 3 months.",MYOCARDIAL INFARCTION,DALTEPARIN
724352412,5/21/2015 10:09:06,1640221476,5/21/2015 10:07:53,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[PREVENTS],[PREVENTS],DALTEPARIN reduced death and MYOCARDIAL INFARCTION,N/A,120,91,-1,140,101,TWrex-cause,803951-FS1,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, DALTEPARIN reduced death and MYOCARDIAL INFARCTION at 1 month but not at 3 months.",MYOCARDIAL INFARCTION,DALTEPARIN
724352412,5/21/2015 10:13:03,1640223470,5/21/2015 10:12:41,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],reduced,N/A,120,91,-1,140,101,TWrex-cause,803951-FS1,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, DALTEPARIN reduced death and MYOCARDIAL INFARCTION at 1 month but not at 3 months.",MYOCARDIAL INFARCTION,DALTEPARIN
724352412,5/21/2015 10:25:49,1640229540,5/21/2015 10:25:35,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[TREATS],[TREATS],DALTEPARIN,none,120,91,-1,140,101,TWrex-cause,803951-FS1,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, DALTEPARIN reduced death and MYOCARDIAL INFARCTION at 1 month but not at 3 months.",MYOCARDIAL INFARCTION,DALTEPARIN
724352412,5/21/2015 10:30:48,1640231782,5/21/2015 10:28:42,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[PREVENTS],[PREVENTS],reduced,N/A,120,91,-1,140,101,TWrex-cause,803951-FS1,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, DALTEPARIN reduced death and MYOCARDIAL INFARCTION at 1 month but not at 3 months.",MYOCARDIAL INFARCTION,DALTEPARIN
724352413,5/21/2015 07:00:33,1640123492,5/21/2015 07:00:16,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,[PREVENTS],[PREVENTS],ENOXAPARIN for prevention of DEEP VEIN THROMBOSIS,n/a,86,27,-1,105,37,TWrex-cause,804767-FS1,1]  Efficacy and safety of ENOXAPARIN versus unfractionated heparin for prevention of DEEP VEIN THROMBOSIS in elective cancer surgery: a double blind randomized multicentre trial with venographic assessment.,DEEP VEIN THROMBOSIS,ENOXAPARIN
724352413,5/21/2015 07:06:54,1640126801,5/21/2015 07:06:38,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[PREVENTS],[PREVENTS],prevention,N/A,86,27,-1,105,37,TWrex-cause,804767-FS1,1]  Efficacy and safety of ENOXAPARIN versus unfractionated heparin for prevention of DEEP VEIN THROMBOSIS in elective cancer surgery: a double blind randomized multicentre trial with venographic assessment.,DEEP VEIN THROMBOSIS,ENOXAPARIN
724352413,5/21/2015 07:09:19,1640128163,5/21/2015 07:09:07,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[PREVENTS],[PREVENTS],prevention,N/A,86,27,-1,105,37,TWrex-cause,804767-FS1,1]  Efficacy and safety of ENOXAPARIN versus unfractionated heparin for prevention of DEEP VEIN THROMBOSIS in elective cancer surgery: a double blind randomized multicentre trial with venographic assessment.,DEEP VEIN THROMBOSIS,ENOXAPARIN
724352413,5/21/2015 07:12:03,1640129607,5/21/2015 07:11:34,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF] [IS_A],"[IS_A]
[PART_OF]",of of a,N/A,86,27,-1,105,37,TWrex-cause,804767-FS1,1]  Efficacy and safety of ENOXAPARIN versus unfractionated heparin for prevention of DEEP VEIN THROMBOSIS in elective cancer surgery: a double blind randomized multicentre trial with venographic assessment.,DEEP VEIN THROMBOSIS,ENOXAPARIN
724352413,5/21/2015 07:20:12,1640134294,5/21/2015 07:19:53,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[PREVENTS],[PREVENTS],for prevention of,N/A,86,27,-1,105,37,TWrex-cause,804767-FS1,1]  Efficacy and safety of ENOXAPARIN versus unfractionated heparin for prevention of DEEP VEIN THROMBOSIS in elective cancer surgery: a double blind randomized multicentre trial with venographic assessment.,DEEP VEIN THROMBOSIS,ENOXAPARIN
724352413,5/21/2015 07:23:17,1640135830,5/21/2015 07:22:56,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[PREVENTS],[PREVENTS],prevention of,N/A,86,27,-1,105,37,TWrex-cause,804767-FS1,1]  Efficacy and safety of ENOXAPARIN versus unfractionated heparin for prevention of DEEP VEIN THROMBOSIS in elective cancer surgery: a double blind randomized multicentre trial with venographic assessment.,DEEP VEIN THROMBOSIS,ENOXAPARIN
724352413,5/21/2015 07:34:49,1640141872,5/21/2015 07:34:17,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [ASSOCIATED_WITH] [IS_A],"[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",of of a with,N/A,86,27,-1,105,37,TWrex-cause,804767-FS1,1]  Efficacy and safety of ENOXAPARIN versus unfractionated heparin for prevention of DEEP VEIN THROMBOSIS in elective cancer surgery: a double blind randomized multicentre trial with venographic assessment.,DEEP VEIN THROMBOSIS,ENOXAPARIN
724352413,5/21/2015 07:37:11,1640143101,5/21/2015 07:36:45,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[PREVENTS],[PREVENTS],prevention of,N/A,86,27,-1,105,37,TWrex-cause,804767-FS1,1]  Efficacy and safety of ENOXAPARIN versus unfractionated heparin for prevention of DEEP VEIN THROMBOSIS in elective cancer surgery: a double blind randomized multicentre trial with venographic assessment.,DEEP VEIN THROMBOSIS,ENOXAPARIN
724352413,5/21/2015 07:40:21,1640144862,5/21/2015 07:40:00,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],versus heparin,n/a,86,27,-1,105,37,TWrex-cause,804767-FS1,1]  Efficacy and safety of ENOXAPARIN versus unfractionated heparin for prevention of DEEP VEIN THROMBOSIS in elective cancer surgery: a double blind randomized multicentre trial with venographic assessment.,DEEP VEIN THROMBOSIS,ENOXAPARIN
724352413,5/21/2015 07:54:36,1640152518,5/21/2015 07:54:11,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF] [ASSOCIATED_WITH] [IS_A],"[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",of of a trial,N/A,86,27,-1,105,37,TWrex-cause,804767-FS1,1]  Efficacy and safety of ENOXAPARIN versus unfractionated heparin for prevention of DEEP VEIN THROMBOSIS in elective cancer surgery: a double blind randomized multicentre trial with venographic assessment.,DEEP VEIN THROMBOSIS,ENOXAPARIN
724352413,5/21/2015 07:55:03,1640152824,5/21/2015 07:54:43,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[PREVENTS],[PREVENTS],prevention of,N/A,86,27,-1,105,37,TWrex-cause,804767-FS1,1]  Efficacy and safety of ENOXAPARIN versus unfractionated heparin for prevention of DEEP VEIN THROMBOSIS in elective cancer surgery: a double blind randomized multicentre trial with venographic assessment.,DEEP VEIN THROMBOSIS,ENOXAPARIN
724352413,5/21/2015 08:00:21,1640155506,5/21/2015 07:58:40,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,[TREATS],[TREATS],prevention,-,86,27,-1,105,37,TWrex-cause,804767-FS1,1]  Efficacy and safety of ENOXAPARIN versus unfractionated heparin for prevention of DEEP VEIN THROMBOSIS in elective cancer surgery: a double blind randomized multicentre trial with venographic assessment.,DEEP VEIN THROMBOSIS,ENOXAPARIN
724352413,5/21/2015 08:13:24,1640162462,5/21/2015 08:12:53,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[PART_OF] [IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",of of a with,N/A,86,27,-1,105,37,TWrex-cause,804767-FS1,1]  Efficacy and safety of ENOXAPARIN versus unfractionated heparin for prevention of DEEP VEIN THROMBOSIS in elective cancer surgery: a double blind randomized multicentre trial with venographic assessment.,DEEP VEIN THROMBOSIS,ENOXAPARIN
724352413,5/21/2015 08:24:34,1640168631,5/21/2015 08:23:54,false,clixsense,1,12843982,AUS,08,Perth,180.216.79.226,[PREVENTS],[PREVENTS],ENOXAPARIN for prevention DEEP VEIN THROMBOSIS,N/A,86,27,-1,105,37,TWrex-cause,804767-FS1,1]  Efficacy and safety of ENOXAPARIN versus unfractionated heparin for prevention of DEEP VEIN THROMBOSIS in elective cancer surgery: a double blind randomized multicentre trial with venographic assessment.,DEEP VEIN THROMBOSIS,ENOXAPARIN
724352413,5/21/2015 08:25:25,1640169124,5/21/2015 08:25:05,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[TREATS],[TREATS],ENOXAPARIN prevention DEEP VEIN THROMBOSIS,n/a,86,27,-1,105,37,TWrex-cause,804767-FS1,1]  Efficacy and safety of ENOXAPARIN versus unfractionated heparin for prevention of DEEP VEIN THROMBOSIS in elective cancer surgery: a double blind randomized multicentre trial with venographic assessment.,DEEP VEIN THROMBOSIS,ENOXAPARIN
724352414,5/21/2015 11:13:55,1640252741,5/21/2015 11:13:14,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and argyria must be distinguished,N/A,0,144,1,33,159,TWrex-cause,814568-FS1,"POSTINFLAMMATORY HYPERPIGMENTATION pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, HEMOCHROMATOSIS and argyria must be distinguished from EDP.",POSTINFLAMMATORY HYPERPIGMENTATION,HEMOCHROMATOSIS
724352414,5/21/2015 11:17:12,1640254075,5/21/2015 11:16:29,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]","fixed drug eruption, distinguished from",n/a,0,144,1,33,159,TWrex-cause,814568-FS1,"POSTINFLAMMATORY HYPERPIGMENTATION pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, HEMOCHROMATOSIS and argyria must be distinguished from EDP.",POSTINFLAMMATORY HYPERPIGMENTATION,HEMOCHROMATOSIS
724352414,5/21/2015 11:27:56,1640258593,5/21/2015 11:27:42,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],drug,N/A,0,144,1,33,159,TWrex-cause,814568-FS1,"POSTINFLAMMATORY HYPERPIGMENTATION pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, HEMOCHROMATOSIS and argyria must be distinguished from EDP.",POSTINFLAMMATORY HYPERPIGMENTATION,HEMOCHROMATOSIS
724352414,5/21/2015 11:37:23,1640262850,5/21/2015 11:36:50,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,0,144,1,33,159,TWrex-cause,814568-FS1,"POSTINFLAMMATORY HYPERPIGMENTATION pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, HEMOCHROMATOSIS and argyria must be distinguished from EDP.",POSTINFLAMMATORY HYPERPIGMENTATION,HEMOCHROMATOSIS
724352414,5/21/2015 11:49:18,1640268505,5/21/2015 11:48:31,false,prodege,1,12656479,CAN,NB,Fredericton,198.164.157.90,[CAUSES],[CAUSES],distinguished,N/A,0,144,1,33,159,TWrex-cause,814568-FS1,"POSTINFLAMMATORY HYPERPIGMENTATION pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, HEMOCHROMATOSIS and argyria must be distinguished from EDP.",POSTINFLAMMATORY HYPERPIGMENTATION,HEMOCHROMATOSIS
724352414,5/21/2015 12:17:10,1640280796,5/21/2015 12:16:33,false,neodev,1,20961587,NLD,05,Maastricht,84.26.48.136,[PART_OF],[PART_OF],distinguished,N/A,0,144,1,33,159,TWrex-cause,814568-FS1,"POSTINFLAMMATORY HYPERPIGMENTATION pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, HEMOCHROMATOSIS and argyria must be distinguished from EDP.",POSTINFLAMMATORY HYPERPIGMENTATION,HEMOCHROMATOSIS
724352414,5/21/2015 13:14:33,1640305550,5/21/2015 13:13:34,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,[SYMPTOM],[SYMPTOM],"rosea,",N/A,0,144,1,33,159,TWrex-cause,814568-FS1,"POSTINFLAMMATORY HYPERPIGMENTATION pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, HEMOCHROMATOSIS and argyria must be distinguished from EDP.",POSTINFLAMMATORY HYPERPIGMENTATION,HEMOCHROMATOSIS
724352414,5/21/2015 13:27:27,1640312258,5/21/2015 13:26:11,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,0,144,1,33,159,TWrex-cause,814568-FS1,"POSTINFLAMMATORY HYPERPIGMENTATION pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, HEMOCHROMATOSIS and argyria must be distinguished from EDP.",POSTINFLAMMATORY HYPERPIGMENTATION,HEMOCHROMATOSIS
724352414,5/21/2015 13:31:37,1640314446,5/21/2015 13:30:44,false,gifthulk,1,18666417,USA,PA,Meadville,24.101.97.237,[ASSOCIATED_WITH],[ASSOCIATED_WITH],POSTINFLAMMATORY HYPERPIGMENTATION HEMOCHROMATOSIS and,N/A,0,144,1,33,159,TWrex-cause,814568-FS1,"POSTINFLAMMATORY HYPERPIGMENTATION pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, HEMOCHROMATOSIS and argyria must be distinguished from EDP.",POSTINFLAMMATORY HYPERPIGMENTATION,HEMOCHROMATOSIS
724352414,5/21/2015 14:19:52,1640342058,5/21/2015 14:18:26,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,[IS_A],[IS_A],must be distinguished,N/A,0,144,1,33,159,TWrex-cause,814568-FS1,"POSTINFLAMMATORY HYPERPIGMENTATION pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, HEMOCHROMATOSIS and argyria must be distinguished from EDP.",POSTINFLAMMATORY HYPERPIGMENTATION,HEMOCHROMATOSIS
724352414,5/21/2015 14:22:36,1640343501,5/21/2015 14:22:22,false,neodev,1,32103286,GBR,H9,London,193.109.196.83,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",NO,NO,0,144,1,33,159,TWrex-cause,814568-FS1,"POSTINFLAMMATORY HYPERPIGMENTATION pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, HEMOCHROMATOSIS and argyria must be distinguished from EDP.",POSTINFLAMMATORY HYPERPIGMENTATION,HEMOCHROMATOSIS
724352414,5/21/2015 14:22:38,1640343543,5/21/2015 14:22:20,false,tremorgames,1,17272211,USA,PA,Havertown,173.49.116.92,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],distinguished,N/A,0,144,1,33,159,TWrex-cause,814568-FS1,"POSTINFLAMMATORY HYPERPIGMENTATION pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, HEMOCHROMATOSIS and argyria must be distinguished from EDP.",POSTINFLAMMATORY HYPERPIGMENTATION,HEMOCHROMATOSIS
724352414,5/21/2015 14:24:17,1640344743,5/21/2015 14:23:28,false,elite,1,31856422,GBR,C9,Carlisle,92.19.36.179,[OTHER],[OTHER],must be distinguished,N/A,0,144,1,33,159,TWrex-cause,814568-FS1,"POSTINFLAMMATORY HYPERPIGMENTATION pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, HEMOCHROMATOSIS and argyria must be distinguished from EDP.",POSTINFLAMMATORY HYPERPIGMENTATION,HEMOCHROMATOSIS
724352414,5/21/2015 14:24:30,1640344843,5/21/2015 14:23:31,false,clixsense,1,21484973,GBR,L6,Shrewsbury,86.153.186.21,[OTHER],[OTHER],be distinguished,n/a,0,144,1,33,159,TWrex-cause,814568-FS1,"POSTINFLAMMATORY HYPERPIGMENTATION pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, HEMOCHROMATOSIS and argyria must be distinguished from EDP.",POSTINFLAMMATORY HYPERPIGMENTATION,HEMOCHROMATOSIS
724352414,5/21/2015 14:35:15,1640351633,5/21/2015 14:34:28,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,[SYMPTOM],[SYMPTOM],"POSTINFLAMMATORY HYPERPIGMENTATION pityriasis rosea, lichen planus,",n/a,0,144,1,33,159,TWrex-cause,814568-FS1,"POSTINFLAMMATORY HYPERPIGMENTATION pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, HEMOCHROMATOSIS and argyria must be distinguished from EDP.",POSTINFLAMMATORY HYPERPIGMENTATION,HEMOCHROMATOSIS
724352415,5/21/2015 08:52:22,1640183163,5/21/2015 08:51:46,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,[OTHER],[OTHER],reassured,Reassured,100,149,1,114,157,TWrex-cause,813513-FS1,"Again, it is easier to inform and instruct parents once they have been reassured that their child's FEBRILE SEIZURE does not mean that he or she has EPILEPSY",FEBRILE SEIZURE,EPILEPSY
724352415,5/21/2015 08:55:28,1640184745,5/21/2015 08:54:58,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[CONTRAINDICATES],[CONTRAINDICATES],does not mean that he or she has,N/A,100,149,1,114,157,TWrex-cause,813513-FS1,"Again, it is easier to inform and instruct parents once they have been reassured that their child's FEBRILE SEIZURE does not mean that he or she has EPILEPSY",FEBRILE SEIZURE,EPILEPSY
724352415,5/21/2015 08:55:44,1640184901,5/21/2015 08:54:45,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"Again, it is easier to inform and instruct parents once they have been reassured that their child's FEBRILE SEIZURE does not mean that he or she has EPILEPSY",n/a,100,149,1,114,157,TWrex-cause,813513-FS1,"Again, it is easier to inform and instruct parents once they have been reassured that their child's FEBRILE SEIZURE does not mean that he or she has EPILEPSY",FEBRILE SEIZURE,EPILEPSY
724352415,5/21/2015 08:58:14,1640186030,5/21/2015 08:57:20,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[OTHER] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[OTHER]","FEBRILE SEIZURE does not mean EPILE<span id=""transmark""></span>PSY",n/a,100,149,1,114,157,TWrex-cause,813513-FS1,"Again, it is easier to inform and instruct parents once they have been reassured that their child's FEBRILE SEIZURE does not mean that he or she has EPILEPSY",FEBRILE SEIZURE,EPILEPSY
724352415,5/21/2015 09:00:28,1640187221,5/21/2015 08:59:50,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[IS_A] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]",is or,"129 , 131 Discontinue ETANERCEPT if serious infection or SEPSIS develops.
Which of the following statements is EXPRESSED in the SENTENCE above?
SEPSIS causes ETANERCEPT
ETANERCEPT causes SEPSIS
-causes- is NOT EXPRESSED between the two PHRASES",100,149,1,114,157,TWrex-cause,813513-FS1,"Again, it is easier to inform and instruct parents once they have been reassured that their child's FEBRILE SEIZURE does not mean that he or she has EPILEPSY",FEBRILE SEIZURE,EPILEPSY
724352415,5/21/2015 09:10:28,1640192395,5/21/2015 09:09:44,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],does not mean he or she has,N/A,100,149,1,114,157,TWrex-cause,813513-FS1,"Again, it is easier to inform and instruct parents once they have been reassured that their child's FEBRILE SEIZURE does not mean that he or she has EPILEPSY",FEBRILE SEIZURE,EPILEPSY
724352415,5/21/2015 09:10:36,1640192485,5/21/2015 09:10:12,false,neodev,1.0,15848372,AUS,02,Jannali,14.200.59.55,[CONTRAINDICATES],[CONTRAINDICATES],does not mean,N/A,100,149,1,114,157,TWrex-cause,813513-FS1,"Again, it is easier to inform and instruct parents once they have been reassured that their child's FEBRILE SEIZURE does not mean that he or she has EPILEPSY",FEBRILE SEIZURE,EPILEPSY
724352415,5/21/2015 09:25:26,1640199751,5/21/2015 09:24:51,false,clixsense,1.0,28570371,NLD,"","",91.213.37.165,[SYMPTOM],[SYMPTOM],does not mean,N/A,100,149,1,114,157,TWrex-cause,813513-FS1,"Again, it is easier to inform and instruct parents once they have been reassured that their child's FEBRILE SEIZURE does not mean that he or she has EPILEPSY",FEBRILE SEIZURE,EPILEPSY
724352415,5/21/2015 09:29:08,1640201794,5/21/2015 09:28:30,false,neodev,1.0,31195295,GBR,"","",46.208.164.162,[NONE],[NONE],N/A,does not mean,100,149,1,114,157,TWrex-cause,813513-FS1,"Again, it is easier to inform and instruct parents once they have been reassured that their child's FEBRILE SEIZURE does not mean that he or she has EPILEPSY",FEBRILE SEIZURE,EPILEPSY
724352415,5/21/2015 09:34:55,1640204777,5/21/2015 09:34:42,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[SIDE_EFFECT],[SIDE_EFFECT],does not mean,N/A,100,149,1,114,157,TWrex-cause,813513-FS1,"Again, it is easier to inform and instruct parents once they have been reassured that their child's FEBRILE SEIZURE does not mean that he or she has EPILEPSY",FEBRILE SEIZURE,EPILEPSY
724352415,5/21/2015 09:45:52,1640209929,5/21/2015 09:45:39,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[SIDE_EFFECT],[SIDE_EFFECT],does not mean,N/A,100,149,1,114,157,TWrex-cause,813513-FS1,"Again, it is easier to inform and instruct parents once they have been reassured that their child's FEBRILE SEIZURE does not mean that he or she has EPILEPSY",FEBRILE SEIZURE,EPILEPSY
724352415,5/21/2015 10:12:23,1640223018,5/21/2015 10:09:54,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[NONE],[NONE],none,"no relation, as the siezure has nothing to do with the condition",100,149,1,114,157,TWrex-cause,813513-FS1,"Again, it is easier to inform and instruct parents once they have been reassured that their child's FEBRILE SEIZURE does not mean that he or she has EPILEPSY",FEBRILE SEIZURE,EPILEPSY
724352415,5/21/2015 10:13:42,1640223800,5/21/2015 10:13:26,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[SIDE_EFFECT],[SIDE_EFFECT],not mean,N/A,100,149,1,114,157,TWrex-cause,813513-FS1,"Again, it is easier to inform and instruct parents once they have been reassured that their child's FEBRILE SEIZURE does not mean that he or she has EPILEPSY",FEBRILE SEIZURE,EPILEPSY
724352415,5/21/2015 10:26:25,1640229848,5/21/2015 10:26:13,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[SYMPTOM],[SYMPTOM],EPILEPSY,none,100,149,1,114,157,TWrex-cause,813513-FS1,"Again, it is easier to inform and instruct parents once they have been reassured that their child's FEBRILE SEIZURE does not mean that he or she has EPILEPSY",FEBRILE SEIZURE,EPILEPSY
724352415,5/21/2015 10:31:03,1640231837,5/21/2015 10:30:50,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[PART_OF],[PART_OF],not mean,N/A,100,149,1,114,157,TWrex-cause,813513-FS1,"Again, it is easier to inform and instruct parents once they have been reassured that their child's FEBRILE SEIZURE does not mean that he or she has EPILEPSY",FEBRILE SEIZURE,EPILEPSY
724352416,5/21/2015 10:39:02,1640235826,5/21/2015 10:38:46,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[SYMPTOM],[SYMPTOM],presence,N/A,14,35,1,33,74,TWrex-cause,810489-FS1,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS
724352416,5/21/2015 10:49:36,1640241565,5/21/2015 10:49:00,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],Prevalence of,n/a,14,35,1,33,74,TWrex-cause,810489-FS1,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS
724352416,5/21/2015 11:04:03,1640248532,5/21/2015 11:02:40,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[NONE],[NONE],N/A,There is nothing connecting to two words.,14,35,1,33,74,TWrex-cause,810489-FS1,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS
724352416,5/21/2015 11:05:32,1640249144,5/21/2015 11:04:37,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[PART_OF],[PART_OF],Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS,N/A,14,35,1,33,74,TWrex-cause,810489-FS1,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS
724352416,5/21/2015 11:09:24,1640250843,5/21/2015 11:08:25,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[SYMPTOM] [PART_OF],"[SYMPTOM]
[PART_OF]",Prevalence of presence of in,n/a,14,35,1,33,74,TWrex-cause,810489-FS1,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS
724352416,5/21/2015 11:19:13,1640254961,5/21/2015 11:18:57,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[IS_A],[IS_A],and,N/A,14,35,1,33,74,TWrex-cause,810489-FS1,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS
724352416,5/21/2015 11:34:21,1640261495,5/21/2015 11:34:05,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],PRODUCING,n/a,14,35,1,33,74,TWrex-cause,810489-FS1,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS
724352416,5/21/2015 11:44:29,1640266286,5/21/2015 11:42:24,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[PREVENTS],[PREVENTS],Prevalence of,n/a,14,35,1,33,74,TWrex-cause,810489-FS1,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS
724352416,5/21/2015 11:45:36,1640266906,5/21/2015 11:45:25,false,prodege,1.0,12656479,CAN,NB,Fredericton,198.164.157.90,[CAUSES],[CAUSES],Prevalence,N/A,14,35,1,33,74,TWrex-cause,810489-FS1,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS
724352416,5/21/2015 12:13:15,1640279007,5/21/2015 12:12:44,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[OTHER],[OTHER],presence,N/A,14,35,1,33,74,TWrex-cause,810489-FS1,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS
724352416,5/21/2015 12:30:57,1640287077,5/21/2015 12:29:49,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[ASSOCIATED_WITH] [CAUSES] [SIDE_EFFECT],"[CAUSES]
[ASSOCIATED_WITH]
[SIDE_EFFECT]",TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS,N/A,14,35,1,33,74,TWrex-cause,810489-FS1,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS
724352416,5/21/2015 12:39:29,1640290841,5/21/2015 12:39:17,false,neodev,1,31789301,CAN,QC,Montréal,192.99.6.125,[NONE],[NONE],no,no,14,35,1,33,74,TWrex-cause,810489-FS1,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS
724352416,5/21/2015 12:58:18,1640298726,5/21/2015 12:57:55,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,[NONE],[NONE],n/a,n/a,14,35,1,33,74,TWrex-cause,810489-FS1,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS
724352416,5/21/2015 13:08:21,1640302779,5/21/2015 13:07:28,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[PREVENTS],[PREVENTS],TOXIC SHOCK SYNDROME,N/A,14,35,1,33,74,TWrex-cause,810489-FS1,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS
724352416,5/21/2015 13:09:03,1640303046,5/21/2015 13:08:37,false,clixsense,1,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],Prevalence TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS presence antibodies,na,14,35,1,33,74,TWrex-cause,810489-FS1,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS
724352417,5/21/2015 06:59:49,1640123188,5/21/2015 06:59:19,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,[TREATS],[TREATS],to SEVERE DISSEMINATED HISTOPLASMOSIS: Initial regimen IV AMPHOTERICIN,n/a,65,120,-1,98,137,TWrex-cause,800602-FS1,"441  HIV infected infants and children with moderately severe to SEVERE DISSEMINATED HISTOPLASMOSIS: Initial regimen of IV AMPHOTERICIN B given for at least 1 2 weeks, followed by itraconazole (oral solution) 2 5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2 5 mg/kg (up to 200 mg) twice daily for 12 months.",SEVERE DISSEMINATED HISTOPLASMOSIS,IV AMPHOTERICIN B
724352417,5/21/2015 07:04:47,1640125626,5/21/2015 07:04:22,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],Initial regimen,N/A,65,120,-1,98,137,TWrex-cause,800602-FS1,"441  HIV infected infants and children with moderately severe to SEVERE DISSEMINATED HISTOPLASMOSIS: Initial regimen of IV AMPHOTERICIN B given for at least 1 2 weeks, followed by itraconazole (oral solution) 2 5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2 5 mg/kg (up to 200 mg) twice daily for 12 months.",SEVERE DISSEMINATED HISTOPLASMOSIS,IV AMPHOTERICIN B
724352417,5/21/2015 07:08:44,1640127814,5/21/2015 07:08:32,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,65,120,-1,98,137,TWrex-cause,800602-FS1,"441  HIV infected infants and children with moderately severe to SEVERE DISSEMINATED HISTOPLASMOSIS: Initial regimen of IV AMPHOTERICIN B given for at least 1 2 weeks, followed by itraconazole (oral solution) 2 5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2 5 mg/kg (up to 200 mg) twice daily for 12 months.",SEVERE DISSEMINATED HISTOPLASMOSIS,IV AMPHOTERICIN B
724352417,5/21/2015 07:10:46,1640128960,5/21/2015 07:10:17,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],with by,N/A,65,120,-1,98,137,TWrex-cause,800602-FS1,"441  HIV infected infants and children with moderately severe to SEVERE DISSEMINATED HISTOPLASMOSIS: Initial regimen of IV AMPHOTERICIN B given for at least 1 2 weeks, followed by itraconazole (oral solution) 2 5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2 5 mg/kg (up to 200 mg) twice daily for 12 months.",SEVERE DISSEMINATED HISTOPLASMOSIS,IV AMPHOTERICIN B
724352417,5/21/2015 07:19:00,1640133473,5/21/2015 07:18:32,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],Initial regimen,N/A,65,120,-1,98,137,TWrex-cause,800602-FS1,"441  HIV infected infants and children with moderately severe to SEVERE DISSEMINATED HISTOPLASMOSIS: Initial regimen of IV AMPHOTERICIN B given for at least 1 2 weeks, followed by itraconazole (oral solution) 2 5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2 5 mg/kg (up to 200 mg) twice daily for 12 months.",SEVERE DISSEMINATED HISTOPLASMOSIS,IV AMPHOTERICIN B
724352417,5/21/2015 07:21:14,1640134758,5/21/2015 07:20:28,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],Initial regimen of,N/A,65,120,-1,98,137,TWrex-cause,800602-FS1,"441  HIV infected infants and children with moderately severe to SEVERE DISSEMINATED HISTOPLASMOSIS: Initial regimen of IV AMPHOTERICIN B given for at least 1 2 weeks, followed by itraconazole (oral solution) 2 5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2 5 mg/kg (up to 200 mg) twice daily for 12 months.",SEVERE DISSEMINATED HISTOPLASMOSIS,IV AMPHOTERICIN B
724352417,5/21/2015 07:33:34,1640141315,5/21/2015 07:32:58,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[PART_OF]",with of by,N/A,65,120,-1,98,137,TWrex-cause,800602-FS1,"441  HIV infected infants and children with moderately severe to SEVERE DISSEMINATED HISTOPLASMOSIS: Initial regimen of IV AMPHOTERICIN B given for at least 1 2 weeks, followed by itraconazole (oral solution) 2 5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2 5 mg/kg (up to 200 mg) twice daily for 12 months.",SEVERE DISSEMINATED HISTOPLASMOSIS,IV AMPHOTERICIN B
724352417,5/21/2015 07:36:04,1640142591,5/21/2015 07:35:35,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],Initial regimen of,N/A,65,120,-1,98,137,TWrex-cause,800602-FS1,"441  HIV infected infants and children with moderately severe to SEVERE DISSEMINATED HISTOPLASMOSIS: Initial regimen of IV AMPHOTERICIN B given for at least 1 2 weeks, followed by itraconazole (oral solution) 2 5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2 5 mg/kg (up to 200 mg) twice daily for 12 months.",SEVERE DISSEMINATED HISTOPLASMOSIS,IV AMPHOTERICIN B
724352417,5/21/2015 07:38:58,1640144078,5/21/2015 07:38:41,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],regimen,n/a,65,120,-1,98,137,TWrex-cause,800602-FS1,"441  HIV infected infants and children with moderately severe to SEVERE DISSEMINATED HISTOPLASMOSIS: Initial regimen of IV AMPHOTERICIN B given for at least 1 2 weeks, followed by itraconazole (oral solution) 2 5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2 5 mg/kg (up to 200 mg) twice daily for 12 months.",SEVERE DISSEMINATED HISTOPLASMOSIS,IV AMPHOTERICIN B
724352417,5/21/2015 07:53:31,1640151953,5/21/2015 07:52:52,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]",with of,N/A,65,120,-1,98,137,TWrex-cause,800602-FS1,"441  HIV infected infants and children with moderately severe to SEVERE DISSEMINATED HISTOPLASMOSIS: Initial regimen of IV AMPHOTERICIN B given for at least 1 2 weeks, followed by itraconazole (oral solution) 2 5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2 5 mg/kg (up to 200 mg) twice daily for 12 months.",SEVERE DISSEMINATED HISTOPLASMOSIS,IV AMPHOTERICIN B
724352417,5/21/2015 07:54:07,1640152274,5/21/2015 07:53:41,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],regimen of given,N/A,65,120,-1,98,137,TWrex-cause,800602-FS1,"441  HIV infected infants and children with moderately severe to SEVERE DISSEMINATED HISTOPLASMOSIS: Initial regimen of IV AMPHOTERICIN B given for at least 1 2 weeks, followed by itraconazole (oral solution) 2 5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2 5 mg/kg (up to 200 mg) twice daily for 12 months.",SEVERE DISSEMINATED HISTOPLASMOSIS,IV AMPHOTERICIN B
724352417,5/21/2015 07:57:45,1640154126,5/21/2015 07:57:17,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,[TREATS],[TREATS],given,-,65,120,-1,98,137,TWrex-cause,800602-FS1,"441  HIV infected infants and children with moderately severe to SEVERE DISSEMINATED HISTOPLASMOSIS: Initial regimen of IV AMPHOTERICIN B given for at least 1 2 weeks, followed by itraconazole (oral solution) 2 5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2 5 mg/kg (up to 200 mg) twice daily for 12 months.",SEVERE DISSEMINATED HISTOPLASMOSIS,IV AMPHOTERICIN B
724352417,5/21/2015 08:12:18,1640161875,5/21/2015 08:11:48,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[PART_OF]",with of by,N/A,65,120,-1,98,137,TWrex-cause,800602-FS1,"441  HIV infected infants and children with moderately severe to SEVERE DISSEMINATED HISTOPLASMOSIS: Initial regimen of IV AMPHOTERICIN B given for at least 1 2 weeks, followed by itraconazole (oral solution) 2 5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2 5 mg/kg (up to 200 mg) twice daily for 12 months.",SEVERE DISSEMINATED HISTOPLASMOSIS,IV AMPHOTERICIN B
724352417,5/21/2015 08:22:16,1640167370,5/21/2015 08:19:25,false,clixsense,1.0,12843982,AUS,08,Perth,180.216.79.226,[TREATS],[TREATS],SEVERE DISSEMINATED HISTOPLASMOSIS: Initial regimen of IV AMPHOTERICIN B,N/A,65,120,-1,98,137,TWrex-cause,800602-FS1,"441  HIV infected infants and children with moderately severe to SEVERE DISSEMINATED HISTOPLASMOSIS: Initial regimen of IV AMPHOTERICIN B given for at least 1 2 weeks, followed by itraconazole (oral solution) 2 5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2 5 mg/kg (up to 200 mg) twice daily for 12 months.",SEVERE DISSEMINATED HISTOPLASMOSIS,IV AMPHOTERICIN B
724352417,5/21/2015 08:24:21,1640168485,5/21/2015 08:23:37,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[TREATS],[TREATS],SEVERE DISSEMINATED HISTOPLASMOSIS: regimen IV AMPHOTERICIN,n/a,65,120,-1,98,137,TWrex-cause,800602-FS1,"441  HIV infected infants and children with moderately severe to SEVERE DISSEMINATED HISTOPLASMOSIS: Initial regimen of IV AMPHOTERICIN B given for at least 1 2 weeks, followed by itraconazole (oral solution) 2 5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2 5 mg/kg (up to 200 mg) twice daily for 12 months.",SEVERE DISSEMINATED HISTOPLASMOSIS,IV AMPHOTERICIN B
724352418,5/21/2015 08:53:36,1640183794,5/21/2015 08:53:18,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,[TREATS],[TREATS],Treatment,Treatment,53,98,1,71,129,TWrex-cause,810527-FS1,102  Granuloma Inguinale (Donovanosis)  Treatment of GRANULOMA INGUINALE (donovanosis) caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
724352418,5/21/2015 08:55:58,1640184993,5/21/2015 08:55:45,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[CAUSES],[CAUSES],caused by,N/A,53,98,1,71,129,TWrex-cause,810527-FS1,102  Granuloma Inguinale (Donovanosis)  Treatment of GRANULOMA INGUINALE (donovanosis) caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
724352418,5/21/2015 08:57:33,1640185679,5/21/2015 08:57:10,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Granuloma Inguinale (Donovanosis) Treatment of GRANULOMA INGUINALE (donovanosis) caused by CALYMMATOBACTERIUM GRANULOMATIS,n/a,53,98,1,71,129,TWrex-cause,810527-FS1,102  Granuloma Inguinale (Donovanosis)  Treatment of GRANULOMA INGUINALE (donovanosis) caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
724352418,5/21/2015 09:00:12,1640187153,5/21/2015 08:59:45,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[CAUSES],[CAUSES],"GRANULOMA INGUINALE caused by CALYMMATOBACTERIUM GRAN<span id=""transmark""></span>ULOMATIS",n/a,53,98,1,71,129,TWrex-cause,810527-FS1,102  Granuloma Inguinale (Donovanosis)  Treatment of GRANULOMA INGUINALE (donovanosis) caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
724352418,5/21/2015 09:02:13,1640188140,5/21/2015 09:01:48,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[PART_OF] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]",of caused by,N/A,53,98,1,71,129,TWrex-cause,810527-FS1,102  Granuloma Inguinale (Donovanosis)  Treatment of GRANULOMA INGUINALE (donovanosis) caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
724352418,5/21/2015 09:11:13,1640192807,5/21/2015 09:10:50,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[CAUSES],[CAUSES],caused by,N/A,53,98,1,71,129,TWrex-cause,810527-FS1,102  Granuloma Inguinale (Donovanosis)  Treatment of GRANULOMA INGUINALE (donovanosis) caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
724352418,5/21/2015 09:12:25,1640193498,5/21/2015 09:11:19,false,neodev,1.0,15848372,AUS,02,Jannali,14.200.59.55,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],caused by,N/A,53,98,1,71,129,TWrex-cause,810527-FS1,102  Granuloma Inguinale (Donovanosis)  Treatment of GRANULOMA INGUINALE (donovanosis) caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
724352418,5/21/2015 09:35:21,1640204953,5/21/2015 09:35:10,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[CAUSES],[CAUSES],caused,N/A,53,98,1,71,129,TWrex-cause,810527-FS1,102  Granuloma Inguinale (Donovanosis)  Treatment of GRANULOMA INGUINALE (donovanosis) caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
724352418,5/21/2015 09:46:21,1640210207,5/21/2015 09:46:09,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],caused,N/A,53,98,1,71,129,TWrex-cause,810527-FS1,102  Granuloma Inguinale (Donovanosis)  Treatment of GRANULOMA INGUINALE (donovanosis) caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
724352418,5/21/2015 10:13:44,1640223837,5/21/2015 10:13:06,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],GRANULOMA INGUINALE caused by CALYMMATOBACTERIUM GRANULOMATIS,N/A,53,98,1,71,129,TWrex-cause,810527-FS1,102  Granuloma Inguinale (Donovanosis)  Treatment of GRANULOMA INGUINALE (donovanosis) caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
724352418,5/21/2015 10:14:18,1640224116,5/21/2015 10:14:03,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[CAUSES],[CAUSES],caused,N/A,53,98,1,71,129,TWrex-cause,810527-FS1,102  Granuloma Inguinale (Donovanosis)  Treatment of GRANULOMA INGUINALE (donovanosis) caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
724352418,5/21/2015 10:27:14,1640230105,5/21/2015 10:27:01,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[TREATS],[TREATS],CALYMMATOBACTERIUM GRANULOMATIS,none,53,98,1,71,129,TWrex-cause,810527-FS1,102  Granuloma Inguinale (Donovanosis)  Treatment of GRANULOMA INGUINALE (donovanosis) caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
724352418,5/21/2015 10:31:31,1640232076,5/21/2015 10:31:17,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",Treatment caused,N/A,53,98,1,71,129,TWrex-cause,810527-FS1,102  Granuloma Inguinale (Donovanosis)  Treatment of GRANULOMA INGUINALE (donovanosis) caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
724352418,5/21/2015 10:39:03,1640235827,5/21/2015 10:38:25,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by,n/a,53,98,1,71,129,TWrex-cause,810527-FS1,102  Granuloma Inguinale (Donovanosis)  Treatment of GRANULOMA INGUINALE (donovanosis) caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
724352418,5/21/2015 10:43:50,1640238441,5/21/2015 10:43:22,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,53,98,1,71,129,TWrex-cause,810527-FS1,102  Granuloma Inguinale (Donovanosis)  Treatment of GRANULOMA INGUINALE (donovanosis) caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS
724352419,5/21/2015 07:02:30,1640124481,5/21/2015 07:02:10,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,[TREATS],[TREATS],CONVENTIONAL IV AMPHOTERICIN B used for initial treatment of BLASTOMYCOSIS,n/a,133,21,-1,145,51,TWrex-cause,800848-FS1,"291 ,   424 ,   436  CONVENTIONAL IV AMPHOTERICIN B or a lipid formulation of IV amphotericin B can be used for initial treatment of BLASTOMYCOSIS",BLASTOMYCOSIS,CONVENTIONAL IV AMPHOTERICIN B
724352419,5/21/2015 07:10:06,1640128537,5/21/2015 07:09:51,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment,N/A,133,21,-1,145,51,TWrex-cause,800848-FS1,"291 ,   424 ,   436  CONVENTIONAL IV AMPHOTERICIN B or a lipid formulation of IV amphotericin B can be used for initial treatment of BLASTOMYCOSIS",BLASTOMYCOSIS,CONVENTIONAL IV AMPHOTERICIN B
724352419,5/21/2015 07:10:37,1640128879,5/21/2015 07:10:23,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,133,21,-1,145,51,TWrex-cause,800848-FS1,"291 ,   424 ,   436  CONVENTIONAL IV AMPHOTERICIN B or a lipid formulation of IV amphotericin B can be used for initial treatment of BLASTOMYCOSIS",BLASTOMYCOSIS,CONVENTIONAL IV AMPHOTERICIN B
724352419,5/21/2015 07:14:47,1640131157,5/21/2015 07:14:18,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]
[PART_OF]",or a of of,N/A,133,21,-1,145,51,TWrex-cause,800848-FS1,"291 ,   424 ,   436  CONVENTIONAL IV AMPHOTERICIN B or a lipid formulation of IV amphotericin B can be used for initial treatment of BLASTOMYCOSIS",BLASTOMYCOSIS,CONVENTIONAL IV AMPHOTERICIN B
724352419,5/21/2015 07:24:12,1640136369,5/21/2015 07:23:48,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],initial treatment,N/A,133,21,-1,145,51,TWrex-cause,800848-FS1,"291 ,   424 ,   436  CONVENTIONAL IV AMPHOTERICIN B or a lipid formulation of IV amphotericin B can be used for initial treatment of BLASTOMYCOSIS",BLASTOMYCOSIS,CONVENTIONAL IV AMPHOTERICIN B
724352419,5/21/2015 07:26:31,1640137600,5/21/2015 07:26:03,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],initial treatment of,N/A,133,21,-1,145,51,TWrex-cause,800848-FS1,"291 ,   424 ,   436  CONVENTIONAL IV AMPHOTERICIN B or a lipid formulation of IV amphotericin B can be used for initial treatment of BLASTOMYCOSIS",BLASTOMYCOSIS,CONVENTIONAL IV AMPHOTERICIN B
724352419,5/21/2015 07:37:44,1640143519,5/21/2015 07:37:10,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]
[PART_OF]",or a of,N/A,133,21,-1,145,51,TWrex-cause,800848-FS1,"291 ,   424 ,   436  CONVENTIONAL IV AMPHOTERICIN B or a lipid formulation of IV amphotericin B can be used for initial treatment of BLASTOMYCOSIS",BLASTOMYCOSIS,CONVENTIONAL IV AMPHOTERICIN B
724352419,5/21/2015 07:39:24,1640144351,5/21/2015 07:39:04,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],treatment of,N/A,133,21,-1,145,51,TWrex-cause,800848-FS1,"291 ,   424 ,   436  CONVENTIONAL IV AMPHOTERICIN B or a lipid formulation of IV amphotericin B can be used for initial treatment of BLASTOMYCOSIS",BLASTOMYCOSIS,CONVENTIONAL IV AMPHOTERICIN B
724352419,5/21/2015 07:42:13,1640145868,5/21/2015 07:41:57,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],initial treatment,n/a,133,21,-1,145,51,TWrex-cause,800848-FS1,"291 ,   424 ,   436  CONVENTIONAL IV AMPHOTERICIN B or a lipid formulation of IV amphotericin B can be used for initial treatment of BLASTOMYCOSIS",BLASTOMYCOSIS,CONVENTIONAL IV AMPHOTERICIN B
724352419,5/21/2015 07:56:48,1640153726,5/21/2015 07:56:26,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[DIAGNOSE_BY_TEST_OR_DRUG] [IS_A] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]
[PART_OF]",or a of,N/A,133,21,-1,145,51,TWrex-cause,800848-FS1,"291 ,   424 ,   436  CONVENTIONAL IV AMPHOTERICIN B or a lipid formulation of IV amphotericin B can be used for initial treatment of BLASTOMYCOSIS",BLASTOMYCOSIS,CONVENTIONAL IV AMPHOTERICIN B
724352419,5/21/2015 07:59:29,1640155073,5/21/2015 07:59:07,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],treatment of,N/A,133,21,-1,145,51,TWrex-cause,800848-FS1,"291 ,   424 ,   436  CONVENTIONAL IV AMPHOTERICIN B or a lipid formulation of IV amphotericin B can be used for initial treatment of BLASTOMYCOSIS",BLASTOMYCOSIS,CONVENTIONAL IV AMPHOTERICIN B
724352419,5/21/2015 08:03:28,1640157099,5/21/2015 08:03:14,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,[TREATS],[TREATS],initial treatment,-,133,21,-1,145,51,TWrex-cause,800848-FS1,"291 ,   424 ,   436  CONVENTIONAL IV AMPHOTERICIN B or a lipid formulation of IV amphotericin B can be used for initial treatment of BLASTOMYCOSIS",BLASTOMYCOSIS,CONVENTIONAL IV AMPHOTERICIN B
724352419,5/21/2015 08:28:13,1640170608,5/21/2015 08:27:25,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[TREATS],[TREATS],CONVENTIONAL IV AMPHOTERICIN B or initial treatment BLASTOMYCOSIS,n/a,133,21,-1,145,51,TWrex-cause,800848-FS1,"291 ,   424 ,   436  CONVENTIONAL IV AMPHOTERICIN B or a lipid formulation of IV amphotericin B can be used for initial treatment of BLASTOMYCOSIS",BLASTOMYCOSIS,CONVENTIONAL IV AMPHOTERICIN B
724352419,5/21/2015 08:32:21,1640172872,5/21/2015 08:32:05,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[TREATS],[TREATS],treatment,N/A,133,21,-1,145,51,TWrex-cause,800848-FS1,"291 ,   424 ,   436  CONVENTIONAL IV AMPHOTERICIN B or a lipid formulation of IV amphotericin B can be used for initial treatment of BLASTOMYCOSIS",BLASTOMYCOSIS,CONVENTIONAL IV AMPHOTERICIN B
724352419,5/21/2015 08:33:04,1640173309,5/21/2015 08:32:23,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],"CONVENTIONAL IV AMPHOTERICIN B used for treatment of BLA<span id=""transmark""></span>STOMYCOSIS",n/a,133,21,-1,145,51,TWrex-cause,800848-FS1,"291 ,   424 ,   436  CONVENTIONAL IV AMPHOTERICIN B or a lipid formulation of IV amphotericin B can be used for initial treatment of BLASTOMYCOSIS",BLASTOMYCOSIS,CONVENTIONAL IV AMPHOTERICIN B
724352420,5/21/2015 08:53:17,1640183569,5/21/2015 08:52:23,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,[SIDE_EFFECT],[SIDE_EFFECT],not,Side effect,53,19,-1,68,28,TWrex-cause,803162-FS1,1 •  Do not resume ALOSETRON in patients who develop ISCHEMIC COLITIS,ISCHEMIC COLITIS,ALOSETRON
724352420,5/21/2015 08:55:44,1640184908,5/21/2015 08:55:29,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[MANIFESTATION],[MANIFESTATION],Do not resume in patients who develop,N/A,53,19,-1,68,28,TWrex-cause,803162-FS1,1 •  Do not resume ALOSETRON in patients who develop ISCHEMIC COLITIS,ISCHEMIC COLITIS,ALOSETRON
724352420,5/21/2015 08:57:09,1640185525,5/21/2015 08:55:45,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Do not resume ALOSETRON in patients who develop ISCHEMIC COLITIS,n/a,53,19,-1,68,28,TWrex-cause,803162-FS1,1 •  Do not resume ALOSETRON in patients who develop ISCHEMIC COLITIS,ISCHEMIC COLITIS,ALOSETRON
724352420,5/21/2015 08:59:44,1640186804,5/21/2015 08:58:16,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[ASSOCIATED_WITH] [OTHER],"[ASSOCIATED_WITH]
[OTHER]","Do not resu<span id=""transmark""></span>me ALOSETRON in ISCHEMIC COLITIS",n/a,53,19,-1,68,28,TWrex-cause,803162-FS1,1 •  Do not resume ALOSETRON in patients who develop ISCHEMIC COLITIS,ISCHEMIC COLITIS,ALOSETRON
724352420,5/21/2015 09:01:45,1640187904,5/21/2015 09:00:38,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[SIDE_EFFECT],[SIDE_EFFECT],ISCHEMIC,N/A,53,19,-1,68,28,TWrex-cause,803162-FS1,1 •  Do not resume ALOSETRON in patients who develop ISCHEMIC COLITIS,ISCHEMIC COLITIS,ALOSETRON
724352420,5/21/2015 09:10:49,1640192590,5/21/2015 09:10:29,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",in patients who develop,N/A,53,19,-1,68,28,TWrex-cause,803162-FS1,1 •  Do not resume ALOSETRON in patients who develop ISCHEMIC COLITIS,ISCHEMIC COLITIS,ALOSETRON
724352420,5/21/2015 09:11:18,1640192849,5/21/2015 09:10:38,false,neodev,1.0,15848372,AUS,02,Jannali,14.200.59.55,[CONTRAINDICATES],[CONTRAINDICATES],Do not resume,N/A,53,19,-1,68,28,TWrex-cause,803162-FS1,1 •  Do not resume ALOSETRON in patients who develop ISCHEMIC COLITIS,ISCHEMIC COLITIS,ALOSETRON
724352420,5/21/2015 09:29:24,1640201897,5/21/2015 09:29:09,false,neodev,1.0,31195295,GBR,"","",46.208.164.162,[CONTRAINDICATES],[CONTRAINDICATES],Do not,N/A,53,19,-1,68,28,TWrex-cause,803162-FS1,1 •  Do not resume ALOSETRON in patients who develop ISCHEMIC COLITIS,ISCHEMIC COLITIS,ALOSETRON
724352420,5/21/2015 09:35:08,1640204868,5/21/2015 09:34:57,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[CAUSES],[CAUSES],develop,N/A,53,19,-1,68,28,TWrex-cause,803162-FS1,1 •  Do not resume ALOSETRON in patients who develop ISCHEMIC COLITIS,ISCHEMIC COLITIS,ALOSETRON
724352420,5/21/2015 09:46:07,1640210109,5/21/2015 09:45:54,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[PREVENTS],[PREVENTS],Do not resume,N/A,53,19,-1,68,28,TWrex-cause,803162-FS1,1 •  Do not resume ALOSETRON in patients who develop ISCHEMIC COLITIS,ISCHEMIC COLITIS,ALOSETRON
724352420,5/21/2015 10:13:05,1640223481,5/21/2015 10:12:24,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CONTRAINDICATES],[CONTRAINDICATES],Do not resume ALOSETRON ISCHEMIC COLITIS,N/A,53,19,-1,68,28,TWrex-cause,803162-FS1,1 •  Do not resume ALOSETRON in patients who develop ISCHEMIC COLITIS,ISCHEMIC COLITIS,ALOSETRON
724352420,5/21/2015 10:14:01,1640223952,5/21/2015 10:13:45,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[SYMPTOM],[SYMPTOM],develop,N/A,53,19,-1,68,28,TWrex-cause,803162-FS1,1 •  Do not resume ALOSETRON in patients who develop ISCHEMIC COLITIS,ISCHEMIC COLITIS,ALOSETRON
724352420,5/21/2015 10:26:59,1640230023,5/21/2015 10:26:26,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[CAUSES],[CAUSES],ISCHEMIC COLITIS,none,53,19,-1,68,28,TWrex-cause,803162-FS1,1 •  Do not resume ALOSETRON in patients who develop ISCHEMIC COLITIS,ISCHEMIC COLITIS,ALOSETRON
724352420,5/21/2015 10:31:16,1640231954,5/21/2015 10:31:05,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[SYMPTOM],[SYMPTOM],resume,N/A,53,19,-1,68,28,TWrex-cause,803162-FS1,1 •  Do not resume ALOSETRON in patients who develop ISCHEMIC COLITIS,ISCHEMIC COLITIS,ALOSETRON
724352420,5/21/2015 10:38:24,1640235537,5/21/2015 10:36:44,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CONTRAINDICATES],[CONTRAINDICATES],Do not resume in patients who develop,n/a,53,19,-1,68,28,TWrex-cause,803162-FS1,1 •  Do not resume ALOSETRON in patients who develop ISCHEMIC COLITIS,ISCHEMIC COLITIS,ALOSETRON
724352421,5/21/2015 10:39:17,1640235936,5/21/2015 10:39:04,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[CONTRAINDICATES],[CONTRAINDICATES],characterized,N/A,43,2,1,46,14,TWrex-cause,813484-FS1,"• FIBROMYALGIA characterized by widespread PAIN and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",PAIN,FIBROMYALGIA
724352421,5/21/2015 10:50:02,1640241824,5/21/2015 10:49:37,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],characterized by,n/a,43,2,1,46,14,TWrex-cause,813484-FS1,"• FIBROMYALGIA characterized by widespread PAIN and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",PAIN,FIBROMYALGIA
724352421,5/21/2015 11:04:34,1640248732,5/21/2015 11:04:06,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM],[SYMPTOM],characterized by,N/A,43,2,1,46,14,TWrex-cause,813484-FS1,"• FIBROMYALGIA characterized by widespread PAIN and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",PAIN,FIBROMYALGIA
724352421,5/21/2015 11:05:56,1640249309,5/21/2015 11:05:35,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],characterized by widespread,N/A,43,2,1,46,14,TWrex-cause,813484-FS1,"• FIBROMYALGIA characterized by widespread PAIN and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",PAIN,FIBROMYALGIA
724352421,5/21/2015 11:10:39,1640251430,5/21/2015 11:09:26,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[SYMPTOM] [MANIFESTATION] [LOCATION] [ASSOCIATED_WITH],"[LOCATION]
[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",characterized PAIN occurs seen in,n/a,43,2,1,46,14,TWrex-cause,813484-FS1,"• FIBROMYALGIA characterized by widespread PAIN and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",PAIN,FIBROMYALGIA
724352421,5/21/2015 11:19:28,1640255073,5/21/2015 11:19:15,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[SYMPTOM],[SYMPTOM],characterized,N/A,43,2,1,46,14,TWrex-cause,813484-FS1,"• FIBROMYALGIA characterized by widespread PAIN and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",PAIN,FIBROMYALGIA
724352421,5/21/2015 11:34:38,1640261614,5/21/2015 11:34:22,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],characterized by,n/a,43,2,1,46,14,TWrex-cause,813484-FS1,"• FIBROMYALGIA characterized by widespread PAIN and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",PAIN,FIBROMYALGIA
724352421,5/21/2015 11:45:54,1640267069,5/21/2015 11:45:37,false,prodege,1.0,12656479,CAN,NB,Fredericton,198.164.157.90,[CAUSES],[CAUSES],characterized,N/A,43,2,1,46,14,TWrex-cause,813484-FS1,"• FIBROMYALGIA characterized by widespread PAIN and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",PAIN,FIBROMYALGIA
724352421,5/21/2015 11:46:07,1640267135,5/21/2015 11:44:30,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[SYMPTOM],[SYMPTOM],characterized by,n/a,43,2,1,46,14,TWrex-cause,813484-FS1,"• FIBROMYALGIA characterized by widespread PAIN and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",PAIN,FIBROMYALGIA
724352421,5/21/2015 12:13:57,1640279272,5/21/2015 12:13:16,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[MANIFESTATION],[MANIFESTATION],characterized,N/A,43,2,1,46,14,TWrex-cause,813484-FS1,"• FIBROMYALGIA characterized by widespread PAIN and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",PAIN,FIBROMYALGIA
724352421,5/21/2015 12:31:35,1640287379,5/21/2015 12:30:58,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES] [ASSOCIATED_WITH],"[CAUSES]
[ASSOCIATED_WITH]",FIBROMYALGIA characterized by widespread PAIN,N/A,43,2,1,46,14,TWrex-cause,813484-FS1,"• FIBROMYALGIA characterized by widespread PAIN and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",PAIN,FIBROMYALGIA
724352421,5/21/2015 12:39:39,1640290986,5/21/2015 12:39:30,false,neodev,1.0,31789301,CAN,QC,Montréal,192.99.6.125,[NONE],[NONE],no,no,43,2,1,46,14,TWrex-cause,813484-FS1,"• FIBROMYALGIA characterized by widespread PAIN and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",PAIN,FIBROMYALGIA
724352421,5/21/2015 12:59:13,1640299037,5/21/2015 12:58:19,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,[SYMPTOM],[SYMPTOM],characterized,characterized,43,2,1,46,14,TWrex-cause,813484-FS1,"• FIBROMYALGIA characterized by widespread PAIN and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",PAIN,FIBROMYALGIA
724352421,5/21/2015 13:09:24,1640303250,5/21/2015 13:08:23,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[SYMPTOM],[SYMPTOM],"PAIN tender points,",N/A,43,2,1,46,14,TWrex-cause,813484-FS1,"• FIBROMYALGIA characterized by widespread PAIN and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",PAIN,FIBROMYALGIA
724352421,5/21/2015 13:16:33,1640306802,5/21/2015 13:15:15,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES] [TREATS],"[TREATS]
[CAUSES]",occurs,N/A,43,2,1,46,14,TWrex-cause,813484-FS1,"• FIBROMYALGIA characterized by widespread PAIN and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",PAIN,FIBROMYALGIA
724352422,5/21/2015 09:02:55,1640188535,5/21/2015 09:02:39,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[TREATS],[TREATS],in the treatment of,N/A,86,42,-1,101,65,TWrex-cause,800691-FS1,"Lange DS, Richards HM, Guarnieri J et al. KETOCONAZOLE 2% SHAMPOO in the treatment of TINEA VERSICOLOR: a multicenter, randomized, double blind, placebo controlled trial.",TINEA VERSICOLOR,KETOCONAZOLE 2% SHAMPOO
724352422,5/21/2015 09:20:37,1640197455,5/21/2015 09:20:14,false,neodev,1.0,15848372,AUS,02,Jannali,14.200.59.55,[TREATS],[TREATS],treatment,N/A,86,42,-1,101,65,TWrex-cause,800691-FS1,"Lange DS, Richards HM, Guarnieri J et al. KETOCONAZOLE 2% SHAMPOO in the treatment of TINEA VERSICOLOR: a multicenter, randomized, double blind, placebo controlled trial.",TINEA VERSICOLOR,KETOCONAZOLE 2% SHAMPOO
724352422,5/21/2015 09:40:19,1640207208,5/21/2015 09:40:07,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],treatment,N/A,86,42,-1,101,65,TWrex-cause,800691-FS1,"Lange DS, Richards HM, Guarnieri J et al. KETOCONAZOLE 2% SHAMPOO in the treatment of TINEA VERSICOLOR: a multicenter, randomized, double blind, placebo controlled trial.",TINEA VERSICOLOR,KETOCONAZOLE 2% SHAMPOO
724352422,5/21/2015 09:49:51,1640211899,5/21/2015 09:49:39,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treatment,N/A,86,42,-1,101,65,TWrex-cause,800691-FS1,"Lange DS, Richards HM, Guarnieri J et al. KETOCONAZOLE 2% SHAMPOO in the treatment of TINEA VERSICOLOR: a multicenter, randomized, double blind, placebo controlled trial.",TINEA VERSICOLOR,KETOCONAZOLE 2% SHAMPOO
724352422,5/21/2015 10:18:41,1640226286,5/21/2015 10:18:23,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],treatment,N/A,86,42,-1,101,65,TWrex-cause,800691-FS1,"Lange DS, Richards HM, Guarnieri J et al. KETOCONAZOLE 2% SHAMPOO in the treatment of TINEA VERSICOLOR: a multicenter, randomized, double blind, placebo controlled trial.",TINEA VERSICOLOR,KETOCONAZOLE 2% SHAMPOO
724352422,5/21/2015 10:27:47,1640230401,5/21/2015 10:27:10,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],KETOCONAZOLE 2% SHAMPOO the treatment TINEA VERSICOLOR:,N/A,86,42,-1,101,65,TWrex-cause,800691-FS1,"Lange DS, Richards HM, Guarnieri J et al. KETOCONAZOLE 2% SHAMPOO in the treatment of TINEA VERSICOLOR: a multicenter, randomized, double blind, placebo controlled trial.",TINEA VERSICOLOR,KETOCONAZOLE 2% SHAMPOO
724352422,5/21/2015 10:31:26,1640232039,5/21/2015 10:31:13,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[TREATS],[TREATS],TINEA VERSICOLOR:,none,86,42,-1,101,65,TWrex-cause,800691-FS1,"Lange DS, Richards HM, Guarnieri J et al. KETOCONAZOLE 2% SHAMPOO in the treatment of TINEA VERSICOLOR: a multicenter, randomized, double blind, placebo controlled trial.",TINEA VERSICOLOR,KETOCONAZOLE 2% SHAMPOO
724352422,5/21/2015 10:37:20,1640235047,5/21/2015 10:37:05,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treatment,N/A,86,42,-1,101,65,TWrex-cause,800691-FS1,"Lange DS, Richards HM, Guarnieri J et al. KETOCONAZOLE 2% SHAMPOO in the treatment of TINEA VERSICOLOR: a multicenter, randomized, double blind, placebo controlled trial.",TINEA VERSICOLOR,KETOCONAZOLE 2% SHAMPOO
724352422,5/21/2015 10:46:39,1640239928,5/21/2015 10:46:20,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],in the treatment of,n/a,86,42,-1,101,65,TWrex-cause,800691-FS1,"Lange DS, Richards HM, Guarnieri J et al. KETOCONAZOLE 2% SHAMPOO in the treatment of TINEA VERSICOLOR: a multicenter, randomized, double blind, placebo controlled trial.",TINEA VERSICOLOR,KETOCONAZOLE 2% SHAMPOO
724352422,5/21/2015 10:56:56,1640245224,5/21/2015 10:56:35,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],in the treatment,N/A,86,42,-1,101,65,TWrex-cause,800691-FS1,"Lange DS, Richards HM, Guarnieri J et al. KETOCONAZOLE 2% SHAMPOO in the treatment of TINEA VERSICOLOR: a multicenter, randomized, double blind, placebo controlled trial.",TINEA VERSICOLOR,KETOCONAZOLE 2% SHAMPOO
724352422,5/21/2015 10:57:59,1640245704,5/21/2015 10:57:38,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,86,42,-1,101,65,TWrex-cause,800691-FS1,"Lange DS, Richards HM, Guarnieri J et al. KETOCONAZOLE 2% SHAMPOO in the treatment of TINEA VERSICOLOR: a multicenter, randomized, double blind, placebo controlled trial.",TINEA VERSICOLOR,KETOCONAZOLE 2% SHAMPOO
724352422,5/21/2015 11:00:56,1640247244,5/21/2015 11:00:07,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",in treatment controlled trial.,n/a,86,42,-1,101,65,TWrex-cause,800691-FS1,"Lange DS, Richards HM, Guarnieri J et al. KETOCONAZOLE 2% SHAMPOO in the treatment of TINEA VERSICOLOR: a multicenter, randomized, double blind, placebo controlled trial.",TINEA VERSICOLOR,KETOCONAZOLE 2% SHAMPOO
724352422,5/21/2015 11:17:32,1640254234,5/21/2015 11:17:19,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],treatment,N/A,86,42,-1,101,65,TWrex-cause,800691-FS1,"Lange DS, Richards HM, Guarnieri J et al. KETOCONAZOLE 2% SHAMPOO in the treatment of TINEA VERSICOLOR: a multicenter, randomized, double blind, placebo controlled trial.",TINEA VERSICOLOR,KETOCONAZOLE 2% SHAMPOO
724352422,5/21/2015 11:32:14,1640260586,5/21/2015 11:32:02,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,86,42,-1,101,65,TWrex-cause,800691-FS1,"Lange DS, Richards HM, Guarnieri J et al. KETOCONAZOLE 2% SHAMPOO in the treatment of TINEA VERSICOLOR: a multicenter, randomized, double blind, placebo controlled trial.",TINEA VERSICOLOR,KETOCONAZOLE 2% SHAMPOO
724352422,5/21/2015 11:36:32,1640262516,5/21/2015 11:35:10,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],in the treatment of,n/a,86,42,-1,101,65,TWrex-cause,800691-FS1,"Lange DS, Richards HM, Guarnieri J et al. KETOCONAZOLE 2% SHAMPOO in the treatment of TINEA VERSICOLOR: a multicenter, randomized, double blind, placebo controlled trial.",TINEA VERSICOLOR,KETOCONAZOLE 2% SHAMPOO
724352423,5/21/2015 07:06:30,1640126504,5/21/2015 07:06:08,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,[OTHER],[OTHER],NEUROPATHIC PAIN can be generalized to the (GENERALIZED VULVODYNIA),n/a,2,59,1,17,81,TWrex-cause,813761-FS1,• NEUROPATHIC PAIN can be generalized to the entire vulva (GENERALIZED VULVODYNIA) and is coupled with a normal physical exam.,NEUROPATHIC PAIN,GENERALIZED VULVODYNIA
724352423,5/21/2015 07:13:20,1640130311,5/21/2015 07:13:04,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,2,59,1,17,81,TWrex-cause,813761-FS1,• NEUROPATHIC PAIN can be generalized to the entire vulva (GENERALIZED VULVODYNIA) and is coupled with a normal physical exam.,NEUROPATHIC PAIN,GENERALIZED VULVODYNIA
724352423,5/21/2015 07:20:02,1640134198,5/21/2015 07:18:15,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[LOCATION] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[LOCATION]",generalized physical exam.,N/A,2,59,1,17,81,TWrex-cause,813761-FS1,• NEUROPATHIC PAIN can be generalized to the entire vulva (GENERALIZED VULVODYNIA) and is coupled with a normal physical exam.,NEUROPATHIC PAIN,GENERALIZED VULVODYNIA
724352423,5/21/2015 07:21:08,1640134681,5/21/2015 07:20:40,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]",is with a,N/A,2,59,1,17,81,TWrex-cause,813761-FS1,• NEUROPATHIC PAIN can be generalized to the entire vulva (GENERALIZED VULVODYNIA) and is coupled with a normal physical exam.,NEUROPATHIC PAIN,GENERALIZED VULVODYNIA
724352423,5/21/2015 07:32:23,1640140655,5/21/2015 07:31:39,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[PART_OF] [IS_A],"[IS_A]
[PART_OF]",can be generalized to,N/A,2,59,1,17,81,TWrex-cause,813761-FS1,• NEUROPATHIC PAIN can be generalized to the entire vulva (GENERALIZED VULVODYNIA) and is coupled with a normal physical exam.,NEUROPATHIC PAIN,GENERALIZED VULVODYNIA
724352423,5/21/2015 07:35:23,1640142228,5/21/2015 07:34:35,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[LOCATION],[LOCATION],can be generalized to the,N/A,2,59,1,17,81,TWrex-cause,813761-FS1,• NEUROPATHIC PAIN can be generalized to the entire vulva (GENERALIZED VULVODYNIA) and is coupled with a normal physical exam.,NEUROPATHIC PAIN,GENERALIZED VULVODYNIA
724352423,5/21/2015 07:44:16,1640146869,5/21/2015 07:43:40,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A],[IS_A],is a,N/A,2,59,1,17,81,TWrex-cause,813761-FS1,• NEUROPATHIC PAIN can be generalized to the entire vulva (GENERALIZED VULVODYNIA) and is coupled with a normal physical exam.,NEUROPATHIC PAIN,GENERALIZED VULVODYNIA
724352423,5/21/2015 07:45:54,1640147705,5/21/2015 07:45:11,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[PART_OF],[PART_OF],can be generalized,N/A,2,59,1,17,81,TWrex-cause,813761-FS1,• NEUROPATHIC PAIN can be generalized to the entire vulva (GENERALIZED VULVODYNIA) and is coupled with a normal physical exam.,NEUROPATHIC PAIN,GENERALIZED VULVODYNIA
724352423,5/21/2015 07:45:55,1640147722,5/21/2015 07:45:33,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PART_OF],[PART_OF],generalized,n/a,2,59,1,17,81,TWrex-cause,813761-FS1,• NEUROPATHIC PAIN can be generalized to the entire vulva (GENERALIZED VULVODYNIA) and is coupled with a normal physical exam.,NEUROPATHIC PAIN,GENERALIZED VULVODYNIA
724352423,5/21/2015 08:02:33,1640156525,5/21/2015 08:02:11,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]",is with a,N/A,2,59,1,17,81,TWrex-cause,813761-FS1,• NEUROPATHIC PAIN can be generalized to the entire vulva (GENERALIZED VULVODYNIA) and is coupled with a normal physical exam.,NEUROPATHIC PAIN,GENERALIZED VULVODYNIA
724352423,5/21/2015 08:05:41,1640158312,5/21/2015 08:04:41,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[IS_A],[IS_A],PAIN,N/A,2,59,1,17,81,TWrex-cause,813761-FS1,• NEUROPATHIC PAIN can be generalized to the entire vulva (GENERALIZED VULVODYNIA) and is coupled with a normal physical exam.,NEUROPATHIC PAIN,GENERALIZED VULVODYNIA
724352423,5/21/2015 08:19:57,1640166172,5/21/2015 08:19:37,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,[SYMPTOM],[SYMPTOM],generalized,-,2,59,1,17,81,TWrex-cause,813761-FS1,• NEUROPATHIC PAIN can be generalized to the entire vulva (GENERALIZED VULVODYNIA) and is coupled with a normal physical exam.,NEUROPATHIC PAIN,GENERALIZED VULVODYNIA
724352423,5/21/2015 08:34:12,1640173941,5/21/2015 08:33:47,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],NEUROPATHIC PAIN (GENERALIZED VULVODYNIA) exam.,n/a,2,59,1,17,81,TWrex-cause,813761-FS1,• NEUROPATHIC PAIN can be generalized to the entire vulva (GENERALIZED VULVODYNIA) and is coupled with a normal physical exam.,NEUROPATHIC PAIN,GENERALIZED VULVODYNIA
724352423,5/21/2015 08:42:19,1640177973,5/21/2015 08:41:14,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"NEUROPATHIC PAIN can be (GENERALIZED VUL<span id=""transmark""></span>VODYNIA)",n/a,2,59,1,17,81,TWrex-cause,813761-FS1,• NEUROPATHIC PAIN can be generalized to the entire vulva (GENERALIZED VULVODYNIA) and is coupled with a normal physical exam.,NEUROPATHIC PAIN,GENERALIZED VULVODYNIA
724352423,5/21/2015 08:43:32,1640178698,5/21/2015 08:42:48,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[ASSOCIATED_WITH],[ASSOCIATED_WITH],NEUROPATHIC PAIN can be generalized to the entire vulva (GENERALIZED VULVODYNIA) and is coupled with a normal physical exam.,n/a,2,59,1,17,81,TWrex-cause,813761-FS1,• NEUROPATHIC PAIN can be generalized to the entire vulva (GENERALIZED VULVODYNIA) and is coupled with a normal physical exam.,NEUROPATHIC PAIN,GENERALIZED VULVODYNIA
724352424,5/21/2015 08:46:21,1640180147,5/21/2015 08:45:39,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,[ASSOCIATED_WITH],[ASSOCIATED_WITH],involves,Associated with,17,0,1,20,30,TWrex-cause,814334-FS1,COMPLEX REGIONAL PAIN SYNDROME sometimes involves sympathetically maintained PAIN,PAIN,COMPLEX REGIONAL PAIN SYNDROME
724352424,5/21/2015 08:46:57,1640180463,5/21/2015 08:46:28,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[SYMPTOM],[SYMPTOM],SYNDROME,N/A,17,0,1,20,30,TWrex-cause,814334-FS1,COMPLEX REGIONAL PAIN SYNDROME sometimes involves sympathetically maintained PAIN,PAIN,COMPLEX REGIONAL PAIN SYNDROME
724352424,5/21/2015 08:48:00,1640180930,5/21/2015 08:47:36,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM],[SYMPTOM],COMPLEX REGIONAL PAIN SYNDROME sometimes involves sympathetically maintained PAIN,n/a,17,0,1,20,30,TWrex-cause,814334-FS1,COMPLEX REGIONAL PAIN SYNDROME sometimes involves sympathetically maintained PAIN,PAIN,COMPLEX REGIONAL PAIN SYNDROME
724352424,5/21/2015 08:49:02,1640181366,5/21/2015 08:48:26,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[ASSOCIATED_WITH] [OTHER] [TREATS],"[TREATS]
[ASSOCIATED_WITH]
[OTHER]","COMPLEX REGIONAL PAIN SYNDROME sometimes involves sympathetically maintained PA<span id=""transmark""></span>IN",n/a,17,0,1,20,30,TWrex-cause,814334-FS1,COMPLEX REGIONAL PAIN SYNDROME sometimes involves sympathetically maintained PAIN,PAIN,COMPLEX REGIONAL PAIN SYNDROME
724352424,5/21/2015 08:50:48,1640182318,5/21/2015 08:50:26,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[SYMPTOM],[SYMPTOM],involves sympathetically maintained,N/A,17,0,1,20,30,TWrex-cause,814334-FS1,COMPLEX REGIONAL PAIN SYNDROME sometimes involves sympathetically maintained PAIN,PAIN,COMPLEX REGIONAL PAIN SYNDROME
724352424,5/21/2015 08:52:01,1640182972,5/21/2015 08:50:55,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,[SYMPTOM],[SYMPTOM],involves,N/A,17,0,1,20,30,TWrex-cause,814334-FS1,COMPLEX REGIONAL PAIN SYNDROME sometimes involves sympathetically maintained PAIN,PAIN,COMPLEX REGIONAL PAIN SYNDROME
724352424,5/21/2015 09:02:37,1640188391,5/21/2015 09:02:07,false,neodev,1.0,15848372,AUS,02,Jannali,14.200.59.55,[MANIFESTATION],[MANIFESTATION],involves,N/A,17,0,1,20,30,TWrex-cause,814334-FS1,COMPLEX REGIONAL PAIN SYNDROME sometimes involves sympathetically maintained PAIN,PAIN,COMPLEX REGIONAL PAIN SYNDROME
724352424,5/21/2015 09:05:01,1640189551,5/21/2015 09:04:25,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",involves,N/A,17,0,1,20,30,TWrex-cause,814334-FS1,COMPLEX REGIONAL PAIN SYNDROME sometimes involves sympathetically maintained PAIN,PAIN,COMPLEX REGIONAL PAIN SYNDROME
724352424,5/21/2015 09:17:27,1640196065,5/21/2015 09:16:29,false,clixsense,1.0,28570371,NLD,"","",91.213.37.165,[SYMPTOM],[SYMPTOM],maintained,N/A,17,0,1,20,30,TWrex-cause,814334-FS1,COMPLEX REGIONAL PAIN SYNDROME sometimes involves sympathetically maintained PAIN,PAIN,COMPLEX REGIONAL PAIN SYNDROME
724352424,5/21/2015 09:24:13,1640199100,5/21/2015 09:23:07,false,neodev,1.0,31195295,GBR,"","",46.208.164.162,[SYMPTOM],[SYMPTOM],involves,N/A,17,0,1,20,30,TWrex-cause,814334-FS1,COMPLEX REGIONAL PAIN SYNDROME sometimes involves sympathetically maintained PAIN,PAIN,COMPLEX REGIONAL PAIN SYNDROME
724352424,5/21/2015 09:32:53,1640203684,5/21/2015 09:32:20,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[SYMPTOM],[SYMPTOM],sympathetically,N/A,17,0,1,20,30,TWrex-cause,814334-FS1,COMPLEX REGIONAL PAIN SYNDROME sometimes involves sympathetically maintained PAIN,PAIN,COMPLEX REGIONAL PAIN SYNDROME
724352424,5/21/2015 09:43:46,1640208876,5/21/2015 09:42:25,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[SYMPTOM],[SYMPTOM],sympathetically,N/A,17,0,1,20,30,TWrex-cause,814334-FS1,COMPLEX REGIONAL PAIN SYNDROME sometimes involves sympathetically maintained PAIN,PAIN,COMPLEX REGIONAL PAIN SYNDROME
724352424,5/21/2015 10:01:02,1640217499,5/21/2015 09:59:53,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION],[MANIFESTATION],COMPLEX REGIONAL PAIN SYNDROME involves PAIN,N/A,17,0,1,20,30,TWrex-cause,814334-FS1,COMPLEX REGIONAL PAIN SYNDROME sometimes involves sympathetically maintained PAIN,PAIN,COMPLEX REGIONAL PAIN SYNDROME
724352424,5/21/2015 10:04:06,1640219044,5/21/2015 10:02:01,false,vivatic,1,13889585,GBR,A1,Dagenham,2.28.66.9,[MANIFESTATION] [ASSOCIATED_WITH] [PART_OF],"[MANIFESTATION]
[ASSOCIATED_WITH]
[PART_OF]",involves,I have not selected NONE,17,0,1,20,30,TWrex-cause,814334-FS1,COMPLEX REGIONAL PAIN SYNDROME sometimes involves sympathetically maintained PAIN,PAIN,COMPLEX REGIONAL PAIN SYNDROME
724352424,5/21/2015 10:10:59,1640222434,5/21/2015 10:10:45,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],maintained,N/A,17,0,1,20,30,TWrex-cause,814334-FS1,COMPLEX REGIONAL PAIN SYNDROME sometimes involves sympathetically maintained PAIN,PAIN,COMPLEX REGIONAL PAIN SYNDROME
724352425,5/21/2015 06:58:39,1640122458,5/21/2015 06:58:14,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,[PREVENTS],[PREVENTS],ASPIRIN reducing INFARCTION,n/a,186,132,-1,199,139,TWrex-cause,800454-FS1,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low dose aspirin as effective as high dose ASPIRIN for reducing perioperative stroke, myocardial INFARCTION (MI and death after CE.",INFARCTION (MI,ASPIRIN
724352425,5/21/2015 07:01:49,1640124148,5/21/2015 07:01:07,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[PREVENTS],[PREVENTS],reducing,N/A,186,132,-1,199,139,TWrex-cause,800454-FS1,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low dose aspirin as effective as high dose ASPIRIN for reducing perioperative stroke, myocardial INFARCTION (MI and death after CE.",INFARCTION (MI,ASPIRIN
724352425,5/21/2015 07:07:59,1640127395,5/21/2015 07:07:45,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],effective,N/A,186,132,-1,199,139,TWrex-cause,800454-FS1,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low dose aspirin as effective as high dose ASPIRIN for reducing perioperative stroke, myocardial INFARCTION (MI and death after CE.",INFARCTION (MI,ASPIRIN
724352425,5/21/2015 07:09:20,1640128181,5/21/2015 07:08:44,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A],[IS_A],as,N/A,186,132,-1,199,139,TWrex-cause,800454-FS1,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low dose aspirin as effective as high dose ASPIRIN for reducing perioperative stroke, myocardial INFARCTION (MI and death after CE.",INFARCTION (MI,ASPIRIN
724352425,5/21/2015 07:17:37,1640132710,5/21/2015 07:16:44,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],for reducing,N/A,186,132,-1,199,139,TWrex-cause,800454-FS1,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low dose aspirin as effective as high dose ASPIRIN for reducing perioperative stroke, myocardial INFARCTION (MI and death after CE.",INFARCTION (MI,ASPIRIN
724352425,5/21/2015 07:18:57,1640133429,5/21/2015 07:16:57,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",for reducing,N/A,186,132,-1,199,139,TWrex-cause,800454-FS1,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low dose aspirin as effective as high dose ASPIRIN for reducing perioperative stroke, myocardial INFARCTION (MI and death after CE.",INFARCTION (MI,ASPIRIN
724352425,5/21/2015 07:31:35,1640140288,5/21/2015 07:30:57,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A],[IS_A],is,N/A,186,132,-1,199,139,TWrex-cause,800454-FS1,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low dose aspirin as effective as high dose ASPIRIN for reducing perioperative stroke, myocardial INFARCTION (MI and death after CE.",INFARCTION (MI,ASPIRIN
724352425,5/21/2015 07:34:53,1640141919,5/21/2015 07:34:32,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],for reducing,N/A,186,132,-1,199,139,TWrex-cause,800454-FS1,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low dose aspirin as effective as high dose ASPIRIN for reducing perioperative stroke, myocardial INFARCTION (MI and death after CE.",INFARCTION (MI,ASPIRIN
724352425,5/21/2015 07:37:36,1640143397,5/21/2015 07:37:10,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PREVENTS],[PREVENTS],reducing perioperative,www.toptal.com › Blog,186,132,-1,199,139,TWrex-cause,800454-FS1,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low dose aspirin as effective as high dose ASPIRIN for reducing perioperative stroke, myocardial INFARCTION (MI and death after CE.",INFARCTION (MI,ASPIRIN
724352425,5/21/2015 07:50:08,1640149908,5/21/2015 07:49:58,false,elite,1.0,31913360,GBR,"","",88.150.133.60,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],endarterectomy,ddsd,186,132,-1,199,139,TWrex-cause,800454-FS1,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low dose aspirin as effective as high dose ASPIRIN for reducing perioperative stroke, myocardial INFARCTION (MI and death after CE.",INFARCTION (MI,ASPIRIN
724352425,5/21/2015 07:51:50,1640150956,5/21/2015 07:51:25,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A],[IS_A],is,N/A,186,132,-1,199,139,TWrex-cause,800454-FS1,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low dose aspirin as effective as high dose ASPIRIN for reducing perioperative stroke, myocardial INFARCTION (MI and death after CE.",INFARCTION (MI,ASPIRIN
724352425,5/21/2015 07:52:35,1640151350,5/21/2015 07:52:02,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[PREVENTS],[PREVENTS],reducing,N/A,186,132,-1,199,139,TWrex-cause,800454-FS1,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low dose aspirin as effective as high dose ASPIRIN for reducing perioperative stroke, myocardial INFARCTION (MI and death after CE.",INFARCTION (MI,ASPIRIN
724352425,5/21/2015 07:56:42,1640153682,5/21/2015 07:56:02,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,[TREATS],[TREATS],effective,-,186,132,-1,199,139,TWrex-cause,800454-FS1,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low dose aspirin as effective as high dose ASPIRIN for reducing perioperative stroke, myocardial INFARCTION (MI and death after CE.",INFARCTION (MI,ASPIRIN
724352425,5/21/2015 08:10:39,1640160923,5/21/2015 08:10:10,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[IS_A],[IS_A],is,N/A,186,132,-1,199,139,TWrex-cause,800454-FS1,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low dose aspirin as effective as high dose ASPIRIN for reducing perioperative stroke, myocardial INFARCTION (MI and death after CE.",INFARCTION (MI,ASPIRIN
724352425,5/21/2015 08:17:54,1640164902,5/21/2015 08:17:13,false,clixsense,1.0,12843982,AUS,08,Perth,180.216.79.226,[PREVENTS],[PREVENTS],ASPIRIN for reducing INFARCTION (MI,N/A,186,132,-1,199,139,TWrex-cause,800454-FS1,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low dose aspirin as effective as high dose ASPIRIN for reducing perioperative stroke, myocardial INFARCTION (MI and death after CE.",INFARCTION (MI,ASPIRIN
724352426,5/21/2015 07:05:06,1640125754,5/21/2015 07:04:46,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,[ASSOCIATED_WITH],[ASSOCIATED_WITH],WOUND BOTULISM or C BOTULINUM organism,n/a,3,55,1,16,66,TWrex-cause,810498-FS1,In WOUND BOTULISM finding toxin in serum or isolating  C BOTULINUM  organism on anaerobic culture of the wound confirms the diagnosis.,WOUND BOTULISM,C BOTULINUM
724352426,5/21/2015 07:12:26,1640129844,5/21/2015 07:12:12,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],confirms the diagnosis.,N/A,3,55,1,16,66,TWrex-cause,810498-FS1,In WOUND BOTULISM finding toxin in serum or isolating  C BOTULINUM  organism on anaerobic culture of the wound confirms the diagnosis.,WOUND BOTULISM,C BOTULINUM
724352426,5/21/2015 07:15:59,1640131871,5/21/2015 07:13:40,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis.,N/A,3,55,1,16,66,TWrex-cause,810498-FS1,In WOUND BOTULISM finding toxin in serum or isolating  C BOTULINUM  organism on anaerobic culture of the wound confirms the diagnosis.,WOUND BOTULISM,C BOTULINUM
724352426,5/21/2015 07:18:28,1640133199,5/21/2015 07:17:59,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",or of,N/A,3,55,1,16,66,TWrex-cause,810498-FS1,In WOUND BOTULISM finding toxin in serum or isolating  C BOTULINUM  organism on anaerobic culture of the wound confirms the diagnosis.,WOUND BOTULISM,C BOTULINUM
724352426,5/21/2015 07:29:36,1640139130,5/21/2015 07:29:04,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],confirms,N/A,3,55,1,16,66,TWrex-cause,810498-FS1,In WOUND BOTULISM finding toxin in serum or isolating  C BOTULINUM  organism on anaerobic culture of the wound confirms the diagnosis.,WOUND BOTULISM,C BOTULINUM
724352426,5/21/2015 07:31:20,1640140181,5/21/2015 07:30:35,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[NONE],[NONE],N/A,Same.,3,55,1,16,66,TWrex-cause,810498-FS1,In WOUND BOTULISM finding toxin in serum or isolating  C BOTULINUM  organism on anaerobic culture of the wound confirms the diagnosis.,WOUND BOTULISM,C BOTULINUM
724352426,5/21/2015 07:41:21,1640145436,5/21/2015 07:40:57,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",or of,N/A,3,55,1,16,66,TWrex-cause,810498-FS1,In WOUND BOTULISM finding toxin in serum or isolating  C BOTULINUM  organism on anaerobic culture of the wound confirms the diagnosis.,WOUND BOTULISM,C BOTULINUM
724352426,5/21/2015 07:43:30,1640146351,5/21/2015 07:42:52,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],culture of the wound confirms the diagnosis.,N/A,3,55,1,16,66,TWrex-cause,810498-FS1,In WOUND BOTULISM finding toxin in serum or isolating  C BOTULINUM  organism on anaerobic culture of the wound confirms the diagnosis.,WOUND BOTULISM,C BOTULINUM
724352426,5/21/2015 07:44:32,1640147007,5/21/2015 07:44:10,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PART_OF],[PART_OF],isolating,n/a,3,55,1,16,66,TWrex-cause,810498-FS1,In WOUND BOTULISM finding toxin in serum or isolating  C BOTULINUM  organism on anaerobic culture of the wound confirms the diagnosis.,WOUND BOTULISM,C BOTULINUM
724352426,5/21/2015 08:00:20,1640155492,5/21/2015 07:59:54,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",or of,N/A,3,55,1,16,66,TWrex-cause,810498-FS1,In WOUND BOTULISM finding toxin in serum or isolating  C BOTULINUM  organism on anaerobic culture of the wound confirms the diagnosis.,WOUND BOTULISM,C BOTULINUM
724352426,5/21/2015 08:03:16,1640157010,5/21/2015 08:02:20,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],finding C BOTULINUM diagnosis.,N/A,3,55,1,16,66,TWrex-cause,810498-FS1,In WOUND BOTULISM finding toxin in serum or isolating  C BOTULINUM  organism on anaerobic culture of the wound confirms the diagnosis.,WOUND BOTULISM,C BOTULINUM
724352426,5/21/2015 08:11:23,1640161378,5/21/2015 08:09:58,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],finding,-,3,55,1,16,66,TWrex-cause,810498-FS1,In WOUND BOTULISM finding toxin in serum or isolating  C BOTULINUM  organism on anaerobic culture of the wound confirms the diagnosis.,WOUND BOTULISM,C BOTULINUM
724352426,5/21/2015 08:31:59,1640172659,5/21/2015 08:31:32,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[TREATS],[TREATS],WOUND BOTULISM finding serum isolating C BOTULINUM,n/a,3,55,1,16,66,TWrex-cause,810498-FS1,In WOUND BOTULISM finding toxin in serum or isolating  C BOTULINUM  organism on anaerobic culture of the wound confirms the diagnosis.,WOUND BOTULISM,C BOTULINUM
724352426,5/21/2015 08:39:02,1640176448,5/21/2015 08:38:18,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"In WOUND BOTULISM isolating C BOTULINUM confirms th<span id=""transmark""></span>e diagnosis.",n.a,3,55,1,16,66,TWrex-cause,810498-FS1,In WOUND BOTULISM finding toxin in serum or isolating  C BOTULINUM  organism on anaerobic culture of the wound confirms the diagnosis.,WOUND BOTULISM,C BOTULINUM
724352426,5/21/2015 08:42:42,1640178192,5/21/2015 08:41:54,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis.,Diagnosis,3,55,1,16,66,TWrex-cause,810498-FS1,In WOUND BOTULISM finding toxin in serum or isolating  C BOTULINUM  organism on anaerobic culture of the wound confirms the diagnosis.,WOUND BOTULISM,C BOTULINUM
724352427,5/21/2015 07:04:15,1640125317,5/21/2015 07:03:55,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,[MANIFESTATION],[MANIFESTATION],"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",n/a,40,3,-1,61,24,TWrex-cause,804416-FS1,"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",IRON DEFICIENCY ANEMIA,NEGATIVE IRON BALANCE
724352427,5/21/2015 07:11:51,1640129522,5/21/2015 07:11:32,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],is the result.,N/A,40,3,-1,61,24,TWrex-cause,804416-FS1,"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",IRON DEFICIENCY ANEMIA,NEGATIVE IRON BALANCE
724352427,5/21/2015 07:12:37,1640129935,5/21/2015 07:12:10,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],result.,N/A,40,3,-1,61,24,TWrex-cause,804416-FS1,"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",IRON DEFICIENCY ANEMIA,NEGATIVE IRON BALANCE
724352427,5/21/2015 07:17:20,1640132579,5/21/2015 07:16:56,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A],[IS_A],is,N/A,40,3,-1,61,24,TWrex-cause,804416-FS1,"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",IRON DEFICIENCY ANEMIA,NEGATIVE IRON BALANCE
724352427,5/21/2015 07:28:02,1640138262,5/21/2015 07:27:23,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"If persists,",N/A,40,3,-1,61,24,TWrex-cause,804416-FS1,"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",IRON DEFICIENCY ANEMIA,NEGATIVE IRON BALANCE
724352427,5/21/2015 07:29:48,1640139262,5/21/2015 07:29:20,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],is the result.,N/A,40,3,-1,61,24,TWrex-cause,804416-FS1,"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",IRON DEFICIENCY ANEMIA,NEGATIVE IRON BALANCE
724352427,5/21/2015 07:40:06,1640144722,5/21/2015 07:39:44,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A],[IS_A],is,N/A,40,3,-1,61,24,TWrex-cause,804416-FS1,"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",IRON DEFICIENCY ANEMIA,NEGATIVE IRON BALANCE
724352427,5/21/2015 07:42:06,1640145804,5/21/2015 07:41:32,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[SIDE_EFFECT],[SIDE_EFFECT],"persists, then",N/A,40,3,-1,61,24,TWrex-cause,804416-FS1,"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",IRON DEFICIENCY ANEMIA,NEGATIVE IRON BALANCE
724352427,5/21/2015 07:43:49,1640146588,5/21/2015 07:43:33,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],result.,n/a,40,3,-1,61,24,TWrex-cause,804416-FS1,"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",IRON DEFICIENCY ANEMIA,NEGATIVE IRON BALANCE
724352427,5/21/2015 07:59:17,1640155002,5/21/2015 07:58:54,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A],[IS_A],is,N/A,40,3,-1,61,24,TWrex-cause,804416-FS1,"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",IRON DEFICIENCY ANEMIA,NEGATIVE IRON BALANCE
724352427,5/21/2015 08:01:46,1640156180,5/21/2015 08:01:26,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CAUSES],[CAUSES],result.,N/A,40,3,-1,61,24,TWrex-cause,804416-FS1,"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",IRON DEFICIENCY ANEMIA,NEGATIVE IRON BALANCE
724352427,5/21/2015 08:08:54,1640160111,5/21/2015 08:08:08,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,[TREATS] [MANIFESTATION],"[TREATS]
[MANIFESTATION]",result.,-,40,3,-1,61,24,TWrex-cause,804416-FS1,"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",IRON DEFICIENCY ANEMIA,NEGATIVE IRON BALANCE
724352427,5/21/2015 08:31:03,1640172154,5/21/2015 08:29:57,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[CAUSES],[CAUSES],NEGATIVE IRON BALANCE IRON DEFICIENCY ANEMIA,n/a,40,3,-1,61,24,TWrex-cause,804416-FS1,"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",IRON DEFICIENCY ANEMIA,NEGATIVE IRON BALANCE
724352427,5/21/2015 08:37:05,1640175400,5/21/2015 08:36:33,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[CAUSES] [SIDE_EFFECT],"[CAUSES]
[SIDE_EFFECT]","If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the re<span id=""transmark""></span>sult.",n/a,40,3,-1,61,24,TWrex-cause,804416-FS1,"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",IRON DEFICIENCY ANEMIA,NEGATIVE IRON BALANCE
724352427,5/21/2015 08:41:56,1640177784,5/21/2015 08:41:11,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",n/a,40,3,-1,61,24,TWrex-cause,804416-FS1,"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",IRON DEFICIENCY ANEMIA,NEGATIVE IRON BALANCE
724352428,5/21/2015 09:01:12,1640187621,5/21/2015 09:00:54,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[TREATS],[TREATS],as maintenance therapy for,N/A,113,74,-1,151,85,TWrex-cause,800338-FS1,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus FLUCONAZOLE as maintenance therapy for AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS",AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
724352428,5/21/2015 09:06:28,1640190232,5/21/2015 09:05:26,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS],[PREVENTS],A comparison of itraconazole versus FLUCONAZOLE as maintenance therapy for AIDS ASSOCIATED CRYPTOCOCCAL,n/a,113,74,-1,151,85,TWrex-cause,800338-FS1,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus FLUCONAZOLE as maintenance therapy for AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS",AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
724352428,5/21/2015 09:18:46,1640196604,5/21/2015 09:18:27,false,neodev,1.0,15848372,AUS,02,Jannali,14.200.59.55,[TREATS],[TREATS],maintenance therapy,N/A,113,74,-1,151,85,TWrex-cause,800338-FS1,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus FLUCONAZOLE as maintenance therapy for AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS",AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
724352428,5/21/2015 09:37:41,1640206051,5/21/2015 09:37:29,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],therapy,N/A,113,74,-1,151,85,TWrex-cause,800338-FS1,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus FLUCONAZOLE as maintenance therapy for AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS",AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
724352428,5/21/2015 09:48:44,1640211271,5/21/2015 09:48:30,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],therapy,N/A,113,74,-1,151,85,TWrex-cause,800338-FS1,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus FLUCONAZOLE as maintenance therapy for AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS",AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
724352428,5/21/2015 10:17:09,1640225406,5/21/2015 10:16:56,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],therapy,N/A,113,74,-1,151,85,TWrex-cause,800338-FS1,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus FLUCONAZOLE as maintenance therapy for AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS",AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
724352428,5/21/2015 10:24:26,1640228928,5/21/2015 10:23:50,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],FLUCONAZOLE as maintenance therapy for AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS,N/A,113,74,-1,151,85,TWrex-cause,800338-FS1,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus FLUCONAZOLE as maintenance therapy for AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS",AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
724352428,5/21/2015 10:30:12,1640231518,5/21/2015 10:29:55,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],FLUCONAZOLE,none,113,74,-1,151,85,TWrex-cause,800338-FS1,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus FLUCONAZOLE as maintenance therapy for AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS",AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
724352428,5/21/2015 10:36:08,1640234301,5/21/2015 10:33:45,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],therapy,N/A,113,74,-1,151,85,TWrex-cause,800338-FS1,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus FLUCONAZOLE as maintenance therapy for AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS",AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
724352428,5/21/2015 10:44:41,1640238918,5/21/2015 10:44:13,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],maintenance therapy for,n/a,113,74,-1,151,85,TWrex-cause,800338-FS1,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus FLUCONAZOLE as maintenance therapy for AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS",AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
724352428,5/21/2015 10:54:13,1640243946,5/21/2015 10:53:40,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],as maintenance therapy,N/A,113,74,-1,151,85,TWrex-cause,800338-FS1,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus FLUCONAZOLE as maintenance therapy for AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS",AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
724352428,5/21/2015 10:54:49,1640244262,5/21/2015 10:54:17,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],maintenance therapy for,N/A,113,74,-1,151,85,TWrex-cause,800338-FS1,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus FLUCONAZOLE as maintenance therapy for AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS",AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
724352428,5/21/2015 10:56:35,1640245074,5/21/2015 10:55:32,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[TREATS] [ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",comparison versus therapy ASSOCIATED,n/a,113,74,-1,151,85,TWrex-cause,800338-FS1,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus FLUCONAZOLE as maintenance therapy for AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS",AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
724352428,5/21/2015 11:15:58,1640253559,5/21/2015 11:13:57,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],therapy,N/A,113,74,-1,151,85,TWrex-cause,800338-FS1,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus FLUCONAZOLE as maintenance therapy for AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS",AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
724352428,5/21/2015 11:30:20,1640259722,5/21/2015 11:30:03,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],maintenance therapy,n/a,113,74,-1,151,85,TWrex-cause,800338-FS1,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus FLUCONAZOLE as maintenance therapy for AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS",AIDS ASSOCIATED CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
724352429,5/21/2015 08:57:14,1640185581,5/21/2015 08:56:33,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,Associated with,93,115,1,96,128,TWrex-cause,811229-FS1,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, PUUMALA VIRUS and Dobrava/Belgrade virus.",HFRS,PUUMALA VIRUS
724352429,5/21/2015 08:58:57,1640186416,5/21/2015 08:58:39,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[CAUSES],[CAUSES],other hantaviruses causing HFRS are PUUMALA VIRUS,N/A,93,115,1,96,128,TWrex-cause,811229-FS1,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, PUUMALA VIRUS and Dobrava/Belgrade virus.",HFRS,PUUMALA VIRUS
724352429,5/21/2015 09:02:58,1640188547,5/21/2015 09:02:26,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],"Hemorrhagic fever with renal syndrome Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, PUUMALA VIRUS and Dobrava/Belgrade virus.",n/a,93,115,1,96,128,TWrex-cause,811229-FS1,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, PUUMALA VIRUS and Dobrava/Belgrade virus.",HFRS,PUUMALA VIRUS
724352429,5/21/2015 09:15:11,1640194982,5/21/2015 09:14:47,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[IS_A],[IS_A],are,N/A,93,115,1,96,128,TWrex-cause,811229-FS1,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, PUUMALA VIRUS and Dobrava/Belgrade virus.",HFRS,PUUMALA VIRUS
724352429,5/21/2015 09:16:58,1640195769,5/21/2015 09:16:28,false,neodev,1.0,15848372,AUS,02,Jannali,14.200.59.55,[MANIFESTATION],[MANIFESTATION],causing,N/A,93,115,1,96,128,TWrex-cause,811229-FS1,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, PUUMALA VIRUS and Dobrava/Belgrade virus.",HFRS,PUUMALA VIRUS
724352429,5/21/2015 09:36:43,1640205557,5/21/2015 09:36:32,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[CAUSES],[CAUSES],causing,N/A,93,115,1,96,128,TWrex-cause,811229-FS1,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, PUUMALA VIRUS and Dobrava/Belgrade virus.",HFRS,PUUMALA VIRUS
724352429,5/21/2015 09:47:49,1640210874,5/21/2015 09:47:36,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[SIDE_EFFECT],[SIDE_EFFECT],and,N/A,93,115,1,96,128,TWrex-cause,811229-FS1,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, PUUMALA VIRUS and Dobrava/Belgrade virus.",HFRS,PUUMALA VIRUS
724352429,5/21/2015 10:16:05,1640224957,5/21/2015 10:15:43,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[IS_A],[IS_A],are,N/A,93,115,1,96,128,TWrex-cause,811229-FS1,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, PUUMALA VIRUS and Dobrava/Belgrade virus.",HFRS,PUUMALA VIRUS
724352429,5/21/2015 10:20:39,1640227290,5/21/2015 10:19:39,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],other hantaviruses causing HFRS PUUMALA VIRUS,N/A,93,115,1,96,128,TWrex-cause,811229-FS1,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, PUUMALA VIRUS and Dobrava/Belgrade virus.",HFRS,PUUMALA VIRUS
724352429,5/21/2015 10:28:55,1640230903,5/21/2015 10:28:41,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[CAUSES],[CAUSES],HFRS,none,93,115,1,96,128,TWrex-cause,811229-FS1,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, PUUMALA VIRUS and Dobrava/Belgrade virus.",HFRS,PUUMALA VIRUS
724352429,5/21/2015 10:32:55,1640232846,5/21/2015 10:32:43,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Along,N/A,93,115,1,96,128,TWrex-cause,811229-FS1,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, PUUMALA VIRUS and Dobrava/Belgrade virus.",HFRS,PUUMALA VIRUS
724352429,5/21/2015 10:42:41,1640237828,5/21/2015 10:41:49,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],causing,n/a,93,115,1,96,128,TWrex-cause,811229-FS1,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, PUUMALA VIRUS and Dobrava/Belgrade virus.",HFRS,PUUMALA VIRUS
724352429,5/21/2015 10:50:29,1640242093,5/21/2015 10:49:31,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[PART_OF],[PART_OF],"HFRS are Seoul virus, PUUMALA",N/A,93,115,1,96,128,TWrex-cause,811229-FS1,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, PUUMALA VIRUS and Dobrava/Belgrade virus.",HFRS,PUUMALA VIRUS
724352429,5/21/2015 10:50:46,1640242186,5/21/2015 10:50:05,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],causing,N/A,93,115,1,96,128,TWrex-cause,811229-FS1,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, PUUMALA VIRUS and Dobrava/Belgrade virus.",HFRS,PUUMALA VIRUS
724352429,5/21/2015 10:51:26,1640242567,5/21/2015 10:50:43,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[ASSOCIATED_WITH] [CAUSES],"[CAUSES]
[ASSOCIATED_WITH]",with with causing,n/a,93,115,1,96,128,TWrex-cause,811229-FS1,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, PUUMALA VIRUS and Dobrava/Belgrade virus.",HFRS,PUUMALA VIRUS
724352430,5/21/2015 10:40:04,1640236372,5/21/2015 10:39:52,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[ASSOCIATED_WITH],[ASSOCIATED_WITH],include,N/A,74,19,1,89,22,TWrex-cause,813092-FS1,"Common features of TTP and HUS include microangiopathic hemolytic anemia, THROMBOCYTOPENIA and the presence of platelet fibrin thrombi in the small vessels.",THROMBOCYTOPENIA,TTP
724352430,5/21/2015 11:07:04,1640249779,5/21/2015 11:06:16,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",Common features,n/a,74,19,1,89,22,TWrex-cause,813092-FS1,"Common features of TTP and HUS include microangiopathic hemolytic anemia, THROMBOCYTOPENIA and the presence of platelet fibrin thrombi in the small vessels.",THROMBOCYTOPENIA,TTP
724352430,5/21/2015 11:09:27,1640250866,5/21/2015 11:08:19,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[SYMPTOM],[SYMPTOM],Common features of TTP,N/A,74,19,1,89,22,TWrex-cause,813092-FS1,"Common features of TTP and HUS include microangiopathic hemolytic anemia, THROMBOCYTOPENIA and the presence of platelet fibrin thrombi in the small vessels.",THROMBOCYTOPENIA,TTP
724352430,5/21/2015 11:13:55,1640252727,5/21/2015 11:13:19,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[SYMPTOM] [PART_OF],"[SYMPTOM]
[PART_OF]",features include presence,n/a,74,19,1,89,22,TWrex-cause,813092-FS1,"Common features of TTP and HUS include microangiopathic hemolytic anemia, THROMBOCYTOPENIA and the presence of platelet fibrin thrombi in the small vessels.",THROMBOCYTOPENIA,TTP
724352430,5/21/2015 11:26:46,1640258078,5/21/2015 11:26:33,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[ASSOCIATED_WITH],[ASSOCIATED_WITH],include,N/A,74,19,1,89,22,TWrex-cause,813092-FS1,"Common features of TTP and HUS include microangiopathic hemolytic anemia, THROMBOCYTOPENIA and the presence of platelet fibrin thrombi in the small vessels.",THROMBOCYTOPENIA,TTP
724352430,5/21/2015 11:35:44,1640262075,5/21/2015 11:35:32,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,74,19,1,89,22,TWrex-cause,813092-FS1,"Common features of TTP and HUS include microangiopathic hemolytic anemia, THROMBOCYTOPENIA and the presence of platelet fibrin thrombi in the small vessels.",THROMBOCYTOPENIA,TTP
724352430,5/21/2015 11:47:18,1640267653,5/21/2015 11:46:58,false,prodege,1.0,12656479,CAN,NB,Fredericton,198.164.157.90,[CAUSES],[CAUSES],features,N/A,74,19,1,89,22,TWrex-cause,813092-FS1,"Common features of TTP and HUS include microangiopathic hemolytic anemia, THROMBOCYTOPENIA and the presence of platelet fibrin thrombi in the small vessels.",THROMBOCYTOPENIA,TTP
724352430,5/21/2015 11:58:04,1640272445,5/21/2015 11:55:38,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[SYMPTOM] [LOCATION],"[LOCATION]
[SYMPTOM]",Common features,n/a,74,19,1,89,22,TWrex-cause,813092-FS1,"Common features of TTP and HUS include microangiopathic hemolytic anemia, THROMBOCYTOPENIA and the presence of platelet fibrin thrombi in the small vessels.",THROMBOCYTOPENIA,TTP
724352430,5/21/2015 12:15:28,1640279956,5/21/2015 12:15:02,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[MANIFESTATION],[MANIFESTATION],include,N/A,74,19,1,89,22,TWrex-cause,813092-FS1,"Common features of TTP and HUS include microangiopathic hemolytic anemia, THROMBOCYTOPENIA and the presence of platelet fibrin thrombi in the small vessels.",THROMBOCYTOPENIA,TTP
724352430,5/21/2015 12:35:11,1640288844,5/21/2015 12:34:10,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[ASSOCIATED_WITH],[ASSOCIATED_WITH],features of TTP include THROMBOCYTOPENIA,N/A,74,19,1,89,22,TWrex-cause,813092-FS1,"Common features of TTP and HUS include microangiopathic hemolytic anemia, THROMBOCYTOPENIA and the presence of platelet fibrin thrombi in the small vessels.",THROMBOCYTOPENIA,TTP
724352430,5/21/2015 13:11:40,1640304284,5/21/2015 13:11:24,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[SYMPTOM],[SYMPTOM],"hemolytic anemia,",N/A,74,19,1,89,22,TWrex-cause,813092-FS1,"Common features of TTP and HUS include microangiopathic hemolytic anemia, THROMBOCYTOPENIA and the presence of platelet fibrin thrombi in the small vessels.",THROMBOCYTOPENIA,TTP
724352430,5/21/2015 13:21:29,1640309366,5/21/2015 13:20:07,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[PART_OF],[PART_OF],Common features of TTP include THROMBOCYTOPENIA,N/A,74,19,1,89,22,TWrex-cause,813092-FS1,"Common features of TTP and HUS include microangiopathic hemolytic anemia, THROMBOCYTOPENIA and the presence of platelet fibrin thrombi in the small vessels.",THROMBOCYTOPENIA,TTP
724352430,5/21/2015 13:21:41,1640309437,5/21/2015 13:20:07,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],features,N/A,74,19,1,89,22,TWrex-cause,813092-FS1,"Common features of TTP and HUS include microangiopathic hemolytic anemia, THROMBOCYTOPENIA and the presence of platelet fibrin thrombi in the small vessels.",THROMBOCYTOPENIA,TTP
724352430,5/21/2015 14:02:08,1640330767,5/21/2015 14:00:52,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[SYMPTOM],[SYMPTOM],Common features include,n/a,74,19,1,89,22,TWrex-cause,813092-FS1,"Common features of TTP and HUS include microangiopathic hemolytic anemia, THROMBOCYTOPENIA and the presence of platelet fibrin thrombi in the small vessels.",THROMBOCYTOPENIA,TTP
724352430,5/21/2015 14:07:13,1640333985,5/21/2015 14:06:46,false,clixsense,1.0,12843982,AUS,08,Perth,180.216.79.226,[SYMPTOM],[SYMPTOM],Common features of TTP include THROMBOCYTOPENIA,N/A,74,19,1,89,22,TWrex-cause,813092-FS1,"Common features of TTP and HUS include microangiopathic hemolytic anemia, THROMBOCYTOPENIA and the presence of platelet fibrin thrombi in the small vessels.",THROMBOCYTOPENIA,TTP
724352431,5/21/2015 10:39:30,1640236053,5/21/2015 10:39:19,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[LOCATION],[LOCATION],international,N/A,365,281,-1,373,289,TWrex-cause,803294-FS1,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving WARFARIN (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning PREGNANCY; or geographic location that would prevent follow up.",PREGNANCY,WARFARIN
724352431,5/21/2015 11:04:26,1640248701,5/21/2015 11:04:00,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CONTRAINDICATES],[CONTRAINDICATES],contraindication to,n/a,365,281,-1,373,289,TWrex-cause,803294-FS1,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving WARFARIN (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning PREGNANCY; or geographic location that would prevent follow up.",PREGNANCY,WARFARIN
724352431,5/21/2015 11:05:23,1640249077,5/21/2015 11:04:36,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],Exclusion criteria,N/A,365,281,-1,373,289,TWrex-cause,803294-FS1,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving WARFARIN (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning PREGNANCY; or geographic location that would prevent follow up.",PREGNANCY,WARFARIN
724352431,5/21/2015 11:06:40,1640249607,5/21/2015 11:06:00,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CONTRAINDICATES],[CONTRAINDICATES],contraindication to warfarin; objectively confirmed,N/A,365,281,-1,373,289,TWrex-cause,803294-FS1,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving WARFARIN (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning PREGNANCY; or geographic location that would prevent follow up.",PREGNANCY,WARFARIN
724352431,5/21/2015 11:12:09,1640252079,5/21/2015 11:10:41,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG] [CONTRAINDICATES] [TREATS] [LOCATION] [CAUSES] [SIDE_EFFECT],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[LOCATION]
[CONTRAINDICATES]
[ASSOCIATED_WITH]
[SIDE_EFFECT]",clinically in contraindication confirmed recurrent receiving location,n/a,365,281,-1,373,289,TWrex-cause,803294-FS1,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving WARFARIN (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning PREGNANCY; or geographic location that would prevent follow up.",PREGNANCY,WARFARIN
724352431,5/21/2015 11:26:16,1640257955,5/21/2015 11:26:03,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[PREVENTS],[PREVENTS],prevent,N/A,365,281,-1,373,289,TWrex-cause,803294-FS1,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving WARFARIN (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning PREGNANCY; or geographic location that would prevent follow up.",PREGNANCY,WARFARIN
724352431,5/21/2015 11:35:09,1640261772,5/21/2015 11:34:39,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],while receiving,n/a,365,281,-1,373,289,TWrex-cause,803294-FS1,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving WARFARIN (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning PREGNANCY; or geographic location that would prevent follow up.",PREGNANCY,WARFARIN
724352431,5/21/2015 11:46:05,1640267144,5/21/2015 11:45:56,false,prodege,1.0,12656479,CAN,NB,Fredericton,198.164.157.90,[CAUSES],[CAUSES],recurrent,N/A,365,281,-1,373,289,TWrex-cause,803294-FS1,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving WARFARIN (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning PREGNANCY; or geographic location that would prevent follow up.",PREGNANCY,WARFARIN
724352431,5/21/2015 11:47:22,1640267673,5/21/2015 11:46:09,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[CAUSES],[CAUSES],while receiving,n/a,365,281,-1,373,289,TWrex-cause,803294-FS1,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving WARFARIN (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning PREGNANCY; or geographic location that would prevent follow up.",PREGNANCY,WARFARIN
724352431,5/21/2015 12:14:25,1640279452,5/21/2015 12:13:57,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[CONTRAINDICATES],[CONTRAINDICATES],contraindication,N/A,365,281,-1,373,289,TWrex-cause,803294-FS1,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving WARFARIN (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning PREGNANCY; or geographic location that would prevent follow up.",PREGNANCY,WARFARIN
724352431,5/21/2015 12:32:59,1640287927,5/21/2015 12:31:37,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[NONE],[NONE],N/A,It just syas be careful,365,281,-1,373,289,TWrex-cause,803294-FS1,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving WARFARIN (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning PREGNANCY; or geographic location that would prevent follow up.",PREGNANCY,WARFARIN
724352431,5/21/2015 13:10:29,1640303703,5/21/2015 13:09:25,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[SYMPTOM],[SYMPTOM],"diathesis; stroke,",N/A,365,281,-1,373,289,TWrex-cause,803294-FS1,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving WARFARIN (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning PREGNANCY; or geographic location that would prevent follow up.",PREGNANCY,WARFARIN
724352431,5/21/2015 13:18:40,1640307753,5/21/2015 13:16:35,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CONTRAINDICATES],[CONTRAINDICATES],contraindication,N/A,365,281,-1,373,289,TWrex-cause,803294-FS1,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving WARFARIN (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning PREGNANCY; or geographic location that would prevent follow up.",PREGNANCY,WARFARIN
724352431,5/21/2015 13:19:07,1640308083,5/21/2015 13:16:55,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CONTRAINDICATES],[CONTRAINDICATES],contraindication to warfarin; confirmed recurrent thrombosis while receiving WARFARIN pregnancy,N/A,365,281,-1,373,289,TWrex-cause,803294-FS1,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving WARFARIN (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning PREGNANCY; or geographic location that would prevent follow up.",PREGNANCY,WARFARIN
724352431,5/21/2015 13:59:18,1640329049,5/21/2015 13:59:01,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[CONTRAINDICATES],[CONTRAINDICATES],contraindication to,n/a,365,281,-1,373,289,TWrex-cause,803294-FS1,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving WARFARIN (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning PREGNANCY; or geographic location that would prevent follow up.",PREGNANCY,WARFARIN
724352432,5/21/2015 08:49:55,1640181818,5/21/2015 08:49:26,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,[CONTRAINDICATES],[CONTRAINDICATES],AVOID,Avoid,64,13,-1,72,25,TWrex-cause,803297-FS1,"AVOID USING PODOPHYLLIN podophyllotoxin, and imiquimod during PREGNANCY",PREGNANCY,PODOPHYLLIN
724352432,5/21/2015 08:52:25,1640183223,5/21/2015 08:51:56,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"AVOID USING PODOPHYLLIN podophyllotoxin, and imiquimod during PREGNANCY",n/a,64,13,-1,72,25,TWrex-cause,803297-FS1,"AVOID USING PODOPHYLLIN podophyllotoxin, and imiquimod during PREGNANCY",PREGNANCY,PODOPHYLLIN
724352432,5/21/2015 08:53:18,1640183587,5/21/2015 08:50:53,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[CAUSES],[CAUSES],USING,N/A,64,13,-1,72,25,TWrex-cause,803297-FS1,"AVOID USING PODOPHYLLIN podophyllotoxin, and imiquimod during PREGNANCY",PREGNANCY,PODOPHYLLIN
724352432,5/21/2015 08:53:37,1640183796,5/21/2015 08:53:00,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[CONTRAINDICATES],[CONTRAINDICATES],AVOID USING during,N/A,64,13,-1,72,25,TWrex-cause,803297-FS1,"AVOID USING PODOPHYLLIN podophyllotoxin, and imiquimod during PREGNANCY",PREGNANCY,PODOPHYLLIN
724352432,5/21/2015 08:53:43,1640183812,5/21/2015 08:52:52,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[CONTRAINDICATES] [OTHER],"[CONTRAINDICATES]
[OTHER]","AVOID USING PODOPHYLLIN during PRE<span id=""transmark""></span>GNANCY",n/a,64,13,-1,72,25,TWrex-cause,803297-FS1,"AVOID USING PODOPHYLLIN podophyllotoxin, and imiquimod during PREGNANCY",PREGNANCY,PODOPHYLLIN
724352432,5/21/2015 09:08:05,1640191062,5/21/2015 09:07:41,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[CONTRAINDICATES],[CONTRAINDICATES],AVOID USING during,N/A,64,13,-1,72,25,TWrex-cause,803297-FS1,"AVOID USING PODOPHYLLIN podophyllotoxin, and imiquimod during PREGNANCY",PREGNANCY,PODOPHYLLIN
724352432,5/21/2015 09:08:48,1640191520,5/21/2015 09:08:16,false,neodev,1.0,15848372,AUS,02,Jannali,14.200.59.55,[ASSOCIATED_WITH],[ASSOCIATED_WITH],AVOID USING,N/A,64,13,-1,72,25,TWrex-cause,803297-FS1,"AVOID USING PODOPHYLLIN podophyllotoxin, and imiquimod during PREGNANCY",PREGNANCY,PODOPHYLLIN
724352432,5/21/2015 09:23:03,1640198641,5/21/2015 09:22:31,false,clixsense,1.0,28570371,NLD,"","",91.213.37.165,[SIDE_EFFECT],[SIDE_EFFECT],AVOID,N/A,64,13,-1,72,25,TWrex-cause,803297-FS1,"AVOID USING PODOPHYLLIN podophyllotoxin, and imiquimod during PREGNANCY",PREGNANCY,PODOPHYLLIN
724352432,5/21/2015 09:27:01,1640200618,5/21/2015 09:26:41,false,neodev,1.0,31195295,GBR,"","",46.208.164.162,[CONTRAINDICATES],[CONTRAINDICATES],AVOID,N/A,64,13,-1,72,25,TWrex-cause,803297-FS1,"AVOID USING PODOPHYLLIN podophyllotoxin, and imiquimod during PREGNANCY",PREGNANCY,PODOPHYLLIN
724352432,5/21/2015 09:34:00,1640204323,5/21/2015 09:33:47,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[LOCATION],[LOCATION],during,N/A,64,13,-1,72,25,TWrex-cause,803297-FS1,"AVOID USING PODOPHYLLIN podophyllotoxin, and imiquimod during PREGNANCY",PREGNANCY,PODOPHYLLIN
724352432,5/21/2015 09:44:52,1640209418,5/21/2015 09:44:40,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[PREVENTS],[PREVENTS],AVOID,N/A,64,13,-1,72,25,TWrex-cause,803297-FS1,"AVOID USING PODOPHYLLIN podophyllotoxin, and imiquimod during PREGNANCY",PREGNANCY,PODOPHYLLIN
724352432,5/21/2015 10:07:00,1640220438,5/21/2015 10:06:06,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CONTRAINDICATES],[CONTRAINDICATES],AVOID USING PODOPHYLLIN during PREGNANCY,N/A,64,13,-1,72,25,TWrex-cause,803297-FS1,"AVOID USING PODOPHYLLIN podophyllotoxin, and imiquimod during PREGNANCY",PREGNANCY,PODOPHYLLIN
724352432,5/21/2015 10:12:24,1640223033,5/21/2015 10:12:10,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[CAUSES],[CAUSES],during,N/A,64,13,-1,72,25,TWrex-cause,803297-FS1,"AVOID USING PODOPHYLLIN podophyllotoxin, and imiquimod during PREGNANCY",PREGNANCY,PODOPHYLLIN
724352432,5/21/2015 10:25:16,1640229296,5/21/2015 10:24:59,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[PREVENTS],[PREVENTS],PODOPHYLLIN,none,64,13,-1,72,25,TWrex-cause,803297-FS1,"AVOID USING PODOPHYLLIN podophyllotoxin, and imiquimod during PREGNANCY",PREGNANCY,PODOPHYLLIN
724352432,5/21/2015 10:28:28,1640230733,5/21/2015 10:26:20,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CONTRAINDICATES],[CONTRAINDICATES],AVOID USING,N/A,64,13,-1,72,25,TWrex-cause,803297-FS1,"AVOID USING PODOPHYLLIN podophyllotoxin, and imiquimod during PREGNANCY",PREGNANCY,PODOPHYLLIN
724352433,5/21/2015 11:20:39,1640255592,5/21/2015 11:19:33,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[PREVENTS] [TREATS] [MANIFESTATION] [ASSOCIATED_WITH],"[TREATS]
[PREVENTS]
[MANIFESTATION]
[ASSOCIATED_WITH]",Prevention recommended for of INFECTIONS recommended.,n/a,33,144,1,60,168,TWrex-cause,815038-FS1,"104 ,   152  Prevention of Avian INFLUENZA A VIRUS INFECTIONS   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A AND B VIRUS INFECTIONS has been recommended.",INFLUENZA A VIRUS INFECTIONS,A AND B VIRUS INFECTIONS
724352433,5/21/2015 11:29:01,1640259096,5/21/2015 11:28:47,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[PREVENTS],[PREVENTS],Prevention,N/A,33,144,1,60,168,TWrex-cause,815038-FS1,"104 ,   152  Prevention of Avian INFLUENZA A VIRUS INFECTIONS   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A AND B VIRUS INFECTIONS has been recommended.",INFLUENZA A VIRUS INFECTIONS,A AND B VIRUS INFECTIONS
724352433,5/21/2015 12:18:39,1640281385,5/21/2015 12:18:16,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[PREVENTS],[PREVENTS],Prevention,N/A,33,144,1,60,168,TWrex-cause,815038-FS1,"104 ,   152  Prevention of Avian INFLUENZA A VIRUS INFECTIONS   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A AND B VIRUS INFECTIONS has been recommended.",INFLUENZA A VIRUS INFECTIONS,A AND B VIRUS INFECTIONS
724352433,5/21/2015 13:16:25,1640306754,5/21/2015 13:15:49,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[SYMPTOM],[SYMPTOM],VIRUS INFECTIONS,N/A,33,144,1,60,168,TWrex-cause,815038-FS1,"104 ,   152  Prevention of Avian INFLUENZA A VIRUS INFECTIONS   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A AND B VIRUS INFECTIONS has been recommended.",INFLUENZA A VIRUS INFECTIONS,A AND B VIRUS INFECTIONS
724352433,5/21/2015 13:33:32,1640315351,5/21/2015 13:32:09,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[PREVENTS],[PREVENTS],prophylaxis,N/A,33,144,1,60,168,TWrex-cause,815038-FS1,"104 ,   152  Prevention of Avian INFLUENZA A VIRUS INFECTIONS   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A AND B VIRUS INFECTIONS has been recommended.",INFLUENZA A VIRUS INFECTIONS,A AND B VIRUS INFECTIONS
724352433,5/21/2015 14:23:32,1640344111,5/21/2015 14:23:20,false,neodev,1.0,32103286,GBR,H9,London,193.109.196.83,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",NO,NO,33,144,1,60,168,TWrex-cause,815038-FS1,"104 ,   152  Prevention of Avian INFLUENZA A VIRUS INFECTIONS   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A AND B VIRUS INFECTIONS has been recommended.",INFLUENZA A VIRUS INFECTIONS,A AND B VIRUS INFECTIONS
724352433,5/21/2015 14:23:46,1640344213,5/21/2015 14:22:45,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[IS_A],[IS_A],influenza A AND B,N/A,33,144,1,60,168,TWrex-cause,815038-FS1,"104 ,   152  Prevention of Avian INFLUENZA A VIRUS INFECTIONS   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A AND B VIRUS INFECTIONS has been recommended.",INFLUENZA A VIRUS INFECTIONS,A AND B VIRUS INFECTIONS
724352433,5/21/2015 14:26:08,1640345833,5/21/2015 14:25:30,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[IS_A],[IS_A],seasonal influenza,N/A,33,144,1,60,168,TWrex-cause,815038-FS1,"104 ,   152  Prevention of Avian INFLUENZA A VIRUS INFECTIONS   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A AND B VIRUS INFECTIONS has been recommended.",INFLUENZA A VIRUS INFECTIONS,A AND B VIRUS INFECTIONS
724352433,5/21/2015 14:27:49,1640346875,5/21/2015 14:27:00,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[NONE],[NONE],n/a,no relationship specified,33,144,1,60,168,TWrex-cause,815038-FS1,"104 ,   152  Prevention of Avian INFLUENZA A VIRUS INFECTIONS   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A AND B VIRUS INFECTIONS has been recommended.",INFLUENZA A VIRUS INFECTIONS,A AND B VIRUS INFECTIONS
724352433,5/21/2015 14:36:55,1640352698,5/21/2015 14:36:33,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[PREVENTS],[PREVENTS],104 152 Prevention of Avian INFLUENZA A VIRUS INFECTIONS,n/a,33,144,1,60,168,TWrex-cause,815038-FS1,"104 ,   152  Prevention of Avian INFLUENZA A VIRUS INFECTIONS   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A AND B VIRUS INFECTIONS has been recommended.",INFLUENZA A VIRUS INFECTIONS,A AND B VIRUS INFECTIONS
724352433,5/21/2015 14:50:13,1640360228,5/21/2015 14:48:52,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[PREVENTS],[PREVENTS],Prevention of INFLUENZA A VIRUS INFECTIONS recommended A AND B VIRUS INFECTIONS,N/A,33,144,1,60,168,TWrex-cause,815038-FS1,"104 ,   152  Prevention of Avian INFLUENZA A VIRUS INFECTIONS   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A AND B VIRUS INFECTIONS has been recommended.",INFLUENZA A VIRUS INFECTIONS,A AND B VIRUS INFECTIONS
724352433,5/21/2015 14:58:39,1640364734,5/21/2015 14:57:03,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[IS_A] [PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",INFLUENZA A VIRUS INFECTIONS seasonal influenza A AND B VIRUS INFECTIONS,N/A,33,144,1,60,168,TWrex-cause,815038-FS1,"104 ,   152  Prevention of Avian INFLUENZA A VIRUS INFECTIONS   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A AND B VIRUS INFECTIONS has been recommended.",INFLUENZA A VIRUS INFECTIONS,A AND B VIRUS INFECTIONS
724352433,5/21/2015 15:03:26,1640367373,5/21/2015 15:03:07,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],Prevention INFLUENZA A VIRUS INFECTIONS Oral Dosage recommended A AND B VIRUS INFECTIONS recommended.,na,33,144,1,60,168,TWrex-cause,815038-FS1,"104 ,   152  Prevention of Avian INFLUENZA A VIRUS INFECTIONS   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A AND B VIRUS INFECTIONS has been recommended.",INFLUENZA A VIRUS INFECTIONS,A AND B VIRUS INFECTIONS
724352433,5/21/2015 15:03:54,1640367578,5/21/2015 15:01:37,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[PREVENTS],[PREVENTS],Prevention Avian INFLUENZA A VIRUS INFECTIONS Oral Dosage of seasonal influenza A AND B VIRUS INFECTIONS recommended.,na,33,144,1,60,168,TWrex-cause,815038-FS1,"104 ,   152  Prevention of Avian INFLUENZA A VIRUS INFECTIONS   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A AND B VIRUS INFECTIONS has been recommended.",INFLUENZA A VIRUS INFECTIONS,A AND B VIRUS INFECTIONS
724352433,5/21/2015 15:23:13,1640378562,5/21/2015 15:21:38,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[PREVENTS],[PREVENTS],recommended,recommendation of this medicine helps prevent the flu,33,144,1,60,168,TWrex-cause,815038-FS1,"104 ,   152  Prevention of Avian INFLUENZA A VIRUS INFECTIONS   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A AND B VIRUS INFECTIONS has been recommended.",INFLUENZA A VIRUS INFECTIONS,A AND B VIRUS INFECTIONS
724352434,5/21/2015 09:03:26,1640188767,5/21/2015 09:02:56,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[TREATS],[TREATS],used in continuous subcutaneous insulin infusion therapy,N/A,157,68,-1,171,82,TWrex-cause,804269-FS1,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN ASPART
724352434,5/21/2015 09:21:01,1640197601,5/21/2015 09:20:39,false,neodev,1.0,15848372,AUS,02,Jannali,14.200.59.55,[TREATS],[TREATS],infusion therapy,N/A,157,68,-1,171,82,TWrex-cause,804269-FS1,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN ASPART
724352434,5/21/2015 09:40:33,1640207310,5/21/2015 09:40:21,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],used,N/A,157,68,-1,171,82,TWrex-cause,804269-FS1,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN ASPART
724352434,5/21/2015 09:50:04,1640212030,5/21/2015 09:49:54,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],therapy,N/A,157,68,-1,171,82,TWrex-cause,804269-FS1,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN ASPART
724352434,5/21/2015 10:18:57,1640226431,5/21/2015 10:18:43,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],infusion therapy,N/A,157,68,-1,171,82,TWrex-cause,804269-FS1,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN ASPART
724352434,5/21/2015 10:28:29,1640230744,5/21/2015 10:27:48,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],INSULIN ASPART used in therapy TYPE 1 DIABETES,N/A,157,68,-1,171,82,TWrex-cause,804269-FS1,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN ASPART
724352434,5/21/2015 10:31:52,1640232279,5/21/2015 10:31:27,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[CAUSES],[CAUSES],TYPE 1 DIABETES,none,157,68,-1,171,82,TWrex-cause,804269-FS1,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN ASPART
724352434,5/21/2015 10:37:34,1640235178,5/21/2015 10:37:22,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],therapy,N/A,157,68,-1,171,82,TWrex-cause,804269-FS1,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN ASPART
724352434,5/21/2015 10:46:56,1640240103,5/21/2015 10:46:40,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],used in therapy,n/a,157,68,-1,171,82,TWrex-cause,804269-FS1,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN ASPART
724352434,5/21/2015 10:58:37,1640246030,5/21/2015 10:58:03,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],infusion therapy,N/A,157,68,-1,171,82,TWrex-cause,804269-FS1,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN ASPART
724352434,5/21/2015 11:00:46,1640247158,5/21/2015 11:00:23,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],used in continuous,N/A,157,68,-1,171,82,TWrex-cause,804269-FS1,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN ASPART
724352434,5/21/2015 11:02:32,1640247877,5/21/2015 11:00:57,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[TREATS] [ASSOCIATED_WITH] [IS_A],"[TREATS]
[ASSOCIATED_WITH]
[IS_A]",compatibility used therapy in with,n/a,157,68,-1,171,82,TWrex-cause,804269-FS1,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN ASPART
724352434,5/21/2015 11:17:47,1640254394,5/21/2015 11:17:35,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],therapy,N/A,157,68,-1,171,82,TWrex-cause,804269-FS1,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN ASPART
724352434,5/21/2015 11:32:40,1640260767,5/21/2015 11:32:15,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],infusion therapy,n/a,157,68,-1,171,82,TWrex-cause,804269-FS1,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN ASPART
724352434,5/21/2015 11:39:45,1640264085,5/21/2015 11:38:50,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],used in continuous subcutaneous insulin infusion therapy in patients with,n/a,157,68,-1,171,82,TWrex-cause,804269-FS1,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN ASPART
724352435,5/21/2015 07:05:30,1640125953,5/21/2015 07:05:07,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,[MANIFESTATION],[MANIFESTATION],OVARIAN HYPERSTIMULATION SYNDROME life threatening ASCITES,n/a,208,0,1,214,33,TWrex-cause,812960-FS1,"OVARIAN HYPERSTIMULATION SYNDROME occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life threatening ASCITES and hypovolemia.",ASCITES,OVARIAN HYPERSTIMULATION SYNDROME
724352435,5/21/2015 07:12:41,1640129998,5/21/2015 07:12:27,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],occurs in,N/A,208,0,1,214,33,TWrex-cause,812960-FS1,"OVARIAN HYPERSTIMULATION SYNDROME occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life threatening ASCITES and hypovolemia.",ASCITES,OVARIAN HYPERSTIMULATION SYNDROME
724352435,5/21/2015 07:16:48,1640132289,5/21/2015 07:16:00,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],causing,N/A,208,0,1,214,33,TWrex-cause,812960-FS1,"OVARIAN HYPERSTIMULATION SYNDROME occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life threatening ASCITES and hypovolemia.",ASCITES,OVARIAN HYPERSTIMULATION SYNDROME
724352435,5/21/2015 07:19:12,1640133613,5/21/2015 07:18:31,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF] [CAUSES],"[CAUSES]
[PART_OF]",of causing,N/A,208,0,1,214,33,TWrex-cause,812960-FS1,"OVARIAN HYPERSTIMULATION SYNDROME occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life threatening ASCITES and hypovolemia.",ASCITES,OVARIAN HYPERSTIMULATION SYNDROME
724352435,5/21/2015 07:30:13,1640139448,5/21/2015 07:29:38,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[MANIFESTATION] [CAUSES],"[CAUSES]
[MANIFESTATION]",causing,N/A,208,0,1,214,33,TWrex-cause,812960-FS1,"OVARIAN HYPERSTIMULATION SYNDROME occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life threatening ASCITES and hypovolemia.",ASCITES,OVARIAN HYPERSTIMULATION SYNDROME
724352435,5/21/2015 07:31:52,1640140458,5/21/2015 07:31:22,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],causing,N/A,208,0,1,214,33,TWrex-cause,812960-FS1,"OVARIAN HYPERSTIMULATION SYNDROME occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life threatening ASCITES and hypovolemia.",ASCITES,OVARIAN HYPERSTIMULATION SYNDROME
724352435,5/21/2015 07:42:00,1640145741,5/21/2015 07:41:25,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[SYMPTOM] [CAUSES],"[CAUSES]
[SYMPTOM]",SYNDROME causing,N/A,208,0,1,214,33,TWrex-cause,812960-FS1,"OVARIAN HYPERSTIMULATION SYNDROME occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life threatening ASCITES and hypovolemia.",ASCITES,OVARIAN HYPERSTIMULATION SYNDROME
724352435,5/21/2015 07:44:21,1640146932,5/21/2015 07:43:30,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[MANIFESTATION],[MANIFESTATION],causing potentially life threatening,N/A,208,0,1,214,33,TWrex-cause,812960-FS1,"OVARIAN HYPERSTIMULATION SYNDROME occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life threatening ASCITES and hypovolemia.",ASCITES,OVARIAN HYPERSTIMULATION SYNDROME
724352435,5/21/2015 07:44:51,1640147177,5/21/2015 07:44:33,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],causing,n/a,208,0,1,214,33,TWrex-cause,812960-FS1,"OVARIAN HYPERSTIMULATION SYNDROME occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life threatening ASCITES and hypovolemia.",ASCITES,OVARIAN HYPERSTIMULATION SYNDROME
724352435,5/21/2015 08:00:48,1640155696,5/21/2015 08:00:22,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[CAUSES],[CAUSES],causing,N/A,208,0,1,214,33,TWrex-cause,812960-FS1,"OVARIAN HYPERSTIMULATION SYNDROME occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life threatening ASCITES and hypovolemia.",ASCITES,OVARIAN HYPERSTIMULATION SYNDROME
724352435,5/21/2015 08:03:38,1640157203,5/21/2015 08:03:17,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CAUSES],[CAUSES],causing,N/A,208,0,1,214,33,TWrex-cause,812960-FS1,"OVARIAN HYPERSTIMULATION SYNDROME occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life threatening ASCITES and hypovolemia.",ASCITES,OVARIAN HYPERSTIMULATION SYNDROME
724352435,5/21/2015 08:18:32,1640165232,5/21/2015 08:17:49,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,[CAUSES],[CAUSES],causing,-,208,0,1,214,33,TWrex-cause,812960-FS1,"OVARIAN HYPERSTIMULATION SYNDROME occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life threatening ASCITES and hypovolemia.",ASCITES,OVARIAN HYPERSTIMULATION SYNDROME
724352435,5/21/2015 08:32:53,1640173227,5/21/2015 08:32:00,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[SYMPTOM] [LOCATION] [MANIFESTATION] [CAUSES],"[CAUSES]
[LOCATION]
[SYMPTOM]
[MANIFESTATION]",OVARIAN HYPERSTIMULATION SYNDROME causing potentially ASCITES,n/a,208,0,1,214,33,TWrex-cause,812960-FS1,"OVARIAN HYPERSTIMULATION SYNDROME occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life threatening ASCITES and hypovolemia.",ASCITES,OVARIAN HYPERSTIMULATION SYNDROME
724352435,5/21/2015 08:39:42,1640176763,5/21/2015 08:39:04,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[CAUSES],[CAUSES],"OVARIAN HYPERSTIMULATION SYNDROME causing ASCIT<span id=""transmark""></span>ES",n/a,208,0,1,214,33,TWrex-cause,812960-FS1,"OVARIAN HYPERSTIMULATION SYNDROME occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life threatening ASCITES and hypovolemia.",ASCITES,OVARIAN HYPERSTIMULATION SYNDROME
724352435,5/21/2015 08:42:47,1640178239,5/21/2015 08:41:58,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]","OVARIAN HYPERSTIMULATION SYNDROME occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life threatening ASCITES and hypovolemia.",n/a,208,0,1,214,33,TWrex-cause,812960-FS1,"OVARIAN HYPERSTIMULATION SYNDROME occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life threatening ASCITES and hypovolemia.",ASCITES,OVARIAN HYPERSTIMULATION SYNDROME
724352436,5/21/2015 07:07:27,1640127067,5/21/2015 07:07:09,false,clixsense,1,30130805,USA,MI,Wyandotte,63.141.31.35,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ACUTE UNCOMPLICATED GONORRHOEA with CEFTRIAXONE RO 13 9904,n/a,55,108,-1,84,130,TWrex-cause,800986-FS1,"Eichmann A, Weidmann G, Havas L. One dose treatment of ACUTE UNCOMPLICATED GONORRHOEA of male patients with CEFTRIAXONE RO 13 9904 a new parenteral cephalosporin: a dose range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",ACUTE UNCOMPLICATED GONORRHOEA,CEFTRIAXONE RO 13 9904
724352436,5/21/2015 07:14:05,1640130747,5/21/2015 07:13:51,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,55,108,-1,84,130,TWrex-cause,800986-FS1,"Eichmann A, Weidmann G, Havas L. One dose treatment of ACUTE UNCOMPLICATED GONORRHOEA of male patients with CEFTRIAXONE RO 13 9904 a new parenteral cephalosporin: a dose range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",ACUTE UNCOMPLICATED GONORRHOEA,CEFTRIAXONE RO 13 9904
724352436,5/21/2015 07:21:45,1640134957,5/21/2015 07:21:15,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment,N/A,55,108,-1,84,130,TWrex-cause,800986-FS1,"Eichmann A, Weidmann G, Havas L. One dose treatment of ACUTE UNCOMPLICATED GONORRHOEA of male patients with CEFTRIAXONE RO 13 9904 a new parenteral cephalosporin: a dose range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",ACUTE UNCOMPLICATED GONORRHOEA,CEFTRIAXONE RO 13 9904
724352436,5/21/2015 07:24:40,1640136635,5/21/2015 07:24:04,false,neodev,1,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF] [ASSOCIATED_WITH] [IS_A],"[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",of of with a,N/A,55,108,-1,84,130,TWrex-cause,800986-FS1,"Eichmann A, Weidmann G, Havas L. One dose treatment of ACUTE UNCOMPLICATED GONORRHOEA of male patients with CEFTRIAXONE RO 13 9904 a new parenteral cephalosporin: a dose range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",ACUTE UNCOMPLICATED GONORRHOEA,CEFTRIAXONE RO 13 9904
724352436,5/21/2015 07:35:11,1640142050,5/21/2015 07:34:46,false,neodev,1,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],One dose treatment of,N/A,55,108,-1,84,130,TWrex-cause,800986-FS1,"Eichmann A, Weidmann G, Havas L. One dose treatment of ACUTE UNCOMPLICATED GONORRHOEA of male patients with CEFTRIAXONE RO 13 9904 a new parenteral cephalosporin: a dose range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",ACUTE UNCOMPLICATED GONORRHOEA,CEFTRIAXONE RO 13 9904
724352436,5/21/2015 07:37:30,1640143291,5/21/2015 07:37:05,false,bitcoinget,1,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],treatment of,N/A,55,108,-1,84,130,TWrex-cause,800986-FS1,"Eichmann A, Weidmann G, Havas L. One dose treatment of ACUTE UNCOMPLICATED GONORRHOEA of male patients with CEFTRIAXONE RO 13 9904 a new parenteral cephalosporin: a dose range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",ACUTE UNCOMPLICATED GONORRHOEA,CEFTRIAXONE RO 13 9904
724352436,5/21/2015 07:46:44,1640148191,5/21/2015 07:46:05,false,neodev,1,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [ASSOCIATED_WITH] [IS_A],"[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",of with a a,N/A,55,108,-1,84,130,TWrex-cause,800986-FS1,"Eichmann A, Weidmann G, Havas L. One dose treatment of ACUTE UNCOMPLICATED GONORRHOEA of male patients with CEFTRIAXONE RO 13 9904 a new parenteral cephalosporin: a dose range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",ACUTE UNCOMPLICATED GONORRHOEA,CEFTRIAXONE RO 13 9904
724352436,5/21/2015 07:46:51,1640148255,5/21/2015 07:46:36,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment of,n/a,55,108,-1,84,130,TWrex-cause,800986-FS1,"Eichmann A, Weidmann G, Havas L. One dose treatment of ACUTE UNCOMPLICATED GONORRHOEA of male patients with CEFTRIAXONE RO 13 9904 a new parenteral cephalosporin: a dose range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",ACUTE UNCOMPLICATED GONORRHOEA,CEFTRIAXONE RO 13 9904
724352436,5/21/2015 07:46:57,1640148294,5/21/2015 07:46:37,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],One dose treatment,N/A,55,108,-1,84,130,TWrex-cause,800986-FS1,"Eichmann A, Weidmann G, Havas L. One dose treatment of ACUTE UNCOMPLICATED GONORRHOEA of male patients with CEFTRIAXONE RO 13 9904 a new parenteral cephalosporin: a dose range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",ACUTE UNCOMPLICATED GONORRHOEA,CEFTRIAXONE RO 13 9904
724352436,5/21/2015 08:05:38,1640158300,5/21/2015 08:04:36,false,neodev,1,29579905,GBR,"","",5.152.206.71,[IS_A] [PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]
[PART_OF]","A, of of with",N/A,55,108,-1,84,130,TWrex-cause,800986-FS1,"Eichmann A, Weidmann G, Havas L. One dose treatment of ACUTE UNCOMPLICATED GONORRHOEA of male patients with CEFTRIAXONE RO 13 9904 a new parenteral cephalosporin: a dose range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",ACUTE UNCOMPLICATED GONORRHOEA,CEFTRIAXONE RO 13 9904
724352436,5/21/2015 08:06:54,1640158895,5/21/2015 08:06:36,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],treatment of,N/A,55,108,-1,84,130,TWrex-cause,800986-FS1,"Eichmann A, Weidmann G, Havas L. One dose treatment of ACUTE UNCOMPLICATED GONORRHOEA of male patients with CEFTRIAXONE RO 13 9904 a new parenteral cephalosporin: a dose range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",ACUTE UNCOMPLICATED GONORRHOEA,CEFTRIAXONE RO 13 9904
724352436,5/21/2015 08:21:15,1640166828,5/21/2015 08:20:56,false,cointasker,1,21783324,NLD,11,Schiedam,194.13.104.194,[TREATS],[TREATS],treatment,-,55,108,-1,84,130,TWrex-cause,800986-FS1,"Eichmann A, Weidmann G, Havas L. One dose treatment of ACUTE UNCOMPLICATED GONORRHOEA of male patients with CEFTRIAXONE RO 13 9904 a new parenteral cephalosporin: a dose range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",ACUTE UNCOMPLICATED GONORRHOEA,CEFTRIAXONE RO 13 9904
724352436,5/21/2015 08:36:28,1640175120,5/21/2015 08:35:50,false,prodege,1,18793920,USA,CA,Salinas,73.162.0.87,[TREATS],[TREATS],treatment ACUTE UNCOMPLICATED GONORRHOEA CEFTRIAXONE,n/a,55,108,-1,84,130,TWrex-cause,800986-FS1,"Eichmann A, Weidmann G, Havas L. One dose treatment of ACUTE UNCOMPLICATED GONORRHOEA of male patients with CEFTRIAXONE RO 13 9904 a new parenteral cephalosporin: a dose range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",ACUTE UNCOMPLICATED GONORRHOEA,CEFTRIAXONE RO 13 9904
724352436,5/21/2015 08:45:05,1640179496,5/21/2015 08:44:13,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"One dose treatment of ACUTE UNCOMPLICATED GONORRHOEA of male patients with CEFTRIAXONE RO 13 9904 a new parenteral cephalosporin: a dose range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",n/a,55,108,-1,84,130,TWrex-cause,800986-FS1,"Eichmann A, Weidmann G, Havas L. One dose treatment of ACUTE UNCOMPLICATED GONORRHOEA of male patients with CEFTRIAXONE RO 13 9904 a new parenteral cephalosporin: a dose range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",ACUTE UNCOMPLICATED GONORRHOEA,CEFTRIAXONE RO 13 9904
724352436,5/21/2015 08:47:48,1640180865,5/21/2015 08:47:23,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,[TREATS],[TREATS],treatment,Treatment,55,108,-1,84,130,TWrex-cause,800986-FS1,"Eichmann A, Weidmann G, Havas L. One dose treatment of ACUTE UNCOMPLICATED GONORRHOEA of male patients with CEFTRIAXONE RO 13 9904 a new parenteral cephalosporin: a dose range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",ACUTE UNCOMPLICATED GONORRHOEA,CEFTRIAXONE RO 13 9904
724352437,5/21/2015 10:40:17,1640236457,5/21/2015 10:40:06,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],systemic therapy,N/A,140,245,-1,168,257,TWrex-cause,804393-FS1,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), RECALCITRANT PLAQUE PSORIASIS that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, METHOTREXATE PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",RECALCITRANT PLAQUE PSORIASIS,METHOTREXATE
724352437,5/21/2015 11:07:22,1640249898,5/21/2015 11:07:05,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],therapy,n/a,140,245,-1,168,257,TWrex-cause,804393-FS1,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), RECALCITRANT PLAQUE PSORIASIS that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, METHOTREXATE PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",RECALCITRANT PLAQUE PSORIASIS,METHOTREXATE
724352437,5/21/2015 11:11:00,1640251543,5/21/2015 11:09:31,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated or cannot be tolerated.,N/A,140,245,-1,168,257,TWrex-cause,804393-FS1,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), RECALCITRANT PLAQUE PSORIASIS that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, METHOTREXATE PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",RECALCITRANT PLAQUE PSORIASIS,METHOTREXATE
724352437,5/21/2015 11:14:44,1640253143,5/21/2015 11:13:56,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[TREATS] [ASSOCIATED_WITH] [PART_OF] [CONTRAINDICATES],"[TREATS]
[CONTRAINDICATES]
[ASSOCIATED_WITH]
[PART_OF]",Treatment of with therapy in therapy contraindicated,n/a,140,245,-1,168,257,TWrex-cause,804393-FS1,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), RECALCITRANT PLAQUE PSORIASIS that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, METHOTREXATE PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",RECALCITRANT PLAQUE PSORIASIS,METHOTREXATE
724352437,5/21/2015 11:27:01,1640258180,5/21/2015 11:26:49,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],therapy,N/A,140,245,-1,168,257,TWrex-cause,804393-FS1,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), RECALCITRANT PLAQUE PSORIASIS that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, METHOTREXATE PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",RECALCITRANT PLAQUE PSORIASIS,METHOTREXATE
724352437,5/21/2015 11:36:08,1640262300,5/21/2015 11:35:45,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],Treatment,n/a,140,245,-1,168,257,TWrex-cause,804393-FS1,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), RECALCITRANT PLAQUE PSORIASIS that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, METHOTREXATE PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",RECALCITRANT PLAQUE PSORIASIS,METHOTREXATE
724352437,5/21/2015 11:48:07,1640268019,5/21/2015 11:47:19,false,prodege,1,12656479,CAN,NB,Fredericton,198.164.157.90,[TREATS],[TREATS],contraindicated,N/A,140,245,-1,168,257,TWrex-cause,804393-FS1,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), RECALCITRANT PLAQUE PSORIASIS that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, METHOTREXATE PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",RECALCITRANT PLAQUE PSORIASIS,METHOTREXATE
724352437,5/21/2015 11:58:50,1640272783,5/21/2015 11:58:05,false,clixsense,1,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],systemic therapy,n/a,140,245,-1,168,257,TWrex-cause,804393-FS1,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), RECALCITRANT PLAQUE PSORIASIS that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, METHOTREXATE PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",RECALCITRANT PLAQUE PSORIASIS,METHOTREXATE
724352437,5/21/2015 12:15:51,1640280180,5/21/2015 12:15:29,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],Treatment,N/A,140,245,-1,168,257,TWrex-cause,804393-FS1,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), RECALCITRANT PLAQUE PSORIASIS that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, METHOTREXATE PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",RECALCITRANT PLAQUE PSORIASIS,METHOTREXATE
724352437,5/21/2015 12:36:15,1640289219,5/21/2015 12:35:11,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],RECALCITRANT PLAQUE PSORIASIS responsive to METHOTREXATE,N/A,140,245,-1,168,257,TWrex-cause,804393-FS1,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), RECALCITRANT PLAQUE PSORIASIS that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, METHOTREXATE PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",RECALCITRANT PLAQUE PSORIASIS,METHOTREXATE
724352437,5/21/2015 13:12:45,1640304774,5/21/2015 13:11:41,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],PSORIASIS,N/A,140,245,-1,168,257,TWrex-cause,804393-FS1,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), RECALCITRANT PLAQUE PSORIASIS that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, METHOTREXATE PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",RECALCITRANT PLAQUE PSORIASIS,METHOTREXATE
724352437,5/21/2015 13:22:45,1640309852,5/21/2015 13:21:30,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],with RECALCITRANT PLAQUE PSORIASIS METHOTREXATE for therapy,N/A,140,245,-1,168,257,TWrex-cause,804393-FS1,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), RECALCITRANT PLAQUE PSORIASIS that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, METHOTREXATE PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",RECALCITRANT PLAQUE PSORIASIS,METHOTREXATE
724352437,5/21/2015 13:23:16,1640310114,5/21/2015 13:21:42,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],therapy,N/A,140,245,-1,168,257,TWrex-cause,804393-FS1,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), RECALCITRANT PLAQUE PSORIASIS that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, METHOTREXATE PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",RECALCITRANT PLAQUE PSORIASIS,METHOTREXATE
724352437,5/21/2015 14:03:31,1640331534,5/21/2015 14:02:10,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],systemic therapy,n/a,140,245,-1,168,257,TWrex-cause,804393-FS1,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), RECALCITRANT PLAQUE PSORIASIS that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, METHOTREXATE PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",RECALCITRANT PLAQUE PSORIASIS,METHOTREXATE
724352437,5/21/2015 14:15:39,1640339125,5/21/2015 14:14:39,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],systemic therapy,N/A,140,245,-1,168,257,TWrex-cause,804393-FS1,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), RECALCITRANT PLAQUE PSORIASIS that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, METHOTREXATE PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",RECALCITRANT PLAQUE PSORIASIS,METHOTREXATE
724352438,5/21/2015 09:00:08,1640187101,5/21/2015 08:59:38,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],In evaluating women for was found to have better discriminatory ability,N/A,26,76,-1,43,117,TWrex-cause,803065-FS1,"• In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",CUSHING'S SYNDROME,1 MG DEXAMETHASONE SUPPRESSION
724352438,5/21/2015 09:04:47,1640189456,5/21/2015 09:03:52,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC 51.",n/a,26,76,-1,43,117,TWrex-cause,803065-FS1,"• In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",CUSHING'S SYNDROME,1 MG DEXAMETHASONE SUPPRESSION
724352438,5/21/2015 09:17:55,1640196212,5/21/2015 09:15:50,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],was found have better discriminatory ability,N/A,26,76,-1,43,117,TWrex-cause,803065-FS1,"• In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",CUSHING'S SYNDROME,1 MG DEXAMETHASONE SUPPRESSION
724352438,5/21/2015 09:18:01,1640196256,5/21/2015 09:17:33,false,neodev,1.0,15848372,AUS,02,Jannali,14.200.59.55,[TREATS],[TREATS],discriminatory ability,N/A,26,76,-1,43,117,TWrex-cause,803065-FS1,"• In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",CUSHING'S SYNDROME,1 MG DEXAMETHASONE SUPPRESSION
724352438,5/21/2015 09:37:13,1640205825,5/21/2015 09:37:00,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[SYMPTOM],[SYMPTOM],"syndrome,",N/A,26,76,-1,43,117,TWrex-cause,803065-FS1,"• In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",CUSHING'S SYNDROME,1 MG DEXAMETHASONE SUPPRESSION
724352438,5/21/2015 09:48:16,1640211051,5/21/2015 09:48:05,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[SYMPTOM],[SYMPTOM],"syndrome,",N/A,26,76,-1,43,117,TWrex-cause,803065-FS1,"• In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",CUSHING'S SYNDROME,1 MG DEXAMETHASONE SUPPRESSION
724352438,5/21/2015 10:16:41,1640225188,5/21/2015 10:16:26,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[SYMPTOM],[SYMPTOM],"syndrome,",N/A,26,76,-1,43,117,TWrex-cause,803065-FS1,"• In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",CUSHING'S SYNDROME,1 MG DEXAMETHASONE SUPPRESSION
724352438,5/21/2015 10:23:06,1640228387,5/21/2015 10:22:15,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],evaluating for CUSHING'S SYNDROME 1 MG DEXAMETHASONE SUPPRESSION better discriminatory ability,N/A,26,76,-1,43,117,TWrex-cause,803065-FS1,"• In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",CUSHING'S SYNDROME,1 MG DEXAMETHASONE SUPPRESSION
724352438,5/21/2015 10:29:36,1640231257,5/21/2015 10:29:18,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],DEXAMETHASONE SUPPRESSION,none,26,76,-1,43,117,TWrex-cause,803065-FS1,"• In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",CUSHING'S SYNDROME,1 MG DEXAMETHASONE SUPPRESSION
724352438,5/21/2015 10:33:27,1640233106,5/21/2015 10:33:13,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[SYMPTOM],[SYMPTOM],"ovary syndrome,",N/A,26,76,-1,43,117,TWrex-cause,803065-FS1,"• In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",CUSHING'S SYNDROME,1 MG DEXAMETHASONE SUPPRESSION
724352438,5/21/2015 10:43:32,1640238296,5/21/2015 10:43:04,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],In evaluating,n/a,26,76,-1,43,117,TWrex-cause,803065-FS1,"• In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",CUSHING'S SYNDROME,1 MG DEXAMETHASONE SUPPRESSION
724352438,5/21/2015 10:52:35,1640243073,5/21/2015 10:51:45,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],midnight cortisol was found to have better discriminatory ability,N/A,26,76,-1,43,117,TWrex-cause,803065-FS1,"• In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",CUSHING'S SYNDROME,1 MG DEXAMETHASONE SUPPRESSION
724352438,5/21/2015 10:53:21,1640243533,5/21/2015 10:51:49,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",better discriminatory ability,N/A,26,76,-1,43,117,TWrex-cause,803065-FS1,"• In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",CUSHING'S SYNDROME,1 MG DEXAMETHASONE SUPPRESSION
724352438,5/21/2015 10:54:29,1640244096,5/21/2015 10:52:54,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],evaluating,n/a,26,76,-1,43,117,TWrex-cause,803065-FS1,"• In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",CUSHING'S SYNDROME,1 MG DEXAMETHASONE SUPPRESSION
724352438,5/21/2015 11:05:53,1640249283,5/21/2015 11:04:06,false,neodev,1,11001780,AUS,07,Elwood,14.201.215.31,[TREATS],[TREATS],discriminatory ability,N/A,26,76,-1,43,117,TWrex-cause,803065-FS1,"• In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",CUSHING'S SYNDROME,1 MG DEXAMETHASONE SUPPRESSION
724352439,5/21/2015 07:06:07,1640126322,5/21/2015 07:05:50,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,[LOCATION],[LOCATION],ERGOT POISONING isolated from ERGOT,n/a,0,0,1,14,5,TWrex-cause,812173-FS1,ERGOT POISONING    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ERGOT,ERGOT POISONING,ERGOT
724352439,5/21/2015 07:13:03,1640130204,5/21/2015 07:12:53,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,0,0,1,14,5,TWrex-cause,812173-FS1,ERGOT POISONING    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ERGOT,ERGOT POISONING,ERGOT
724352439,5/21/2015 07:18:14,1640133075,5/21/2015 07:17:46,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[PART_OF],[PART_OF],isolated from,N/A,0,0,1,14,5,TWrex-cause,812173-FS1,ERGOT POISONING    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ERGOT,ERGOT POISONING,ERGOT
724352439,5/21/2015 07:20:37,1640134487,5/21/2015 07:20:09,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A],[IS_A],An,N/A,0,0,1,14,5,TWrex-cause,812173-FS1,ERGOT POISONING    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ERGOT,ERGOT POISONING,ERGOT
724352439,5/21/2015 07:31:38,1640140309,5/21/2015 07:31:08,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[PART_OF],[PART_OF],isolated from,N/A,0,0,1,14,5,TWrex-cause,812173-FS1,ERGOT POISONING    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ERGOT,ERGOT POISONING,ERGOT
724352439,5/21/2015 07:34:33,1640141715,5/21/2015 07:33:48,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[NONE],[NONE],N/A,Same.,0,0,1,14,5,TWrex-cause,812173-FS1,ERGOT POISONING    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ERGOT,ERGOT POISONING,ERGOT
724352439,5/21/2015 07:43:37,1640146474,5/21/2015 07:43:12,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A],[IS_A],An,N/A,0,0,1,14,5,TWrex-cause,812173-FS1,ERGOT POISONING    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ERGOT,ERGOT POISONING,ERGOT
724352439,5/21/2015 07:45:10,1640147361,5/21/2015 07:44:40,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[OTHER],[OTHER],isolated from,N/A,0,0,1,14,5,TWrex-cause,812173-FS1,ERGOT POISONING    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ERGOT,ERGOT POISONING,ERGOT
724352439,5/21/2015 07:45:32,1640147533,5/21/2015 07:45:13,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],isolated,n/a,0,0,1,14,5,TWrex-cause,812173-FS1,ERGOT POISONING    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ERGOT,ERGOT POISONING,ERGOT
724352439,5/21/2015 08:02:08,1640156341,5/21/2015 08:01:51,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A],[IS_A],An,N/A,0,0,1,14,5,TWrex-cause,812173-FS1,ERGOT POISONING    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ERGOT,ERGOT POISONING,ERGOT
724352439,5/21/2015 08:04:40,1640157766,5/21/2015 08:04:08,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CAUSES],[CAUSES],poisoning,N/A,0,0,1,14,5,TWrex-cause,812173-FS1,ERGOT POISONING    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ERGOT,ERGOT POISONING,ERGOT
724352439,5/21/2015 08:19:36,1640165923,5/21/2015 08:18:54,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,[PART_OF],[PART_OF],from,-,0,0,1,14,5,TWrex-cause,812173-FS1,ERGOT POISONING    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ERGOT,ERGOT POISONING,ERGOT
724352439,5/21/2015 08:33:46,1640173771,5/21/2015 08:33:22,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[PART_OF],[PART_OF],ERGOT POISONING SEE: ERGOT,n/a,0,0,1,14,5,TWrex-cause,812173-FS1,ERGOT POISONING    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ERGOT,ERGOT POISONING,ERGOT
724352439,5/21/2015 08:41:13,1640177419,5/21/2015 08:40:14,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[CAUSES] [OTHER] [ASSOCIATED_WITH],"[CAUSES]
[ASSOCIATED_WITH]
[OTHER]","ERGOT POISONING isolated from ERG<span id=""transmark""></span>OT",n/a,0,0,1,14,5,TWrex-cause,812173-FS1,ERGOT POISONING    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ERGOT,ERGOT POISONING,ERGOT
724352439,5/21/2015 08:43:12,1640178470,5/21/2015 08:42:43,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,[ASSOCIATED_WITH],[ASSOCIATED_WITH],principle,Associated with,0,0,1,14,5,TWrex-cause,812173-FS1,ERGOT POISONING    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ERGOT,ERGOT POISONING,ERGOT
724352440,5/21/2015 11:08:14,1640250328,5/21/2015 11:07:23,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[OTHER],[OTHER],Keywords:,"different keywords listed, not indicating relation between them",195,224,-1,222,254,TWrex-cause,805244-FS1,A nonselective β blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta antagonists Esophageal and GASTRIC VARICES HYPERTENSION PORTAL LIVER CIRRHOSIS TIMOLOL  ACP Journal Club.,GASTRIC VARICES HYPERTENSION,PORTAL LIVER CIRRHOSIS TIMOLOL
724352440,5/21/2015 11:12:09,1640252081,5/21/2015 11:11:03,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Esophageal and GASTRIC VARICES HYPERTENSION PORTAL LIVER CIRRHOSIS TIMOLOL ACP,N/A,195,224,-1,222,254,TWrex-cause,805244-FS1,A nonselective β blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta antagonists Esophageal and GASTRIC VARICES HYPERTENSION PORTAL LIVER CIRRHOSIS TIMOLOL  ACP Journal Club.,GASTRIC VARICES HYPERTENSION,PORTAL LIVER CIRRHOSIS TIMOLOL
724352440,5/21/2015 11:15:28,1640253380,5/21/2015 11:14:45,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[PREVENTS] [PART_OF],"[PREVENTS]
[PART_OF]",prevent in,n/a,195,224,-1,222,254,TWrex-cause,805244-FS1,A nonselective β blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta antagonists Esophageal and GASTRIC VARICES HYPERTENSION PORTAL LIVER CIRRHOSIS TIMOLOL  ACP Journal Club.,GASTRIC VARICES HYPERTENSION,PORTAL LIVER CIRRHOSIS TIMOLOL
724352440,5/21/2015 11:27:26,1640258359,5/21/2015 11:27:04,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[PREVENTS],[PREVENTS],prevent,N/A,195,224,-1,222,254,TWrex-cause,805244-FS1,A nonselective β blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta antagonists Esophageal and GASTRIC VARICES HYPERTENSION PORTAL LIVER CIRRHOSIS TIMOLOL  ACP Journal Club.,GASTRIC VARICES HYPERTENSION,PORTAL LIVER CIRRHOSIS TIMOLOL
724352440,5/21/2015 11:36:35,1640262530,5/21/2015 11:36:09,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Keywords:,n/a,195,224,-1,222,254,TWrex-cause,805244-FS1,A nonselective β blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta antagonists Esophageal and GASTRIC VARICES HYPERTENSION PORTAL LIVER CIRRHOSIS TIMOLOL  ACP Journal Club.,GASTRIC VARICES HYPERTENSION,PORTAL LIVER CIRRHOSIS TIMOLOL
724352440,5/21/2015 11:48:19,1640268093,5/21/2015 11:48:08,false,prodege,1.0,12656479,CAN,NB,Fredericton,198.164.157.90,[CAUSES],[CAUSES],varices,N/A,195,224,-1,222,254,TWrex-cause,805244-FS1,A nonselective β blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta antagonists Esophageal and GASTRIC VARICES HYPERTENSION PORTAL LIVER CIRRHOSIS TIMOLOL  ACP Journal Club.,GASTRIC VARICES HYPERTENSION,PORTAL LIVER CIRRHOSIS TIMOLOL
724352440,5/21/2015 11:59:40,1640273122,5/21/2015 11:58:51,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[NONE],[NONE],n/a,n/a,195,224,-1,222,254,TWrex-cause,805244-FS1,A nonselective β blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta antagonists Esophageal and GASTRIC VARICES HYPERTENSION PORTAL LIVER CIRRHOSIS TIMOLOL  ACP Journal Club.,GASTRIC VARICES HYPERTENSION,PORTAL LIVER CIRRHOSIS TIMOLOL
724352440,5/21/2015 12:16:09,1640280296,5/21/2015 12:15:52,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[PREVENTS],[PREVENTS],prevent,N/A,195,224,-1,222,254,TWrex-cause,805244-FS1,A nonselective β blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta antagonists Esophageal and GASTRIC VARICES HYPERTENSION PORTAL LIVER CIRRHOSIS TIMOLOL  ACP Journal Club.,GASTRIC VARICES HYPERTENSION,PORTAL LIVER CIRRHOSIS TIMOLOL
724352440,5/21/2015 12:37:43,1640289862,5/21/2015 12:36:20,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[NONE],[NONE],N/A,"Its the same thing, long name",195,224,-1,222,254,TWrex-cause,805244-FS1,A nonselective β blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta antagonists Esophageal and GASTRIC VARICES HYPERTENSION PORTAL LIVER CIRRHOSIS TIMOLOL  ACP Journal Club.,GASTRIC VARICES HYPERTENSION,PORTAL LIVER CIRRHOSIS TIMOLOL
724352440,5/21/2015 13:13:07,1640304940,5/21/2015 13:12:47,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],GASTRIC,N/A,195,224,-1,222,254,TWrex-cause,805244-FS1,A nonselective β blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta antagonists Esophageal and GASTRIC VARICES HYPERTENSION PORTAL LIVER CIRRHOSIS TIMOLOL  ACP Journal Club.,GASTRIC VARICES HYPERTENSION,PORTAL LIVER CIRRHOSIS TIMOLOL
724352440,5/21/2015 13:24:47,1640310880,5/21/2015 13:23:17,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[PART_OF],[PART_OF],GASTRIC VARICES HYPERTENSION PORTAL LIVER CIRRHOSIS TIMOLOL,N/A,195,224,-1,222,254,TWrex-cause,805244-FS1,A nonselective β blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta antagonists Esophageal and GASTRIC VARICES HYPERTENSION PORTAL LIVER CIRRHOSIS TIMOLOL  ACP Journal Club.,GASTRIC VARICES HYPERTENSION,PORTAL LIVER CIRRHOSIS TIMOLOL
724352440,5/21/2015 13:25:04,1640311010,5/21/2015 13:22:46,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[PREVENTS],[PREVENTS],prevent GASTRIC VARICES HYPERTENSION PORTAL LIVER CIRRHOSIS TIMOLOL,N/A,195,224,-1,222,254,TWrex-cause,805244-FS1,A nonselective β blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta antagonists Esophageal and GASTRIC VARICES HYPERTENSION PORTAL LIVER CIRRHOSIS TIMOLOL  ACP Journal Club.,GASTRIC VARICES HYPERTENSION,PORTAL LIVER CIRRHOSIS TIMOLOL
724352440,5/21/2015 14:05:34,1640332776,5/21/2015 14:03:32,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[NONE],[NONE],n/a,"""GASTRIC VARICES HYPERTENSION PORTAL LIVER CIRRHOSIS TIMOLOL""  seems to be ONE term, you just cut it into two right down the middle",195,224,-1,222,254,TWrex-cause,805244-FS1,A nonselective β blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta antagonists Esophageal and GASTRIC VARICES HYPERTENSION PORTAL LIVER CIRRHOSIS TIMOLOL  ACP Journal Club.,GASTRIC VARICES HYPERTENSION,PORTAL LIVER CIRRHOSIS TIMOLOL
724352440,5/21/2015 14:17:27,1640340123,5/21/2015 14:15:40,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[ASSOCIATED_WITH],[ASSOCIATED_WITH],gastroesophageal varices in cirrhosis,N/A,195,224,-1,222,254,TWrex-cause,805244-FS1,A nonselective β blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta antagonists Esophageal and GASTRIC VARICES HYPERTENSION PORTAL LIVER CIRRHOSIS TIMOLOL  ACP Journal Club.,GASTRIC VARICES HYPERTENSION,PORTAL LIVER CIRRHOSIS TIMOLOL
724352440,5/21/2015 14:22:03,1640343200,5/21/2015 14:21:49,false,neodev,1.0,32103286,GBR,H9,London,193.109.196.83,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",NO,NO,195,224,-1,222,254,TWrex-cause,805244-FS1,A nonselective β blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta antagonists Esophageal and GASTRIC VARICES HYPERTENSION PORTAL LIVER CIRRHOSIS TIMOLOL  ACP Journal Club.,GASTRIC VARICES HYPERTENSION,PORTAL LIVER CIRRHOSIS TIMOLOL
724352441,5/21/2015 06:58:57,1640122652,5/21/2015 06:58:39,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ARTHRITIS feature of SLE,n/a,121,80,1,129,83,TWrex-cause,813386-FS1,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  ARTHRITIS is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",ARTHRITIS,SLE
724352441,5/21/2015 07:04:02,1640125238,5/21/2015 07:01:50,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[IS_A],[IS_A],is a feature,N/A,121,80,1,129,83,TWrex-cause,813386-FS1,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  ARTHRITIS is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",ARTHRITIS,SLE
724352441,5/21/2015 07:08:18,1640127549,5/21/2015 07:08:02,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[ASSOCIATED_WITH],[ASSOCIATED_WITH],feature of both,N/A,121,80,1,129,83,TWrex-cause,813386-FS1,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  ARTHRITIS is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",ARTHRITIS,SLE
724352441,5/21/2015 07:09:46,1640128328,5/21/2015 07:09:23,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[DIAGNOSE_BY_TEST_OR_DRUG] [IS_A],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]",or is,N/A,121,80,1,129,83,TWrex-cause,813386-FS1,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  ARTHRITIS is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",ARTHRITIS,SLE
724352441,5/21/2015 07:18:06,1640132998,5/21/2015 07:17:39,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[MANIFESTATION],[MANIFESTATION],feature,N/A,121,80,1,129,83,TWrex-cause,813386-FS1,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  ARTHRITIS is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",ARTHRITIS,SLE
724352441,5/21/2015 07:19:46,1640134019,5/21/2015 07:18:59,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],exam,N/A,121,80,1,129,83,TWrex-cause,813386-FS1,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  ARTHRITIS is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",ARTHRITIS,SLE
724352441,5/21/2015 07:32:22,1640140651,5/21/2015 07:31:38,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH] [IS_A] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",or with is a of or of or,N/A,121,80,1,129,83,TWrex-cause,813386-FS1,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  ARTHRITIS is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",ARTHRITIS,SLE
724352441,5/21/2015 07:35:17,1640142135,5/21/2015 07:34:54,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],feature of,N/A,121,80,1,129,83,TWrex-cause,813386-FS1,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  ARTHRITIS is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",ARTHRITIS,SLE
724352441,5/21/2015 07:38:11,1640143738,5/21/2015 07:37:37,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PART_OF],[PART_OF],feature of,n/a,121,80,1,129,83,TWrex-cause,813386-FS1,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  ARTHRITIS is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",ARTHRITIS,SLE
724352441,5/21/2015 07:50:18,1640149953,5/21/2015 07:50:09,false,elite,1.0,31913360,GBR,"","",88.150.133.60,[CAUSES],[CAUSES],Musculoskeletal,dd,121,80,1,129,83,TWrex-cause,813386-FS1,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  ARTHRITIS is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",ARTHRITIS,SLE
724352441,5/21/2015 07:52:27,1640151238,5/21/2015 07:51:53,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[DIAGNOSE_BY_TEST_OR_DRUG] [IS_A] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]
[PART_OF]",or is a of or or,N/A,121,80,1,129,83,TWrex-cause,813386-FS1,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  ARTHRITIS is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",ARTHRITIS,SLE
724352441,5/21/2015 07:53:21,1640151847,5/21/2015 07:52:36,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[SYMPTOM],[SYMPTOM],feature of,N/A,121,80,1,129,83,TWrex-cause,813386-FS1,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  ARTHRITIS is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",ARTHRITIS,SLE
724352441,5/21/2015 07:56:59,1640153806,5/21/2015 07:56:44,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,[ASSOCIATED_WITH],[ASSOCIATED_WITH],feature,-,121,80,1,129,83,TWrex-cause,813386-FS1,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  ARTHRITIS is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",ARTHRITIS,SLE
724352441,5/21/2015 08:11:22,1640161374,5/21/2015 08:10:43,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH] [IS_A] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",or with is a of of or,N/A,121,80,1,129,83,TWrex-cause,813386-FS1,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  ARTHRITIS is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",ARTHRITIS,SLE
724352441,5/21/2015 08:18:48,1640165391,5/21/2015 08:17:57,false,clixsense,1.0,12843982,AUS,08,Perth,180.216.79.226,[SYMPTOM],[SYMPTOM],ARTHRITIS is a feature of SLE,N/A,121,80,1,129,83,TWrex-cause,813386-FS1,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  ARTHRITIS is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",ARTHRITIS,SLE
724352442,5/21/2015 11:16:32,1640253732,5/21/2015 11:16:03,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],infusion to reduce the incidence,N/A,92,20,-1,103,38,TWrex-cause,800750-FS1,• Administer either 5% OR 10% DEXTROSE during quinidine infusion to reduce the incidence of HYPOGLYCEMIA,HYPOGLYCEMIA,5% OR 10% DEXTROSE
724352442,5/21/2015 11:19:32,1640255108,5/21/2015 11:18:28,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS] [ASSOCIATED_WITH],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",Administer during infusion reduce incidence,n/a,92,20,-1,103,38,TWrex-cause,800750-FS1,• Administer either 5% OR 10% DEXTROSE during quinidine infusion to reduce the incidence of HYPOGLYCEMIA,HYPOGLYCEMIA,5% OR 10% DEXTROSE
724352442,5/21/2015 11:28:45,1640258995,5/21/2015 11:28:31,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],reduce,N/A,92,20,-1,103,38,TWrex-cause,800750-FS1,• Administer either 5% OR 10% DEXTROSE during quinidine infusion to reduce the incidence of HYPOGLYCEMIA,HYPOGLYCEMIA,5% OR 10% DEXTROSE
724352442,5/21/2015 12:18:15,1640281165,5/21/2015 12:17:51,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],reduce,N/A,92,20,-1,103,38,TWrex-cause,800750-FS1,• Administer either 5% OR 10% DEXTROSE during quinidine infusion to reduce the incidence of HYPOGLYCEMIA,HYPOGLYCEMIA,5% OR 10% DEXTROSE
724352442,5/21/2015 13:15:48,1640306370,5/21/2015 13:15:32,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[MANIFESTATION],[MANIFESTATION],DEXTROSE,N/A,92,20,-1,103,38,TWrex-cause,800750-FS1,• Administer either 5% OR 10% DEXTROSE during quinidine infusion to reduce the incidence of HYPOGLYCEMIA,HYPOGLYCEMIA,5% OR 10% DEXTROSE
724352442,5/21/2015 13:32:08,1640314731,5/21/2015 13:31:01,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],Administer to reduce the incidence,N/A,92,20,-1,103,38,TWrex-cause,800750-FS1,• Administer either 5% OR 10% DEXTROSE during quinidine infusion to reduce the incidence of HYPOGLYCEMIA,HYPOGLYCEMIA,5% OR 10% DEXTROSE
724352442,5/21/2015 13:35:42,1640316487,5/21/2015 13:34:34,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",Administer 5% OR 10% DEXTROSE during quinidine infusion to reduce incidence of HYPOGLYCEMIA,N/A,92,20,-1,103,38,TWrex-cause,800750-FS1,• Administer either 5% OR 10% DEXTROSE during quinidine infusion to reduce the incidence of HYPOGLYCEMIA,HYPOGLYCEMIA,5% OR 10% DEXTROSE
724352442,5/21/2015 14:22:44,1640343608,5/21/2015 14:21:33,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[PREVENTS],[PREVENTS],to reduce the incidence,N/A,92,20,-1,103,38,TWrex-cause,800750-FS1,• Administer either 5% OR 10% DEXTROSE during quinidine infusion to reduce the incidence of HYPOGLYCEMIA,HYPOGLYCEMIA,5% OR 10% DEXTROSE
724352442,5/21/2015 14:23:18,1640343927,5/21/2015 14:23:05,false,neodev,1.0,32103286,GBR,H9,London,193.109.196.83,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES] [NONE],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[NONE]",NO,NO,92,20,-1,103,38,TWrex-cause,800750-FS1,• Administer either 5% OR 10% DEXTROSE during quinidine infusion to reduce the incidence of HYPOGLYCEMIA,HYPOGLYCEMIA,5% OR 10% DEXTROSE
724352442,5/21/2015 14:25:27,1640345465,5/21/2015 14:25:14,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[TREATS],[TREATS],Administer either,N/A,92,20,-1,103,38,TWrex-cause,800750-FS1,• Administer either 5% OR 10% DEXTROSE during quinidine infusion to reduce the incidence of HYPOGLYCEMIA,HYPOGLYCEMIA,5% OR 10% DEXTROSE
724352442,5/21/2015 14:26:59,1640346400,5/21/2015 14:26:24,false,clixsense,1.0,21484973,GBR,L6,Shrewsbury,86.153.186.21,[PREVENTS],[PREVENTS],to reduce,n/a,92,20,-1,103,38,TWrex-cause,800750-FS1,• Administer either 5% OR 10% DEXTROSE during quinidine infusion to reduce the incidence of HYPOGLYCEMIA,HYPOGLYCEMIA,5% OR 10% DEXTROSE
724352442,5/21/2015 14:36:32,1640352431,5/21/2015 14:35:56,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],Administer either 5% OR 10% DEXTROSE during quinidine infusion reduce incidence of HYPOGLYCEMIA,n/a,92,20,-1,103,38,TWrex-cause,800750-FS1,• Administer either 5% OR 10% DEXTROSE during quinidine infusion to reduce the incidence of HYPOGLYCEMIA,HYPOGLYCEMIA,5% OR 10% DEXTROSE
724352442,5/21/2015 14:48:51,1640359633,5/21/2015 14:47:58,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[PREVENTS],[PREVENTS],Administer 5% OR 10% DEXTROSE to reduce incidence of HYPOGLYCEMIA,N/A,92,20,-1,103,38,TWrex-cause,800750-FS1,• Administer either 5% OR 10% DEXTROSE during quinidine infusion to reduce the incidence of HYPOGLYCEMIA,HYPOGLYCEMIA,5% OR 10% DEXTROSE
724352442,5/21/2015 15:01:36,1640366328,5/21/2015 15:00:50,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,[PREVENTS],[PREVENTS],Administer DEXTROSE to reduce incidence of HYPOGLYCEMIA,na,92,20,-1,103,38,TWrex-cause,800750-FS1,• Administer either 5% OR 10% DEXTROSE during quinidine infusion to reduce the incidence of HYPOGLYCEMIA,HYPOGLYCEMIA,5% OR 10% DEXTROSE
724352442,5/21/2015 15:03:05,1640367116,5/21/2015 15:02:52,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],DEXTROSE during quinidine reduce incidence HYPOGLYCEMIA,na,92,20,-1,103,38,TWrex-cause,800750-FS1,• Administer either 5% OR 10% DEXTROSE during quinidine infusion to reduce the incidence of HYPOGLYCEMIA,HYPOGLYCEMIA,5% OR 10% DEXTROSE
724352443,5/21/2015 10:38:43,1640235709,5/21/2015 10:38:31,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[MANIFESTATION],[MANIFESTATION],compared,N/A,78,64,-1,117,73,TWrex-cause,803985-FS1,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with LIDOCAINE for SHOCK RESISTANT VENTRICULAR FIBRILLATION",SHOCK RESISTANT VENTRICULAR FIBRILLATION,LIDOCAINE
724352443,5/21/2015 10:48:59,1640241179,5/21/2015 10:48:26,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],for,n/a,78,64,-1,117,73,TWrex-cause,803985-FS1,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with LIDOCAINE for SHOCK RESISTANT VENTRICULAR FIBRILLATION",SHOCK RESISTANT VENTRICULAR FIBRILLATION,LIDOCAINE
724352443,5/21/2015 11:02:37,1640247946,5/21/2015 11:02:04,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],for,N/A,78,64,-1,117,73,TWrex-cause,803985-FS1,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with LIDOCAINE for SHOCK RESISTANT VENTRICULAR FIBRILLATION",SHOCK RESISTANT VENTRICULAR FIBRILLATION,LIDOCAINE
724352443,5/21/2015 11:04:33,1640248735,5/21/2015 11:04:07,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],for,N/A,78,64,-1,117,73,TWrex-cause,803985-FS1,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with LIDOCAINE for SHOCK RESISTANT VENTRICULAR FIBRILLATION",SHOCK RESISTANT VENTRICULAR FIBRILLATION,LIDOCAINE
724352443,5/21/2015 11:08:25,1640250419,5/21/2015 11:07:36,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[ASSOCIATED_WITH] [CONTRAINDICATES],"[CONTRAINDICATES]
[ASSOCIATED_WITH]",as compared with,n/a,78,64,-1,117,73,TWrex-cause,803985-FS1,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with LIDOCAINE for SHOCK RESISTANT VENTRICULAR FIBRILLATION",SHOCK RESISTANT VENTRICULAR FIBRILLATION,LIDOCAINE
724352443,5/21/2015 11:18:55,1640254867,5/21/2015 11:18:40,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[SYMPTOM],[SYMPTOM],for,N/A,78,64,-1,117,73,TWrex-cause,803985-FS1,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with LIDOCAINE for SHOCK RESISTANT VENTRICULAR FIBRILLATION",SHOCK RESISTANT VENTRICULAR FIBRILLATION,LIDOCAINE
724352443,5/21/2015 11:34:03,1640261379,5/21/2015 11:33:48,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],for,n/a,78,64,-1,117,73,TWrex-cause,803985-FS1,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with LIDOCAINE for SHOCK RESISTANT VENTRICULAR FIBRILLATION",SHOCK RESISTANT VENTRICULAR FIBRILLATION,LIDOCAINE
724352443,5/21/2015 11:42:23,1640265259,5/21/2015 11:41:10,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",for,n/a,78,64,-1,117,73,TWrex-cause,803985-FS1,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with LIDOCAINE for SHOCK RESISTANT VENTRICULAR FIBRILLATION",SHOCK RESISTANT VENTRICULAR FIBRILLATION,LIDOCAINE
724352443,5/21/2015 11:45:24,1640266855,5/21/2015 11:45:06,false,prodege,1.0,12656479,CAN,NB,Fredericton,198.164.157.90,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],compared,N/A,78,64,-1,117,73,TWrex-cause,803985-FS1,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with LIDOCAINE for SHOCK RESISTANT VENTRICULAR FIBRILLATION",SHOCK RESISTANT VENTRICULAR FIBRILLATION,LIDOCAINE
724352443,5/21/2015 12:12:42,1640278756,5/21/2015 12:12:10,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[OTHER],[OTHER],compared,N/A,78,64,-1,117,73,TWrex-cause,803985-FS1,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with LIDOCAINE for SHOCK RESISTANT VENTRICULAR FIBRILLATION",SHOCK RESISTANT VENTRICULAR FIBRILLATION,LIDOCAINE
724352443,5/21/2015 12:29:48,1640286588,5/21/2015 12:29:05,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],LIDOCAINE for SHOCK RESISTANT VENTRICULAR FIBRILLATION,N/A,78,64,-1,117,73,TWrex-cause,803985-FS1,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with LIDOCAINE for SHOCK RESISTANT VENTRICULAR FIBRILLATION",SHOCK RESISTANT VENTRICULAR FIBRILLATION,LIDOCAINE
724352443,5/21/2015 12:39:16,1640290709,5/21/2015 12:39:05,false,neodev,1.0,31789301,CAN,QC,Montréal,192.99.6.125,[NONE],[NONE],no,no,78,64,-1,117,73,TWrex-cause,803985-FS1,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with LIDOCAINE for SHOCK RESISTANT VENTRICULAR FIBRILLATION",SHOCK RESISTANT VENTRICULAR FIBRILLATION,LIDOCAINE
724352443,5/21/2015 12:57:53,1640298535,5/21/2015 12:57:27,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,[TREATS],[TREATS],for,treats,78,64,-1,117,73,TWrex-cause,803985-FS1,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with LIDOCAINE for SHOCK RESISTANT VENTRICULAR FIBRILLATION",SHOCK RESISTANT VENTRICULAR FIBRILLATION,LIDOCAINE
724352443,5/21/2015 13:07:26,1640302426,5/21/2015 13:06:57,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],LIDOCAINE,N/A,78,64,-1,117,73,TWrex-cause,803985-FS1,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with LIDOCAINE for SHOCK RESISTANT VENTRICULAR FIBRILLATION",SHOCK RESISTANT VENTRICULAR FIBRILLATION,LIDOCAINE
724352443,5/21/2015 13:08:35,1640302887,5/21/2015 13:07:19,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],compared LIDOCAINE for SHOCK RESISTANT VENTRICULAR FIBRILLATION,na,78,64,-1,117,73,TWrex-cause,803985-FS1,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with LIDOCAINE for SHOCK RESISTANT VENTRICULAR FIBRILLATION",SHOCK RESISTANT VENTRICULAR FIBRILLATION,LIDOCAINE
724352444,5/21/2015 07:08:12,1640127494,5/21/2015 07:07:51,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,[SYMPTOM],[SYMPTOM],PV risk factors for THROMBOSIS,n/a,96,16,1,105,18,TWrex-cause,812730-FS1,"• Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",THROMBOSIS,PV
724352444,5/21/2015 07:23:34,1640136026,5/21/2015 07:22:39,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[MANIFESTATION],[MANIFESTATION],presence,N/A,96,16,1,105,18,TWrex-cause,812730-FS1,"• Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",THROMBOSIS,PV
724352444,5/21/2015 07:26:12,1640137409,5/21/2015 07:25:25,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",by or of,N/A,96,16,1,105,18,TWrex-cause,812730-FS1,"• Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",THROMBOSIS,PV
724352444,5/21/2015 07:37:02,1640143011,5/21/2015 07:35:57,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[ASSOCIATED_WITH],[ASSOCIATED_WITH],presence or absence of risk factors,N/A,96,16,1,105,18,TWrex-cause,812730-FS1,"• Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",THROMBOSIS,PV
724352444,5/21/2015 07:38:58,1640144085,5/21/2015 07:37:58,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],presence or absence of risk factors for,N/A,96,16,1,105,18,TWrex-cause,812730-FS1,"• Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",THROMBOSIS,PV
724352444,5/21/2015 07:47:33,1640148618,5/21/2015 07:47:11,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],risk factors for,n/a,96,16,1,105,18,TWrex-cause,812730-FS1,"• Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",THROMBOSIS,PV
724352444,5/21/2015 07:47:48,1640148714,5/21/2015 07:47:27,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],Management in,N/A,96,16,1,105,18,TWrex-cause,812730-FS1,"• Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",THROMBOSIS,PV
724352444,5/21/2015 07:48:00,1640148816,5/21/2015 07:47:30,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",by or of,N/A,96,16,1,105,18,TWrex-cause,812730-FS1,"• Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",THROMBOSIS,PV
724352444,5/21/2015 08:06:49,1640158874,5/21/2015 08:06:18,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",by or of,N/A,96,16,1,105,18,TWrex-cause,812730-FS1,"• Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",THROMBOSIS,PV
724352444,5/21/2015 08:08:03,1640159602,5/21/2015 08:07:23,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[OTHER],[OTHER],risk factors,N/A,96,16,1,105,18,TWrex-cause,812730-FS1,"• Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",THROMBOSIS,PV
724352444,5/21/2015 08:24:36,1640168679,5/21/2015 08:23:30,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,[OTHER],[OTHER],should be,-,96,16,1,105,18,TWrex-cause,812730-FS1,"• Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",THROMBOSIS,PV
724352444,5/21/2015 08:37:53,1640175860,5/21/2015 08:37:18,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[TREATS],[TREATS],PV THROMBOSIS,n/a,96,16,1,105,18,TWrex-cause,812730-FS1,"• Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",THROMBOSIS,PV
724352444,5/21/2015 08:45:18,1640179572,5/21/2015 08:44:41,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,[SYMPTOM],[SYMPTOM],presence,Synptom,96,16,1,105,18,TWrex-cause,812730-FS1,"• Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",THROMBOSIS,PV
724352444,5/21/2015 08:45:59,1640179911,5/21/2015 08:45:38,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",by or of,N/A,96,16,1,105,18,TWrex-cause,812730-FS1,"• Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",THROMBOSIS,PV
724352444,5/21/2015 08:47:03,1640180525,5/21/2015 08:46:11,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION],[MANIFESTATION],"Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",n/a,96,16,1,105,18,TWrex-cause,812730-FS1,"• Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",THROMBOSIS,PV
724352445,5/21/2015 07:08:26,1640127679,5/21/2015 07:08:13,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,[CAUSES],[CAUSES],BOTULISM caused by production of BOTULINUM TOXIN,n/a,0,33,1,7,48,TWrex-cause,810555-FS1,BOTULISM caused by production of BOTULINUM TOXIN in the colon following ingestion of spores of  Clostridium botulinum.,BOTULISM,BOTULINUM TOXIN
724352445,5/21/2015 07:23:55,1640136185,5/21/2015 07:23:35,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],caused,N/A,0,33,1,7,48,TWrex-cause,810555-FS1,BOTULISM caused by production of BOTULINUM TOXIN in the colon following ingestion of spores of  Clostridium botulinum.,BOTULISM,BOTULINUM TOXIN
724352445,5/21/2015 07:26:43,1640137695,5/21/2015 07:26:15,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",by of of of,N/A,0,33,1,7,48,TWrex-cause,810555-FS1,BOTULISM caused by production of BOTULINUM TOXIN in the colon following ingestion of spores of  Clostridium botulinum.,BOTULISM,BOTULINUM TOXIN
724352445,5/21/2015 07:37:20,1640143210,5/21/2015 07:37:03,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CAUSES],[CAUSES],caused by,N/A,0,33,1,7,48,TWrex-cause,810555-FS1,BOTULISM caused by production of BOTULINUM TOXIN in the colon following ingestion of spores of  Clostridium botulinum.,BOTULISM,BOTULINUM TOXIN
724352445,5/21/2015 07:39:44,1640144509,5/21/2015 07:39:00,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],caused by,N/A,0,33,1,7,48,TWrex-cause,810555-FS1,BOTULISM caused by production of BOTULINUM TOXIN in the colon following ingestion of spores of  Clostridium botulinum.,BOTULISM,BOTULINUM TOXIN
724352445,5/21/2015 07:47:49,1640148717,5/21/2015 07:47:33,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],caused by,n/a,0,33,1,7,48,TWrex-cause,810555-FS1,BOTULISM caused by production of BOTULINUM TOXIN in the colon following ingestion of spores of  Clostridium botulinum.,BOTULISM,BOTULINUM TOXIN
724352445,5/21/2015 07:48:03,1640148827,5/21/2015 07:47:49,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],caused by production of,N/A,0,33,1,7,48,TWrex-cause,810555-FS1,BOTULISM caused by production of BOTULINUM TOXIN in the colon following ingestion of spores of  Clostridium botulinum.,BOTULISM,BOTULINUM TOXIN
724352445,5/21/2015 07:48:29,1640148993,5/21/2015 07:48:03,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]",caused by of of of,N/A,0,33,1,7,48,TWrex-cause,810555-FS1,BOTULISM caused by production of BOTULINUM TOXIN in the colon following ingestion of spores of  Clostridium botulinum.,BOTULISM,BOTULINUM TOXIN
724352445,5/21/2015 08:07:26,1640159244,5/21/2015 08:06:52,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]",caused by of of of,N/A,0,33,1,7,48,TWrex-cause,810555-FS1,BOTULISM caused by production of BOTULINUM TOXIN in the colon following ingestion of spores of  Clostridium botulinum.,BOTULISM,BOTULINUM TOXIN
724352445,5/21/2015 08:08:25,1640159836,5/21/2015 08:08:03,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CAUSES],[CAUSES],caused by,N/A,0,33,1,7,48,TWrex-cause,810555-FS1,BOTULISM caused by production of BOTULINUM TOXIN in the colon following ingestion of spores of  Clostridium botulinum.,BOTULISM,BOTULINUM TOXIN
724352445,5/21/2015 08:24:49,1640168813,5/21/2015 08:24:37,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,[CAUSES],[CAUSES],caused,-,0,33,1,7,48,TWrex-cause,810555-FS1,BOTULISM caused by production of BOTULINUM TOXIN in the colon following ingestion of spores of  Clostridium botulinum.,BOTULISM,BOTULINUM TOXIN
724352445,5/21/2015 08:45:38,1640179715,5/21/2015 08:45:19,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,[CAUSES],[CAUSES],caused,Caused,0,33,1,7,48,TWrex-cause,810555-FS1,BOTULISM caused by production of BOTULINUM TOXIN in the colon following ingestion of spores of  Clostridium botulinum.,BOTULISM,BOTULINUM TOXIN
724352445,5/21/2015 08:46:25,1640180183,5/21/2015 08:46:03,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]",caused by of of of,N/A,0,33,1,7,48,TWrex-cause,810555-FS1,BOTULISM caused by production of BOTULINUM TOXIN in the colon following ingestion of spores of  Clostridium botulinum.,BOTULISM,BOTULINUM TOXIN
724352445,5/21/2015 08:47:35,1640180744,5/21/2015 08:47:04,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],BOTULISM caused by production of BOTULINUM TOXIN in the colon following ingestion of spores of Clostridium botulinum.,n/a,0,33,1,7,48,TWrex-cause,810555-FS1,BOTULISM caused by production of BOTULINUM TOXIN in the colon following ingestion of spores of  Clostridium botulinum.,BOTULISM,BOTULINUM TOXIN
724352445,5/21/2015 08:48:25,1640181145,5/21/2015 08:47:57,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[CAUSES],[CAUSES],"BOTULISM caused by BOTULINUM TOX<span id=""transmark""></span>IN",n/a,0,33,1,7,48,TWrex-cause,810555-FS1,BOTULISM caused by production of BOTULINUM TOXIN in the colon following ingestion of spores of  Clostridium botulinum.,BOTULISM,BOTULINUM TOXIN
724352446,5/21/2015 11:09:19,1640250807,5/21/2015 11:08:14,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],treatment of,n/a,95,62,-1,123,74,TWrex-cause,800358-FS1,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus CLOMIPRAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER: a multicenter, randomized, double blind, parallel group comparison.",OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
724352446,5/21/2015 11:13:09,1640252479,5/21/2015 11:12:12,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],in the treatment,N/A,95,62,-1,123,74,TWrex-cause,800358-FS1,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus CLOMIPRAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER: a multicenter, randomized, double blind, parallel group comparison.",OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
724352446,5/21/2015 11:16:28,1640253708,5/21/2015 11:15:29,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",versus treatment comparison.,n/a,95,62,-1,123,74,TWrex-cause,800358-FS1,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus CLOMIPRAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER: a multicenter, randomized, double blind, parallel group comparison.",OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
724352446,5/21/2015 11:27:40,1640258469,5/21/2015 11:27:29,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],treatment,N/A,95,62,-1,123,74,TWrex-cause,800358-FS1,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus CLOMIPRAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER: a multicenter, randomized, double blind, parallel group comparison.",OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
724352446,5/21/2015 11:36:48,1640262594,5/21/2015 11:36:36,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,95,62,-1,123,74,TWrex-cause,800358-FS1,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus CLOMIPRAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER: a multicenter, randomized, double blind, parallel group comparison.",OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
724352446,5/21/2015 11:48:29,1640268182,5/21/2015 11:48:19,false,prodege,1.0,12656479,CAN,NB,Fredericton,198.164.157.90,[TREATS],[TREATS],treatment,N/A,95,62,-1,123,74,TWrex-cause,800358-FS1,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus CLOMIPRAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER: a multicenter, randomized, double blind, parallel group comparison.",OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
724352446,5/21/2015 12:00:16,1640273333,5/21/2015 11:59:41,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],in the treatment of,n/a,95,62,-1,123,74,TWrex-cause,800358-FS1,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus CLOMIPRAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER: a multicenter, randomized, double blind, parallel group comparison.",OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
724352446,5/21/2015 12:16:31,1640280436,5/21/2015 12:16:10,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],treatment,N/A,95,62,-1,123,74,TWrex-cause,800358-FS1,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus CLOMIPRAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER: a multicenter, randomized, double blind, parallel group comparison.",OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
724352446,5/21/2015 12:38:15,1640290240,5/21/2015 12:37:44,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],CLOMIPRAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER:,N/A,95,62,-1,123,74,TWrex-cause,800358-FS1,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus CLOMIPRAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER: a multicenter, randomized, double blind, parallel group comparison.",OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
724352446,5/21/2015 13:13:33,1640305129,5/21/2015 13:13:08,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],CLOMIPRAMINE,N/A,95,62,-1,123,74,TWrex-cause,800358-FS1,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus CLOMIPRAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER: a multicenter, randomized, double blind, parallel group comparison.",OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
724352446,5/21/2015 13:26:03,1640311692,5/21/2015 13:25:05,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],CLOMIPRAMINE in treatment of OBSESSIVE COMPULSIVE DISORDER:,N/A,95,62,-1,123,74,TWrex-cause,800358-FS1,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus CLOMIPRAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER: a multicenter, randomized, double blind, parallel group comparison.",OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
724352446,5/21/2015 13:26:10,1640311742,5/21/2015 13:24:48,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment,N/A,95,62,-1,123,74,TWrex-cause,800358-FS1,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus CLOMIPRAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER: a multicenter, randomized, double blind, parallel group comparison.",OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
724352446,5/21/2015 14:07:39,1640334243,5/21/2015 14:05:35,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],in the treatment of,n/a,95,62,-1,123,74,TWrex-cause,800358-FS1,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus CLOMIPRAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER: a multicenter, randomized, double blind, parallel group comparison.",OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
724352446,5/21/2015 14:18:25,1640340888,5/21/2015 14:17:27,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,95,62,-1,123,74,TWrex-cause,800358-FS1,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus CLOMIPRAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER: a multicenter, randomized, double blind, parallel group comparison.",OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
724352446,5/21/2015 14:22:20,1640343333,5/21/2015 14:22:08,false,neodev,1.0,32103286,GBR,H9,London,193.109.196.83,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",NO,NO,95,62,-1,123,74,TWrex-cause,800358-FS1,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus CLOMIPRAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER: a multicenter, randomized, double blind, parallel group comparison.",OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE
724352447,5/21/2015 08:48:53,1640181334,5/21/2015 08:48:24,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,[CAUSES],[CAUSES],Inflammation,Cause,88,0,-1,93,13,TWrex-cause,802539-FS1,"KERATOUVEITIS    Inflammation of both the cornea and the uveal tract (i.e., of both the CORNEA and the iris, ciliary body, and choroid.",CORNEA,KERATOUVEITIS
724352447,5/21/2015 08:50:20,1640182068,5/21/2015 08:48:21,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[PART_OF],[PART_OF],of of,N/A,88,0,-1,93,13,TWrex-cause,802539-FS1,"KERATOUVEITIS    Inflammation of both the cornea and the uveal tract (i.e., of both the CORNEA and the iris, ciliary body, and choroid.",CORNEA,KERATOUVEITIS
724352447,5/21/2015 08:51:09,1640182449,5/21/2015 08:50:10,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION] [LOCATION],"[LOCATION]
[MANIFESTATION]","KERATOUVEITIS Inflammation of both the cornea and the uveal tract (i.e., of both the CORNEA and the iris, ciliary body, and choroid.",n/a,88,0,-1,93,13,TWrex-cause,802539-FS1,"KERATOUVEITIS    Inflammation of both the cornea and the uveal tract (i.e., of both the CORNEA and the iris, ciliary body, and choroid.",CORNEA,KERATOUVEITIS
724352447,5/21/2015 08:51:48,1640182874,5/21/2015 08:50:15,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"KERATOUVEITIS Inflammation of both the CORNEA and th<span id=""transmark""></span>e iris,",n/a,88,0,-1,93,13,TWrex-cause,802539-FS1,"KERATOUVEITIS    Inflammation of both the cornea and the uveal tract (i.e., of both the CORNEA and the iris, ciliary body, and choroid.",CORNEA,KERATOUVEITIS
724352447,5/21/2015 08:52:22,1640183161,5/21/2015 08:51:53,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[LOCATION],[LOCATION],Inflammation of both the cornea and the uveal tract,N/A,88,0,-1,93,13,TWrex-cause,802539-FS1,"KERATOUVEITIS    Inflammation of both the cornea and the uveal tract (i.e., of both the CORNEA and the iris, ciliary body, and choroid.",CORNEA,KERATOUVEITIS
724352447,5/21/2015 09:06:28,1640190224,5/21/2015 09:06:03,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[NONE],[NONE],N/A,No clear relation.,88,0,-1,93,13,TWrex-cause,802539-FS1,"KERATOUVEITIS    Inflammation of both the cornea and the uveal tract (i.e., of both the CORNEA and the iris, ciliary body, and choroid.",CORNEA,KERATOUVEITIS
724352447,5/21/2015 09:07:56,1640190984,5/21/2015 09:07:33,false,neodev,1.0,15848372,AUS,02,Jannali,14.200.59.55,[OTHER],[OTHER],Inflammation of,N/A,88,0,-1,93,13,TWrex-cause,802539-FS1,"KERATOUVEITIS    Inflammation of both the cornea and the uveal tract (i.e., of both the CORNEA and the iris, ciliary body, and choroid.",CORNEA,KERATOUVEITIS
724352447,5/21/2015 09:21:03,1640197624,5/21/2015 09:19:42,false,clixsense,1.0,28570371,NLD,"","",91.213.37.165,[MANIFESTATION],[MANIFESTATION],Inflammation,N/A,88,0,-1,93,13,TWrex-cause,802539-FS1,"KERATOUVEITIS    Inflammation of both the cornea and the uveal tract (i.e., of both the CORNEA and the iris, ciliary body, and choroid.",CORNEA,KERATOUVEITIS
724352447,5/21/2015 09:26:03,1640200162,5/21/2015 09:25:28,false,neodev,1.0,31195295,GBR,"","",46.208.164.162,[LOCATION],[LOCATION],of the cornea of the CORNEA,N/A,88,0,-1,93,13,TWrex-cause,802539-FS1,"KERATOUVEITIS    Inflammation of both the cornea and the uveal tract (i.e., of both the CORNEA and the iris, ciliary body, and choroid.",CORNEA,KERATOUVEITIS
724352447,5/21/2015 09:33:34,1640203986,5/21/2015 09:33:22,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[PREVENTS],[PREVENTS],Inflammation,N/A,88,0,-1,93,13,TWrex-cause,802539-FS1,"KERATOUVEITIS    Inflammation of both the cornea and the uveal tract (i.e., of both the CORNEA and the iris, ciliary body, and choroid.",CORNEA,KERATOUVEITIS
724352447,5/21/2015 09:44:25,1640209234,5/21/2015 09:44:14,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[ASSOCIATED_WITH],[ASSOCIATED_WITH],both,N/A,88,0,-1,93,13,TWrex-cause,802539-FS1,"KERATOUVEITIS    Inflammation of both the cornea and the uveal tract (i.e., of both the CORNEA and the iris, ciliary body, and choroid.",CORNEA,KERATOUVEITIS
724352447,5/21/2015 10:05:02,1640219459,5/21/2015 10:03:52,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION],[MANIFESTATION],KERATOUVEITIS Inflammation both CORNEA,N/A,88,0,-1,93,13,TWrex-cause,802539-FS1,"KERATOUVEITIS    Inflammation of both the cornea and the uveal tract (i.e., of both the CORNEA and the iris, ciliary body, and choroid.",CORNEA,KERATOUVEITIS
724352447,5/21/2015 10:11:51,1640222849,5/21/2015 10:11:34,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[CAUSES],[CAUSES],both,N/A,88,0,-1,93,13,TWrex-cause,802539-FS1,"KERATOUVEITIS    Inflammation of both the cornea and the uveal tract (i.e., of both the CORNEA and the iris, ciliary body, and choroid.",CORNEA,KERATOUVEITIS
724352447,5/21/2015 10:24:39,1640228950,5/21/2015 10:24:22,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[CAUSES],[CAUSES],KERATOUVEITIS,none,88,0,-1,93,13,TWrex-cause,802539-FS1,"KERATOUVEITIS    Inflammation of both the cornea and the uveal tract (i.e., of both the CORNEA and the iris, ciliary body, and choroid.",CORNEA,KERATOUVEITIS
724352447,5/21/2015 10:25:33,1640229425,5/21/2015 10:23:34,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[LOCATION],[LOCATION],Inflammation of,N/A,88,0,-1,93,13,TWrex-cause,802539-FS1,"KERATOUVEITIS    Inflammation of both the cornea and the uveal tract (i.e., of both the CORNEA and the iris, ciliary body, and choroid.",CORNEA,KERATOUVEITIS
724352448,5/21/2015 07:03:24,1640124939,5/21/2015 07:03:00,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,[SYMPTOM],[SYMPTOM],DEMENTIA WITH LEWY BODIES decline recurrent VISUAL HALLUCINATIONS,n/a,100,2,1,120,27,TWrex-cause,812738-FS1,"◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating symptoms, recurrent VISUAL HALLUCINATIONS and spontaneous, extrapyramidal signs ( 45.",VISUAL HALLUCINATIONS,DEMENTIA WITH LEWY BODIES
724352448,5/21/2015 07:11:01,1640129085,5/21/2015 07:10:37,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[SYMPTOM],[SYMPTOM],"symptoms, recurrent",N/A,100,2,1,120,27,TWrex-cause,812738-FS1,"◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating symptoms, recurrent VISUAL HALLUCINATIONS and spontaneous, extrapyramidal signs ( 45.",VISUAL HALLUCINATIONS,DEMENTIA WITH LEWY BODIES
724352448,5/21/2015 07:11:14,1640129212,5/21/2015 07:11:03,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],"symptoms,",N/A,100,2,1,120,27,TWrex-cause,812738-FS1,"◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating symptoms, recurrent VISUAL HALLUCINATIONS and spontaneous, extrapyramidal signs ( 45.",VISUAL HALLUCINATIONS,DEMENTIA WITH LEWY BODIES
724352448,5/21/2015 07:16:07,1640131956,5/21/2015 07:15:41,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]",WITH is a,N/A,100,2,1,120,27,TWrex-cause,812738-FS1,"◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating symptoms, recurrent VISUAL HALLUCINATIONS and spontaneous, extrapyramidal signs ( 45.",VISUAL HALLUCINATIONS,DEMENTIA WITH LEWY BODIES
724352448,5/21/2015 07:26:32,1640137611,5/21/2015 07:24:57,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[SYMPTOM],[SYMPTOM],"fluctuating symptoms, recurrent",N/A,100,2,1,120,27,TWrex-cause,812738-FS1,"◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating symptoms, recurrent VISUAL HALLUCINATIONS and spontaneous, extrapyramidal signs ( 45.",VISUAL HALLUCINATIONS,DEMENTIA WITH LEWY BODIES
724352448,5/21/2015 07:28:31,1640138586,5/21/2015 07:27:37,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[SYMPTOM] [CAUSES],"[CAUSES]
[SYMPTOM]","fluctuating symptoms, recurrent",N/A,100,2,1,120,27,TWrex-cause,812738-FS1,"◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating symptoms, recurrent VISUAL HALLUCINATIONS and spontaneous, extrapyramidal signs ( 45.",VISUAL HALLUCINATIONS,DEMENTIA WITH LEWY BODIES
724352448,5/21/2015 07:39:05,1640144223,5/21/2015 07:38:39,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[ASSOCIATED_WITH] [IS_A],"[ASSOCIATED_WITH]
[IS_A]",WITH is a with,N/A,100,2,1,120,27,TWrex-cause,812738-FS1,"◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating symptoms, recurrent VISUAL HALLUCINATIONS and spontaneous, extrapyramidal signs ( 45.",VISUAL HALLUCINATIONS,DEMENTIA WITH LEWY BODIES
724352448,5/21/2015 07:40:45,1640145077,5/21/2015 07:40:05,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[SYMPTOM],[SYMPTOM],signs,N/A,100,2,1,120,27,TWrex-cause,812738-FS1,"◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating symptoms, recurrent VISUAL HALLUCINATIONS and spontaneous, extrapyramidal signs ( 45.",VISUAL HALLUCINATIONS,DEMENTIA WITH LEWY BODIES
724352448,5/21/2015 07:43:12,1640146233,5/21/2015 07:42:46,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PART_OF],[PART_OF],with,n/a,100,2,1,120,27,TWrex-cause,812738-FS1,"◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating symptoms, recurrent VISUAL HALLUCINATIONS and spontaneous, extrapyramidal signs ( 45.",VISUAL HALLUCINATIONS,DEMENTIA WITH LEWY BODIES
724352448,5/21/2015 07:58:23,1640154440,5/21/2015 07:57:51,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]
[IS_A]","is a with symptoms,",N/A,100,2,1,120,27,TWrex-cause,812738-FS1,"◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating symptoms, recurrent VISUAL HALLUCINATIONS and spontaneous, extrapyramidal signs ( 45.",VISUAL HALLUCINATIONS,DEMENTIA WITH LEWY BODIES
724352448,5/21/2015 08:00:39,1640155625,5/21/2015 08:00:10,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[SYMPTOM],[SYMPTOM],"symptoms,",N/A,100,2,1,120,27,TWrex-cause,812738-FS1,"◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating symptoms, recurrent VISUAL HALLUCINATIONS and spontaneous, extrapyramidal signs ( 45.",VISUAL HALLUCINATIONS,DEMENTIA WITH LEWY BODIES
724352448,5/21/2015 08:06:29,1640158706,5/21/2015 08:04:11,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,[SYMPTOM],[SYMPTOM],"fluctuating symptoms,",-,100,2,1,120,27,TWrex-cause,812738-FS1,"◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating symptoms, recurrent VISUAL HALLUCINATIONS and spontaneous, extrapyramidal signs ( 45.",VISUAL HALLUCINATIONS,DEMENTIA WITH LEWY BODIES
724352448,5/21/2015 08:29:22,1640171182,5/21/2015 08:28:50,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[SYMPTOM],[SYMPTOM],DEMENTIA WITH LEWY BODIES recurrent VISUAL HALLUCINATIONS,n/a,100,2,1,120,27,TWrex-cause,812738-FS1,"◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating symptoms, recurrent VISUAL HALLUCINATIONS and spontaneous, extrapyramidal signs ( 45.",VISUAL HALLUCINATIONS,DEMENTIA WITH LEWY BODIES
724352448,5/21/2015 08:35:15,1640174443,5/21/2015 08:34:22,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[SYMPTOM],[SYMPTOM],"DEMENTIA WITH LEWY BODIES symptoms, VISUAL HALLU<span id=""transmark""></span>CINATIONS",n/a,100,2,1,120,27,TWrex-cause,812738-FS1,"◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating symptoms, recurrent VISUAL HALLUCINATIONS and spontaneous, extrapyramidal signs ( 45.",VISUAL HALLUCINATIONS,DEMENTIA WITH LEWY BODIES
724352448,5/21/2015 08:40:03,1640176951,5/21/2015 08:39:26,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,[SYMPTOM],[SYMPTOM],"symptoms,",Symptom,100,2,1,120,27,TWrex-cause,812738-FS1,"◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating symptoms, recurrent VISUAL HALLUCINATIONS and spontaneous, extrapyramidal signs ( 45.",VISUAL HALLUCINATIONS,DEMENTIA WITH LEWY BODIES
724352449,5/21/2015 07:00:15,1640123367,5/21/2015 06:59:50,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,[SYMPTOM],[SYMPTOM],reported DIARRHEA,n/a,129,107,1,136,137,TWrex-cause,814917-FS1,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
724352449,5/21/2015 07:06:37,1640126601,5/21/2015 07:04:49,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[SYMPTOM],[SYMPTOM],reported,N/A,129,107,1,136,137,TWrex-cause,814917-FS1,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
724352449,5/21/2015 07:09:06,1640128040,5/21/2015 07:08:45,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[PART_OF],[PART_OF],also known as,N/A,129,107,1,136,137,TWrex-cause,814917-FS1,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
724352449,5/21/2015 07:11:31,1640129342,5/21/2015 07:10:50,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],or,N/A,129,107,1,136,137,TWrex-cause,814917-FS1,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
724352449,5/21/2015 07:19:51,1640134076,5/21/2015 07:19:01,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[MANIFESTATION] [IS_A],"[MANIFESTATION]
[IS_A]",may range,N/A,129,107,1,136,137,TWrex-cause,814917-FS1,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
724352449,5/21/2015 07:22:37,1640135507,5/21/2015 07:21:16,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[NONE],[NONE],N/A,Same.,129,107,1,136,137,TWrex-cause,814917-FS1,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
724352449,5/21/2015 07:34:13,1640141569,5/21/2015 07:33:37,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",or with,N/A,129,107,1,136,137,TWrex-cause,814917-FS1,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
724352449,5/21/2015 07:36:44,1640142850,5/21/2015 07:36:04,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[IS_A],[IS_A],also known as,N/A,129,107,1,136,137,TWrex-cause,814917-FS1,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
724352449,5/21/2015 07:39:58,1640144633,5/21/2015 07:38:59,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[SIDE_EFFECT],[SIDE_EFFECT],range severity,n/a,129,107,1,136,137,TWrex-cause,814917-FS1,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
724352449,5/21/2015 07:54:08,1640152281,5/21/2015 07:53:34,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",or with,N/A,129,107,1,136,137,TWrex-cause,814917-FS1,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
724352449,5/21/2015 07:54:42,1640152583,5/21/2015 07:54:09,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[IS_A],[IS_A],DIARRHEA,N/A,129,107,1,136,137,TWrex-cause,814917-FS1,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
724352449,5/21/2015 07:58:38,1640154582,5/21/2015 07:57:46,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,[SYMPTOM],[SYMPTOM],difficile,-,129,107,1,136,137,TWrex-cause,814917-FS1,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
724352449,5/21/2015 08:12:48,1640162129,5/21/2015 08:12:21,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",or with,N/A,129,107,1,136,137,TWrex-cause,814917-FS1,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
724352449,5/21/2015 08:23:50,1640168220,5/21/2015 08:22:21,false,clixsense,1.0,12843982,AUS,08,Perth,180.216.79.226,[IS_A],[IS_A],difficile associated diarrhea also known as ANTIBIOTIC ASSOCIATED DIARRHEA,N/A,129,107,1,136,137,TWrex-cause,814917-FS1,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
724352449,5/21/2015 08:25:04,1640168905,5/21/2015 08:24:22,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[MANIFESTATION] [PART_OF],"[MANIFESTATION]
[PART_OF]",ANTIBIOTIC ASSOCIATED DIARRHEA DIARRHEA,n/a,129,107,1,136,137,TWrex-cause,814917-FS1,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
724352450,5/21/2015 08:54:45,1640184419,5/21/2015 08:54:23,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,Associated,117,31,1,126,49,TWrex-cause,810719-FS1,"Some patients go on to develop LATE STAGE ROSACEA characterized by coarse tissue hyperplasia of the cheeks and nose (RHINOPHYMA caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",RHINOPHYMA,LATE STAGE ROSACEA
724352450,5/21/2015 08:57:14,1640185580,5/21/2015 08:56:44,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[MANIFESTATION],[MANIFESTATION],characterized by (RHINOPHYMA,N/A,117,31,1,126,49,TWrex-cause,810719-FS1,"Some patients go on to develop LATE STAGE ROSACEA characterized by coarse tissue hyperplasia of the cheeks and nose (RHINOPHYMA caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",RHINOPHYMA,LATE STAGE ROSACEA
724352450,5/21/2015 08:59:25,1640186640,5/21/2015 08:58:42,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]","Some patients go on to develop LATE STAGE ROSACEA characterized by coarse tissue hyperplasia of the cheeks and nose (RHINOPHYMA caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",n/a,117,31,1,126,49,TWrex-cause,810719-FS1,"Some patients go on to develop LATE STAGE ROSACEA characterized by coarse tissue hyperplasia of the cheeks and nose (RHINOPHYMA caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",RHINOPHYMA,LATE STAGE ROSACEA
724352450,5/21/2015 09:01:59,1640188037,5/21/2015 09:01:33,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]","LATE STAGE ROSACEA characterized by (RHIN<span id=""transmark""></span>OPHYMA",n/a,117,31,1,126,49,TWrex-cause,810719-FS1,"Some patients go on to develop LATE STAGE ROSACEA characterized by coarse tissue hyperplasia of the cheeks and nose (RHINOPHYMA caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",RHINOPHYMA,LATE STAGE ROSACEA
724352450,5/21/2015 09:03:16,1640188703,5/21/2015 09:02:47,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF] [CAUSES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]",by of caused by,N/A,117,31,1,126,49,TWrex-cause,810719-FS1,"Some patients go on to develop LATE STAGE ROSACEA characterized by coarse tissue hyperplasia of the cheeks and nose (RHINOPHYMA caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",RHINOPHYMA,LATE STAGE ROSACEA
724352450,5/21/2015 09:12:05,1640193234,5/21/2015 09:11:38,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",characterized by,N/A,117,31,1,126,49,TWrex-cause,810719-FS1,"Some patients go on to develop LATE STAGE ROSACEA characterized by coarse tissue hyperplasia of the cheeks and nose (RHINOPHYMA caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",RHINOPHYMA,LATE STAGE ROSACEA
724352450,5/21/2015 09:13:34,1640194088,5/21/2015 09:13:08,false,neodev,1.0,15848372,AUS,02,Jannali,14.200.59.55,[CAUSES],[CAUSES],characterized,N/A,117,31,1,126,49,TWrex-cause,810719-FS1,"Some patients go on to develop LATE STAGE ROSACEA characterized by coarse tissue hyperplasia of the cheeks and nose (RHINOPHYMA caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",RHINOPHYMA,LATE STAGE ROSACEA
724352450,5/21/2015 09:35:51,1640205246,5/21/2015 09:35:38,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],characterized,N/A,117,31,1,126,49,TWrex-cause,810719-FS1,"Some patients go on to develop LATE STAGE ROSACEA characterized by coarse tissue hyperplasia of the cheeks and nose (RHINOPHYMA caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",RHINOPHYMA,LATE STAGE ROSACEA
724352450,5/21/2015 09:46:51,1640210408,5/21/2015 09:46:35,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[ASSOCIATED_WITH],[ASSOCIATED_WITH],characterized,N/A,117,31,1,126,49,TWrex-cause,810719-FS1,"Some patients go on to develop LATE STAGE ROSACEA characterized by coarse tissue hyperplasia of the cheeks and nose (RHINOPHYMA caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",RHINOPHYMA,LATE STAGE ROSACEA
724352450,5/21/2015 10:14:53,1640224399,5/21/2015 10:14:35,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[CONTRAINDICATES],[CONTRAINDICATES],characterized,N/A,117,31,1,126,49,TWrex-cause,810719-FS1,"Some patients go on to develop LATE STAGE ROSACEA characterized by coarse tissue hyperplasia of the cheeks and nose (RHINOPHYMA caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",RHINOPHYMA,LATE STAGE ROSACEA
724352450,5/21/2015 10:16:01,1640224923,5/21/2015 10:15:03,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION],[MANIFESTATION],LATE STAGE ROSACEA characterized by (RHINOPHYMA,N/A,117,31,1,126,49,TWrex-cause,810719-FS1,"Some patients go on to develop LATE STAGE ROSACEA characterized by coarse tissue hyperplasia of the cheeks and nose (RHINOPHYMA caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",RHINOPHYMA,LATE STAGE ROSACEA
724352450,5/21/2015 10:27:44,1640230398,5/21/2015 10:27:27,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[CAUSES],[CAUSES],(RHINOPHYMA,none,117,31,1,126,49,TWrex-cause,810719-FS1,"Some patients go on to develop LATE STAGE ROSACEA characterized by coarse tissue hyperplasia of the cheeks and nose (RHINOPHYMA caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",RHINOPHYMA,LATE STAGE ROSACEA
724352450,5/21/2015 10:31:59,1640232321,5/21/2015 10:31:46,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[SYMPTOM],[SYMPTOM],characterized,N/A,117,31,1,126,49,TWrex-cause,810719-FS1,"Some patients go on to develop LATE STAGE ROSACEA characterized by coarse tissue hyperplasia of the cheeks and nose (RHINOPHYMA caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",RHINOPHYMA,LATE STAGE ROSACEA
724352450,5/21/2015 10:40:23,1640236488,5/21/2015 10:39:51,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],characterized by,n/a,117,31,1,126,49,TWrex-cause,810719-FS1,"Some patients go on to develop LATE STAGE ROSACEA characterized by coarse tissue hyperplasia of the cheeks and nose (RHINOPHYMA caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",RHINOPHYMA,LATE STAGE ROSACEA
724352450,5/21/2015 10:46:13,1640239697,5/21/2015 10:45:28,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],characterized by coarse tissue,N/A,117,31,1,126,49,TWrex-cause,810719-FS1,"Some patients go on to develop LATE STAGE ROSACEA characterized by coarse tissue hyperplasia of the cheeks and nose (RHINOPHYMA caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",RHINOPHYMA,LATE STAGE ROSACEA
724352451,5/21/2015 06:57:09,1640121699,5/21/2015 06:56:45,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,[IS_A],[IS_A],composed CALCIUM PHOSPHATE,n/a,56,124,-1,69,141,TWrex-cause,803070-FS1,"• About 80% of stones contain calcium, and about 80% of CALCIUM STONES are composed mostly of calcium oxalate; the rest are CALCIUM PHOSPHATE",CALCIUM STONES,CALCIUM PHOSPHATE
724352451,5/21/2015 06:59:27,1640122927,5/21/2015 06:58:29,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[PART_OF],[PART_OF],composed,N/A,56,124,-1,69,141,TWrex-cause,803070-FS1,"• About 80% of stones contain calcium, and about 80% of CALCIUM STONES are composed mostly of calcium oxalate; the rest are CALCIUM PHOSPHATE",CALCIUM STONES,CALCIUM PHOSPHATE
724352451,5/21/2015 07:07:31,1640127082,5/21/2015 07:07:08,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[PART_OF],[PART_OF],the rest are,N/A,56,124,-1,69,141,TWrex-cause,803070-FS1,"• About 80% of stones contain calcium, and about 80% of CALCIUM STONES are composed mostly of calcium oxalate; the rest are CALCIUM PHOSPHATE",CALCIUM STONES,CALCIUM PHOSPHATE
724352451,5/21/2015 07:08:08,1640127461,5/21/2015 07:07:28,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF],[PART_OF],of of of,N/A,56,124,-1,69,141,TWrex-cause,803070-FS1,"• About 80% of stones contain calcium, and about 80% of CALCIUM STONES are composed mostly of calcium oxalate; the rest are CALCIUM PHOSPHATE",CALCIUM STONES,CALCIUM PHOSPHATE
724352451,5/21/2015 07:15:33,1640131556,5/21/2015 07:14:45,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[IS_A],[IS_A],the rest are,N/A,56,124,-1,69,141,TWrex-cause,803070-FS1,"• About 80% of stones contain calcium, and about 80% of CALCIUM STONES are composed mostly of calcium oxalate; the rest are CALCIUM PHOSPHATE",CALCIUM STONES,CALCIUM PHOSPHATE
724352451,5/21/2015 07:16:16,1640132054,5/21/2015 07:14:23,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[OTHER],[OTHER],are composed,N/A,56,124,-1,69,141,TWrex-cause,803070-FS1,"• About 80% of stones contain calcium, and about 80% of CALCIUM STONES are composed mostly of calcium oxalate; the rest are CALCIUM PHOSPHATE",CALCIUM STONES,CALCIUM PHOSPHATE
724352451,5/21/2015 07:30:26,1640139555,5/21/2015 07:29:36,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF],[PART_OF],of of,N/A,56,124,-1,69,141,TWrex-cause,803070-FS1,"• About 80% of stones contain calcium, and about 80% of CALCIUM STONES are composed mostly of calcium oxalate; the rest are CALCIUM PHOSPHATE",CALCIUM STONES,CALCIUM PHOSPHATE
724352451,5/21/2015 07:34:11,1640141548,5/21/2015 07:33:35,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[PART_OF],[PART_OF],the rest are,N/A,56,124,-1,69,141,TWrex-cause,803070-FS1,"• About 80% of stones contain calcium, and about 80% of CALCIUM STONES are composed mostly of calcium oxalate; the rest are CALCIUM PHOSPHATE",CALCIUM STONES,CALCIUM PHOSPHATE
724352451,5/21/2015 07:36:52,1640142958,5/21/2015 07:36:28,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PART_OF],[PART_OF],composed,n/a,56,124,-1,69,141,TWrex-cause,803070-FS1,"• About 80% of stones contain calcium, and about 80% of CALCIUM STONES are composed mostly of calcium oxalate; the rest are CALCIUM PHOSPHATE",CALCIUM STONES,CALCIUM PHOSPHATE
724352451,5/21/2015 07:49:40,1640149637,5/21/2015 07:49:25,false,elite,1.0,31913360,GBR,"","",88.150.133.60,[CAUSES],[CAUSES],STONES,gfgg,56,124,-1,69,141,TWrex-cause,803070-FS1,"• About 80% of stones contain calcium, and about 80% of CALCIUM STONES are composed mostly of calcium oxalate; the rest are CALCIUM PHOSPHATE",CALCIUM STONES,CALCIUM PHOSPHATE
724352451,5/21/2015 07:50:57,1640150307,5/21/2015 07:50:14,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF],[PART_OF],of of of,N/A,56,124,-1,69,141,TWrex-cause,803070-FS1,"• About 80% of stones contain calcium, and about 80% of CALCIUM STONES are composed mostly of calcium oxalate; the rest are CALCIUM PHOSPHATE",CALCIUM STONES,CALCIUM PHOSPHATE
724352451,5/21/2015 07:51:37,1640150803,5/21/2015 07:51:05,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CAUSES],[CAUSES],composed of,N/A,56,124,-1,69,141,TWrex-cause,803070-FS1,"• About 80% of stones contain calcium, and about 80% of CALCIUM STONES are composed mostly of calcium oxalate; the rest are CALCIUM PHOSPHATE",CALCIUM STONES,CALCIUM PHOSPHATE
724352451,5/21/2015 07:55:02,1640152805,5/21/2015 07:54:32,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,[ASSOCIATED_WITH],[ASSOCIATED_WITH],composed,-,56,124,-1,69,141,TWrex-cause,803070-FS1,"• About 80% of stones contain calcium, and about 80% of CALCIUM STONES are composed mostly of calcium oxalate; the rest are CALCIUM PHOSPHATE",CALCIUM STONES,CALCIUM PHOSPHATE
724352451,5/21/2015 08:09:39,1640160414,5/21/2015 08:09:08,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[PART_OF],[PART_OF],of of of,N/A,56,124,-1,69,141,TWrex-cause,803070-FS1,"• About 80% of stones contain calcium, and about 80% of CALCIUM STONES are composed mostly of calcium oxalate; the rest are CALCIUM PHOSPHATE",CALCIUM STONES,CALCIUM PHOSPHATE
724352451,5/21/2015 08:16:31,1640164086,5/21/2015 08:15:07,false,clixsense,1.0,12843982,AUS,08,Perth,180.216.79.226,[PART_OF],[PART_OF],CALCIUM STONES are composed of CALCIUM PHOSPHATE,n/a,56,124,-1,69,141,TWrex-cause,803070-FS1,"• About 80% of stones contain calcium, and about 80% of CALCIUM STONES are composed mostly of calcium oxalate; the rest are CALCIUM PHOSPHATE",CALCIUM STONES,CALCIUM PHOSPHATE
724352452,5/21/2015 09:03:58,1640189036,5/21/2015 09:03:27,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is associated with,N/A,63,29,1,76,32,TWrex-cause,813390-FS1,"Ophthalmic system findings : DKC reportedly is associated with CONJUNCTIVITIS blepharitides, and pterygium.",CONJUNCTIVITIS,DKC
724352452,5/21/2015 09:21:22,1640197762,5/21/2015 09:21:02,false,neodev,1.0,15848372,AUS,02,Jannali,14.200.59.55,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,63,29,1,76,32,TWrex-cause,813390-FS1,"Ophthalmic system findings : DKC reportedly is associated with CONJUNCTIVITIS blepharitides, and pterygium.",CONJUNCTIVITIS,DKC
724352452,5/21/2015 09:40:56,1640207464,5/21/2015 09:40:34,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,63,29,1,76,32,TWrex-cause,813390-FS1,"Ophthalmic system findings : DKC reportedly is associated with CONJUNCTIVITIS blepharitides, and pterygium.",CONJUNCTIVITIS,DKC
724352452,5/21/2015 09:50:18,1640212112,5/21/2015 09:50:06,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,63,29,1,76,32,TWrex-cause,813390-FS1,"Ophthalmic system findings : DKC reportedly is associated with CONJUNCTIVITIS blepharitides, and pterygium.",CONJUNCTIVITIS,DKC
724352452,5/21/2015 10:19:14,1640226569,5/21/2015 10:18:59,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,63,29,1,76,32,TWrex-cause,813390-FS1,"Ophthalmic system findings : DKC reportedly is associated with CONJUNCTIVITIS blepharitides, and pterygium.",CONJUNCTIVITIS,DKC
724352452,5/21/2015 10:29:06,1640230999,5/21/2015 10:28:31,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],DKC associated with CONJUNCTIVITIS,N/A,63,29,1,76,32,TWrex-cause,813390-FS1,"Ophthalmic system findings : DKC reportedly is associated with CONJUNCTIVITIS blepharitides, and pterygium.",CONJUNCTIVITIS,DKC
724352452,5/21/2015 10:32:12,1640232499,5/21/2015 10:31:53,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],CONJUNCTIVITIS,none,63,29,1,76,32,TWrex-cause,813390-FS1,"Ophthalmic system findings : DKC reportedly is associated with CONJUNCTIVITIS blepharitides, and pterygium.",CONJUNCTIVITIS,DKC
724352452,5/21/2015 10:37:48,1640235264,5/21/2015 10:37:36,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,63,29,1,76,32,TWrex-cause,813390-FS1,"Ophthalmic system findings : DKC reportedly is associated with CONJUNCTIVITIS blepharitides, and pterygium.",CONJUNCTIVITIS,DKC
724352452,5/21/2015 10:47:16,1640240249,5/21/2015 10:46:57,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is associated with,n/a,63,29,1,76,32,TWrex-cause,813390-FS1,"Ophthalmic system findings : DKC reportedly is associated with CONJUNCTIVITIS blepharitides, and pterygium.",CONJUNCTIVITIS,DKC
724352452,5/21/2015 10:59:06,1640246334,5/21/2015 10:58:41,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,63,29,1,76,32,TWrex-cause,813390-FS1,"Ophthalmic system findings : DKC reportedly is associated with CONJUNCTIVITIS blepharitides, and pterygium.",CONJUNCTIVITIS,DKC
724352452,5/21/2015 11:01:56,1640247615,5/21/2015 11:00:48,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,63,29,1,76,32,TWrex-cause,813390-FS1,"Ophthalmic system findings : DKC reportedly is associated with CONJUNCTIVITIS blepharitides, and pterygium.",CONJUNCTIVITIS,DKC
724352452,5/21/2015 11:04:43,1640248792,5/21/2015 11:02:32,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[ASSOCIATED_WITH] [PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[PART_OF]",findings associated with,n/a,63,29,1,76,32,TWrex-cause,813390-FS1,"Ophthalmic system findings : DKC reportedly is associated with CONJUNCTIVITIS blepharitides, and pterygium.",CONJUNCTIVITIS,DKC
724352452,5/21/2015 11:18:00,1640254505,5/21/2015 11:17:49,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,63,29,1,76,32,TWrex-cause,813390-FS1,"Ophthalmic system findings : DKC reportedly is associated with CONJUNCTIVITIS blepharitides, and pterygium.",CONJUNCTIVITIS,DKC
724352452,5/21/2015 11:32:53,1640260839,5/21/2015 11:32:41,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,n/a,63,29,1,76,32,TWrex-cause,813390-FS1,"Ophthalmic system findings : DKC reportedly is associated with CONJUNCTIVITIS blepharitides, and pterygium.",CONJUNCTIVITIS,DKC
724352452,5/21/2015 11:37:01,1640262668,5/21/2015 11:36:33,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is associated with,n/a,63,29,1,76,32,TWrex-cause,813390-FS1,"Ophthalmic system findings : DKC reportedly is associated with CONJUNCTIVITIS blepharitides, and pterygium.",CONJUNCTIVITIS,DKC
724352453,5/21/2015 08:48:18,1640181080,5/21/2015 08:47:49,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",of or,N/A,108,79,-1,128,86,TWrex-cause,804440-FS1,"CONCLUSION  In participants who have no clinical evidence of vascular disease, ASPIRIN reduces the risk for MYOCARDIAL INFARCTION but does not reduce the risk for stroke or vascular death.",MYOCARDIAL INFARCTION,ASPIRIN
724352453,5/21/2015 08:48:23,1640181140,5/21/2015 08:47:49,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,[PREVENTS],[PREVENTS],reduces,Prevents,108,79,-1,128,86,TWrex-cause,804440-FS1,"CONCLUSION  In participants who have no clinical evidence of vascular disease, ASPIRIN reduces the risk for MYOCARDIAL INFARCTION but does not reduce the risk for stroke or vascular death.",MYOCARDIAL INFARCTION,ASPIRIN
724352453,5/21/2015 08:50:10,1640181932,5/21/2015 08:49:18,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS],[PREVENTS],"CONCLUSION In participants who have no clinical evidence of vascular disease, ASPIRIN reduces the risk for MYOCARDIAL INFARCTION but does not reduce the risk for stroke or vascular death.",n/a,108,79,-1,128,86,TWrex-cause,804440-FS1,"CONCLUSION  In participants who have no clinical evidence of vascular disease, ASPIRIN reduces the risk for MYOCARDIAL INFARCTION but does not reduce the risk for stroke or vascular death.",MYOCARDIAL INFARCTION,ASPIRIN
724352453,5/21/2015 08:50:13,1640181995,5/21/2015 08:49:45,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[PREVENTS],[PREVENTS],"ASPIRIN reduces risk for MYOCARDIAL INFA<span id=""transmark""></span>RCTION",n/a,108,79,-1,128,86,TWrex-cause,804440-FS1,"CONCLUSION  In participants who have no clinical evidence of vascular disease, ASPIRIN reduces the risk for MYOCARDIAL INFARCTION but does not reduce the risk for stroke or vascular death.",MYOCARDIAL INFARCTION,ASPIRIN
724352453,5/21/2015 08:51:51,1640182897,5/21/2015 08:51:29,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[PREVENTS],[PREVENTS],reduces the risk for,N/A,108,79,-1,128,86,TWrex-cause,804440-FS1,"CONCLUSION  In participants who have no clinical evidence of vascular disease, ASPIRIN reduces the risk for MYOCARDIAL INFARCTION but does not reduce the risk for stroke or vascular death.",MYOCARDIAL INFARCTION,ASPIRIN
724352453,5/21/2015 09:06:02,1640190056,5/21/2015 09:05:45,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[PREVENTS],[PREVENTS],reduces the risk for,N/A,108,79,-1,128,86,TWrex-cause,804440-FS1,"CONCLUSION  In participants who have no clinical evidence of vascular disease, ASPIRIN reduces the risk for MYOCARDIAL INFARCTION but does not reduce the risk for stroke or vascular death.",MYOCARDIAL INFARCTION,ASPIRIN
724352453,5/21/2015 09:07:32,1640190860,5/21/2015 09:07:06,false,neodev,1.0,15848372,AUS,02,Jannali,14.200.59.55,[OTHER],[OTHER],reduces,N/A,108,79,-1,128,86,TWrex-cause,804440-FS1,"CONCLUSION  In participants who have no clinical evidence of vascular disease, ASPIRIN reduces the risk for MYOCARDIAL INFARCTION but does not reduce the risk for stroke or vascular death.",MYOCARDIAL INFARCTION,ASPIRIN
724352453,5/21/2015 09:19:40,1640197014,5/21/2015 09:18:59,false,clixsense,1.0,28570371,NLD,"","",91.213.37.165,[PREVENTS],[PREVENTS],reduces risk,N/A,108,79,-1,128,86,TWrex-cause,804440-FS1,"CONCLUSION  In participants who have no clinical evidence of vascular disease, ASPIRIN reduces the risk for MYOCARDIAL INFARCTION but does not reduce the risk for stroke or vascular death.",MYOCARDIAL INFARCTION,ASPIRIN
724352453,5/21/2015 09:25:27,1640199770,5/21/2015 09:24:59,false,neodev,1.0,31195295,GBR,"","",46.208.164.162,[PREVENTS],[PREVENTS],reduces the risk,N/A,108,79,-1,128,86,TWrex-cause,804440-FS1,"CONCLUSION  In participants who have no clinical evidence of vascular disease, ASPIRIN reduces the risk for MYOCARDIAL INFARCTION but does not reduce the risk for stroke or vascular death.",MYOCARDIAL INFARCTION,ASPIRIN
724352453,5/21/2015 09:33:20,1640203889,5/21/2015 09:33:09,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],reduces,N/A,108,79,-1,128,86,TWrex-cause,804440-FS1,"CONCLUSION  In participants who have no clinical evidence of vascular disease, ASPIRIN reduces the risk for MYOCARDIAL INFARCTION but does not reduce the risk for stroke or vascular death.",MYOCARDIAL INFARCTION,ASPIRIN
724352453,5/21/2015 09:44:12,1640209115,5/21/2015 09:44:00,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[SYMPTOM],[SYMPTOM],vascular,N/A,108,79,-1,128,86,TWrex-cause,804440-FS1,"CONCLUSION  In participants who have no clinical evidence of vascular disease, ASPIRIN reduces the risk for MYOCARDIAL INFARCTION but does not reduce the risk for stroke or vascular death.",MYOCARDIAL INFARCTION,ASPIRIN
724352453,5/21/2015 10:03:51,1640218943,5/21/2015 10:02:38,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[PREVENTS],[PREVENTS],ASPIRIN reduces risk for MYOCARDIAL INFARCTION,N/A,108,79,-1,128,86,TWrex-cause,804440-FS1,"CONCLUSION  In participants who have no clinical evidence of vascular disease, ASPIRIN reduces the risk for MYOCARDIAL INFARCTION but does not reduce the risk for stroke or vascular death.",MYOCARDIAL INFARCTION,ASPIRIN
724352453,5/21/2015 10:11:32,1640222675,5/21/2015 10:11:19,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],reduces,N/A,108,79,-1,128,86,TWrex-cause,804440-FS1,"CONCLUSION  In participants who have no clinical evidence of vascular disease, ASPIRIN reduces the risk for MYOCARDIAL INFARCTION but does not reduce the risk for stroke or vascular death.",MYOCARDIAL INFARCTION,ASPIRIN
724352453,5/21/2015 10:23:31,1640228590,5/21/2015 10:22:28,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PREVENTS],[PREVENTS],reduces the risk for,N/A,108,79,-1,128,86,TWrex-cause,804440-FS1,"CONCLUSION  In participants who have no clinical evidence of vascular disease, ASPIRIN reduces the risk for MYOCARDIAL INFARCTION but does not reduce the risk for stroke or vascular death.",MYOCARDIAL INFARCTION,ASPIRIN
724352453,5/21/2015 10:24:21,1640228907,5/21/2015 10:24:01,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[CAUSES],[CAUSES],MYOCARDIAL INFARCTION,none,108,79,-1,128,86,TWrex-cause,804440-FS1,"CONCLUSION  In participants who have no clinical evidence of vascular disease, ASPIRIN reduces the risk for MYOCARDIAL INFARCTION but does not reduce the risk for stroke or vascular death.",MYOCARDIAL INFARCTION,ASPIRIN
724352454,5/21/2015 09:02:38,1640188397,5/21/2015 09:02:12,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[NONE],[NONE],N/A,TWO TERMS ARE UNRELATED.,128,75,-1,149,107,TWrex-cause,803197-FS1,"HRT is contraindicated in women who smoke or in women with a history of an ESTROGEN DEPENDENT BREAST CANCER endometrial cancer, THROMBOEMBOLIC DISEASE acute liver disease, and vaginal bleeding of unknown cause.",THROMBOEMBOLIC DISEASE,ESTROGEN DEPENDENT BREAST CANCER
724352454,5/21/2015 09:20:12,1640197282,5/21/2015 09:19:39,false,neodev,1.0,15848372,AUS,02,Jannali,14.200.59.55,[OTHER],[OTHER],and,N/A,128,75,-1,149,107,TWrex-cause,803197-FS1,"HRT is contraindicated in women who smoke or in women with a history of an ESTROGEN DEPENDENT BREAST CANCER endometrial cancer, THROMBOEMBOLIC DISEASE acute liver disease, and vaginal bleeding of unknown cause.",THROMBOEMBOLIC DISEASE,ESTROGEN DEPENDENT BREAST CANCER
724352454,5/21/2015 09:40:05,1640207147,5/21/2015 09:39:50,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[SYMPTOM],[SYMPTOM],"disease,",N/A,128,75,-1,149,107,TWrex-cause,803197-FS1,"HRT is contraindicated in women who smoke or in women with a history of an ESTROGEN DEPENDENT BREAST CANCER endometrial cancer, THROMBOEMBOLIC DISEASE acute liver disease, and vaginal bleeding of unknown cause.",THROMBOEMBOLIC DISEASE,ESTROGEN DEPENDENT BREAST CANCER
724352454,5/21/2015 09:49:38,1640211743,5/21/2015 09:49:26,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[SYMPTOM],[SYMPTOM],"liver disease,",N/A,128,75,-1,149,107,TWrex-cause,803197-FS1,"HRT is contraindicated in women who smoke or in women with a history of an ESTROGEN DEPENDENT BREAST CANCER endometrial cancer, THROMBOEMBOLIC DISEASE acute liver disease, and vaginal bleeding of unknown cause.",THROMBOEMBOLIC DISEASE,ESTROGEN DEPENDENT BREAST CANCER
724352454,5/21/2015 10:18:21,1640226069,5/21/2015 10:18:04,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[CAUSES],[CAUSES],cause.,N/A,128,75,-1,149,107,TWrex-cause,803197-FS1,"HRT is contraindicated in women who smoke or in women with a history of an ESTROGEN DEPENDENT BREAST CANCER endometrial cancer, THROMBOEMBOLIC DISEASE acute liver disease, and vaginal bleeding of unknown cause.",THROMBOEMBOLIC DISEASE,ESTROGEN DEPENDENT BREAST CANCER
724352454,5/21/2015 10:27:08,1640230048,5/21/2015 10:26:17,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ESTROGEN DEPENDENT BREAST CANCER THROMBOEMBOLIC DISEASE,N/A,128,75,-1,149,107,TWrex-cause,803197-FS1,"HRT is contraindicated in women who smoke or in women with a history of an ESTROGEN DEPENDENT BREAST CANCER endometrial cancer, THROMBOEMBOLIC DISEASE acute liver disease, and vaginal bleeding of unknown cause.",THROMBOEMBOLIC DISEASE,ESTROGEN DEPENDENT BREAST CANCER
724352454,5/21/2015 10:31:12,1640231911,5/21/2015 10:30:57,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],THROMBOEMBOLIC DISEASE,none,128,75,-1,149,107,TWrex-cause,803197-FS1,"HRT is contraindicated in women who smoke or in women with a history of an ESTROGEN DEPENDENT BREAST CANCER endometrial cancer, THROMBOEMBOLIC DISEASE acute liver disease, and vaginal bleeding of unknown cause.",THROMBOEMBOLIC DISEASE,ESTROGEN DEPENDENT BREAST CANCER
724352454,5/21/2015 10:37:03,1640234931,5/21/2015 10:36:51,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],endometrial,N/A,128,75,-1,149,107,TWrex-cause,803197-FS1,"HRT is contraindicated in women who smoke or in women with a history of an ESTROGEN DEPENDENT BREAST CANCER endometrial cancer, THROMBOEMBOLIC DISEASE acute liver disease, and vaginal bleeding of unknown cause.",THROMBOEMBOLIC DISEASE,ESTROGEN DEPENDENT BREAST CANCER
724352454,5/21/2015 10:46:19,1640239775,5/21/2015 10:45:52,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[NONE],[NONE],n/a,different conditions are listed,128,75,-1,149,107,TWrex-cause,803197-FS1,"HRT is contraindicated in women who smoke or in women with a history of an ESTROGEN DEPENDENT BREAST CANCER endometrial cancer, THROMBOEMBOLIC DISEASE acute liver disease, and vaginal bleeding of unknown cause.",THROMBOEMBOLIC DISEASE,ESTROGEN DEPENDENT BREAST CANCER
724352454,5/21/2015 10:56:32,1640245033,5/21/2015 10:55:56,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated in,N/A,128,75,-1,149,107,TWrex-cause,803197-FS1,"HRT is contraindicated in women who smoke or in women with a history of an ESTROGEN DEPENDENT BREAST CANCER endometrial cancer, THROMBOEMBOLIC DISEASE acute liver disease, and vaginal bleeding of unknown cause.",THROMBOEMBOLIC DISEASE,ESTROGEN DEPENDENT BREAST CANCER
724352454,5/21/2015 10:57:34,1640245530,5/21/2015 10:56:51,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],history of,N/A,128,75,-1,149,107,TWrex-cause,803197-FS1,"HRT is contraindicated in women who smoke or in women with a history of an ESTROGEN DEPENDENT BREAST CANCER endometrial cancer, THROMBOEMBOLIC DISEASE acute liver disease, and vaginal bleeding of unknown cause.",THROMBOEMBOLIC DISEASE,ESTROGEN DEPENDENT BREAST CANCER
724352454,5/21/2015 11:00:06,1640246805,5/21/2015 10:59:28,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated,n/a,128,75,-1,149,107,TWrex-cause,803197-FS1,"HRT is contraindicated in women who smoke or in women with a history of an ESTROGEN DEPENDENT BREAST CANCER endometrial cancer, THROMBOEMBOLIC DISEASE acute liver disease, and vaginal bleeding of unknown cause.",THROMBOEMBOLIC DISEASE,ESTROGEN DEPENDENT BREAST CANCER
724352454,5/21/2015 11:17:16,1640254111,5/21/2015 11:17:05,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[CAUSES],[CAUSES],cause.,N/A,128,75,-1,149,107,TWrex-cause,803197-FS1,"HRT is contraindicated in women who smoke or in women with a history of an ESTROGEN DEPENDENT BREAST CANCER endometrial cancer, THROMBOEMBOLIC DISEASE acute liver disease, and vaginal bleeding of unknown cause.",THROMBOEMBOLIC DISEASE,ESTROGEN DEPENDENT BREAST CANCER
724352454,5/21/2015 11:32:00,1640260456,5/21/2015 11:31:07,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],history and,n/a,128,75,-1,149,107,TWrex-cause,803197-FS1,"HRT is contraindicated in women who smoke or in women with a history of an ESTROGEN DEPENDENT BREAST CANCER endometrial cancer, THROMBOEMBOLIC DISEASE acute liver disease, and vaginal bleeding of unknown cause.",THROMBOEMBOLIC DISEASE,ESTROGEN DEPENDENT BREAST CANCER
724352454,5/21/2015 11:35:10,1640261780,5/21/2015 11:34:30,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,[NONE],[NONE],n/a,n/a,128,75,-1,149,107,TWrex-cause,803197-FS1,"HRT is contraindicated in women who smoke or in women with a history of an ESTROGEN DEPENDENT BREAST CANCER endometrial cancer, THROMBOEMBOLIC DISEASE acute liver disease, and vaginal bleeding of unknown cause.",THROMBOEMBOLIC DISEASE,ESTROGEN DEPENDENT BREAST CANCER
724352455,5/21/2015 08:57:49,1640185843,5/21/2015 08:57:16,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,[CONTRAINDICATES],[CONTRAINDICATES],reported,Contraindications,157,101,-1,184,112,TWrex-cause,803991-FS1,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of PROPRANOLOL during pregnancy, labor, and delivery for a SUPRAVENTRICULAR TACHYCARDIA",SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL
724352455,5/21/2015 08:59:37,1640186748,5/21/2015 08:58:59,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[TREATS],[TREATS],"received during pregnancy, for a",n/a,157,101,-1,184,112,TWrex-cause,803991-FS1,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of PROPRANOLOL during pregnancy, labor, and delivery for a SUPRAVENTRICULAR TACHYCARDIA",SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL
724352455,5/21/2015 09:03:51,1640189001,5/21/2015 09:03:00,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of PROPRANOLOL during pregnancy, labor, and delivery for a SUPRAVENTRICULAR TACHYCARDIA",n/a,157,101,-1,184,112,TWrex-cause,803991-FS1,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of PROPRANOLOL during pregnancy, labor, and delivery for a SUPRAVENTRICULAR TACHYCARDIA",SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL
724352455,5/21/2015 09:15:49,1640195206,5/21/2015 09:15:12,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[NONE],[NONE],N/A,No clear relation.,157,101,-1,184,112,TWrex-cause,803991-FS1,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of PROPRANOLOL during pregnancy, labor, and delivery for a SUPRAVENTRICULAR TACHYCARDIA",SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL
724352455,5/21/2015 09:17:32,1640196086,5/21/2015 09:16:59,false,neodev,1.0,15848372,AUS,02,Jannali,14.200.59.55,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],received for,N/A,157,101,-1,184,112,TWrex-cause,803991-FS1,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of PROPRANOLOL during pregnancy, labor, and delivery for a SUPRAVENTRICULAR TACHYCARDIA",SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL
724352455,5/21/2015 09:36:59,1640205702,5/21/2015 09:36:46,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[SYMPTOM],[SYMPTOM],delivery,N/A,157,101,-1,184,112,TWrex-cause,803991-FS1,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of PROPRANOLOL during pregnancy, labor, and delivery for a SUPRAVENTRICULAR TACHYCARDIA",SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL
724352455,5/21/2015 09:48:03,1640210942,5/21/2015 09:47:51,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[SIDE_EFFECT],[SIDE_EFFECT],during,N/A,157,101,-1,184,112,TWrex-cause,803991-FS1,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of PROPRANOLOL during pregnancy, labor, and delivery for a SUPRAVENTRICULAR TACHYCARDIA",SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL
724352455,5/21/2015 10:16:24,1640225039,5/21/2015 10:16:08,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[CAUSES],[CAUSES],delivery,N/A,157,101,-1,184,112,TWrex-cause,803991-FS1,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of PROPRANOLOL during pregnancy, labor, and delivery for a SUPRAVENTRICULAR TACHYCARDIA",SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL
724352455,5/21/2015 10:22:14,1640228021,5/21/2015 10:20:40,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],PROPRANOLOL for a SUPRAVENTRICULAR TACHYCARDIA,N/A,157,101,-1,184,112,TWrex-cause,803991-FS1,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of PROPRANOLOL during pregnancy, labor, and delivery for a SUPRAVENTRICULAR TACHYCARDIA",SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL
724352455,5/21/2015 10:29:16,1640231155,5/21/2015 10:28:56,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],SUPRAVENTRICULAR TACHYCARDIA,none,157,101,-1,184,112,TWrex-cause,803991-FS1,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of PROPRANOLOL during pregnancy, labor, and delivery for a SUPRAVENTRICULAR TACHYCARDIA",SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL
724352455,5/21/2015 10:33:12,1640232978,5/21/2015 10:32:57,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[ASSOCIATED_WITH],[ASSOCIATED_WITH],delivery,N/A,157,101,-1,184,112,TWrex-cause,803991-FS1,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of PROPRANOLOL during pregnancy, labor, and delivery for a SUPRAVENTRICULAR TACHYCARDIA",SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL
724352455,5/21/2015 10:43:02,1640237987,5/21/2015 10:42:42,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],received for,n/a,157,101,-1,184,112,TWrex-cause,803991-FS1,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of PROPRANOLOL during pregnancy, labor, and delivery for a SUPRAVENTRICULAR TACHYCARDIA",SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL
724352455,5/21/2015 10:51:42,1640242736,5/21/2015 10:50:34,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],received 160 mg of PROPRANOLOL,N/A,157,101,-1,184,112,TWrex-cause,803991-FS1,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of PROPRANOLOL during pregnancy, labor, and delivery for a SUPRAVENTRICULAR TACHYCARDIA",SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL
724352455,5/21/2015 10:51:46,1640242777,5/21/2015 10:50:49,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],received for a,N/A,157,101,-1,184,112,TWrex-cause,803991-FS1,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of PROPRANOLOL during pregnancy, labor, and delivery for a SUPRAVENTRICULAR TACHYCARDIA",SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL
724352455,5/21/2015 10:52:53,1640243243,5/21/2015 10:51:26,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[SIDE_EFFECT] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SIDE_EFFECT]",Hypoglycemia respiratory depression were reported received,n/a,157,101,-1,184,112,TWrex-cause,803991-FS1,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of PROPRANOLOL during pregnancy, labor, and delivery for a SUPRAVENTRICULAR TACHYCARDIA",SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL
724352456,5/21/2015 06:59:18,1640122880,5/21/2015 06:58:58,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,[TREATS],[TREATS],alRIFAPENTINE treating PULMONARY TUBERCULOSIS,n/a,93,29,-1,114,40,TWrex-cause,800362-FS1,"Tam CM, Chan SL, Lam CW et alRIFAPENTINE and isoniazid in the continuation phase of treating PULMONARY TUBERCULOSIS",PULMONARY TUBERCULOSIS,RIFAPENTINE
724352456,5/21/2015 07:04:21,1640125364,5/21/2015 07:04:03,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treating,N/A,93,29,-1,114,40,TWrex-cause,800362-FS1,"Tam CM, Chan SL, Lam CW et alRIFAPENTINE and isoniazid in the continuation phase of treating PULMONARY TUBERCULOSIS",PULMONARY TUBERCULOSIS,RIFAPENTINE
724352456,5/21/2015 07:08:31,1640127683,5/21/2015 07:08:20,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treating,N/A,93,29,-1,114,40,TWrex-cause,800362-FS1,"Tam CM, Chan SL, Lam CW et alRIFAPENTINE and isoniazid in the continuation phase of treating PULMONARY TUBERCULOSIS",PULMONARY TUBERCULOSIS,RIFAPENTINE
724352456,5/21/2015 07:10:13,1640128640,5/21/2015 07:09:49,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF],[PART_OF],of,N/A,93,29,-1,114,40,TWrex-cause,800362-FS1,"Tam CM, Chan SL, Lam CW et alRIFAPENTINE and isoniazid in the continuation phase of treating PULMONARY TUBERCULOSIS",PULMONARY TUBERCULOSIS,RIFAPENTINE
724352456,5/21/2015 07:18:31,1640133208,5/21/2015 07:18:07,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treating,N/A,93,29,-1,114,40,TWrex-cause,800362-FS1,"Tam CM, Chan SL, Lam CW et alRIFAPENTINE and isoniazid in the continuation phase of treating PULMONARY TUBERCULOSIS",PULMONARY TUBERCULOSIS,RIFAPENTINE
724352456,5/21/2015 07:20:27,1640134407,5/21/2015 07:19:47,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],treating,N/A,93,29,-1,114,40,TWrex-cause,800362-FS1,"Tam CM, Chan SL, Lam CW et alRIFAPENTINE and isoniazid in the continuation phase of treating PULMONARY TUBERCULOSIS",PULMONARY TUBERCULOSIS,RIFAPENTINE
724352456,5/21/2015 07:32:55,1640140940,5/21/2015 07:32:27,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF],[PART_OF],of,N/A,93,29,-1,114,40,TWrex-cause,800362-FS1,"Tam CM, Chan SL, Lam CW et alRIFAPENTINE and isoniazid in the continuation phase of treating PULMONARY TUBERCULOSIS",PULMONARY TUBERCULOSIS,RIFAPENTINE
724352456,5/21/2015 07:35:34,1640142310,5/21/2015 07:35:18,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],treating,N/A,93,29,-1,114,40,TWrex-cause,800362-FS1,"Tam CM, Chan SL, Lam CW et alRIFAPENTINE and isoniazid in the continuation phase of treating PULMONARY TUBERCULOSIS",PULMONARY TUBERCULOSIS,RIFAPENTINE
724352456,5/21/2015 07:38:40,1640143902,5/21/2015 07:38:11,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treating,n/a,93,29,-1,114,40,TWrex-cause,800362-FS1,"Tam CM, Chan SL, Lam CW et alRIFAPENTINE and isoniazid in the continuation phase of treating PULMONARY TUBERCULOSIS",PULMONARY TUBERCULOSIS,RIFAPENTINE
724352456,5/21/2015 07:52:48,1640151474,5/21/2015 07:52:30,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF],[PART_OF],of,N/A,93,29,-1,114,40,TWrex-cause,800362-FS1,"Tam CM, Chan SL, Lam CW et alRIFAPENTINE and isoniazid in the continuation phase of treating PULMONARY TUBERCULOSIS",PULMONARY TUBERCULOSIS,RIFAPENTINE
724352456,5/21/2015 07:53:40,1640152052,5/21/2015 07:53:22,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],treating,N/A,93,29,-1,114,40,TWrex-cause,800362-FS1,"Tam CM, Chan SL, Lam CW et alRIFAPENTINE and isoniazid in the continuation phase of treating PULMONARY TUBERCULOSIS",PULMONARY TUBERCULOSIS,RIFAPENTINE
724352456,5/21/2015 07:57:16,1640153887,5/21/2015 07:57:00,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,[TREATS],[TREATS],treating,-,93,29,-1,114,40,TWrex-cause,800362-FS1,"Tam CM, Chan SL, Lam CW et alRIFAPENTINE and isoniazid in the continuation phase of treating PULMONARY TUBERCULOSIS",PULMONARY TUBERCULOSIS,RIFAPENTINE
724352456,5/21/2015 08:11:45,1640161583,5/21/2015 08:11:26,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[PART_OF],[PART_OF],of,N/A,93,29,-1,114,40,TWrex-cause,800362-FS1,"Tam CM, Chan SL, Lam CW et alRIFAPENTINE and isoniazid in the continuation phase of treating PULMONARY TUBERCULOSIS",PULMONARY TUBERCULOSIS,RIFAPENTINE
724352456,5/21/2015 08:19:22,1640165799,5/21/2015 08:18:49,false,clixsense,1.0,12843982,AUS,08,Perth,180.216.79.226,[TREATS],[TREATS],alRIFAPENTINE treating PULMONARY TUBERCULOSIS,N/A,93,29,-1,114,40,TWrex-cause,800362-FS1,"Tam CM, Chan SL, Lam CW et alRIFAPENTINE and isoniazid in the continuation phase of treating PULMONARY TUBERCULOSIS",PULMONARY TUBERCULOSIS,RIFAPENTINE
724352456,5/21/2015 08:23:36,1640168075,5/21/2015 08:23:07,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[TREATS],[TREATS],alRIFAPENTINE treating PULMONARY TUBERCULOSIS,n/a,93,29,-1,114,40,TWrex-cause,800362-FS1,"Tam CM, Chan SL, Lam CW et alRIFAPENTINE and isoniazid in the continuation phase of treating PULMONARY TUBERCULOSIS",PULMONARY TUBERCULOSIS,RIFAPENTINE
724352457,5/21/2015 07:04:45,1640125574,5/21/2015 07:04:16,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,[OTHER],[OTHER],with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE,n/a,75,18,1,84,43,TWrex-cause,813035-FS1,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA
724352457,5/21/2015 07:12:11,1640129666,5/21/2015 07:11:53,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],dosage,N/A,75,18,1,84,43,TWrex-cause,813035-FS1,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA
724352457,5/21/2015 07:13:39,1640130473,5/21/2015 07:12:38,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[SYMPTOM],[SYMPTOM],who has,N/A,75,18,1,84,43,TWrex-cause,813035-FS1,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA
724352457,5/21/2015 07:17:55,1640132826,5/21/2015 07:17:23,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[ASSOCIATED_WITH] [IS_A] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]",or with,N/A,75,18,1,84,43,TWrex-cause,813035-FS1,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA
724352457,5/21/2015 07:29:03,1640138813,5/21/2015 07:28:04,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[ASSOCIATED_WITH],[ASSOCIATED_WITH],who has,N/A,75,18,1,84,43,TWrex-cause,813035-FS1,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA
724352457,5/21/2015 07:30:33,1640139656,5/21/2015 07:29:49,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[PART_OF] [MANIFESTATION],"[MANIFESTATION]
[PART_OF]",who has clinically significant,N/A,75,18,1,84,43,TWrex-cause,813035-FS1,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA
724352457,5/21/2015 07:40:54,1640145178,5/21/2015 07:40:10,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG] [IS_A] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",a with or of with with,N/A,75,18,1,84,43,TWrex-cause,813035-FS1,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA
724352457,5/21/2015 07:42:50,1640146096,5/21/2015 07:42:08,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],who has clinically significant,N/A,75,18,1,84,43,TWrex-cause,813035-FS1,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA
724352457,5/21/2015 07:44:09,1640146838,5/21/2015 07:43:49,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],who has,n/a,75,18,1,84,43,TWrex-cause,813035-FS1,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA
724352457,5/21/2015 07:59:51,1640155298,5/21/2015 07:59:19,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [ASSOCIATED_WITH] [PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",a with or of with,N/A,75,18,1,84,43,TWrex-cause,813035-FS1,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA
724352457,5/21/2015 08:02:19,1640156418,5/21/2015 08:01:47,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[MANIFESTATION],[MANIFESTATION],has,N/A,75,18,1,84,43,TWrex-cause,813035-FS1,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA
724352457,5/21/2015 08:09:57,1640160555,5/21/2015 08:08:55,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,[SYMPTOM],[SYMPTOM],who has,-,75,18,1,84,43,TWrex-cause,813035-FS1,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA
724352457,5/21/2015 08:31:30,1640172367,5/21/2015 08:31:04,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[SYMPTOM],[SYMPTOM],ESSENTIAL THROMBOCYTHEMIA who has HEMORRHAGE,n/a,75,18,1,84,43,TWrex-cause,813035-FS1,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA
724352457,5/21/2015 08:38:16,1640176094,5/21/2015 08:37:07,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[ASSOCIATED_WITH] [OTHER],"[ASSOCIATED_WITH]
[OTHER]",In patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE,n/a,75,18,1,84,43,TWrex-cause,813035-FS1,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA
724352457,5/21/2015 08:41:53,1640177749,5/21/2015 08:41:24,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,Associated with,75,18,1,84,43,TWrex-cause,813035-FS1,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA
724352458,5/21/2015 10:32:43,1640232746,5/21/2015 10:32:27,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[CAUSES],[CAUSES],BLOCK PC,none,104,64,1,108,72,TWrex-cause,812740-FS1,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, BLOCK PC et al. Unexplained in hospital FEVER following cardiac surgery.",FEVER,BLOCK PC
724352458,5/21/2015 10:38:30,1640235586,5/21/2015 10:38:06,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[OTHER],[OTHER],Unexplained,N/A,104,64,1,108,72,TWrex-cause,812740-FS1,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, BLOCK PC et al. Unexplained in hospital FEVER following cardiac surgery.",FEVER,BLOCK PC
724352458,5/21/2015 10:48:26,1640240890,5/21/2015 10:47:39,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[NONE],[NONE],n/a,"BLOCK is an author, I believe",104,64,1,108,72,TWrex-cause,812740-FS1,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, BLOCK PC et al. Unexplained in hospital FEVER following cardiac surgery.",FEVER,BLOCK PC
724352458,5/21/2015 11:01:59,1640247628,5/21/2015 11:00:04,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[NONE],[NONE],N/A,The two words are unrelated.,104,64,1,108,72,TWrex-cause,812740-FS1,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, BLOCK PC et al. Unexplained in hospital FEVER following cardiac surgery.",FEVER,BLOCK PC
724352458,5/21/2015 11:04:01,1640248531,5/21/2015 11:03:15,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[NONE],[NONE],N/A,BLOCK PC is a name,104,64,1,108,72,TWrex-cause,812740-FS1,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, BLOCK PC et al. Unexplained in hospital FEVER following cardiac surgery.",FEVER,BLOCK PC
724352458,5/21/2015 11:07:35,1640249960,5/21/2015 11:05:49,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[SYMPTOM] [IS_A] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]
[IS_A]",Unexplained FEVER,n/a,104,64,1,108,72,TWrex-cause,812740-FS1,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, BLOCK PC et al. Unexplained in hospital FEVER following cardiac surgery.",FEVER,BLOCK PC
724352458,5/21/2015 11:18:38,1640254712,5/21/2015 11:18:20,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[OTHER],[OTHER],Unexplained,N/A,104,64,1,108,72,TWrex-cause,812740-FS1,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, BLOCK PC et al. Unexplained in hospital FEVER following cardiac surgery.",FEVER,BLOCK PC
724352458,5/21/2015 11:33:47,1640261254,5/21/2015 11:33:19,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],in,n/a,104,64,1,108,72,TWrex-cause,812740-FS1,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, BLOCK PC et al. Unexplained in hospital FEVER following cardiac surgery.",FEVER,BLOCK PC
724352458,5/21/2015 11:41:08,1640264660,5/21/2015 11:39:47,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[OTHER],[OTHER],Unexplained in hospital,n/a,104,64,1,108,72,TWrex-cause,812740-FS1,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, BLOCK PC et al. Unexplained in hospital FEVER following cardiac surgery.",FEVER,BLOCK PC
724352458,5/21/2015 11:45:05,1640266671,5/21/2015 11:44:44,false,prodege,1.0,12656479,CAN,NB,Fredericton,198.164.157.90,[CAUSES],[CAUSES],Unexplained,N/A,104,64,1,108,72,TWrex-cause,812740-FS1,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, BLOCK PC et al. Unexplained in hospital FEVER following cardiac surgery.",FEVER,BLOCK PC
724352458,5/21/2015 12:12:10,1640278494,5/21/2015 12:11:08,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[OTHER],[OTHER],following,N/A,104,64,1,108,72,TWrex-cause,812740-FS1,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, BLOCK PC et al. Unexplained in hospital FEVER following cardiac surgery.",FEVER,BLOCK PC
724352458,5/21/2015 12:29:03,1640286311,5/21/2015 12:28:02,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[NONE],[NONE],N/A,there was none related,104,64,1,108,72,TWrex-cause,812740-FS1,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, BLOCK PC et al. Unexplained in hospital FEVER following cardiac surgery.",FEVER,BLOCK PC
724352458,5/21/2015 12:39:03,1640290560,5/21/2015 12:38:53,false,neodev,1.0,31789301,CAN,QC,Montréal,192.99.6.125,[NONE],[NONE],no,no,104,64,1,108,72,TWrex-cause,812740-FS1,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, BLOCK PC et al. Unexplained in hospital FEVER following cardiac surgery.",FEVER,BLOCK PC
724352458,5/21/2015 12:57:25,1640298335,5/21/2015 12:57:06,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,[NONE],[NONE],n/a,n/a,104,64,1,108,72,TWrex-cause,812740-FS1,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, BLOCK PC et al. Unexplained in hospital FEVER following cardiac surgery.",FEVER,BLOCK PC
724352458,5/21/2015 13:07:17,1640302410,5/21/2015 13:06:27,false,clixsense,1.0,6574449,USA,"","",216.216.68.85,[OTHER],[OTHER],BLOCK PC FEVER following cardiac surgery.,na,104,64,1,108,72,TWrex-cause,812740-FS1,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, BLOCK PC et al. Unexplained in hospital FEVER following cardiac surgery.",FEVER,BLOCK PC
724352459,5/21/2015 07:01:00,1640123766,5/21/2015 07:00:34,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],MUSCLE CONTRACTIONS shows RAGGED RED FIBERS,n/a,112,194,1,170,211,TWrex-cause,813797-FS1,"Myoclonic epilepsy with ragged red fibers (MERRF):  This is a progressive disease characterized by uncontrolled MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES), dementia, ataxia and myopathy, which shows RAGGED RED FIBERS (indicating mitochondrial proliferation) with specialized stains when biopsied.",MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES),RAGGED RED FIBERS
724352459,5/21/2015 07:07:57,1640127369,5/21/2015 07:06:55,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[MANIFESTATION],[MANIFESTATION],which shows,N/A,112,194,1,170,211,TWrex-cause,813797-FS1,"Myoclonic epilepsy with ragged red fibers (MERRF):  This is a progressive disease characterized by uncontrolled MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES), dementia, ataxia and myopathy, which shows RAGGED RED FIBERS (indicating mitochondrial proliferation) with specialized stains when biopsied.",MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES),RAGGED RED FIBERS
724352459,5/21/2015 07:09:37,1640128296,5/21/2015 07:09:19,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],shows,N/A,112,194,1,170,211,TWrex-cause,813797-FS1,"Myoclonic epilepsy with ragged red fibers (MERRF):  This is a progressive disease characterized by uncontrolled MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES), dementia, ataxia and myopathy, which shows RAGGED RED FIBERS (indicating mitochondrial proliferation) with specialized stains when biopsied.",MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES),RAGGED RED FIBERS
724352459,5/21/2015 07:12:41,1640130005,5/21/2015 07:12:06,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]",is a by,N/A,112,194,1,170,211,TWrex-cause,813797-FS1,"Myoclonic epilepsy with ragged red fibers (MERRF):  This is a progressive disease characterized by uncontrolled MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES), dementia, ataxia and myopathy, which shows RAGGED RED FIBERS (indicating mitochondrial proliferation) with specialized stains when biopsied.",MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES),RAGGED RED FIBERS
724352459,5/21/2015 07:21:31,1640134848,5/21/2015 07:20:14,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[MANIFESTATION],[MANIFESTATION],which shows,N/A,112,194,1,170,211,TWrex-cause,813797-FS1,"Myoclonic epilepsy with ragged red fibers (MERRF):  This is a progressive disease characterized by uncontrolled MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES), dementia, ataxia and myopathy, which shows RAGGED RED FIBERS (indicating mitochondrial proliferation) with specialized stains when biopsied.",MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES),RAGGED RED FIBERS
724352459,5/21/2015 07:24:08,1640136318,5/21/2015 07:23:20,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[NONE],[NONE],N/A,Unrelated.,112,194,1,170,211,TWrex-cause,813797-FS1,"Myoclonic epilepsy with ragged red fibers (MERRF):  This is a progressive disease characterized by uncontrolled MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES), dementia, ataxia and myopathy, which shows RAGGED RED FIBERS (indicating mitochondrial proliferation) with specialized stains when biopsied.",MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES),RAGGED RED FIBERS
724352459,5/21/2015 07:35:26,1640142256,5/21/2015 07:34:52,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[ASSOCIATED_WITH] [IS_A],"[ASSOCIATED_WITH]
[IS_A]",with is a with,N/A,112,194,1,170,211,TWrex-cause,813797-FS1,"Myoclonic epilepsy with ragged red fibers (MERRF):  This is a progressive disease characterized by uncontrolled MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES), dementia, ataxia and myopathy, which shows RAGGED RED FIBERS (indicating mitochondrial proliferation) with specialized stains when biopsied.",MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES),RAGGED RED FIBERS
724352459,5/21/2015 07:37:33,1640143319,5/21/2015 07:37:12,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[SYMPTOM],[SYMPTOM],which shows,N/A,112,194,1,170,211,TWrex-cause,813797-FS1,"Myoclonic epilepsy with ragged red fibers (MERRF):  This is a progressive disease characterized by uncontrolled MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES), dementia, ataxia and myopathy, which shows RAGGED RED FIBERS (indicating mitochondrial proliferation) with specialized stains when biopsied.",MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES),RAGGED RED FIBERS
724352459,5/21/2015 07:40:40,1640145021,5/21/2015 07:40:22,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PART_OF],[PART_OF],shows,n/a,112,194,1,170,211,TWrex-cause,813797-FS1,"Myoclonic epilepsy with ragged red fibers (MERRF):  This is a progressive disease characterized by uncontrolled MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES), dementia, ataxia and myopathy, which shows RAGGED RED FIBERS (indicating mitochondrial proliferation) with specialized stains when biopsied.",MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES),RAGGED RED FIBERS
724352459,5/21/2015 07:55:02,1640152806,5/21/2015 07:54:39,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[ASSOCIATED_WITH] [IS_A],"[ASSOCIATED_WITH]
[IS_A]",with is a by,N/A,112,194,1,170,211,TWrex-cause,813797-FS1,"Myoclonic epilepsy with ragged red fibers (MERRF):  This is a progressive disease characterized by uncontrolled MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES), dementia, ataxia and myopathy, which shows RAGGED RED FIBERS (indicating mitochondrial proliferation) with specialized stains when biopsied.",MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES),RAGGED RED FIBERS
724352459,5/21/2015 07:56:16,1640153442,5/21/2015 07:55:05,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[MANIFESTATION],[MANIFESTATION],shows with specialized stains,N/A,112,194,1,170,211,TWrex-cause,813797-FS1,"Myoclonic epilepsy with ragged red fibers (MERRF):  This is a progressive disease characterized by uncontrolled MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES), dementia, ataxia and myopathy, which shows RAGGED RED FIBERS (indicating mitochondrial proliferation) with specialized stains when biopsied.",MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES),RAGGED RED FIBERS
724352459,5/21/2015 08:01:00,1640155811,5/21/2015 08:00:22,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,[SYMPTOM],[SYMPTOM],which shows,-,112,194,1,170,211,TWrex-cause,813797-FS1,"Myoclonic epilepsy with ragged red fibers (MERRF):  This is a progressive disease characterized by uncontrolled MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES), dementia, ataxia and myopathy, which shows RAGGED RED FIBERS (indicating mitochondrial proliferation) with specialized stains when biopsied.",MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES),RAGGED RED FIBERS
724352459,5/21/2015 08:14:12,1640162772,5/21/2015 08:13:29,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[ASSOCIATED_WITH] [IS_A] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]",with is a by with,N/A,112,194,1,170,211,TWrex-cause,813797-FS1,"Myoclonic epilepsy with ragged red fibers (MERRF):  This is a progressive disease characterized by uncontrolled MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES), dementia, ataxia and myopathy, which shows RAGGED RED FIBERS (indicating mitochondrial proliferation) with specialized stains when biopsied.",MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES),RAGGED RED FIBERS
724352459,5/21/2015 08:25:59,1640169388,5/21/2015 08:25:26,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[MANIFESTATION],[MANIFESTATION],"MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES), RAGGED RED FIBERS",n/a,112,194,1,170,211,TWrex-cause,813797-FS1,"Myoclonic epilepsy with ragged red fibers (MERRF):  This is a progressive disease characterized by uncontrolled MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES), dementia, ataxia and myopathy, which shows RAGGED RED FIBERS (indicating mitochondrial proliferation) with specialized stains when biopsied.",MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES),RAGGED RED FIBERS
724352459,5/21/2015 08:30:43,1640171967,5/21/2015 08:30:26,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[SYMPTOM],[SYMPTOM],shows,N/A,112,194,1,170,211,TWrex-cause,813797-FS1,"Myoclonic epilepsy with ragged red fibers (MERRF):  This is a progressive disease characterized by uncontrolled MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES), dementia, ataxia and myopathy, which shows RAGGED RED FIBERS (indicating mitochondrial proliferation) with specialized stains when biopsied.",MUSCLE CONTRACTIONS (MYOCLONIC SEIZURES),RAGGED RED FIBERS
724352460,5/21/2015 08:47:22,1640180643,5/21/2015 08:46:23,false,prodege,1.0,16101132,GBR,G1,Hounslow,90.207.88.197,[SIDE_EFFECT],[SIDE_EFFECT],risk,Side effect,0,65,-1,28,92,TWrex-cause,804447-FS1,"LACTATIONAL AMENORRHEA METHOD  LH    luteinizing hormone  MPA    MEDROXYPROGESTERONE ACETATE  OR    odds ratio  PE    pulmonary embolism  PID    pelvic inflammatory disease  POC    progestin only contraceptive pill  RR    risk ratio  STD    sexually transmitted disease  STI    sexually transmitted infection  TOP    termination of pregnancy, medical abortion  TSS    toxic shock syndrome  UTI    urinary tract infection  VTE    venous thromboembolism.",LACTATIONAL AMENORRHEA METHOD,MEDROXYPROGESTERONE ACETATE
724352460,5/21/2015 08:47:46,1640180849,5/21/2015 08:47:00,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[LOCATION] [DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[LOCATION]
[PART_OF]",LACTATIONAL OR of,N/A,0,65,-1,28,92,TWrex-cause,804447-FS1,"LACTATIONAL AMENORRHEA METHOD  LH    luteinizing hormone  MPA    MEDROXYPROGESTERONE ACETATE  OR    odds ratio  PE    pulmonary embolism  PID    pelvic inflammatory disease  POC    progestin only contraceptive pill  RR    risk ratio  STD    sexually transmitted disease  STI    sexually transmitted infection  TOP    termination of pregnancy, medical abortion  TSS    toxic shock syndrome  UTI    urinary tract infection  VTE    venous thromboembolism.",LACTATIONAL AMENORRHEA METHOD,MEDROXYPROGESTERONE ACETATE
724352460,5/21/2015 08:49:17,1640181475,5/21/2015 08:48:01,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION],[MANIFESTATION],"LACTATIONAL AMENORRHEA METHOD LH luteinizing hormone MPA MEDROXYPROGESTERONE ACETATE OR odds ratio PE pulmonary embolism PID pelvic inflammatory disease POC progestin only contraceptive pill RR risk ratio STD sexually transmitted disease STI sexually transmitted infection TOP termination of pregnancy, medical abortion TSS toxic shock syndrome UTI urinary tract infection VTE venous thromboembolism.",n/a,0,65,-1,28,92,TWrex-cause,804447-FS1,"LACTATIONAL AMENORRHEA METHOD  LH    luteinizing hormone  MPA    MEDROXYPROGESTERONE ACETATE  OR    odds ratio  PE    pulmonary embolism  PID    pelvic inflammatory disease  POC    progestin only contraceptive pill  RR    risk ratio  STD    sexually transmitted disease  STI    sexually transmitted infection  TOP    termination of pregnancy, medical abortion  TSS    toxic shock syndrome  UTI    urinary tract infection  VTE    venous thromboembolism.",LACTATIONAL AMENORRHEA METHOD,MEDROXYPROGESTERONE ACETATE
724352460,5/21/2015 08:49:43,1640181678,5/21/2015 08:49:03,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"LACTATIONAL AMENORRHEA METHOD LH luteinizing hormone MPA MEDROXYPROGESTERONE ACE<span id=""transmark""></span>TATE",n/a,0,65,-1,28,92,TWrex-cause,804447-FS1,"LACTATIONAL AMENORRHEA METHOD  LH    luteinizing hormone  MPA    MEDROXYPROGESTERONE ACETATE  OR    odds ratio  PE    pulmonary embolism  PID    pelvic inflammatory disease  POC    progestin only contraceptive pill  RR    risk ratio  STD    sexually transmitted disease  STI    sexually transmitted infection  TOP    termination of pregnancy, medical abortion  TSS    toxic shock syndrome  UTI    urinary tract infection  VTE    venous thromboembolism.",LACTATIONAL AMENORRHEA METHOD,MEDROXYPROGESTERONE ACETATE
724352460,5/21/2015 08:51:28,1640182684,5/21/2015 08:50:49,false,prodege,1.0,22031444,GBR,B7,Bristol,92.236.71.128,[NONE],[NONE],N/A,CAN'T SEE ANY RELATION BETWEEN THE TWO TERMS,0,65,-1,28,92,TWrex-cause,804447-FS1,"LACTATIONAL AMENORRHEA METHOD  LH    luteinizing hormone  MPA    MEDROXYPROGESTERONE ACETATE  OR    odds ratio  PE    pulmonary embolism  PID    pelvic inflammatory disease  POC    progestin only contraceptive pill  RR    risk ratio  STD    sexually transmitted disease  STI    sexually transmitted infection  TOP    termination of pregnancy, medical abortion  TSS    toxic shock syndrome  UTI    urinary tract infection  VTE    venous thromboembolism.",LACTATIONAL AMENORRHEA METHOD,MEDROXYPROGESTERONE ACETATE
724352460,5/21/2015 09:05:44,1640189900,5/21/2015 09:05:03,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[NONE],[NONE],N/A,No evident relation,0,65,-1,28,92,TWrex-cause,804447-FS1,"LACTATIONAL AMENORRHEA METHOD  LH    luteinizing hormone  MPA    MEDROXYPROGESTERONE ACETATE  OR    odds ratio  PE    pulmonary embolism  PID    pelvic inflammatory disease  POC    progestin only contraceptive pill  RR    risk ratio  STD    sexually transmitted disease  STI    sexually transmitted infection  TOP    termination of pregnancy, medical abortion  TSS    toxic shock syndrome  UTI    urinary tract infection  VTE    venous thromboembolism.",LACTATIONAL AMENORRHEA METHOD,MEDROXYPROGESTERONE ACETATE
724352460,5/21/2015 09:07:04,1640190515,5/21/2015 09:06:34,false,neodev,1.0,15848372,AUS,02,Jannali,14.200.59.55,[PART_OF],[PART_OF],luteinizing hormone,N/A,0,65,-1,28,92,TWrex-cause,804447-FS1,"LACTATIONAL AMENORRHEA METHOD  LH    luteinizing hormone  MPA    MEDROXYPROGESTERONE ACETATE  OR    odds ratio  PE    pulmonary embolism  PID    pelvic inflammatory disease  POC    progestin only contraceptive pill  RR    risk ratio  STD    sexually transmitted disease  STI    sexually transmitted infection  TOP    termination of pregnancy, medical abortion  TSS    toxic shock syndrome  UTI    urinary tract infection  VTE    venous thromboembolism.",LACTATIONAL AMENORRHEA METHOD,MEDROXYPROGESTERONE ACETATE
724352460,5/21/2015 09:18:56,1640196688,5/21/2015 09:17:30,false,clixsense,1.0,28570371,NLD,"","",91.213.37.165,[TREATS],[TREATS],luteinizing,N/A,0,65,-1,28,92,TWrex-cause,804447-FS1,"LACTATIONAL AMENORRHEA METHOD  LH    luteinizing hormone  MPA    MEDROXYPROGESTERONE ACETATE  OR    odds ratio  PE    pulmonary embolism  PID    pelvic inflammatory disease  POC    progestin only contraceptive pill  RR    risk ratio  STD    sexually transmitted disease  STI    sexually transmitted infection  TOP    termination of pregnancy, medical abortion  TSS    toxic shock syndrome  UTI    urinary tract infection  VTE    venous thromboembolism.",LACTATIONAL AMENORRHEA METHOD,MEDROXYPROGESTERONE ACETATE
724352460,5/21/2015 09:24:58,1640199562,5/21/2015 09:24:15,false,neodev,1.0,31195295,GBR,"","",46.208.164.162,[NONE],[NONE],N/A,Just a list of acronyms,0,65,-1,28,92,TWrex-cause,804447-FS1,"LACTATIONAL AMENORRHEA METHOD  LH    luteinizing hormone  MPA    MEDROXYPROGESTERONE ACETATE  OR    odds ratio  PE    pulmonary embolism  PID    pelvic inflammatory disease  POC    progestin only contraceptive pill  RR    risk ratio  STD    sexually transmitted disease  STI    sexually transmitted infection  TOP    termination of pregnancy, medical abortion  TSS    toxic shock syndrome  UTI    urinary tract infection  VTE    venous thromboembolism.",LACTATIONAL AMENORRHEA METHOD,MEDROXYPROGESTERONE ACETATE
724352460,5/21/2015 09:33:08,1640203783,5/21/2015 09:32:55,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[SYMPTOM],[SYMPTOM],hormone,N/A,0,65,-1,28,92,TWrex-cause,804447-FS1,"LACTATIONAL AMENORRHEA METHOD  LH    luteinizing hormone  MPA    MEDROXYPROGESTERONE ACETATE  OR    odds ratio  PE    pulmonary embolism  PID    pelvic inflammatory disease  POC    progestin only contraceptive pill  RR    risk ratio  STD    sexually transmitted disease  STI    sexually transmitted infection  TOP    termination of pregnancy, medical abortion  TSS    toxic shock syndrome  UTI    urinary tract infection  VTE    venous thromboembolism.",LACTATIONAL AMENORRHEA METHOD,MEDROXYPROGESTERONE ACETATE
724352460,5/21/2015 09:43:59,1640209033,5/21/2015 09:43:48,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],hormone,N/A,0,65,-1,28,92,TWrex-cause,804447-FS1,"LACTATIONAL AMENORRHEA METHOD  LH    luteinizing hormone  MPA    MEDROXYPROGESTERONE ACETATE  OR    odds ratio  PE    pulmonary embolism  PID    pelvic inflammatory disease  POC    progestin only contraceptive pill  RR    risk ratio  STD    sexually transmitted disease  STI    sexually transmitted infection  TOP    termination of pregnancy, medical abortion  TSS    toxic shock syndrome  UTI    urinary tract infection  VTE    venous thromboembolism.",LACTATIONAL AMENORRHEA METHOD,MEDROXYPROGESTERONE ACETATE
724352460,5/21/2015 10:02:37,1640218356,5/21/2015 10:01:04,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],LACTATIONAL AMENORRHEA METHOD MEDROXYPROGESTERONE ACETATE,N/A,0,65,-1,28,92,TWrex-cause,804447-FS1,"LACTATIONAL AMENORRHEA METHOD  LH    luteinizing hormone  MPA    MEDROXYPROGESTERONE ACETATE  OR    odds ratio  PE    pulmonary embolism  PID    pelvic inflammatory disease  POC    progestin only contraceptive pill  RR    risk ratio  STD    sexually transmitted disease  STI    sexually transmitted infection  TOP    termination of pregnancy, medical abortion  TSS    toxic shock syndrome  UTI    urinary tract infection  VTE    venous thromboembolism.",LACTATIONAL AMENORRHEA METHOD,MEDROXYPROGESTERONE ACETATE
724352460,5/21/2015 10:11:17,1640222558,5/21/2015 10:11:01,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[SYMPTOM],[SYMPTOM],luteinizing,N/A,0,65,-1,28,92,TWrex-cause,804447-FS1,"LACTATIONAL AMENORRHEA METHOD  LH    luteinizing hormone  MPA    MEDROXYPROGESTERONE ACETATE  OR    odds ratio  PE    pulmonary embolism  PID    pelvic inflammatory disease  POC    progestin only contraceptive pill  RR    risk ratio  STD    sexually transmitted disease  STI    sexually transmitted infection  TOP    termination of pregnancy, medical abortion  TSS    toxic shock syndrome  UTI    urinary tract infection  VTE    venous thromboembolism.",LACTATIONAL AMENORRHEA METHOD,MEDROXYPROGESTERONE ACETATE
724352460,5/21/2015 10:22:25,1640228107,5/21/2015 10:19:59,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PART_OF],[PART_OF],luteinizing hormone,N/A,0,65,-1,28,92,TWrex-cause,804447-FS1,"LACTATIONAL AMENORRHEA METHOD  LH    luteinizing hormone  MPA    MEDROXYPROGESTERONE ACETATE  OR    odds ratio  PE    pulmonary embolism  PID    pelvic inflammatory disease  POC    progestin only contraceptive pill  RR    risk ratio  STD    sexually transmitted disease  STI    sexually transmitted infection  TOP    termination of pregnancy, medical abortion  TSS    toxic shock syndrome  UTI    urinary tract infection  VTE    venous thromboembolism.",LACTATIONAL AMENORRHEA METHOD,MEDROXYPROGESTERONE ACETATE
724352460,5/21/2015 10:24:00,1640228823,5/21/2015 10:23:41,false,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.12,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],LACTATIONAL AMENORRHEA METHOD,none,0,65,-1,28,92,TWrex-cause,804447-FS1,"LACTATIONAL AMENORRHEA METHOD  LH    luteinizing hormone  MPA    MEDROXYPROGESTERONE ACETATE  OR    odds ratio  PE    pulmonary embolism  PID    pelvic inflammatory disease  POC    progestin only contraceptive pill  RR    risk ratio  STD    sexually transmitted disease  STI    sexually transmitted infection  TOP    termination of pregnancy, medical abortion  TSS    toxic shock syndrome  UTI    urinary tract infection  VTE    venous thromboembolism.",LACTATIONAL AMENORRHEA METHOD,MEDROXYPROGESTERONE ACETATE
724352461,5/21/2015 07:01:35,1640124026,5/21/2015 07:01:13,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,[SYMPTOM],[SYMPTOM],PHN continuous burning DERMATOMAL PAIN,n/a,50,14,1,64,17,TWrex-cause,813039-FS1,"Patients with PHN experience a continuous burning DERMATOMAL PAIN on which brief, lancinating pains may be superimposed.",DERMATOMAL PAIN,PHN
724352461,5/21/2015 07:08:58,1640127953,5/21/2015 07:08:17,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[SYMPTOM],[SYMPTOM],experience,N/A,50,14,1,64,17,TWrex-cause,813039-FS1,"Patients with PHN experience a continuous burning DERMATOMAL PAIN on which brief, lancinating pains may be superimposed.",DERMATOMAL PAIN,PHN
724352461,5/21/2015 07:10:04,1640128538,5/21/2015 07:09:51,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],experience continuous burning,N/A,50,14,1,64,17,TWrex-cause,813039-FS1,"Patients with PHN experience a continuous burning DERMATOMAL PAIN on which brief, lancinating pains may be superimposed.",DERMATOMAL PAIN,PHN
724352461,5/21/2015 07:13:41,1640130496,5/21/2015 07:13:13,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,50,14,1,64,17,TWrex-cause,813039-FS1,"Patients with PHN experience a continuous burning DERMATOMAL PAIN on which brief, lancinating pains may be superimposed.",DERMATOMAL PAIN,PHN
724352461,5/21/2015 07:22:32,1640135447,5/21/2015 07:21:55,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",experience,N/A,50,14,1,64,17,TWrex-cause,813039-FS1,"Patients with PHN experience a continuous burning DERMATOMAL PAIN on which brief, lancinating pains may be superimposed.",DERMATOMAL PAIN,PHN
724352461,5/21/2015 07:25:17,1640136934,5/21/2015 07:24:37,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[SYMPTOM],[SYMPTOM],experience a continuous burning,N/A,50,14,1,64,17,TWrex-cause,813039-FS1,"Patients with PHN experience a continuous burning DERMATOMAL PAIN on which brief, lancinating pains may be superimposed.",DERMATOMAL PAIN,PHN
724352461,5/21/2015 07:36:29,1640142726,5/21/2015 07:36:03,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[ASSOCIATED_WITH] [IS_A],"[ASSOCIATED_WITH]
[IS_A]",with a,N/A,50,14,1,64,17,TWrex-cause,813039-FS1,"Patients with PHN experience a continuous burning DERMATOMAL PAIN on which brief, lancinating pains may be superimposed.",DERMATOMAL PAIN,PHN
724352461,5/21/2015 07:38:10,1640143737,5/21/2015 07:37:48,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[MANIFESTATION],[MANIFESTATION],experience a continuous burning,N/A,50,14,1,64,17,TWrex-cause,813039-FS1,"Patients with PHN experience a continuous burning DERMATOMAL PAIN on which brief, lancinating pains may be superimposed.",DERMATOMAL PAIN,PHN
724352461,5/21/2015 07:41:16,1640145342,5/21/2015 07:40:58,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],experience,n/a,50,14,1,64,17,TWrex-cause,813039-FS1,"Patients with PHN experience a continuous burning DERMATOMAL PAIN on which brief, lancinating pains may be superimposed.",DERMATOMAL PAIN,PHN
724352461,5/21/2015 07:55:48,1640153252,5/21/2015 07:55:24,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG] [IS_A],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]",with a be,N/A,50,14,1,64,17,TWrex-cause,813039-FS1,"Patients with PHN experience a continuous burning DERMATOMAL PAIN on which brief, lancinating pains may be superimposed.",DERMATOMAL PAIN,PHN
724352461,5/21/2015 07:56:58,1640153815,5/21/2015 07:56:37,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[SYMPTOM],[SYMPTOM],experience,N/A,50,14,1,64,17,TWrex-cause,813039-FS1,"Patients with PHN experience a continuous burning DERMATOMAL PAIN on which brief, lancinating pains may be superimposed.",DERMATOMAL PAIN,PHN
724352461,5/21/2015 08:02:49,1640156742,5/21/2015 08:02:17,false,cointasker,1.0,21783324,NLD,11,Schiedam,194.13.104.194,[SYMPTOM],[SYMPTOM],experience,-,50,14,1,64,17,TWrex-cause,813039-FS1,"Patients with PHN experience a continuous burning DERMATOMAL PAIN on which brief, lancinating pains may be superimposed.",DERMATOMAL PAIN,PHN
724352461,5/21/2015 08:14:56,1640163270,5/21/2015 08:14:36,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]",with a,N/A,50,14,1,64,17,TWrex-cause,813039-FS1,"Patients with PHN experience a continuous burning DERMATOMAL PAIN on which brief, lancinating pains may be superimposed.",DERMATOMAL PAIN,PHN
724352461,5/21/2015 08:26:41,1640169825,5/21/2015 08:26:17,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[SYMPTOM],[SYMPTOM],PHN experience burning DERMATOMAL PAIN,n/a,50,14,1,64,17,TWrex-cause,813039-FS1,"Patients with PHN experience a continuous burning DERMATOMAL PAIN on which brief, lancinating pains may be superimposed.",DERMATOMAL PAIN,PHN
724352461,5/21/2015 08:30:57,1640172123,5/21/2015 08:30:44,false,bitcoinget,1.0,30546513,GBR,G6,Hull,194.42.67.50,[CAUSES],[CAUSES],experience,N/A,50,14,1,64,17,TWrex-cause,813039-FS1,"Patients with PHN experience a continuous burning DERMATOMAL PAIN on which brief, lancinating pains may be superimposed.",DERMATOMAL PAIN,PHN
